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Abstract   
Chorionic plate (CPA) and stem villous (SVA) arteries located at the fetal and 
maternal interface of the placenta respond to stimuli including hypoxia and acidic pH 
which can be the result of an intermittent blood supply. Unlike other vascular tissue 
the placenta lacks nervous control so any response to such stimuli will be 
autoregulated by ion channels. Members of the two pore domain potassium channel 
family (K2P) the Tandem of P domains in a weak inward rectifying (TWIK) related 
potassium channel (TREK-1) and the TWIK Related acid sensitive K+ channel 
(TASK-1/3) have been shown to respond to both intracellular and extracellular pH. 
The hypothesis that there is differential expression and modulation of these candidate 
ion channels in normal pregnancy was tested. Placentae (N) were collected with 
written informed consent from healthy patients undergoing elective Caesarean section 
DW WHUPZeeks). The functional responses of resistance sized arteries P
(n) taken from the SVA and the CPA were characterised using wire myography. 
Vessels were pre-contracted with U46619 and the effect of extracellular pH was 
studied using 1M lactic acid to produce falls of 0.2 pH units over a range of pH 7.4-
6.4. The effects of a variety of ion channel modulators along with tissue oxygenation 
(20%, 5% and 2% O2) were also investigated on the vascular response of CPA and 
SVA. Western blot analysis was performed on crude CPA and SVA tissue 
homogenates with separation by 12% SDS-PAGE to quantify expression of TASK-
1/3 and TREK-1. The subcellular localisation of each ion channel was also examined 
with smooth muscle cells (SMC) cultured from the CPA and SVA by confocal 
immunofluorescence. CPA and SVA were equally positive for TASK 1/3 (N=31) and 
TREK 1 (N=40) at the protein level. SMC from CPA and SVA showed expression for 
TASK 1/3 (N=8) with an increased fluorescence stain around the peri nuclear region. 
TREK-1 (N=12) expression showed a linear organisation that closely overlapped with 
Į DFWLQ IF stain. The acidic pH stimulation triggered a biphasic relaxation that was 
repeated with each subsequent pH insult. A change from pH 7.4-7.2 produced a 29 ± 
3% (n=9) relaxation of CPA which increased to 61 ± 4% at the lowest pH of 6.4 in 
20% pO2. Similarly, altering the pH of pre-constricted SVA caused a 21 ± 2% (n=6) 
fall at pH 7.2 with a maximum relaxation of 69 ± 2% at pH 6.4 (p<0.01). Lowering 
pO2 from 20% to 5% inhibited the relaxation response seen with CPA (45 ± 3%, n=8) 
and SVA (34 ± 3%, n=6) at pH 6.4. CPA were also treated with the TREK-1 blocker 
L-methionine (1mM) which increased the relaxation to 67 ± 7% (n=6 p<0.001) at pH 
6.4. Similarly the TASK 1/3 blocker ZnCl2 (1mM) gave a maximum relaxation of 72 
± 5% (n=8 p<0.01) in 20% pO2. The TREK-1 opener riluzole demonstrated a potent 
relaxation with both CPA (75 ± 5%, n=6) and SVA (78 ± 5%, n=6) in 20% pO2. Our 
data has shown that tissue oxygenation and extracellular pH within the physiological 
range has an important role in controlling vasodilatation in the placenta. Protons are 
readily transported across the cell membrane and can activate a range of targets 
including the K2P channels. The relaxation by riluzole has not been previously 
reported and implicates a direct role for TREK-1 in controlling placental vessel 
function. However, when TREK-1 and TASK-3 channels were blocked, the response 
by CPA to lower pH was exaggerated, and reflects the complex pharmacology of pH 
on vascular function. This also suggests that K2P channel activity can be 
compensated for by other pH sensitive channels and work is currently underway to 
identify the role of other potential ion channels that may be involved in this pathway. 
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1. Introduction 
 
The profound changes that occur during pregnancy are aimed at optimising the 
physiological adaptations required for a successful pregnancy. The normal increase in 
blood flow throughout gestation is the combined result of altered vascular anatomy 
along with changes in the perfusion of both the maternal and placental circulations to 
maintain fetal growth. During pregnancy, the peripheral resistance decreases while the 
maternal cardiac output increases and the processes that bring about the changes are 
not fully understood. Crucially, it has been shown that impaired blood flow may be 
associated with placental and fetal growth dysfunction. Gaining a better insight into 
the precise nature of the external factors that can influence vascular tone may help 
towards an improved understanding of the placental vascular function and is the focus 
of my study. 
 
1.1. Maternal adaptations to pregnancy  
 
Haemodynamic changes within the maternal circulation during pregnancy has 
revealed a series of coordinated adaptations take place to accommodate the demands 
of the growing placenta and fetus. Figure 1.1-1 shows the gradual increase in blood 
plasma volume which eventually reaches a maximal increase in intravascular volume 
of 40-45% when compared to the non-pregnant state (Poston, McCarthy et al., 1995, 
Chamberlain and Broughton Pipkin, 1998). An increase in cardiac output, plasma 
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volume and erythrocyte mass are also observed which help to promote a fall in the 
haematocrit (Kaufmann, Mayhew et al., 2004). The heart rate also progressively 
increases and along with the greater stroke volume to contribute to the increased 
cardiac output also seen (Conclin, 1994, Poston, McCarthy et al., 1995, Pijnenborg, 
Vercruysse et al., 2006, Blackburn, 2007).  
 
 
Figure 1.1-1 showing the main changes in haemodynamic and blood volume that occur 
in the human maternal circulation during pregnancy. The blood volume peaks at around 
34weeks and the levels return close to non-pregnant levels post-delivery (Image obtained 
from Conclin, 1994).  
 
Although the cardiac output increases, a bigger proportionate fall in peripheral 
resistance contributes to the overall fall in blood pressure (BP). These changes are 
also brought about via the widespread release of vasodilators (see Chapter 1.6) in 
response to increased flow. The changes to peripheral resistance are most striking in 
the renal and uterine circulations which act as vital shunts to help cope with the 
increased blood volumes as 10-20% of the total cardiac output is directed to these 
vascular regions. The two main hormones oestrogen and progesterone are important 
for maintaining a successful pregnancy and have been implicated in promoting 
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changes in blood volume due to their ability to regulate the renin-angiotensin system 
(RAS). Oestrogen can increase the circulating levels of angiotensin (Ang), while 
progesterone driven sodium (Na+) loss detected at the macula densa increases renin 
synthesis and release. This results in an increase in Ang II concentrations which in 
turn stimulate aldosterone synthesis and release. This physiological change would 
increase the salt/water reabsorbtion within the renal circulation and in support of this 
view the RAS has been shown to be stimulated during the luteal phase of the 
menstrual cycle and is maintained for the duration of pregnancy (Broughton Pipkin, 
Craven et al., 1981, Symonds, 1981, Walsh, 1985). The RAS system is important for 
facilitating the retention of Na+ to meet the growth demands of the placenta and fetus 
as well as maintaining maternal blood volume. The placenta has also been shown to 
contribute to this process and is a crucial source for progesterone release (Symonds, 
1981). These separate changes all help to compensate for the rise in blood volume by 
bringing about an overall fall in peripheral resistance so as not to place huge demands 
on the maternal circulation.  
 
1.2. Maternal vascular remodelling  
 
Vascular remodelling is a process that involves structural changes to existing 
vessels and occurs amongst other states, in pregnancy. Remodelling is evident in a 
range of vascular beds but is most dramatic in the maternal uterine spiral arteries 
(SA). The process involves removal of the endothelium, disorganising the smooth 
muscle cell layer and vasodilatation. The SA with a narrow lumen are converted into 
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large vessels as the endothelium and internal elastic lamina are eventually replaced by 
placental trophoblast cells (Figure 1.2-1). In the non-pregnant state, the normal 
function of the SA is to contract during menstrual bleeding to limit the loss of blood. 
Following pregnancy, this function is altered to convert the SVA into conduit-like low 
resistance vessels to optimise the flow of blood towards the placental membranes 
(Robertson, Brosens et al., 1973, Roberts, Taylor et al., 1989, Babawale, Mobberley 
et al., 2002). Remodelling is the result of combined maternal and placental factors and 
the alteration in SA physiology seen during pregnancy, helps to bring about dilation 
and reduced contractile activity of the uterine vessels aiding the reduction in BP seen 
during pregnancy (Pijnenborg, Anthony et al., 1991, Arribas, Hillier et al., 1997).  
 
Spiral 
artery 
Decidua
Basalis
Myometrium
Invading 
trophoblasts  
Non pregnant Pregnant Post pregnancy
 
Figure 1.2-1 shows the structural transformation that occurs in the maternal uterine SA 
in response to pregnancy. The SA are a target for the invading placental trophoblast cells 
which increase the diameter of the SA by invasion and create a low resistance to blood flow 
(Image adapted from Maynard, Epstein et al., 2007).  
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Remodelling is a complex mechanism involving key factors that bring about 
the eventual disorganisation of the smooth muscle cells (SMC) and endothelium cells 
(EC) along with degradation of the extracellular matrix (ECM) by proteinases such as 
matrix metalloproteinases (MMP) (Baker and Kingdom, 2004). A key component 
identified with this process is the carefully timed increase in circulating growth 
factors including the vascular endothelial growth factor (VEGF) along with its 
receptor soluble forms like tyrosine kinase-1 (sFlt-1) (Maynard, Min et al., 2003). 
Studies have shown that circulating levels of such angiogenic factors increase during 
the first trimester at the time of SA remodelling and the significance of this lies at the 
centre of understanding the consequences of an angiogenic imbalance. Functional 
investigations have also shown that SA during pregnancy have an altered response to 
circulating contractile agents such as Ang II when compared to non-pregnant tissue 
and this change is thought to be a direct consequence of successful remodelling 
(Kaufmann, 1982, Pijnenborg, Anthony et al., 1991, Kublickiene, Kublickas et al., 
1997). This adaptation would also ensure increased volumes of blood could be 
shunted by these transformed vascular beds towards the placental structures which 
have a high demand for blood to ensure the exchange of crucial substances (Poston, 
McCarthy et al., 1995, Huppertz, 2007, Huppertz, Abe et al., 2007). The structural 
changes of the vascular bed evidently occur before implantation and are complete 
within 6-12 weeks (wks) of gestation. This adaptation is also designed to keep the 
amount of blood flowing into the uterine arteries constant regardless of changes in 
maternal blood pressure (Brosens, Robertson et al., 1972, Pijnenborg, Robertson et 
al., 1981). Interestingly only SA closest to the centre of the placental blastocyst disc 
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are altered while neighbouring vessels appear to remain unaffected. This may be 
explained by the controlled targeting of the trophoblast cells (Chapter 1.3) that target 
blood vessels in the area of the myometrium adjacent to the placental bed to possibly 
ensure maternal blood will enter the placental membranes at a high velocity 
(Robertson, Brosens et al., 1973, Pijnenborg, Anthony et al., 1991).  
 
1.3. Early placental development   
 
The maternal and fetal circulations are closely associated and early 
development of the placenta is aimed at establishing a highly vascularised tissue that 
provides a vital barrier separating the two systems (Kaufmann, 1982, Huppertz, 
2007). The two main processes that are involved include vasculogenesis, where new 
vessels are formed, and angiogenesis, which involves the branching of established 
vessels. The maternal adaptations to pregnancy are almost complete by the end of the 
1st trimester at which point maternal blood will enter the placental intervillous spaces 
(IVS) via the SA which initially begins at 8-9 wks and increases at 12wks (Brosens, 
Robertson et al., 1972, Pijnenborg, Anthony et al., 1991, Lyall, 2005, Huppertz, 
2007). Post fertilisation, the rapidly dividing ovum forms a blastocyst that becomes 
implanted into the maternal endometrial stroma (Figure 1.3-1). The outer layer of the 
blastocyst will go on to form the placental precursor cells, the trophoblast cells, which 
come into direct contact with the endometrium. The trophoblast cells form plugs to 
prevent the premature entry of highly oxygenated maternal blood, which is postulated 
to be a risk factor for early pregnancy loss (Jauniaux, Watson et al., 2000, Blackburn, 
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2007). The invasion of the trophoblast cells has been shown to trigger the remodelling 
and structural changes of SA to convert the vessels to a low resistance and high flow 
vascular region.  
 
 
Figure 1.3-1 shows the rapidly dividing ovum rapidly which forms different populations 
of trophoblast cells. The blastocyst forms the outer cell mass that comes into direct contact 
with the maternal endometrium. Image obtained from http://stages-of-pregnancy-
development.com/pregnancy-week-2/  
 
By 7-8 days the blastocyst proliferates and shows polar growth at the point of 
implantation and two important cell layers can be distinguished at this point;  
x The large cytotrophoblasts with single nuclei  
x Multi nucleated syncytiotrophoblasts which are formed from fusion of 
cytotrophoblast cells  
The developmental changes from these early cell growths to a fully 
functioning villous structure have been summarised in Figure 1.3-2 with a focus on 
the maternal interface of the placenta.  
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A. Day 6-7 B. Day 7-8 C. Day 8-9
D. Day 12-15 E. Day 15-21 F. Day 18-term
 
Figure 1.3-2 summarising the development of the human villous tree during gestation. 
A, B & C show the lacunar stage. D, E&F shows the transition from lacunar to primary, 
secondary and finally tertiary villi. The trophoblast grows in cell columns to form the basal 
segments that help to anchor the placenta. Maternal tissue has been shown in red and fetal 
tissue is blue. Endometrial endothelium (E), embryo blast (EB), cytotrophoblast (CT), 
synctytiotrophoblast (ST), extra-embryonic mesoderm (EM), chorionic plate (CP), trabeculae 
(T), maternal blood lacunae (L), trophoblast shell (TS), endometrial vessel (EV), decidua (D), 
5RKU¶V ILEULQRLG 5) 1LWDEXFK¶V ILEULQRLG 1) WURSKREODVW JLDQW FHOO * H[WUDYLOORXV
cytotrophoblast (EVT), basal plate (BP), placental bed (PB), junctional zone (J), myometrium 
(M). (Image obtained from Benirschke, Kaufmann et al., 2006).   
 
Placental villous development is supported by a range of angiogenic growth 
factors found in both the placental and maternal circulations which are carefully 
balanced at key stages. VEGF and placental like growth factor (PlGF) can be detected 
in maternal plasma at around 6wks and remain high until term (Maynard, Min et al., 
2003, Demir, Kayisli et al., 2004). The growth factors, along with the relatively 
hypoxic environment are needed for angiogenesis to drive an increase in trophoblast 
cell populations to form highly vascularised villi. The growing trophoblast cells take 
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on the phenotype of villous trees and stems that will eventually form a complex 
network of blood vessels that begin to transport blood (Kaufmann, Sen et al., 1979, 
Pijnenborg, Robertson et al., 1981, Roberts, Taylor et al., 1989, Huppertz, Abe et al., 
2007). These early outgrowths undergo extensive angiogenesis, which involves the 
branching of existing vessels, to eventually form well defined arteries, veins and 
arterioles (Huppertz, Abe et al., 2007) which carry oxygenated and deoxygenated 
blood and exchange nutrients with the maternal blood which flows in close proximity 
(Robertson, Brosens et al., 1973, Pijnenborg, Robertson et al., 1981, Roberts, Taylor 
et al., 1989, Fox, 1997, Lyall, 2006).  
The placenta is described as a low resistance system (Myatt, 1992) where 
blood pressure varies significantly and ensures a stable volume of blood is continually 
transported to the fetus (McCarthy, Woolfson et al., 1994). Pressure differences exist 
along the vascular connections and drive blood from the basal plate towards the 
chorionic plate and down the umbilical cord (Brosens, Robertson et al., 1972, 
Pijnenborg, Robertson et al., 1981, Roberts, Taylor et al., 1989, Goldenberg, Iams et 
al., 1996). The early villous trees develop to form fully functioning vessels that lack 
autonomic control and help to keep the fetus constantly perfused. At 20wks no new 
vessels are formed and instead the villi form multiple branches of mature villi which 
are continually replaced with intermediate villi for the remainder of the gestation 
period (Figure 1.3-3) (Fox, 1997, Kaufmann, Mayhew et al., 2004).  
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A. B. 
 
Figure 1.3-3 showing the villous core in more detail. A shows an actual image of a villous 
tree like structure that has been freshly isolated from the placenta. B shows the multiple 
branching villi that comprise a single villous tree. The branches can be classified according to 
their size and structure. The large central villous core (stem villi) branches laterally to form 
the intermediate villi from which the terminal villi are protruding from (Image obtained from 
Benirschke, Kaufmann et al., 2006).  
 
1.4. The term placenta  
 
The human placenta is a key component for successful mammalian 
reproduction and phylogenetic evidence has revealed that a carefully programmed 
development of different tissue layers has to occur for the tissue to perform its 
intended function during gestation (Wildman, Chen et al., 2006). During the first 
12wks the trophoblast cell mass increases to increase the surface area of the villous 
from 0.3m2 to 12.5m2 at term (Jauniaux, Watson et al., 2000, Hampl, Bibova et al., 
2002, Yung, Calabrese et al., 2008). The human placenta is classified as a 
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hemochorial, discoid placenta (Wildman, Chen et al., 2006) and weighs 480 ± 135g at 
term, with a diameter of 18cm and 2.5cm in thickness (Benirschke, Kaufmann et al., 
2006). The placenta is a highly active tissue, with its own oxygen and glucose 
demands, and these are met as a result of the carefully matched flow with the maternal 
circulation flow. As the placenta ages, signs of calcification, increased fibrin deposits, 
infarcts and syncytial knots at the branching villi are observed. This is due to the 
preparation of placental separation whereby the placenta is expelled from the uterus 
and involves shearing of the placental membranes and occurs during the third and 
final stage of delivery (Blackburn, 2007). The placenta is adapted to perform a wide 
range of physiological functions that would be fulfilled by the kidneys, lungs, 
endocrine glands as well as the gastrointestinal tracts of the fetus. A clear boundary 
can be identified within the placenta with multiple lobes on the maternal portion of 
the placenta that contain the vital villous structures. In contrast the fetal portion 
contains the large chorionic vessels which carry blood to the fetus via the umbilical 
cord (Figure 1.4-1). 
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A. View of the chorionic plate (fetal facing)
B. View of the basal plate (maternal facing). 
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Figure 1.4-1 shows a freshly isolated human term placenta. A shows the chorionic plate. 
The amnion layer has been partially peeled back to reveal the vast network of arteries and 
veins which converge towards the umbilical cord. This sample is a full term placenta (37wks) 
and areas of calcification (red arrow) can be seen which is common for a fully developed 
placenta. B shows the same placenta viewed from the basal plate. Individual cotyledons can 
be seen which encase bundles of stem villous arteries and the myometrial plugs mark the 
point where the placenta was implanted within the uterus. An intact umbilical cord along with 
the amniotic sac which once encased the fetus during pregnancy is also observed.  
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1.5. Transport across the placenta  
 
As the placenta lacks any form of autonomic control, vessel diameter is 
believed to be controlled by locally released signalling molecules that alter the action 
of cells (see Chapter 1.6.1) that make up a blood vessel (Kaufmann, 1982, Fitzgerald, 
Mayo et al., 1987, Benirschke, 1998). The placenta is well adapted for this function as 
villous trees are designed to increase the surface area for diffusion of key substances 
and the multiple branching brings the fetal vessels in close proximity to the oxygen 
rich maternal blood. Maternal blood enters the IVS at high pressure and is the main 
junction for exchange of key molecules such as hormones, growth factors, and 
antibodies, while toxins such as urea are excreted in the opposite direction (Figure 
1.5-1) (Ramsey, 1962, Pijnenborg, Robertson et al., 1981, Huppertz, 2007).  
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Figure 1.5-1 showing the cross sectional structure of the human term placenta. The 
placenta can be separated into the fetal and maternal portions which represent the different 
vascular sections of the placenta. The direction of the maternal blood as it enters the IVS is 
also shown. (Image adapted from Saunders, 2009).  
 
The placenta functions as a complete transport system where the oxygen rich 
blood is transported by the placental veins and deoxygenated blood along with waste 
by-products from the fetus are transported towards the maternal circulation, with a 
much higher oxygen content, via the arteries. The molecules that are transported from 
the rich maternal SA blood to the fetus have been summarised in Table 1.5-1. The 
main transport molecules include oxygen (O2), water (H2O), electrolytes, 
carbohydrates, lipids, peptides, vitamins, hormones, pathogens including viruses and 
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any circulating drugs. In the opposite direction, carbon dioxide (CO2), H2O, urea and 
other metabolic waste products as well as hormones synthesised by the fetal and 
placental circulations are transported from the placenta to the uterine veins.  
 
Table 1.5-1 summarising the exchange of substances across the three main transport systems 
that are established during pregnancy (Adapted from Blackburn, 2007).  
Maternal circulation Placental circulation Fetal circulation   
Amino acids 
Antibodies 
Cholesterol 
Drugs 
Fatty acids/lipids 
Glucose 
Hormones 
O2 
Viruses 
Vitamins 
        (fat & water soluble) 
Water 
  Bilirubin 
CO2 
Urea 
Uric acid 
Water 
 
The main exchange processes involve passive and energy requiring active 
transport mechanisms to successfully exchange key substances and can be 
summarised by the equation below;   
 
Diffusion = substance characteristics x surface area x concentration gradient   
/distance 
Exchange of substances occurs at the placental barrier which is made up of 5 
key cell populations (Figure 1.5-2). The placental and maternal circulations come 
into close proximity and form the main point of exchange with the maternal 
circulations but are prevented from mixing by a thin layer of synctytiotrophoblast 
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cells and the basement membrane (Kaufmann, Mayhew et al., 2004, Polin, Fox et al., 
2004). The placental exchange surface is enlarged from 5 m2 at 28wks to 12.5 m2 
shortly before delivery (Nicolaides, Economides et al., 1989, Blechner, 1993, 
Benirschke, 1998, Blackburn, 2007). Exchange of substances is mediated by flow 
while glucose is transported using active transport through specialised transporters 
found in the basement plasma membrane. Any potential disruptions in the flow of 
blood in the placenta can have adverse consequences for the circulatory system and 
limit the O2 supply to the fetus (Schneider, Danko et al., 1984, Blechner, 1993, Polin, 
Fox et al., 2004).  
 
Figure 1.5-2 showing the placental barrier which prevents the direct mixing of the two 
circulations. Any substance transferred from the maternal circulation will cross each cell 
layer before reaching the placental blood vessel. Sc, Stromal core; vct, villous 
cytotrophoblast; st, synctytiotrophoblast; fv, floating villi; is, intervillous space; av, 
anchoring villi; p, proliferative extravillous cytotrophoblast (EVCT); i, invasive EVCT; e, 
endovascular EVCT; gc, giant cells; d, decidual cells; usa, uterine spiral artery. (Image 
adapted from Handschuh et al., 2007).  
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1.6. Control of vascular tone in the placenta  
  
The placenta is devoid of neuronal connections (Prystowsky, 1961, McCarthy, 
Woolfson et al., 1994) and yet maintains the ability to regulate its own blood flow 
which remains the focus of many research studies. A range of mechanical and 
molecular factors influence the control of vessel tone for a blood vessel. In the 
placenta, a careful balance of vasoconstrictors and vasodilators work to control the 
overall perfusion pressure of the tissues (Myatt, 1992, Poston, McCarthy et al., 1995, 
Sweeney, Jones et al., 2006). Isolated blood vessels have demonstrated the ability to 
alter their diameter to respond to acute changes in the volume of blood flow (Figure 
1.6-1). This is possible as blood YHVVHOVKDYH³PHFKDQRVHQVRUV´ZKLFKGHWHFWSK\VLFDO
changes (shear stress) or increasing transmural pressure (wall stress) placed on the 
vessel wall (Bayliss, 1902, Bevan and Osher, 1972, Mulvany and Aalkjaer, 1990). 
Vascular tone is described as the event which brings about a random contraction 
which narrows the lumen diameter. The increase in physical stress on EC, either due 
to an increase in blood flow or circulating autocoids, will trigger a calcium (Ca2+) 
influx into the EC, to alter vessel tone (shown in Figure 1.6-2) (Halpern, Mulvany et 
al., 1978, Jovanovic, Grbovic et al., 1994c, Sweeney, Jones et al., 2006). 
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Figure 1.6-1 showing the structure of a generalised artery. The one cell thick EC layer is 
typically surrounded by several layers of SMC separated only by the elastic interna. The 
whole vessel is held together by the adventia which contains a mixture of connective tissue 
proteins including collagen, elastin, and glycoproteins (Image obtained from Baker and 
Kingdom, 2004).  
 
The EC is a single cell thick layer which lines the lumen of blood vessels and 
is responsible for increasing the vessel diameter and reducing the resistance to the 
flow of blood (Robertson, Schubert et al., 1993, Smit and Iyengar, 1998, Parkington, 
Tonta et al., 1999). The EC is receptive to changes in humoral and haemodynamic 
changes to release a range of factors that can influence the function of cells within the 
blood vessel (Figure 1.6-2). Contraction of a cell is the result of second messenger 
signalling cascades which respond to the entry of Ca2+. Nitric oxide (NO) released 
from the EC can diffuse to the SMC to oppose contractions via activation of adenylate 
F\FODVH WR LQFUHDVH F\FOLF JXDQRVLQH ¶¶ PRQRSKRVSKDWH F*03 6LPLODUO\ the 
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prostaglandin (PG), prostacyclin (PGI2) can increase the production of cyclic 
DGHQRVLQH¶PRQRSKRVSKDWHF$03(King, Gude et al., 1995, Boura, Leitch et al., 
1998, Smit and Iyengar, 1998).  
 
L-arginine Citrulline
Nitric oxide
Contraction
Endothelial cell
Shear stress/agonist
Intracellular Ca2+
Smooth muscle cell
Shear stress/agonist
Intracellular Ca2+
Myosin + actin  Myosin
Guanylate cyclase
GTP Cyclic GMP   
 
Figure 1.6-2 showing the cell signalling events that determine the overall contraction 
and relaxation of blood vessel SMC. NO can promote relaxation of SMC via the release of 
diffusible molecules that originate from the endothelial cell. In this instance cGMP reduces 
the intracellular Ca2+ to uncouple the myosin-actin complex. Image adapted from (Baker and 
Kingdom, 2004).  
 
The placenta has shown to possess some important differences in the vascular 
anatomy and is comprised of three main vessel types (Figure 1.6-3);  
1. Umbilical vessels ±which consist of a single large vein and two arteries which 
separate to supply each half of the placenta, 
2. Chorionic plate arteries (CPA) and veins (CPV)±radially branched at the surface 
and run in parallel to the stem villous arteries (SVA), 
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3. Multiple dividing villi- which are bathed in maternal blood and anchor the 
placenta into the basal plate.   
 
 
Figure 1.6-3 showing the main class of vessels found within the placenta. A shows the 
cross sectional structure of the umbilical cord which contains two arteries that spiral around a 
central vein. The umbilical cord forms the vital link between the fetus and the placenta. B 
shows the point of cord insertion in the chorionic plate where the CPA and CPV branch out 
across the surface of the basal plate and are clearly visible. C shows a villous tree that has 
been cleaned away from its surrounding tissue. The multiple branches increase the surface 
area for exchange with the maternal circulation.  
 
Deoxygenated blood from the fetus is transported in the two umbilical arteries 
which connect to the chorionic plate and spread out radially. The chorionic vessels 
branch extensively into the multiple small villous trees. The veins carry oxygenated 
blood back towards the fetus and the rate of flow is estimated to be 500 ml/min and is 
dependent upon the fetal heart rate. The branches of terminal villi represent the site of 
exchange for O2 and nutrients. There is an important arterial gradient that exists 
across the different vascular regions which help to maintain a low pressure system 
that offers little resistance. The most important placental vascular response is at the 
maternal facing villous arteries and veins which need to cope with the different blood 
pressure and O2 tensions of maternal blood (Myatt, 1992, Poston, McCarthy et al., 
1995, Pijnenborg, Vercruysse et al., 2006, Sweeney, Jones et al., 2006).  
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The presence of SMC within the villous tree implicates these vessels in setting 
the peripheral resistance across the placenta (Kaufmann, 1982, Tanaka, Kuwabara et 
al., 1999). The placental circulation is dependent upon adequate matching of the 
placental and uterine blood flow and it has been shown that key adaptations are made 
to achieve this. The ever importance of this process has been demonstrated with 
diseased states (see Chapter1.7).  
The placenta lacks any form of autonomic regulation and instead the vascular 
function is under the direct influence of locally released hormonal factors and 
mechanisms (Kingdom and Kaufmann, 1999, Kaufmann, Mayhew et al., 2004). This 
has stimulated a focus into the role of agonists that control vascular tone in the 
maternal circulation during pregnancy. Due to the low resistance within the placenta, 
a range of vasoconstrictors (Figure 1.6-4) at a sub maximal dose have been applied to 
stimulate the vessels (Chaudhuri and Furuya, 1991, Myatt, 1992, McCarthy, 
Woolfson et al., 1994, Granger, Alexander et al., 2002, Wang and Zhao, 2010). 
Isolated vessels have shown to be responsive to a range of agonists including to 
serotonin, PGI2, NO and endothelin-1(Et-1) and will be detailed in the following 
sections.  
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Figure 1.6-4  showing the variation in sensitivity to agonists across the placental vessels. 
Each agonist is listed in order of potency. (Image obtained from Myatt, 1992). 
 
1.6.1. Vasoconstrictors  
 
The placenta is an example of a low resistance circulation (Myatt, 1992) and 
unsurprisingly, a very limited number of contractile agents can stimulate the placental 
vessels to produce a potent vasoconstriction response. There is also evidence of 
regional variations in the response produced which may reflect the varying 
distribution of receptors that are found to be expressed across the vascular tissue of 
the placenta.  
Ang II: Ang II can bind to its two main receptors AT1 and AT2 and its ability 
to constrict vessels is determined by which receptor is expressed in the tissue effected 
The placenta expresses the high affinity Ang II receptors and the Ang converting 
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enzyme (ACE) is found in abundance within the placental plasma (Myatt, Brewer et 
al., 1992, Myatt and Webster, 2009, Wang and Zhao, 2010).  
Et-1: Et-1 is a powerful vasoconstrictor released from the EC to initiate long 
lasting contractions of SMC. It is found across the placenta and is most abundant 
within the amniotic fluid and umbilical vessels (Chaudhuri and Furuya, 1991, 
McCarthy, Woolfson et al., 1994, Khalil and Granger, 2002).  
5-hydroxytryptamine (5-HT): 5-HT is an amine which is also a potent 
vasoconstrictor of umbilical arteries and is taken up and stored by circulating platelets 
(Maigaard, Forman et al., 1986, Allen, Skajaa et al., 1991).  
Thromboxane (Tx): the main source of Tx is within platelets where it is 
synthesised and released to promote aggregation of platelets at the site of injury. Tx 
itself is synthesised via the arachidonic acid (AA) eicosanoid pathway (Figure 
1.6.1-1). In the placenta, Tx is produced by the umbilical vein which is a major source 
of the agonist and suggests Tx may have a role at the time of placental separation 
(FitzGerald, Fitzgerald et al., 1987). The placental decidua, trophoblast and amniotic 
tissue are also important sources of Tx within the placenta. While lower 
concentrations of Tx are found within the stem villi and trophoblast cells (Maigaard, 
Forman et al., 1986, Fitzgerald, Mayo et al., 1987, McCarthy, Taylor et al., 1994).  
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Figure 1.6.1-1 summarising the AA pathway to result in the biosynthesis of both TxA2 
and PGI2 (red box). The opposing contractile or relaxation response is the result of TxA2 
bindings its TP receptor or PGI2 binding its IP receptor within the same cell. Image adapted 
from (Myatt and Webster, 2009).  
 
1.6.2. Vasodilators 
 
The physical stress placed upon a vessel will be immediately met with a 
physiological response and the EC is ideally placed to detect acute changes in flow 
and pressure. The EC can influence vascular resistance via the release of important 
factors that can influence the neighbouring cells within the blood vessel. A range of 
vasodilators which have been reported to have an effect on placental vessels include 
the calcitonin gene related peptide (CGRP) which relaxed CPA in vitro (Firth and 
Broughton Pipkin, 1989, Dong, Vegiraju et al., 2004, Dong, Green et al., 2005) while 
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substance P has shown to dilate villous vessels (Benirschke and Kaufmann, 1995, 
Dong, Green et al., 2005). However the predominant vasodilators that have generated 
most interest when understanding the physiology of placental vascular resistance will 
be highlighted in this section.  
PG: PGI2 and PGE2 are potent relaxing agents of placental vessels and are 
synthesised by the AA pathway that also gives arise to circulating Tx. High levels of 
circulating AA help maintain levels of PGI2 which influences SMC via activation of 
cAMP (Allen, Skajaa et al., 1991). PGI2 has a powerful influence on the function of 
chorionic plate and stem villous and it has also been shown that an imbalance of PGI2 
and Tx may lead to increased resistance in the placenta (Walsh, 1985).  
NO: O2 and the NO precursor L-arginine are important stimulants for the 
release of NO. High levels of NO can inhibit corticotrophin releasing hormone 
(CRH), which is found in syncytiotrophoblasts and to forms a negative feedback loop. 
CRH is activated at the time of parturition and placental separation and may be crucial 
in determining the length of gestation (King, Gude et al., 1995). Reductions in tissue 
oxygenation can inhibit the NO converting enzyme NO synthase (NOS) and has been 
linked with an increase in vascular resistance when tissue perfusion is reduced.   
Endothelium derived hyperpolarising factor (EDHF): Inhibition of both 
endothelium derived NO and PGI2 lead to the identification of an additional and 
highly significant vasodilator, EDHF (Boura, Leitch et al., 1998, Yamanaka, Ishikawa 
et al., 1998). EDHF is most important in small vessels where NO and PGI2 release is 
reduced. Relaxation is produced by hyperpolarisation of the cell membrane and 
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EDHF has shown to be important when NO and PGI2 release is reduced (Boura, 
Leitch et al., 1998, Coleman, Tare et al., 2004). 
 
1.6.3. Biophysical factors  
 
Little is known about the influence of biophysical factors such as pO2 which 
alters at key stages of placental development, on vascular tone in the placenta. Any 
increase in vascular resistance will reduce flow mediated responses such as the 
effective transfer of nutrients across the placental membranes. The placenta needs to 
maintain a constant supply of oxygenated blood and any fluctuations in the blood pH, 
glucose, and gases (including O2 and CO2) will alter the functioning of the umbilical 
vessels which could be potentially disastrous for the fetus (Nicolaides, Economides et 
al., 1989, Kingdom, Macara et al., 1994).   
 
1.6.3.1. Tissue oxygenation  
 
The placenta works at a multi organ level providing gas exchange, excreting 
waste products and controlling endocrine function all at the same time. The nutrient 
supply is a major factor for determining the full growth potential of the fetus. Stress or 
insults that occur during the early stages of development can severely disrupt the 
ability of the placenta in performing this function. The pO2 within the placenta has 
shown to alter at key stages of development. Maternal blood entering the IVS spaces 
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at 12wks of gestation causes a significant shift in the pO2 for the from 20mmHg to 
60mmHg (Nicolaides, Economides et al., 1989). The placenta still maintains a low 
partial pressure of O2 (pO2) when compared to adult tissue, to minimise oxidative 
stress which results from an imbalance of the cells production of reactive oxygen 
species (ROS) and the cell¶s antioxidant capacity.  
The relatively low pO2 environment in the early stages of development has the 
advantage that it keeps oxidative stress to a minimum and promotes cell proliferation. 
Entry of maternal blood at high pO2 has the potential to overwhelm the antioxidant 
capacity of the placenta (Burton, 2008). The second major challenge for the placenta 
is the change in pO2 during delivery of the placenta and even this short exposure to 
oxidative stress has shown to introduce important cellular differences within the 
placental tissue (Cindrova-Davies, Yung et al., 2007). It was shown that the extent of 
oxidative damage was dependent on the duration of labour with potentially adverse 
effects on the normal functioning of placental vessels.  
Changes in O2 supply will affect the mitochondria, endoplasmic reticulum 
(ER) and cell membrane potential of excitable cells. Reduced pO2 can lead to hypoxia 
and the placenta has demonstrated the ability to alter vessel tone in response to 
hypoxic insults. The study by Hampl (et al., 2002) showed that the placental vessels 
could constrict in response to hypoxia to redirect blood flow, termed hypoxic 
fetoplacental vasoconstriction (HFPV), and has important parallels with the response 
seen in the pulmonary circulation. pO2 can also regulate cell growth as low pO2 
promotes cell proliferation while high pO2 is needed to allow cell differentiation. 
During the initial stages of pregnancy the placenta is poorly perfused as the vascular 
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connections are not complete. As a result low pO2 helps to drive the rapid increase in 
cytotrophoblast population (Kingdom and Kaufmann, 1999, Huppertz, Kingdom et 
al., 2003). As the trophoblast cells reach the proximity of the IVS the pO2 increases, to 
trigger a switch from proliferation to differentiation of the invading trophoblast cells. 
This suggests hypoxia may have a role in regulating the long term adaptations made 
in the flow of blood in the placenta possibly via the generation of ROS (Jakoubek, 
Bibova et al., 2006). The main ROS identified in the placenta include superoxide 
anions, hydroxyl radicals, hydrogen peroxide (H2O2), and the toxic peroxynitrite 
(ONOO-). ROS can alter vessel function, cellular processes, and cell cycle regulation. 
They also have the capacity to cause lipid peroxidation and long term protein damage 
and crucially can alter vascular tone due to the effects on EC as illustrated in Figure 
1.6.3.1-1.  
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Figure 1.6.3.1-1 shows how reduced perfusion can lead to oxidative stress. ROS can target 
the EC to alter the control of vessel tone and may have a role in control of placental vascular 
function. (Image adapted from Baker and Kingdom, 2004).  
 
ROS increase during pregnancy and can target ion channels and alter the 
physiology of vascular smooth muscle (Brainard, Korovkina et al., 2007, Garovic and 
Hayman, 2007, Maynard, Epstein et al., 2007). Current understanding suggests that 
the placenta may potentially divert blood flow away from O2 deficient areas towards 
highly perfused areas to increase the pO2 (Hampl, Bibova et al., 2002). Oxidative 
stress increases during pregnancy and lipid peroxidation can further complicate the 
condition. This carries a risk for both the mother and the fetus and fetal haemoglobin 
is much more vulnerable to the effects of ROS. Normally the level of ROS produced 
is carefully balanced but this balance changes during pregnancy and lipid peroxides 
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increase while ROS scavengers fall (Huppertz, 2007). This allows ROS and free 
radicals to increase which can be lethal to cells as they cause extensive damage to 
surrounding tissues as well as disrupting the control of Ca2+ movements.  
 
1.6.3.2. Acid base homeostasis 
 
Tissue acidosis can be detrimental for normal tissue function and low pO2 can 
lead to the production of metabolic acids which have shown the ability to alter ion 
channel activity (Holzer, 2009). Hydrogen ions (H+) are highly permeable and can 
freely cross the cell membrane to bind to ion channels such as potassium channels 
(Chapter 1.7.2). There is growing evidence to show changes in intracellular pH [pH]i 
can influence the cellular function in a number of vascular beds. Alterations in pH can 
be the result of changes in ventilation or metabolic dysfunctions all of which alter the 
balance of acid-base ratio which can be rapidly restored through the action of many 
metabolic buffers (Aalkjaer, 1990, Holzer, 2009). The placenta also needs to remove 
excess hydrogen ions (H+) that build up from the high metabolic turnover of the 
growing fetus and presents a unique challenge for the placenta in maintaining its acid 
base balance. Haemoglobin and bicarbonate ions (HCO3-) are the most important 
cellular buffers that work to maintain the resting pH and the Henderson-Hasselbalch 
equation shown below summarises the role of HCO3- in removing H+ with the 
equation below (Canzanelli, Greenblatt et al., 1939, Blechner, 1993).  
 
HCO3- + H+ ֖H2CO3 ֖CO2 +H2O 
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In low O2 environments, the energy currency molecule adenosine 5' 
triphosphate (ATP) can still be produced via anaerobic glycolysis as carbohydrates 
can be broken down to produce pyruvic acid and H+ ions. The excess H+ ions are 
removed by nicotinamide adenine dinucleotide (NAD+) which forms NADH. The 
extra H+ can be combined with O2 in the mitochondria to form a water molecule 
however when O2 is not available the H+ can be accepted by pyruvic acid to form 
lactate which disassociates to form lactic acid. Lactic acid diffuses freely into the 
blood stream and can alter the pH of blood if buffering systems are not functioning 
normally as free H+ ions accumulate (Schneider, Danko et al., 1984).   
H+ ions present a unique challenge for any tissue. H+ can be removed from the 
cell via the Na+-H+ exchanger (NHE) and Na+ can in turn be removed by HCO3- but 
this can reduce the amount of free H2CO3 molecules outside the cells to alter the 
CO2:H2CO3 ratio. The rate limiting step can result in cell pH levels remaining low for 
long periods of time depending upon cell potential (contracting or relaxed) and H2CO3 
availability. This shift in ion balance can alter vasoreactivity and has been studied 
with a view to understand hypertension where patients can have low pH in their blood 
plasma (Canzanelli, Greenblatt et al., 1939, Aalkjaer, 1990, Smith, Austin et al., 
1998). Under hypoxic conditions, the rate of ATP production will fall and 
consequently Na+/K+ pumps cannot maintain the ionic gradients across membranes 
allowing Ca2+ to move freely across the cell to eventually cause cell swelling and 
widespread tissue damage (Schneider, Danko et al., 1984). 
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The balance of pH is also important in the placenta and both the metabolically 
demanding fetus and placenta rely on the maternal circulation to buffer the pH of 
placental blood. The typical pH values for healthy patients have been summarised in 
Table 1.6.3.2-1 pH values also vary with gestational age as shown by samples of 
amniotic fluid which become more acidic in the third trimester as this is the time the 
fetal kidneys mature and begin to excrete waste substances to remove the pH load 
(Serr, Czaczkes et al., 1963, Wilson, Hunter et al., 1977). The rise in uric acid reflects 
the key change in development as the fetus reaches its maximum growth potential and 
also a time when its metabolism will also be increasing exponentially (Schneider, 
Danko et al., 1984, Burton, Jauniaux et al., 2009).  
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Table 1.6.3.2-1 summarising the relative values of key substances measured in blood samples 
from both maternal and fetal umbilical vessels from healthy samples. 
Substance Maternal Umbilical Cord References 
Artery Venous 
pCO2 (kPa) 4.8 ± 0.5 49 ± 1.6 38 ± 1.4 (Blechner, 1993, 
Westgren, Divon et al., 
1995, Shirey, St Pierre 
et al., 1996, Loh, 
Woodworth et al., 1998, 
Martin, Gaillard et al., 
2003) 
pO2(kPa) 12.35 ± 2 18 ± 0.6 29 ± 0.1 (Nicolaides, 
Economides et al., 1989, 
Blechner, 1993, 
Westgren, Divon et al., 
1995, Loh, Woodworth 
et al., 1998) 
Bicarbonate  
(mmol/l) 
26 ± 4 22 ± 0.2 20 ± 0.3 (Economides and 
Nicolaides, 1989, 
Blechner, 1993, 
Westgren, Divon et al., 
1995) 
Lactate  
(mmol/l) 
1 ± 0.5 2.98 ± 1.40 2.80 ± 1.4 (Blechner, 1993, Martin, 
Gaillard et al., 2003) 
pH 7.53 ± 0.6 7.28 ± 0.13 7.35 ± 0.5 (Nicolaides, 
Economides et al., 1989, 
Blechner, 1993, 
Westgren, Divon et al., 
1995, Martin, Gaillard 
et al., 2003) 
 
A recent publication (Bainbridge, Roberts et al., 2009) investigated the link 
with poor blood supply and placental development. This study used cultured 
trophoblast cells that were grown in the presence or absence of uric acid (10mg). 
Hyperuricemia can be detected in comprised pregnancies and raised levels can be 
detected as early as 10wks of gestation. The exact role of uric acid on placental 
growth and development has yet to be established. This study showed that uric acid 
could inhibit trophoblast integration into uterine microvascular EC monolayers which 
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is a key feature of invading trophoblast cells in normal culture conditions. Uric acid 
accumulation can potentially alter the normal function of invading trophoblast and 
could explain the poor remodelling of SA. An increase in uric acid can induce 
inflammation and has been linked to renal disease and increased hypertension. 
However the effect on vessel remodelling is not yet fully known and this study 
provides an important insight in to how metabolic acids can alter the normal working 
of vascular tissue. The concentration of uric acid used (10mg) was similar to the 
levels detected at 9-15wks gestation. This time point is significant as it marks the time 
the cytotrophoblasts will need to migrate and invade the decidual layer of the 
myometrium and any acid base imbalance may have severe consequences for the 
normal development of the placenta (Roberts and Lain, 2002).  
 
1.7. The role of Ion channels   
 
The vascular tone in organs such as the heart or kidneys can be controlled by 
either the nervous system or circulating factors released in the blood or locally 
produced signals. The placenta stands apart from other vascular tissues as is lacks 
autonomic control nerve supply which draws focus on the specific ion channels that 
may be involved with bringing about a vascular response. There is a need to 
understand the profile of ion channels that may be involved in controlling vascular 
tone in the placenta due to the link with poor placental perfusion common to 
compromised pregnancies which may originate from impaired vascular control. 
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The four main ion channel families listed in Table 1.7-1 have been implicated 
in a range of cellular functions and movement of ions across the cell membrane can 
alter the membrane potential of the cell. Vascular tissue is rich in expression of ion 
channels that can directly influence SMC to control the vessel tone. The activity and 
conductance of each ion channels is closely linked with the cells metabolic status and 
hypoxia and pH can alter cellular activity by targeting such ion channels. Vascular 
SMC can respond to changes in the flow of blood by contracting. The contraction is 
mediated by the movement of ions across the cell membrane and changes the size of 
the lumen. The resting membrane potential is normally held at -70mV and this can 
increase to -55mV upon stimulation. Depolarising the membrane allows Ca2+ to enter 
the cell through voltage gated Ca2+ channels (VGCC) while Ca2+ can also be released 
from intracellular stores such as the ER.  
 
Table 1.7-1 showing the 4 main class of ion channels families (transmembrane domain (TM). 
Pore (P)).  
Calcium channels 
(Ca2+) 
Chloride channels 
(Cl-) 
Sodium Channels 
(Na+) 
Potassium 
Channels (K+) 
P/Q Type ClC1-ClC7 Amiloride sensitive Voltage gated  
R Type ClC Ka-Kb Voltage sensitive Ligand gated 
L Type   Inward rectifiers  
T Type   Two pore domain 
N Type    
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1.7.1. L Type calcium channel (CaV1.2) 
 
Ca2+ is an important intracellular messenger that governs a wide range of cell 
activities ranging from cell excitation to regulation of gene expression. Ca2+ enters the 
cell membrane through one of four identified L (Long lasting) Type Ca2+ channels 
(CaV1.1-4). Ca2+ channels are found on the cell membrane and on internal membranes 
of cell organelles including the ER, nucleus and mitochondria (Striessnig, 1999, 
Korovkina and England, 2002). The concentration of Ca2+ is kept low in the 
cytoplasm during cell rest when Ca2+ is taken up into internal stores mainly the ER, 
where it is important for protein synthesis. During cell excitation, Ca2+ levels will rise 
in the cytoplasm to depolarise the membrane potential and in vascular tissue this will 
contract SMC. The main influx of Ca2+ is through the CaV1.2 channel which was first 
identified in cardiomyoctyes (Mikami et al., 1989). The ion channel is a large 210-240 
kDa sized protein which comprises a voltage sensor and conducting pore and is the 
target for a wide range of second messenger molecules. Nifedipine (NIFED) is a 
potent blocker of CaV1.2 and is commonly administered as a treatment for pregnancy 
induced hypertension. The channel blocker was investigated to demonstrate the 
importance of Ca2+ currents in controlling the vasoaction of placental vessels. Cooper 
(et al., 2006) demonstrated that the contraction in response to U46619 was 
significantly inhibited (67% inhibition) in the presence of NIFED which provides 
indirect evidence for the expression of CaV1.2 in the placental arteries. 
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1.7.2. Potassium channels (K+) 
 
The rise in intracellular [Ca2+]i can activate Ca2+sensitive K+ channels which 
are the largest family of ion channels (Table 1.7-1). K+ ions are very important to 
cells as they have the primary function of generating a membrane potential. There are 
four main categories of pore forming K+ ion channels including the voltage gated 
channels, Ca2+ activated and inward rectifier channels. These have been identified in a 
variety of vascular beds and investigations have also shown that their altered 
expression can be linked to various disease phenotypes including hypertension, 
ischaemia and diabetes.  
The membrane potential of a cell is defined as the electrical potential inside 
the cell measured relative to the electrical potential outside of the cell (Perney and 
Kaczmarek, 1991, Blaustein, 2004, Brainard, Korovkina et al., 2007). The resting 
membrane potential is generated by the unequal distribution of ions in the 
extracellular and intracellular fluid and is determined largely by the concentrations of 
K+, Ca2+, Na+, and Chloride (Cl-) ions (Khan, Smith et al., 1997). As the K+ ion has a 
positive charge, differences in the concentration between the cells intracellular and the 
extracellular fluid will generate a voltage membrane (Vm) potential at the membrane 
interface (Hodgkin and Huxley, 1952). The imbalance of K+ ions is also actively 
maintained by cellular transporters including the Na+/K+ ATPase (Blaustein, Kao et 
al., 2004) which have greatest influence on Vm when the cell is at rest. At the resting 
membrane potential of both excitable and non-excitable cells, the concentration of K+ 
ions outside the cell membrane is 3-5mM and inside the cell is 130-160mM, giving a 
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25-fold difference in concentrations and leads to a net negative membrane potential at 
rest (Figure 1.7.2-1) (Lawson, 1996, Lodish, Berk et al., 2000, Blaustein, Kao et al., 
2004).   
 
 
Figure 1.7.2-1 shows how the cell excitability can be influenced by the movement of K+ 
across the cell membrane. Inhibition of K+ channels will increase the cell excitability as K+ 
can no longer move out of the cell. (Image obtained from Sandoz, Douguet et al., 2009).  
 
1.7.2.1. Large conductance potassium channel (BKCa) 
 
Ca2+ activated K+ channels (Table 1.7.2.1-1) are important for SMC function 
and have a central role in regulating vascular tone. The channels are made up of three 
sub families and include the small conductance (SKCa), the intermediate (IKCa) and 
the BKCa. The different channels are identified by the size of their conduction and the 
BKCa in particular has been implicated in regulating active tone (Khan, Smith et al., 
1993, Parkington, Tonta et al., 1999, Korovkina and England, 2002). BKCa channels 
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form intrinsic sensors which respond to changes in Ca2+, membrane depolarisation 
and vasoconstriction and maintain Ca2+ homeostasis.  
 
Table 1.7.2.1-1 listing the main pharmacological agents that can be used to target the each 
type of Calcium activated potassium channels 
Ca2+ activated K+ channels 
 Inhibitors Activators  
BK, maxi (KCa1.1) Charybdotoxin, 
Iberiotoxin, paxilline, 
TEA 
NS1610, NS1619, 
Resveratol 
Intermediate (IKCa, 
(KCa3.1)   
Charybdotoxin, TRAM-
34, Maurotoxin, 
Clotrimazole.  
EB1O, NS309 
Small (SKCa,) (KCa 2.1-
2.3) 
Apamin (APA) EB1O, NS309 
 
At rest the intracellular concentration of Ca2+ is normally kept low but 
following depolarisation, the voltage activated Ca2+ channels permit the entry of the 
ion in to the cell to cause contraction. In blood vessels, the increase in Ca2+ causes 
vasoconstriction of SMC to decrease the blood vessels diameter. This in turn activates 
BKCa which makes it an ideal mechanosensor that links vasoconstriction and 
membrane depolarisation closely together (Khan, Smith et al., 1993). The ion channel 
is responsible for increasing the movement of K+ out of the cell to hyperpolarise the 
membrane potential. The cell cannot therefore respond to further electrical 
stimulation. BKCa can also trigger the release of vasodilators from the EC and are 
becoming more widely studied for their potential role in endothelial dysfunction 
linked with hypertension. Animal models which do not have functioning BKCa 
channels (knockdown of the ȕVXEXQLW in male adult mice models) were resistant to 
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Ca2+ sparks and developed pulmonary hypertension (Brenner, Perez et al., 2000), and 
it would be interesting to determine how this knockdown affected the fetal and/or 
placental development in female pups. This finding further supports the view that 
BKCa channels are important in regulating vascular homeostasis and may have a role 
in controlling placental vascular function (Parkington, Tonta et al., 1999, Scotland, 
Chauhan et al., 2001, Eichhorn and Dobrev, 2007) . 
 
1.7.2.2. ATP sensitive potassium channel (KATP)  
 
The KATP channel is part of the inward rectifier family of K+ channels (Kir 6.1 
or 6.2). It was first identified in cardiac muscle tissue but is also found in vascular 
SMC and EC (Noma et al., 1983, Gutterman, Miura et al., 2005). It is composed of 
four pore forming subunits and four sulphonylurea receptors (SUR) which are the 
ATP binding proteins. The channel activity is determined by the ratio of ADP to ATP 
as high metabolic activity will trigger a fall in the ADP:ATP ratio and this would 
increase the channel opening (Figure 1.7.2.2-1). In vascular tissue this would cause 
SMC membrane hyperpolarisation and induce vasodilatation to perfuse the 
surrounding tissue with more blood. The KATP is an important O2 sensor as ATP levels 
are closely linked to the oxidative state of the cell and oxidative stress will reduce 
KATP activity (Duprat, Guillemare et al., 1995, Seino and Miki, 2003). Studies have 
shown that channel activity can be recovered with the administration of antioxidant 
based therapies (Pasquali et al., 2006,  Brakemeier, Eichler et al., 2003, Ko, Han et 
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al., 2008) while the most effective blocker is glibenclamide (GLB) (Brakemeier, 
Eichler et al., 2003, Ko, Han et al., 2008, Feletou, 2009). 
 
      
 
 
Figure 1.7.2.2-1 illustrating how KATP channels in pancreatic ȕFHOOVUHJXODWHVHFUHWLRQV
of insulin. The gating of KATP is closely linked to the metabolic status. Glucose taken up by 
the cell through the glucose transporter (GLUT2) will alter the level of ATP within the cell 
which inhibits KATP. Image obtained from 
 www.betacell.org/content/articles/print.php?aid=1.  
 
KATP channels may also have a role in the control of placental vascular 
function. Recent work by Jewsbury (et al., 2007) investigated the effect of specific 
KATP blockers on isolated CPA and CPV. The advantage of using pharmacological 
agents that are specific for KATP channels activity is that this would provide a way to 
target SMC function in blood vessels as patch clamp work has previously shown that 
placental vascular SMC but not EC were sensitive to the KATP antagonist GLB. The 
KATP opener pinacidil, but neither cromakalim nor nicorandil could relax CPA in a 
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dose dependant manner when studying isolated vessels with wire myography. More 
interestingly CPV also produced a similar relaxation to pinacidil suggesting that both 
vessel types have the same sensitivity for the KATP agonist. This provides indirect 
evidence for the presence of KATP mRNA in placental vessels from IUGR samples  
(Corcoran, Lacey et al., 2008). The close association with D FHOOV¶metabolic status 
and KATP activation may have important consequences for the highly active placenta 
(Guiet-Bara, Ibrahim et al., 1999, Hussain and Cosgrove, 2005, Wareing, Bai et al., 
2006, Jewsbury, Baker et al., 2007, Feletou, 2009) and there is a need to study 
expression of the ion channel at the protein level.  
 
1.7.3. The two pore domain family of potassium channels (K2P)  
 
The K2P channels are a new family of K+ channels and since the first member 
was identified (tandem of P domains in weak inward rectifier K+, TWIK-1) (see 
Ketchum, Joiner et al., 1995, Lesage, Guillemare et al., 1996), the numbers have 
rapidly grown and currently 15 members have been identified (Figure 1.7.3-1). The 
K2P channels are distinguished by the presence of four transmembrane segments and 
two pore forming domains. Their pharmacological properties vary greatly and recent 
work has shown that they have very different mechanisms of modulation. For 
example TWIK and the TWIK related K+ channel (TREK), demonstrate sensitivity to 
acidic pH conditions inside the cell while TWIK related acid sensitive K+ (TASK) is 
stimulated by weak changes in extracellular pH (Duprat, Lesage et al., 1997, Lesage, 
Lauritzen et al., 1997, Chavez, Gray et al., 1999, Richter, Dvoryanchikov et al., 
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2004). The ion channel family are widely expressed particularly in the central nervous 
system and studies using knockout animal models have shown they may have a role in 
depression and pain sensation. They can function in both excitable and non-excitable 
cells and are crucial for maintaining the resting membrane potential (Duprat, 
Guillemare et al., 1995, Lesage, Guillemare et al., 1996, Reyes, Duprat et al., 1998, 
Gruss, Mathie et al., 2004).  
 
 
Figure 1.7.3-1 showing the phylogeny tree of the 15 K2P family members identified.  
showing the topology of the K2P channel (Image obtained from Honore, 2007).  
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TWIK-1 has been located in heart, brain, placenta, lung, liver, kidney, 
pancreas (Lesage, Guillemare et al., 1996), stomach, prostate & uterus (Medhurst, 
Rennie et al., 2001). Medhurst (et al., 2001) also showed that TWIK-1 mRNA 
expression was highest in human central nervous tissue than in peripheral tissues, 
with the cerebellum giving the highest expression. TWIK-2 (Table 1.7.3-1) is another 
K2P which is 313 amino acids long, its chromosomal location is 19q13 and it has 
53.8% sequence similarity along with 72 and 88% amino acid similarity between the 
1st and 2nd pore respectively to TWIK-1 (Chavez, Gray et al., 1999, Medhurst, Rennie 
et al., 2001). 
 
Table 1.7.3-1 
TWIK-2 (KCNK6) 
Current Open rectifier 
Amino acid  313 
Activators AA 
Blockers Barium (Ba2+), quinine, quinidine, 
volatile anaesthetics 
Distribution (highest) Placenta, heart, colon, spleen, lung, liver, 
kidney, thymus, stomach, prostate, & 
small intestine 
Key references (Lesage, Guillemare et al., 1996, Patel, 
Honore et al., 1998, Chavez, Gray et al., 
1999, Patel, Maingret et al., 2000, 
Goldstein, Bayliss et al., 2005) 
 
TREK-1 (Table 1.7.3-2), TREK-2 (Table 1.7.3-3) and the TWIK Related 
Arachidonic Acid K+ channel (TRAAK) (Table 1.7.3-4) are part of the mechano-
gated members of K2P K+ channels.  Both TREK and TRAAK are activated by stress, 
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cell swelling and membrane stretching which is mostly dependant on the osmolarity 
of the fluid rather than changes to the cytoskeleton (Patel and Honore, 2001). Another 
potent stimulant is AA and polyunsaturated fatty acids such as linoleic acids and 
docosahexaenoic acids, however they are unaffected by saturated fatty acids 
(Maingret, Fosset et al., 1999). An additional modulator of TREK is pH particularly 
in the acidic pH range inside the cell cytosol. If the intracellular fluid becomes 
slightly acidic this will cause a shift in the pressure activity curve towards positive 
and as a result will lead to channel opening at atmospheric pressure (Maingret, Fosset 
et al., 1999). TREK-1 can also respond to cell swelling by opening its channels to 
cause a large efflux of K+ ions which will then change the osmotic potential of the 
extracellular fluid and as a result drive water out to consequently reduce cell swelling. 
TREK-1 and TREK-2 are sensitive to volatile anaesthetics like chloroform, 
diethylether, halothane and isoflurane, while TRAAK is insensitive (Maingret, Patel 
et al., 1999, Patel, Honore et al., 1999, Lesage, Terrenoire et al., 2000). TREK-1 is 
also known to be temperature sensitive in neurons of the hypothalamus and dorsal 
root ganglion and there is a possibility that it could be involved with body temperature 
regulation, but this is not fully supported in the literature (Maingret, Patel et al., 
2000).  
 
Chapter 1 
Introduction 
46 
 
Table 1.7.3-2 
TREK-1 (KCNK2) 
Current Open or voltage dependent 
Amino acid  426 
Activators AA, unsaturated fatty acids, 
lysophospholipids, volatile anaesthetics, 
mechanical stress, & riluzole 
Blockers Ba2+, Zinc (Zn2+), caffeine, curcumin, 
internal acidification, PKA, PKC, & 
quinidine.  
Distribution (highest) Foetal brain, spinal cord, thalamus, 
putamen, cavdate nucleus, stomach, small 
intestine, lung, heart, & brain.  
Key references (Fink, Lesage et al., 1998, Maingret, 
Lauritzen et al., 2000, Maingret, Patel et al., 
2000, Goldstein, Bayliss et al., 2005, 
Lauritzen, Chemin et al., 2005, Chemin, 
Patel et al., 2007) 
Table 1.7.3-3 
TREK-2 (KCNK10) 
Current Open rectifier 
Amino acid  538 
Activators AA, riluzole, isoflurane, halothane, volatile 
anaesthetics, linoleic acid, & intracellular 
acidification 
Blockers PKA, PKC & quinidine 
Distribution (highest) Cerebellum, spleen, testes, kidneys & 
small intestine 
Key references (Lesage, 2003, Goldstein, Bayliss et al., 
2005) 
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Table 1.7.3-4 
TRAAK (KCNK4) 
Current Open rectifier 
Amino acid  393 
Activators AA, riluzole, heat, stretch, & 
lysophospholipids, 
Blockers Gadolinium (Gd3+) & sipatrigine 
Distribution (highest) Brain, retina & spinal cord, amygdale, 
caudate nucleus, temporal cortex, 
hippocampus & placenta 
Key references (Maingret, Patel et al., 2000, Reyes, 
Lauritzen et al., 2000, Goldstein, Bayliss 
et al., 2005, Andresen, Lloyd et al., 2007) 
 
Another member of the K2Ps is TASK which has the main characteristic of 
being sensitive to change in extracellular pH (Table 1.7.3-5). TASK-1 has a 
chromosome location of 2p23 and is a 394 amino acid that produces an outward 
rectification of 14pS (Lesage and Lazdunski, 2000). TASK channels are very 
sensitive to changes in pH with 90% channel activity for TASK-1 at pH 7.7 but only 
10% at pH 6.7, with a 50% inhibition at pH 7.3 (Lesage and Lazdunski, 2000) which 
makes TASK-1 very sensitive as that is only a 0.4 unit increase in acidity. TASK-1 is 
inhibited by local anaesthetics such as lidocaine and bupivacaine and it is opened by 
volatile general anaesthetics such as halothane, and isoflurane at the concentration 
used in general anaesthesia. TASK-1 is most abundantly expressed in the pancreas 
and placenta, as well as the peripheral and CNS tissue (Medhurst, Rennie et al., 
2001). The general role of TASK-1 seems to be helping to maintain the resting 
potential along with the closely related channel TASK-3 (Table 1.7.3-6) (Ketchum, 
Joiner et al., 1995, Lesage, Guillemare et al., 1996, Patel, Maingret et al., 2000). 
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Table 1.7.3-5 
TASK-1 (KCNK3) 
Current Open rectifier 
Amino acids 394 
Activators Halothane, volatile anaesthetics & 
isoflurane 
Blockers Ba2+, Zn2+, external acidification, 
quinidine, anandamide, & AA 
Distribution (highest) Pancreas, placenta, brain, lung, prostrate, 
heart, kidney, uterus, stomach, small 
intestine & colon 
Key references (Duprat, Lesage et al., 1997, Goldstein, 
Bayliss et al., 2005, Duprat, Lauritzen et 
al., 2007) 
Table 1.7.3-6 
TASK-3 (KCNK9) 
Current Not determined 
Amino acid  374 
Activators Halothane  
Blockers External acidification, lidocaine, 
bupivacaine, Zn2+, Copper (Cu2+) & 
ruthenium red 
Distribution (highest) Brain, testis, & stomach 
Key references (Bayliss, Sirois et al., 2003, Goldstein, 
Bayliss et al., 2005, Duprat, Lauritzen et 
al., 2007) 
 
K2P channels expressed in the taste receptors has shown that these channels 
produce the reflex response seen with bitter acidic foods as the channels are activated 
(Medhurst, Rennie et al., 2001, Bayliss, Sirois et al., 2003, Beckett, Han et al., 2008, 
Meuth, Bittner et al., 2008). In other tissues the leak channels have shown to increase 
tissue oxygenation by regulating the diameter of blood vessels and in particular 
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TREK-1 is shown to function in SMC  and is stimulated during cell stretch (Reyes, 
Duprat et al., 1998, Richter, Dvoryanchikov et al., 2004, Xian Tao, Dyachenko et al., 
2006). More recently research in to respiratory ventilation during sleep showed that 
the reduction in breathing and consequent increase in pCO2 will trigger a decrease in 
WKHS+$UHIOH[UHVSRQVH³ZDNLQJUHIOH[´LQWKHEUDLQUHVSRQGVWRWKLVE\LQFUHDVLQJ
the respiratory output inducing behavioural arousal to reduce the pCO2 (Czirjak, 
Fischer et al., 2000, Bayliss, Sirois et al., 2003, Bryan, You et al., 2006).
 
Many groups 
are studying the role of K2P channels in this mechanism to better understand sleep 
disturbances and unexplained infant deaths which occur during sleep (Cluzeaud, 
Reyes et al., 1998, Chavez, Gray et al., 1999, Pountney, Gulkarov et al., 1999, Patel, 
Maingret et al., 2000, Feletou, 2009).  
There is an increasing body of evidence to show that K2P channels are 
expressed in the placenta and suggest the K+ channel family may have a role in 
controlling vessel function. Recent work (Bai, Bugg et al., 2005, Wareing, Bai et al., 
2006) has identified the expression of TASK -1 and TREK- 1 in specific regions of 
the placenta including the trophoblast layer but the functional role of the ion channel 
family within the placenta is incomplete. The TASK channel modulator Anandamide, 
was reported to produce a marginal effect on the vasoactivity of placental CP vessels 
(Wareing, Bai et al., 2006). The detection of K2P channels in the trophoblast also 
suggests a potential role for other K2P channels in the regulation of blood flow in the 
placenta and potentially in the regulation of the acid base balance and provides an 
exciting new insight into how this pathway can be targeted. 
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1.8. Vascular dysfunctions linked with the placenta  
 
The importance of adequate maternal adaptations to pregnancy has been 
demonstrated with complicated pregnancies which show evidence of placental 
insufficiency. Studying abnormalities from diseased tissue has also shown that 
vascular function may hinder the normal growth and development of the fetus 
especially if the insult occurs during the early trimester (Robertson, Brosens et al., 
1973, Ashworth, 1997, Kublickiene, Kublickas et al., 1997, Baker and Kingdom, 
2004, Chaddha, Viero et al., 2004). The adequate growth and development of the 
fetus is only achieved through the carefully timed adaptations to pregnancy that 
results in the efficient exchange of nutrients and gases across the maternal and fetal 
circulations through the placenta. Placental insufficiency is a major risk factor for the 
onset of disease and is believed to be the origins for conditions that result in 
compromised pregnancies such as hypertension linked pregnancy and the most fatal 
pre-eclampsia (PE) and intrauterine growth restriction (IUGR) which will be detailed 
in this section. In cases of PE and IUGR quite often the SA are narrow as they fail to 
re model in this way and blood flow is restricted. The normal remodelling of the SA 
ensures that there is a constant flow of blood which limits the production of ROS. In 
PE it would seem that narrow arteries cause the blood to pass in pulses which favours 
the production of ROS and gives one possible pathway for the development of the 
adverse condition (Blechner, 1970, Moll, 2001, Lyall, 2005, Pijnenborg, Vercruysse 
et al., 2006). 
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1.8.1. PE 
 
PE is a condition that is only seen spontaneously in humans and is described 
as a multisystem condition for which there is currently no cure. PE incidence is 
estimated to account for 4-7% of pregnancies worldwide and is a leading cause 
neonatal and maternal morbidity and mortality. In the UK this accounts for on average 
5/1000 pregnancies per year and 60,000 of maternal deaths are associated with PE 
(Tuffnell, Jankowicz et al., 2005). In addition, a further 20% of those diagnosed with 
PE are thought to be at a greater risk of developing heart disease compared to 2% in 
the wider population (Goldenberg, Culhane et al., 2008). Some cases of heart 
abnormalities following pregnancy have been reported as early as seven years after 
the original diagnosis of PE. This suggests the condition is either causing permanent 
alterations in the vascular system or instead exposing those individuals who are 
already have a risk of heart disease to develop it earlier. The symptoms of PE can 
vary from a mild increase in blood pressure to severe oedema, seizures, liver and renal 
abnormalities. The symptoms commonly occur in the second or third trimester when 
the condition is most difficult to treat due to the risk it places on the fetus (Roberts, 
Taylor et al., 1989, Pijnenborg, Anthony et al., 1991, Goldenberg, Iams et al., 1996, 
Fox, 1997, Bolte, van Geijn et al., 2001, Goldenberg, Culhane et al., 2008). The 
clinical features of PE as defined by the International Society of Hypertension (ISH) 
often present after 20wks and include hypertension (BP >140/90), proteinuria 
(>0.5g/L), edema and if untreated will progress to elcamptic convulsions and 
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pulmonary edema (Roberts and Lain, 2002, Baker and Kingdom, 2004, Garovic and 
Hayman, 2007).  
At the physiological level it has been shown that PE is associated with 
widespread vasoconstriction of the maternal circulation particularly affecting the 
renal, uterine, cerebral and hepatic circulations and increased platelet activation. PE is 
now widely understood to be a disease of the endothelium and evidence has come 
from specific markers as well as functional studies (Roberts, Taylor et al., 1989, 
McCarthy, Taylor et al., 1994, Ashworth, 1997, Maynard, Epstein et al., 2007). The 
second wave of trophoblast invasion is flawed in PE cases (Figure 1.8.1-1) and the 
maternal SA retain their contractile activities. This disorganised vascular remodelling 
will lead to an interrupted blood supply to the placenta and therefore restrict growth of 
the fetus.  
 
Figure 1.8.1-1 shows the key difference in maternal SA between normal and PE samples. 
The invasion of SA in PE is shallow leaving the SA relatively untransformed and the 
trophoblast cells fail to reach the myometrium. (Image obtained from Maynard, Epstein et al., 
2007). 
 
In PE, it has been shown that placental perfusion is greatly reduced. The 
placenta is the main target organ for PE related pathology (Kelly, Stone et al., 2000). 
This may disrupt the carefully balanced oxidative capacity of the low pO2 placenta to 
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increase oxidative stress. The placenta also has a further role in PE and it is now 
understood that a yet to be identified factor may be released from the placenta into the 
maternal circulation marking the second stage of the disease. PE shows remission 
following delivery of the placenta and PE is found in cases of hydatidiform where the 
fetus is absent (Roberts and Lain, 2002, Baker and Kingdom, 2004).  
 
1.8.2. IUGR   
 
In common with PE, IUGR has been linked with reduced placental perfusion. 
IUGR is used to describe babies that fail to reach their full growth potential after 
correcting for maternal weight and ethnicity (Gardosi, Chang et al., 1992). In the 
clinical setting this is defined as birth weights that fall below the 10th centile of the 
expected growth for that specific gestation and accounts for 3-7% of all pregnancies 
(Goldenberg, Culhane et al., 2008, Romo, Carceller et al., 2009). The fetus triples in 
weight during the final trimester and is the point where IUGR can be diagnosed and 
often the clinical intervention is to deliver the baby often occurring before term 
(Gardosi, Mongelli et al., 1995, Baker and Kingdom, 2004).  
Examinations of IUGR effected placenta has shown some anatomical 
differences in the structure and number of terminal villi compared to normal healthy 
samples. This would greatly reduce the transport capacity of the placenta and it has 
been shown that expression of key transporters for nutrients exchange are reduced 
along the basement membrane from IUGR samples (Jansson and Powell, 2007). 
IUGR also has important parallels to PE with placental insufficiency being at the 
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centre of both conditions. This also suggests that a similar pathophysiology may be 
involved in disrupting the normal functioning of the placenta (Burton, Yung et al., 
2008, Scifres and Nelson, 2009, Scifres, Stamilio et al., 2009). Patients diagnosed 
with IUGR and PE have shown to have increased risk of developing PE in subsequent 
pregnancies, along with an increased risk in developing  diabetes, renal disease and 
obesity. Put together with the extra cost of neonatal specialist care required at the time 
of birth and throughout life PE is costing healthcare providers millions each year. The 
increase in mortality is more significant in developing countries which cannot provide 
the adequate health care that is needed to deal with pre term deliveries (Brosens, 
Robertson et al., 1972, Roberts, Taylor et al., 1989, Goldenberg, Iams et al., 1996, 
Goldenberg, Culhane et al., 2008).  
At present the most effective treatment is delivery of the fetus and placenta 
however this may occur before term and contributes to the increasing pre-term 
delivery linked complications seen worldwide costing health providers millions each 
year with neonatal care (Goldenberg, Iams et al., 1996, Fox, 1997, Moutquin, 2003, 
Garovic and Hayman, 2007, Goldenberg, Culhane et al., 2008).  
 
1.9. Methods used to study the placenta  
 
Blood flow is a good clinical marker of how well the placental unit is 
functioning and has advanced the diagnosis of placental abnormalities in vivo 
(Pijnenborg, Dixon et al., 1980, Fox, 1997, Soares and Hunt, 2006, Deurloo, 
Spreeuwenberg et al., 2007). The reduction in blood flow to the placenta observed 
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with IUGR and PE predisposes to impaired fetal growth and development and more 
evidence is needed to understand how vascular tone is controlled across the placenta.  
 
1.9.1. Whole placentae 
 
In vivo methods such as Doppler ultrasounds and echocardiographs have been 
employed to measure changes in feto-placental blood flow and provide a measure of 
blood flow (Fairlie, Moretti et al., 1991, Deurloo, Spreeuwenberg et al., 2007, Moore, 
Ong et al., 2007). They have increasingly been used to provide a measure of fetal 
well-being and give a measure of how the fetal cardiac output changes at different 
stages of pregnancy. Examining Doppler waveforms gives information of the 
widespread resistance as the systolic and diastolic flow can be quantified. Doppler 
ultrasound has been used to measure blood flow velocities to provide clinical markers 
of poor perfusion. In normal pregnancies umbilical end diastolic velocity should 
increase and fetal placental resistance should steadily decrease with gestation (Fairlie, 
Moretti et al., 1991, Myatt, 1992, Soares and Hunt, 2006, Deurloo, Spreeuwenberg et 
al., 2007). This method of studying blood flow gives information in the general 
hemodynamic changes that need to occur and provide a method for detecting 
increased resistance to flow in the venous circulations.  
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1.9.2. Resistance vessels  
 
Doppler waveforms measure changes in large vessels such as the umbilical 
vein but gives limited information on the flow of blood in the peripheral vessels. The 
small diameter vessels in the range of 50-500µm offer the most resistance to flow and 
therefore determine the widespread resistance to flow and need to be studied to better 
understand the regulation of vascular resistance (Mulvany and Aalkjaer, 1990). The 
amount of resistance is proportional to the vessel length while the radius has an 
inverse relationship to the amount of flow. When studying vessels the pressure, flow, 
and radius need to be taken into consideration and small changes in either parameter 
will have a profound effect on intraluminal flow. The main control over flow is by the 
radius of the vessel which can be altered by basal and agonist induced mechanisms. 
The diameter is itself under the influence of the cell layers that comprise the vascular 
wall to generate a force and the amount of force is a measure of tone or active tension 
whereby SMC are activated and can be measured using isolated vessel (Mulvany and 
Halpern, 1977, Halpern, Mulvany et al., 1978). Changes in pressure, flow and 
resistance have been measured using two main techniques, namely perfusion 
myography and wire myography (Figure 1.9.2-1).  
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A B
 
Figure 1.9.2-1 showing the experimental setup for the perfusion (A) and wire (B) 
myograph apparatus. The pressure myograph requires the constant monitoring of the vessel 
diameter using a video display. In contrast wire based myography involves threading the 
vessel on to two stainless steel jaws using two parallel wires which stretch the vessel into a 
flat parallel sheet. The changes in force on the wires as a result of the vessel contracting can 
be recorded by the highly sensitive force transducers. Images obtained from www.dmt.dk.   
 
The perfusion myograph: Increases in shear stress as a result of increased 
flow will induce dilation (Halpern, Mulvany et al., 1978, Spiers and Padmanabhan, 
2005). The perfusion myograph measures vessel diameter in response to changes in 
flow. With this method, the vessel can be perfused to different pressures and the 
lumen diameter is measured by viewing the vessels with an inverted microscope. The 
vessel is mounted between two glass microcannulae and is perfused with normal 
saline which is passed through the lumen using a flow pump. Pressure transducers are 
attached to the opposite side to record the intraluminal pressure and the system is 
closed (Halpern, Mulvany et al., 1978, Halpern, Osol et al., 1984, Mulvany and 
Aalkjaer, 1990). The main advantage is that the vessel is held in a cylindrical shape, 
like that found in vivo, and the shear stress applied can be manipulated along with the 
amount of flow (Dunn, Wellman et al., 1994). However the difficulty with this 
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method is that the direction of flow applied must match the direction of flow in vivo to 
limit the damage to EC (Sen and Semenza, 2004).  
The Wire myograph: In contrast to perfusion myography, the wire myograph 
adapted by Mulvany (et al 1977) uses two fine wires and is useful for measuring force 
generation as well as vessel dimensions of small arteries. The isometric study of 
vessels uses two parallel tungsten wires which are passed through the lumen of the 
vessel. The vessel is then mounted onto two jaws where one is connected to a force 
transducer and the other to a micrometer screw. The jaws are adjustable and allow the 
measurement of blood vessel diameter and wall tension to calculate contractility of 
the vessels. The vessel has to firstly be normalised in order to accurately match the 
conditions the vessel would be held in in vivo and to gain the most active tension. The 
internal circumference (L100) can be adjusted to reflect the conditions found within the 
tissue and 100mmHg (13.1 kPa) which is the internal pressure for rat adult small 
vessels, is commonly used (Mulvany and Aalkjaer, 1990, McPherson, 1992). This can 
be calculated using the Laplace equation which takes the vessel length and 
circumference into account;  
 
Effective pressure (Pi)  ZDOOWHQVLRQLQWHUQDOFLUFXPIHUHQFHȆ 
 
Small resistance arteries have shown the ability of regulating vessel tone and 
isolated blood vessels can spontaneously contract upon stretch (Bevan and Osher, 
1972, Mulvany and Halpern, 1977, Halpern, Mulvany et al., 1978). Two main forces 
apply pressure on the blood vessel, this first being fluid stress which is caused by the 
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volume of blood flowing. While the second is applied along the vessel wall as the 
cross sectional area changes (shear stress). The size of active tone increases with 
smaller vessel sizes and arteries <500µm provide the highest level of resistance. The 
development of active tone controls peripheral resistance and allows vessels to 
respond to changes in the external environment even when vessels are isolated from 
the vascular tissue. This also has an important implication for understanding how the 
vascular system reacts to external stimuli and makes small arteries an important target 
for agonists that can relax vascular SMC (Sen and Semenza, 2004).  
 
1.10. Background to the study  
 
The placenta needs to maintain a low resistance system to deliver sufficient O2 
and nutrients to the fetus. Blood vessels within the placenta respond to challenges in 
maternal blood supply by altering the vessel diameter but the exact nature of the ion 
channels involved in this response are not known. Chronic hypoxia will lower the pH 
and present a unique challenge for the placenta. If the vessels in the placenta fail to 
respond to changes in pH then the tissue will continue to fluctuate. Recent studies 
have shown that the pH sensitive K2P channels are highly expressed in the placental 
trophoblast cells and in the myometrium (Bai, Greenwood et al., 2005) which supplies 
the placenta with its oxygen and nutrient requirements. These findings raise the 
possibility that these ion channels could also provide an important therapeutic target 
for regulating pH within the placental in vivo and requires further investigation.  
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The precise role of K+ in controlling the basal tone across the placental 
vasculature is not fully understood. Moreover it is not clear how hypoxic insults alter 
the physiology of K+ channels. Hampl (et al 2002) has provided an insight into how 
O2 can alter placental vessel function of resistance arteries. My study aims to examine 
further stress by studying the role of pH on CPA and crucially SVA from normal 
samples which are at the maternal facing boundary of the placenta. This is particularly 
important as poor perfusion can limit the normal growth development of the fetus and 
has been linked to the onset of IUGR and PE both of which are leading causes of fetal 
and maternal morbidity.   
The aims of the study were to firstly compare the two types of human 
placental vessels namely the CPA and SVA to examine the characteristic of vessels 
from across the fetomaternal interface of the placenta from normal pregnancies. The 
second aim was to characterise the key O2 and pH sensitive ion channels to identify 
which ion channel(s) have a role in mediating the vascular response of the placenta to 
stress.  
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2. Hypothesis  
 
The study hypothesis states that expression of O2 and pH sensing ion channels 
including the K2P family varies across the placental maternal facing SVA and fetal 
facing CPA, and such ion channels have a role in controlling the response to pH 
stress.  
 
2.1. Objectives  
 
The objectives of this study were to;  
 
x Identify expression of the CaV1.2, BKCa and KATP channel along with the K2P 
members TWIK-2, TREK-1/2, TRAAK, and TASK-1/3 in normal human 
placental blood vessels by Western blotting analysis.  
x Investigate any differences in ion channel expression between PE and normal 
non-labouring placental vessels using Western blotting analysis.  
x Determine the cellular distribution of ion channels within cultured myocytes 
from CPA and SVA using confocal immunofluorescence.  
x Examine the functional responses of both CPA and SVA in response to 
hypoxia and pH stress along with ion channel modulators using wire 
myography.  
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3.  Materials and methods  
3.1. Patient recruitment  
 
Whole placentae and myometrial (MYO) biopsies were obtained from the 
Department of Obstetrics and Gynaecology at the Royal Derby Hospital. Ethical 
approval was obtained from the Derbyshire Ethics Committee. Tissue was collected 
from fully informed patients who had given written consent prior to elective lower 
segment Caesarean section (ELLSCS). The information included in the patient 
information sheet (See Appendix V) was also explained to ensure the patients knew 
and understood what would happen with the samples once they were collected and 
answer any questions the recruit may have. Once consent was obtained three copies of 
the consent forms (Appendix V) were obtained with original signatures, for the 
pDWLHQW¶V RZQ SHUVRQDO UHFRUGV for our secure files and for inclusion the pDWLHQW¶V
medical notes to inform the labour ward staff that consent had been taken. All consent 
forms and sample information was then logged and kept in secure files. Each sample 
was assigned a unique identification code to ensure anonymity and this code was then 
used to follow up the patient information using the medical notes.  
 
3.2. Tissue collection 
 
Two main cohorts of patients, firstly normal (NORM) were recruited to the 
study with full informed written consent. All samples were from singleton 
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pregnancies DQGGHOLYHUHGE\(//6&6DW WHUPJHVWDWLRQ ZNV). The reasons for 
ELLSCS included maternal requests, previous ELLSCS or breech presentation while 
diabetics, smokers and women with high blood pressure were excluded. Any patients 
with a history of cardiac or renal disease, or patients receiving pharmacological 
treatment other than iron supplementation were also excluded. Our second group 
consisted of patients diagnosed with PE which was defined as a BP recording of 
PP+JDIWHUZNVJHVWDWLRQDQGKUSURWHLQXULDRIJ/LQWKHDEVHQFH
of urinary tract infection. 
Women undergoing ELLSCS DW IXOO WHUP  Zks) were approached and 
myometrial (MYO) biopsies of approximately 2x2x1.5cm were taken from the upper 
region of the transverse incision made at the time of ELLSCS (Figure 3.2-1). MYO 
biopsies were transported in chilled Physiological salt solution (PSS, see Appendix I 
for composition) and aerated with 95% O2/5% CO2 before using in experiments. The 
details of the compositions of all the different buffers used along with the suppliers 
and their addresses have been listed in the appendices (Appendix I-IV).   
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A. B. 
Myometrium
 
Figure 3.2-1 shows the source of the MYO biopsy that was obtained at ELLSCS. A 
shows the structural arrangement of a human female reproductive tract and the location of the 
myometrium. (Image obtained from  
www.lab.anhb.uwa.edu.au/mb140/CorePages/FemaleRepro/htm).  
B shows a freshly collected MYO biopsy that has been obtained at ELLSCS.  
  
3.2.1. Isolation of placental arteries 
 
Placentae were collected within 20mins of delivery and transported to the 
Medical School Clinical Sciences laboratory. The amnion was firstly peeled away by 
hand to reveal a vast network of arteries and veins running along the chorionic 
surface. An artery in isolation from a neighbouring vein was identified by following 
that point of cord insertion and was used to identify the smaller resistance sized 
branches that divided further along the tissue. The 4th order branch of the CPA was 
selected (Figure 3.2.1-1) and an incision was made into the tissue to dissect the vessel 
away with its surrounding tissue intact. Three separate samples from each placenta 
were taken in this way and the method of storage for both tissue samples was 
determined by the type of experiment that would be undertaken. Following fine 
dissection to remove any connective tissue, CPA were transferred to room 
temperature PSS and used immediately for wire myography (Chapter 3.7). The CPA 
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branching into the maternal portion of the placenta was also used to identify the 
matched SVA. SVA were removed by scraping away trophoblast tissue using the 
blunt end of a pair of forceps to leave the villous arteries which were dissected away 
from the placenta. In addition non-pressurised CPA and SVA rings were placed in 
fixative for immuohistochemistry (IHC) analysis (Chapter 3.3). For cell culture 
experiments isolated samples were placed in Hanks Balanced Salt Solution (HBSS) 
and cultured within 4hrs of collection (Chapter 3.5), while for Western blotting 
(Chapter 3.4) the isolated arteries were firstly washed in homogenising buffer to 
remove traces of blood before being labelled, dated and then snap frozen in liquid 
nitrogen (N2) then stored at -80oC.  
 
CPA
SVA
IVS
Uterus
2 Umbilical arteries  
4th order 
branch 
Umbilical vein
43
2
1
 
Figure 3.2.1-1 illustrating how the placental arteries were identified in the placenta. The 
4th branch (numbered in image) of the CPA was routinely identified following the point of 
cord insertion. A large section was removed that contained both the CPA and SVA (Image 
adapted from Saunders, 2009).  
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3.3. IHC 
 
1mm long non-pressurised CPA and SVA rings (described in Chapter 3.2.1) 
were firstly cleaned of any surrounding connective tissue and immediately placed in 
BRXLQ¶V VROXWLRQ VHH Appendix I for composition) which is a fixative that has the 
added advantage that it stains tissue yellow so it can be viewed more easily. The 
VDPSOHV ZHUH VWRUHG LQ PO %LMRX WXEHV DW Û& EHIRUH EHLQJ WUDQsported to the 
Advanced Microscopy Unit based at the Queens Medical Centre, Nottingham, for 
sectioning.  
7KHVDPSOHVZHUH UHPRYHG IURP WKH%RXLQ¶V VROXWLRQ WUDQVIHUUHG WRDFOHDQ
35mm petri-dish and a small drop of distilled H2O was added to wash off any excess 
fixative solution. At the same time a small amount of Optimum Cutting Temperature 
(OCT) embedding medium (Tissue Tek) was placed onto a cork disc ready for the 
sample to be added. Using a dissecting microscope (Olympus SZ51), the tissue was 
cut in half using a 22 size scalpel blade to give 0.5mm cross sectional segments which 
could then be transferred to the OCT using fine forceps. The tissue was then 
orientated so the lumen was facing up and the OCT coated disk was immersed face up 
into liquid N2 cooled isopentane allowing for the rapid freezing of tissue specimens. 
This was achieved by placing the isopentane liquid into a plastic pot which fits over 
the liquid N2 container. The isopentane freezes immediately but thaws slowly as it 
was left at room temperature (RT) to give the desired temperature of -116Û& IRU
freezing tissue samples. This was then repeated for each sample to be analysed. The 
freshly frozen samples were then transferred to a cryostat shown in Figure 3.3.1-1 
(Leica CM1900). OCT was added to a cryostat chuck before the cork discs were 
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quickly removed from the isopentane and glued on to the cryostat chuck. The samples 
were then left in the cryostat which was maintained at -Û&IRUPLQs to allow them 
to adjust to the temperature difference at which point the samples were then ready for 
cutting.  
 
3.3.1. Cryostat tissue sectioning  
 
The cryostat has two temperature settings one for the knife blade and the 
second for the anti roll plate (Figure 3.3.1-1). For our blood vessels, the cutting blade 
was set to -Û&ZKLOHWKHDQWLUROOSODWHZDVDGMXVWHGWR-Û&7KLVZDVWKHRSWLPXP
temperature that prevented the tissue slices from rolling up after each cut was made. 
The OCT was firstly trimmed by sectioning with a fresh knife blade until a complete 
tissue section could be seen.  
 
Freezing 
Chamber 
Handle
(rotate clockwise)
Control 
Panel
A B
Anti roll 
plate
Tissue 
sample
Knife blade & 
holder 
Cryostat 
chuck
 
Figure 3.3.1-1 showing the Leica CM1900 that was used to prepare the tissue sections. A 
shows the large chamber which maintains the different temperatures for the knife blade and 
the anti-roll plate. B shows the knife blade in more detail. The handle is used to slowly move 
the anti-roll plate and bring the sample into close contact with the knife blade. The thin 
sections can be collected directly onto glass slides which have been kept at RT.    
Chapter 3 
Materials and methods  
68 
 
 
The instrument parameters were set to give 5µm thick slices. The section was 
then picked up using a gelatine coated slide (76 x 26 x 1.2mm, VWR). This was done 
by holding the slide using a thumb and forefinger and the slide was carefully lowered 
through the open cryostat window and was held over the slice for a few seconds. This 
adhered the sample on to the slide which was then viewed using an inverted 
microscope (Olympus GX41) to ensure a complete vessel cross section had been cut 
and check that no folding had occurred. The slides were allowed to dry at RT and the 
tissue block was wiped clean with 100% acetone and a small brush to clear away any 
tissue debris ready for more samples to then be collected. The knife blade was then 
moved along horizontally to use a fresh cutting edge after each set of slices had been 
taken. 20 slices were taken from each vessel sample and stored in slide trays at RT.  
 
3.3.2. Haematoxylin and eosin (H&E) staining  
 
The H&E technique was used to stain vessels taken from CPA and SVA 
tissue. The slides were placed in a slide rack that can hold up to 10 slides so multiple 
slides can be treated at the same time. The slides were washed in running tap water 
for 5mins before placing them in 500ml glaVV MDU WKDW FRQWDLQHG 0D\HU¶V
Haematoxylin for 10minutes. The samples were then washed again in running tap 
ZDWHUEHIRUHZDVKLQJWKHPLQ6FRWW¶VWDSZDWHUVHHAppendix I for composition) for 
2mins to stain the nuclear chromatin and nuclear membranes blue. The samples were 
washed again in running water for 5mins before placing them in 1% eosin for 3mins.  
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After a brief wash in running water the slides were dehydrated using 
increasing concentrations of alcohol (70%, 90% and 100%) for 2mins each. The 
samples were then cleared using xylene for 5mins before mounting the slides with 
glass coverslips which had been freshly coated in DPX mounting medium and the 
sections were then ready for viewing. A light microscope (Zeiss Axiovert 25) was 
used to visualise the sections and images were captured using an Olympus DP70 
camera and Cell^F software (version 2.8). The Cell^F software programme also 
allows for measurements of the vessels including the wall thickness using the 
software programme for further analysis.  
 
3.3.3. IHC staining for vascular SMC  
 
IHC was performed to localise key proteins of interest in CPA and SVA 
samples. The frozen sections were placed on a slide rack and immersed in a 500ml 
glass staining dish with running tap water for 7mins. The slides were then transferred 
to a glass coplin jar which has been filled with chilled acetone to fix the samples for 
10mins. The slides were then washed in 0.1M PBS (see Appendix I for composition) 
for 5mins to remove any excess fixative. After air drying the slides each sample was 
ringed with a DAKO fine wax pen. This ensured that any antibody added would be 
concentrated over a small surface area while also allowing more than one antibody to 
be added to the same slide without contaminating neighbouring samples as well as 
reducing the volume of antibody preparation that was needed to immerse each 
sample. The slides were firstly blocked with 0.3% H2O2 for 20mins to block 
Chapter 3 
Materials and methods  
70 
 
endogenous peroxidase activity. After a 5min PBS wash the second blocking agent, 
20% horse serum in PBS, was applied for 30mins to block non-specific antibody 
binding. Following the blocking steps the slides were again washed for 5mins in PBS 
and placed face up onto a flat tray that was kept moist to prevent sample dehydration. 
Primary antibody (see Appendix II for dilutions) was placed on each sample for 2hrs 
at RT without any shaking. One sample of CPA and SVA was also incubated with 
multi link control IgG (1:100 dilution) as a negative control and the tray was encased 
in cling film to ensure the samples did not dry out. Following this, the slides were 
again washed in PBS for 5minutes, before the samples were developed using the 
Vectorstain Elite Kit (Universal) (Vector laboratories) following the manufacWXUHU¶V
instructions. This method uses a three stage avidin-biotin complex (ABC) where the 
avidin has four biotin binding pockets (Figure 3.3.3-1). This has the added advantage 
that the same secondary antibody can recognise both monoclonal and polyclonal 
primary antibodies raised in mouse, rabbit and goat species. Briefly 100µl of 
biotinylated secondary antibody was diluted in 5ml 20% horse serum in PBS and one 
drop was added to the samples and left at RT for 30mins. During this time the 
streptadavin-biotin complex was prepared by mixing 100µl of solution A to 100µL of 
solution B and diluted with 5ml PBS. This was left to stand for 30mins in which time 
the slides were then washed in PBS for 5mins before applying the ABC reagent for a 
further 30mins.  
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Figure 3.3.3-1 showing the principle behind the ABC complex. The method uses the ABC 
complex to amplify the signal of the bound secondary antibody. (Image adapted from 
Hoffman, Le et al., 2008).  
 
After a 5min wash in PBS, fresh 3,3' Diaminobenzidine (DAB) was added to 
each sample to localise the antigens. 20µl of DAB chromogen was mixed with 1ml 
buffer substrate and left on the samples for 5mins. Positive immunoreactivity with 
DAB caused the samples to develop to a brown colour. Following a 5min wash in 
3%6 WKH VOLGHV ZHUH FRXQWHUVWDLQHG ZLWK 0D\HU¶V +DHPDWR[\OLQ IRU PLQ ZKLFK
stained any tissue that did not react with the DAB blue. The samples were then 
washed thoroughly in running tap water for 5mins. The samples were then ready for 
the final dehydration steps in graded alcohols (70%, 90%, and 100%) for 1min each. 
The slides were then cleared using xylene before finally mounted using Dpex 
mounting medium. A glass cover slip (number 1 thickness, 22x50mm, VWR) was 
placed over the slides which were then left to dry overnight at RT before being 
imaged. This was repeated at least three times for each sample to confirm the results. 
A light microscope (Zeiss Axiovert 25) was used to visualise the sections and images 
were captured using an Olympus DP70 camera and Cell^F software (version 2.8). 
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3.4. Western blotting  
 
3.4.1. Tissue collection  
 
Paired samples of CPA and SVA were collected in order to make direct 
comparisons of protein expression within the same patient. The matched arteries were 
then washed in chilled homogenising buffer to remove any traces of blood before 
snap freezing in liquid nitrogen and storing at -80oC (described in Chapter 3.2.1).  
 
3.4.2. Control tissue  
 
Women undergoing ELLSCS were also consented for a MYO biopsy 
(described in Chapter 3.2). MYO biopsies were transported to the laboratory in chilled 
PSS and washed thoroughly in homogenising buffer before snap freezing in liquid 
nitrogen and storing at -80oC. Whole female non pregnant rat brain (RB) tissue was 
used as a further positive control tissue and was obtained from the Institute of Cell 
signalling at the University of Nottingham. Briefly adult Sprague Dawley rats were 
decapitated following the Animal Experimentation Act (1986), and the freshly 
removed brain was immediately frozen in liquid N2 and kept at -80ºC.  
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3.4.3. Tissue homogenisation  
 
Samples were removed from cold storage and kept chilled on ice while each 
buffer was also prepared and kept chilled on ice at all times. Mechanical 
homogenisation was the best method for turgid muscle tissue such as the MYO which 
is much tougher to get into suspension when using chopping alone. However a lot of 
heat is generated with this method which can denature the protein structures that we 
were interested in separating. As a result it was imperative to keep all the buffers 
along with the tissue samples chilled at all times. The method involved homogenising 
the tissue for short spurts and then immediately returning the sample to ice to keep the 
sample chilled. The first step of tissue homogenisation was to remove the tissue from 
the storage tubes and place on a glass petri dish placed over an ice bucket to keep the 
samples chilled. Using a 22 gauge scalpel blade that was kept on ice was used to chop 
the tissue into small pieces in homogenisation buffer (HB). To further maintain 
protein integrity the HB was supplemented with protease and phosphatase inhibitors 
added to fresh HB (see Appendix I for composition). As a general guide 1ml of buffer 
was added for every 0.5g of tissue used. The freshly chopped tissue was aspirated 
using sterile 3ml Pasteur pipette to a 14ml BD Falcon round bottom tube. The 
advantage of using a round bottom tube was that all the tissue can come into close 
contact with the homogeniser. The Heidolp DIAX 900 (Heidolh instruments, 
Schwabach, Germany) hand held homogeniser was then introduced into the tube and 
switched on for bursts of 1min followed by returning the tube to ice to allow the 
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clumps of tissue were in suspension and any tissue that still remained was discarded. 
Each sample was carefully prepared in this way after which each sample was then 
passed through a 21 gauge fine needle several times to break down any cells that 
remained in suspension.    
Following the physical breakdown of the protein structures that hold cells 
together we then used a series of centrifugal spins to separate the cell suspension. The 
first spin involved a crude spin to remove tissue clumps centrifuging at 1,000g for 
10mins at 4oC. The resulting supernatant (supernatant 1) was collected and separated 
from pellet 1 and transferred to a clean 2ml eppendorf tube, before being centrifuged 
again at 15,000g (EBA 12R Hettich) for 90mins at 4ºC to pellet the cell membranes 
(pellet 2) and the cytosol (supernatant 2). Pellet 1 was discarded and 200µl of 
Solubilisation buffer was added to pellet 2 which was also vortexed and sonicated 
using an Ultra-Turrax sonicator (VWR) for 15mins on ice before being centrifuged 
again at 1000g, 10mins at 4oC and stored at -80oC. The supernatants 1&2 along with 
pellet 2 would contain a mixture of crude cell pellets and the preliminary data showed 
that supernatant 2 produced the best isolation of cell fractions with the least red blood 
cell (RBC) contamination and was used for all of our subsequent experiments.   
 
3.4.4. Protein determination  
 
The bicinchoninic acid (BCA) assay was chosen and relies upon a change in 
colour on a reduction of Copper (Cu2+) to Cu+ in the presence of proteins. Proteins 
react with alkaline Cu2+ to produce a cuprous cation which in turn reacts with BCA to 
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produce an intense purple pigment. The intensity of the coloured product will be 
directly linked with the concentration of the protein and can be measured using 
spectrometry at a peak absorbance of 562nm. A standard curve was then generated 
based on a known concentration of protein. In the BCA assay the values for the 
bovine serum albumin (BSA) standards were used to produce a calibration graph and 
the straight line equation was used to determine the concentration of protein in the test 
samples (Figure 3.4.4-1).  
 
 
Figure 3.4.4-1 showing the standard curve obtained from BSA controls. This was used to 
calculate protein concentration of our unknown CPA and SVA samples.  
 
BSA protein standards were firstly prepared at concentrations of 0, 0.05, 0.1, 
0.2, 0.4, 0.6, 0.8, and 1 mg/ml from a stock solution of 10 mg/ml of BSA prepared in 
0.9% NaCl. A small aliquot of crude cell pellets (pellet 2, and supernatant 1&2) were 
GLOXWHGWRLQLQ1D&OȝORIHDFKVDPSOHwas added in duplicate to a 96-
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well plate along with ȝORIfreshly prepared BCA working reagent (BCA with 2% 
Copper Sulphate (CuSO4)) was also added to each well. The plate was then left at 
37ºC with gentle agitation for 30mins. The absorbance was subsequently read at 
562nm using a Thermo plate reader (MultiSkan ® Spectrum and Skanlt ® software 
version 2.2) and the final concentration of samples (mg/ml) was determined.  
The final step in preparing samples prior to Western blotting was the addition 
of a denaturing sample buffer. The bonds that hold the subunits together such as 
disulphide bridges common to K2P ion channels form large protein structures and 
need to be disrupted to obtain a quality separation with electrophoresis. This also has 
the advantage that the buffer protects the proteins from further degradation and further 
adds colour to the colourless samples to trace their progression on a gel. Samples 
were diluted in Laemmli loading buffer (see Appendix I for composition) with the 
reducing agent 2% 2-ȕPHUFDSWRHWKDQRO -ȕ0( O IRU HYHU\ O RI VDPSOH
buffer) to achieve a final concentration of 3ȝJȝOODOLTXRWVRIHDFKVDPSOH
were prepared to be used for each experiment to avoid repeated freeze-thaw cycles 
and stored at -80ºC.  
 
3.4.5. SDS PAGE Electrophoresis 
 
The first step in Western blotting is to separate the mixture of proteins within 
the tissue lysate according to the molecular weight of the proteins. Sodium Dodecyl 
Sulphate Polyacrylamide Gel Electrophoresis (SDS-PAGE) was developed as a 
method to separate proteins according to their size and charge (Tiselius, 1937, 
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Towbin, Staehelin et al., 1979). The Bio-Rad mini-protein II electrophoresis unit was 
used and the resolving gel (see Appendix I) was freshly prepared and poured in 
between two glass plates and left to polymerise for 30-40mins. For the present study a 
10% polyacrylamide resolving gel (30% Bis-acrylamide stock solution) was prepared 
to get a better separation of the larger sized proteins (100-150 kDa) using the method 
originally described by Laemmli (1970). Hydrated isobutanol was added to the gel to 
reduce any drying and to prevent any contamination entering from the atmosphere. 
Once the gel had set, the isobutanol was washed off and a 4% stacking gel (see 
Appendix I) was poured directly over the resolving gel and a 10-lane comb was 
carefully slotted in. The placental CPA and SVA samples along with MYO and RB 
were removed from -80ºC storage and denatured by boiling the samples at 95ºC for 
5mins before transferring to ice ready for electrophoresis. Kaleidoscope pre stained 
molecular weight markers (BioRad) were loaded with each gel to monitor the 
migration of proteins. Equal amounts of tissue lysate were added to each lane and 
then resolved by electrophoresis on a 10% (w/v) polyacrylamide resolving gel and 4% 
stacking gel immersed in running buffer (see Appendix I) for 1hour at 40mA (20 mA 
for each gel) and has been shown in Figure 3.4.5-1.  
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Figure 3.4.5-1 showing the Bio-Rad mini-protein II electrophoresis unit. Each sample 
was carefully loaded into separate lanes. The blue dye front line shows the migration of the 
samples and the run was stopped when the dye front reached the bottom of the gel.  
 
3.4.6. Electroblotting  
 
The next stage required the transfer of separated proteins from the acrylamide 
gel to a nitrocellulose membrane so that the target proteins can be probed. The 
method involves using pressure to drive proteins from the negative electrode towards 
a membrane (nitrocellulose or PVDF) at the positive electrode (Figure 3.4.6-1). At 
this point it was vital to prevent protein damage as the high pressure used generates 
heat as a waste product and this could damage the protein structures and reduce the 
quality of the transfer. As a result all transfer buffers were kept chilled, the ice cooling 
unit was stored at -80ºC prior to use and the whole transfer was carried out inside a 
cold room (4ºC). The resolved gels were removed from the glass plate and placed in 
the middle of a sandwich of filter pads, filter paper along with a nitrocellulose 
membrane (Geneflow, 0.2µM pore size) ready to be electroblotted onto. The 
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sandwich was then tightly secured inside a cassette and the whole component was 
held in an electrode module (Figure 3.4.6-1) and filled with ice cold transfer buffer 
(Appendix I). This wet transfer prevents the gel from shrinking under the high 
temperatures that are generated as the voltage is held constant. The electroblotting 
was carried out using a BioRad wet blot system for 2hrs at 100V constant in a cold 
room. As the transfer buffer was prone to heating up at this high voltage setting it was 
replaced with fresh chilled buffer after 1hr. After electroblotting was completed the 
membrane was removed from the cassette and the proteins could be visualised using 
non-specific Ponceau S red solution (0.1% Ponceau, 5% acetic acid v/v). The solution 
was poured over the entire membrane and was used to assess the success of the 
transfer. The Ponceau S stain was washed out with Tris Buffered Saline (TBS) (pH 
7.4) with 0.1% v/v Tween (TBS-T) for 5mins and the blots were then ready for 
blocking.  
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Figure 3.4.6-1 showing the assembly of the transfer sandwich. The entire transfer 
apparatus was placed in a chilled room to minimise the build-up of heat during the transfer. 
Image obtained from http://www.currentprotocols.com/protocol/ns0519 
 
3.4.7. Blocking & antibody application  
 
Before the proteins could be probed with specific antibodies non-specific 
binding was blocked. The nitrocellulose membranes have a high affinity for proteins 
so it was vital to firstly block any unbound regions of the blot with a large protein 
such as BSA or the equally effective Marvel non fat milk solution. Previous work in 
the lab has shown that the ideal concentration to use was 7% w/v non fat dry milk 
(Marvel milk) in TBS-T for 1h at RT with gentle agitation by hand every 10mins. The 
blots were then washed twice with TBS-T for 1min each before application of the 
primary antibodies (see Appendix II for dilutions) prepared in 3% w/v marvel 
milk/TBS overnight on a gentle shaker at 4ºC.  
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3.4.8. Control peptide blocking 
 
The primary antibodies for each ion channel of interest (Alomone) were each 
supplied with a control peptide which is designed to validate the specificity of the 
DQWLERG\7KHSHSWLGHZDVSUHSDUHGXVLQJ WKHPDQXIDFWXUHU¶V LQVWUXFWLRQVZKHUH WKH
peptide was added to an antibody preparation in excess. The peptide will 
competitively bind to the antibody and as a result prevent the antibody from binding 
to the target epitope. This should then prevent the detection of the target band in each 
sample when the secondary antibody is applied. If control peptide was not available, 
the primary antibody was replaced with control IgG (1:1000) instead.  
 
3.4.9.  Ⱦactin measurement 
 
Each Western blotting experiment is prone to fluctuations which may be 
caused by the inconsistent transfer of protein, or protein degradation due to heating. 
To ensure consistency in the data analysis the total protein content of each sample 
needed to be quantified. After each target protein was detected the same nitrocellulose 
PHPEUDQHZDVXVHGWRGHWHFWWKHKRXVHNHHSLQJSURWHLQȕDFWLQ(Ferguson, Carroll et 
al., 2005). The blot was stripped of any bound antibody using a mild alkaline based 
stripping solution (ReBlot Plus, Chemicon International) for 20mins. The solution 
was then removed and the blot was once again washed in TBS-T and blocked using 
5% marvel milk solution in TBS-T for 90mins at RT. The blots were then washed 
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twice with TBS-7IRUPLQHDFKEHIRUHDSSOLFDWLRQRI WKHȕ DFWLQ DQWLERG\
dilution) prepared in 3% w/v marvel milk/TBS overnight on a gentle shaker at 4ºC.  
 
3.4.10. Secondary antibody & data analysis  
 
Secondary antibodies conjugated to an enzyme will initiate a chemical 
reaction to emit chemiluminescence that can be visualised at a specific wavelength. 
The alkaline phosphotase (AP) method uses a hydrolase enzyme that removes 
phosphate groups to initiate a colour change that can be viewed directly using 
chemiluminescence. The advantage of AP conjugated antibodies is that the enzyme 
reaction is stable allowing for the blot to be exposed for longer without any loss of the 
signal intensity. During the course of our studies, the secondary antibody supplied 
from Dako was withdrawn from production. As a result we obtained an alternative AP 
conjugated antibody obtained from Sigma used at a dilution of 1:30,000. Each sample 
was then re-analysed using the new secondary antibody to ensure the accuracy of our 
initial observations.  
After removing any unbound primary antibody with six 5mins washes in TBS-
T the blots were incubated with either goat anti mouse or goat anti rabbit AP 
conjugated secondary antibodies in 3% w/v marvel milk protein/ TBS for 2h at room 
temperature. The blots were then washed again in TBS-T (6x 5mins washes) and 2x 
5mins washes in TBS. The blots were then ready for developing using the nonisotopic 
chemiluminescent detection system Immuno-Star-AP kit (BioRad). The enhancer and 
substrate were combined accorGLQJ WR WKH PDQXIDFWXUHU¶V LQVWUXFWLRQV DQG DGGHG
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evenly to the nitrocellulose membrane which was then protected from direct light. 
After 10mins the excess solution was removed and the blot was viewed using a 
Chemi-Doc imaging system and images were analysed with the BioRad Quantity one 
software (Version 4.5.1 Build 059). Control blots were analysed alongside and each 
PHPEUDQH ZDV H[SRVHG IRU PLQV HDFK 7KH DXWR H[SRVH RSWLRQ VWRSSHG WKH
exposure at the same saturation level (315 pixels) after which the background 
intensity would begin to distort the image and prevent any valid analysis to be 
completed. Both the average and total band intensities were measured after removing 
the background intensity levels using the rolling disc option. This was done for each 
individual lane. The software was also used to approximate the molecular weight of 
the proteins identified using the pre-stained molecular markers as a general guide. The 
pre-stained markers were used to primarily assess the efficiency of the transfer, and 
the different coloured bands provide a rough guide for sizing the different protein 
bands on the gel. All Western blotting experiments were repeated at least three times 
for each patient (N) sample and both the mean ± SEM along with median ± 
interquartile range (IQR) were recorded. Protein expression of the ion channels of 
interest were compared with the Shapiro-Wilk normality test. Multiple means for 
unpaired samples were compared using two way Analysis of variance (ANOVA) 
(non-parametric) with Bonferroni post hoc test while paired observations were 
DQDO\VHGXVLQJWZRWDLOHGVWXGHQWV¶t test (parametric). p values <0.05 caused rejection 
of the null hypothesis.  
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3.5. Culturing SMC  
 
3.5.1. Culturing SMC from CPA and SVA explants  
 
All work was carried out in a sterile Class II bio safety cabinet using aseptic 
techniques. SMC were cultured using explants of CPA and SVA based on the 
methodology of Leik (et al., 2004). The isolated tissue segments (described in Chapter 
3.2.1) were placed in warm Hanks Balanced Salt Solution (HBSS) (See Appendix I 
for composition). The freshly dissected vessels were then cut down the length of the 
artery to expose the lumen and 1mm2 square pieces were placed with the endothelium 
facing down on to a 12-well plate. After a period of 2-4mins sufficient Dulbecco's 
Modified Eagle Medium (DMEM) (See Appendix I for composition), tissue culture 
medium supplemented with 10% (v/v) heat inactivated fetal bovine serum (FBS), 100 
units/ml penicillin and 100µg/ml streptomycin was added to each well. The culture 
plates were then left overnight in a 37oC incubator supplied with 5%CO2/95% air. The 
media was removed after 24hrs and replaced with 2ml of fresh DMEM added slowly 
so as not to dislodge the explant. This allowed the explants to adhere to the culture 
plate and prevent the tissue piece from floating in the medium. Explants that attached 
immediately showed signs of cell growth in the shortest space of time and gave the 
highest yield of cells from a single explant (Figure 3.5.1-1A&B). Following this 
initial media change the media was then replaced every 2-3days.  
Chapter 3 
Materials and methods  
85 
 
After a period of 3-4wks the growing cells could be sub-cultured by simply 
removing the explant and detaching the cells to transfer them into a T-25 tissue 
culture flask. Firstly cells were serum starved overnight to remove any endothelial 
and fibroblast cells which may be contaminating the population of smooth muscle 
cells. The cells were then washed twice in HBSS to remove any serum followed by 
incubation in 0.125% Trypsin-ethylenediaminetetraacetic acid (Trypsin-EDTA) for no 
more than 3mins. The cells were encouraged to disperse by gently scraping the 
bottom of the plate with a broad tipped sterile Pasteur pipette in a circular motion. The 
detached cells were supplemented with FBS and transferred to a 15ml universal and 
centrifuged at 125g 21oC for 5mins. The resulting pellet was washed for a second 
time in HBSS to remove any traces of Trypsin-EDTA and finally re-suspended in 
complete DMEM media and seeded in a new T-25 flask to use in further experiments. 
Following this first passage further subcultures were restricted to only two further 
passages.  
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Figure 3.5.1-1 shows culture of SMC from tissue explants of CPA (A) and SVA (B). Cells 
from CPA explants can be seen after 5 days (C) and reach confluency after 14days (E). E also 
shows cells growing in sheets and the clear space in the centre represents the area where the 
explant (E) once was. In contrast SVA took a lot longer to show signs of cell growth. At the 
same time point (D) a few isolated cells can be seen (white arrows) around the explant and a 
smaller population of cells can be seen after 14days in culture (F). Scale bar 500µm A&B. 
200µm C-E.   
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3.5.2. Culturing SMC from MYO  
 
MYO tissue from non labouring patients (described in Chapter 3.2) was used 
to isolate SMC to be used as a positive control for the antibodies to be tested. The 
freshly collected tissue was immediately washed twice in HBSS and transferred to a 
60mm petri dish and finely minced in 10ml collagenase A (2mg/ml) in HBSS using a 
sterile size 22 scalpel blade. The tissue suspension was then incubated with the 
enzyme solution for 1 hour at 37ºC with gentle trituration every 20mins. The cell 
suspension was then diluted in 5ml HBSS and centrifuged at 100g for 5mins. The 
resulting pellet was washed and centrifuged again twice in HBSS to remove any cell 
debris and finally re-suspended in 5ml of DMEM in a T-25 flask. The media was 
firstly refreshed after 18h and then replaced every 3 days. The cells became confluent 
after 5 days at which point they were ready for fixation (Chapter 3.6.1).  
 
3.5.3. SH SY57 cells  
 
The K2P class of ion channels are reported to be highly expressed in 
mammalian brain tissue (Ketchum, Joiner et al., 1995). As a result further positive 
control of rat brain cells in culture were also included. SH SY57 cells are a 
commercially available neuroblastoma cell line originally cultured from human neural 
tissue and were cultured from frozen cell suspensions that were stored in liquid N2. 
7KH JURZWK PHGLD XVHG ZDV (DJOH¶V PLQLPXP HVVHQWLDO PHGLXP 0(0
(supplemented with 1% essential amino acids and 0.5% sodium pyruvate) mixed with 
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equal amounts of F-12 Ham nutrient mixture (1:1). To prepare the working solution of 
growth media for the cells MEM/F-12 was supplemented with 15% (v/v) FBS and 
100 units/ml penicillin and 100µg/ml streptomycin. Frozen cell pellets were removed 
from storage (liquid N2) and thawed immediately before being transferred to a T-25 
flask with 5ml growth media. Once the cells reached confluence they were then 
transferred to a new culture flask (described in Chapter 3.5.1) and used immediately. 
The cells used were limited to passages 35-40 and were not re-frozen after the final 
passage.  
 
3.6. Immunofluorescence (IF) of SMC 
 
In order to confirm the identity of the freshly cultured CPA and SVA explants, 
cells were stained for markers found specifically in SMC. ThiVLQFOXGHGĮDFWLQZKLFK
is expressed by smooth muscle cells while vimentin is expressed in cells of 
mesenchymal origin and as a result would be predicted to be positive across a range 
of placental cells. Cells were also stained for markers of the endothelium (von 
Willebrand factor & CD31), Fibroblast and leukocytes (CD45) to evaluate the purity 
of our culture population (not shown). In addition to identifying the presence of the 
key cell markers a range of antibodies raised against the CaV1.2, BKCa, KATP, and the 
K2P family of ion channels (TASK 1/3, TRAAK, TREK 1/2 and TWIK-2) were 
included to determine their expression in placental vascular SMC and a full antibody 
list along with working dilutions have been summarised in Appendix II.  
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3.6.1. Fixation of cells  
 
Fixation is the first step that aims to preserve all the cell components and 
prevent cell damage from cell swelling. For our investigation we sought to examine 
membrane bound antibodies so it was imperative that this was not damaged during 
this process. As a result we chose to use paraformaldehyde (PFA) which is the 
preferred method for examining sensitive proteins that may be susceptible to damage 
when using more harsh alcohol based fixatives such as acetone/methanol (Ryter, 
1988). Briefly cells were seeded at a density of 4x105 onto sterile round glass slides 
(35mm; VWR) which were placed in a 24 well plate in advance. Cells were allowed 
to reach confluence (usually 1-2days) before being placed in low serum media (2% 
FBS) and used for fixation. The media was then aspirated off and the cells were 
washed twice in HBSS followed by two gentle 5min washes in  ice cold PBS (pH 7.4, 
Sigma). Each well was then incubated with 4% PFA w/v (see Appendix I for 
composition) for 20mins and any unattached cells were washed off using three short 
PBS washes. A further permeabilisation step was introduced by treating the cells with 
0.5% v/v Igepal in PBS for 15mins at 4oC which helps to aid antibody penetration into 
the cell body. The detergent introduces small punctate holes into the cell membrane to 
enable the epitope to cross the cell boundary (Ryter, 1988).   
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3.6.2. Blocking of non-specific binding sites 
 
Once the cells were fixed they were ready for the blocking stage which is 
important for preventing any non-specific antibody binding. In the first instance the 
fixed cells were blocked for the primary antibody with 3% bovine serum albumin 
(BSA)/1% glycine in PBS for 15mins and then blocked with a mixture of 10% goat 
and 10% chick serum in PBS. After 1h the blocking solution was aspirated and either 
a single antibody (either mouse monoclonal or rabbit polyclonal) (see Appendix II for 
dilutions) or a cocktail mixture of two different primary antibodies VXFKDVĮDFWLQ	
TREK-1 (for dual staining) were freshly prepared in 10% goat serum/10% chick 
serum in PBS and were added to each well (200µl) and left overnight at 4ÛC with 
gentle shaking. A negative control was also used where primary antibody was 
replaced with either control IgG or peptide that had been incubated with the 
UHVSHFWLYHLRQFKDQQHODQWLERG\IROORZLQJWKHPDQXIDFWXUHU¶VLQVWUXFWLRQV (described 
in Chapter 3.4.8). On the following morning, excess primary antibody was removed in 
three 5min washes with chilled PBS. 
 
3.6.3. Secondary antibody application & evaluation  
 
Fluorescent tagged secondary antibodies were used to reveal the location of 
bound primary antibody. The advantage of this method is that the sample will only 
fluoresce when an external light source is introduced to excite the electrons 
(excitation). As the electrons lose this energy they return to the ground state and emit 
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the gained energy in the form of light which can be imaged using a microscope 
(emission). Once the light source is removed the sample will return to its unexcited 
state and for this reason the sample was wrapped in foil to protect it from any direct 
light in between viewings (Paddock, 2000). The culture plate was wrapped in foil to 
protect it from direct light and each well was incubated with a cocktail of both anti 
mouse fluorescein-5-isothiocyanate (FITC) and anti rabbit Tetramethyl Rhodamine 
Iso-Thiocyanate (TRITC) conjugated secondary antibodies (see Appendix II for 
dilutions) in 10% goat and 10% chick serum in PBS for 1.5h in the dark with gentle 
shaking. The wells were then washed three times in PBS for 5mins each. At this point 
the nucleus was also stained using fresh DAPI (1:5000 working dilution in PBS). This 
was added to each well after the final PBS wash for 10mins and then washed 
repeatedly again with PBS. After the final PBS wash the samples were then left in 
PBS: glycerol (1:1 v/v) and were then ready for mounting.  
 
3.6.4. Slide preparation  
 
The cells were viewed using a confocal microscope. In preparation for this 
stage the round glass slides were removed from the 24-well plate using fine forceps 
and placed face up onto a clean glass slide (76x26x1.2mm VWR). This was then 
coated with a drop of PBS: glycerol before a second glass coverslip (22x50mm VWR) 
was carefully placed on top avoiding any air drops that may form. The slides were 
stored in a slide box DWÛ&UHDG\IRUYLHZLQJ 
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3.6.5. Confocal IF  
 
Confocal microscopy is an advancement of IF and has allowed the generation 
of 3D images of cells with much higher resolution. The main difference is that light 
emitted from the specimen is reflected back through a pinhole greatly reducing the 
background light that can distort images when using IF alone (Figure 3.6.5-1). The 
further advantage with this method is that the microscope gives a much more shallow 
depth of field and the ability to collect serial optical sections to form a detailed image. 
The serial sections or Z stacks can then be used to reconstruct the image using image 
software to reconstruct a 3D image of the tissue or cell (Sheppard and Wilson, 1981, 
Paddock, 2000). A further benefit for our investigations is that more than one laser 
can be used simultaneously making it possible to view two differently labelled 
proteins within the same focal plane.   
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Figure 3.6.5-1 showing how a confocal microscope captures images. The important 
difference with confocal IF imaging is that a pin hole restricts the amount of background haze 
that can distort the image and results in a higher resolution image which can be viewed at 
higher magnifications. Image obtained from  
http://www.microscopyu.com/articles/confocal/confocalintrobasics.html.  
 
Mounted slides were placed face down on the slide stage and viewed using a 
Leica TCS SP2 confocal microscope with Acousto-Optical Beam Splitter (AOBS) 
scan head and a 63x glycerol immersion objective lens. Images were captured using 
three laser lines in single scans to eliminate any overlap between the channels. DAPI 
IF was viewed using an Ultraviolet laser (372 nm excitation and 385nm emission). 
FITC was viewed using 488 nm excitation with 505-530 emission (Argon laser) and 
TRITC was viewed with 546nm excitation and 560nm emission (Helium//Neon laser) 
(Figure 3.6.5-2). Each slide was viewed at 3 different magnifications to focus on a 
cluster of cells and then narrow down the field of view to then magnify a single cell.  
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Figure 3.6.5-2 showing the stages involved in capturing the confocal IF image. Once the 
field of view had been selected a range of options needed to be inputted into the software. 1. 
Shows the option for sequential scan as selected. 2. Shows the filters that have been selected 
(FITC and TRITC) The wavelength to be examined can be defined to ensure there is no 
overlap between different lasers. 3. Shows the order in which the microscope will capture 
each image between frames so that a FITC and then a TRITC image was taken across the 
same focal point.  
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3.6.6. 3D images  
 
Following IF staining using SMC specific markers, we were next interested in 
investigating the expression of key ion channels that may be involved in the control of 
placental vascular tone. This was performed using confocal microscopy in order to 
capture high resolution images of each cell population. A Z stack was taken across the 
cell at changing depths which can be merged in to a maximal  projection to show the 
cell in its entirety. The separate stacks were also used to create a 3D image of the cell 
for further analysis. This also allows for high resolution images to be taken of 
intracellular structures and more importantly to identify the precise location of our ion 
channels of interest within SMC.  
 
3.6.7. Confocal image analysis  
      
Three representative pictures were taken of each SMC population and Z stacks 
were collected by taking images at every 2-5µm to form a complete image. The 
separate stacks were then merged to form a single 3D projection and subsequent 
analysis of the individual distribution pattern for each channel was analysed using 
Leica Microsystems software (LCS 2.5 1347). Co-localisation of a chosen protein was 
investigated to determine the interaction with a second protein of interest. This was 
performed by examining the pixel distribution of the merged images and quantify the 
amount of yellow colour which represents areas of co-expression. A region of interest 
(ROI), such as the nucleus, was selected using the Leica software (Leica 
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Microsystems LCS 2.5 1347) to examine the linear distribution of the stain across the 
complete image. This was done to help to identify the peak intensities of the IF stain 
as the objective lens was moved through the cell.  
 
3.6.8. Method optimisation  
 
Two different markers were applied to the same cell to stDLQIRUH[SUHVVLRQRIĮ
actin confirming the SMC identity along with the ion channel of interest. This was 
possible through the use of different fluorescently tagged antibodies that recognise 
mouse PRQRFORQDOĮDFWLQDQGrabbit polyclonal primary antibodies (ion channels). 
The different excitation wavelengths required for each respective florescent tagged 
secondary antibody meant that two different proteins could be localised within the 
same cell. The nucleus was also labelled using DAPI (blue) in addition to identifying 
our proteins of interest. However this introduced an additional problem as ĮDFWLQZDV
also now positive within the nucleus which had not previously been seen when using 
single IF staining (Figure 3.6.8-1) and could not be resolved altering the balance of 
the filters intensity. One explanation for this may be due to the fact that DAPI is a 
strong staining molecule and some excess secondary FITC and/or TRITC conjugated 
antibody has bound to the DAPI molecule. As a result we opted to firstly reduce the 
concentration of the secondary antibodies (Appendix II) and the DAPI step was 
removed.  
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Figure 3.6.8-1 showing confocal microscopy of IF staining along with DAPI to stain the 
nucleus. The main problem encountered was that ERWKĮDFWLQand in this instance TWIK-2 
were appearing positive inside the nucleus (white arrows) which had not been seen prior to 
DAPI staining. As a result this step was removed from the specimen preparation.  
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3.7. Wire myography 
 
Small vessels (200-500µm) offer the most resistance to the flow of blood and 
set the overall peripheral resistance (Bevan and Osher, 1972, Mulvany and Aalkjaer, 
1990). Peripheral resistance will determine the cardiac output, maintain systemic 
blood flow and regulate organ blood flow. Wire based myography uses ring 
preparations to observe the mechanical properties of vessels in vitro (described in 
Chapter 1.9.2). The method involves recording the amount of force (millinewtons 
(mN)) generated on two parallel wires that have been introduced inside the lumen of 
the blood vessel. The force generated by the contracting vessel is then translated into 
isometric tension recordings which can then be analysed (Mulvany and Halpern, 
1977, Halpern, Mulvany et al., 1978, Davis and Gore, 1989). The main advantage of 
this technique is that vessel function can be studied in isolation. This is due to the 
intrinsic nature of vessels that develop basal and myogenic tone in addition to 
responding to external factors such as contractile agonists. The method involves 
dissection of the vessel from its surrounding tissue, before a defined segment is 
mounted onto two parallel wires that are connected to two jaws.   
An important first step with this protocol was to determine the experimental 
settings for the vessels. Each vessel within the vascular tissue will have its own 
optimum wall tension, termed passive tension, and increasing the amount of 
distension on the vessel will increase this tension. The internal vessel circumference 
has a positive relationship with the passive tension and for our studies the internal 
circumference needed to be set to a value (defined as L100) to accurately reflect the 
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circumference of the vessel at which the most active tension is produced while 
maintaining the conditions the vessel would be exposed to in vivo. This is primarily 
determined by the pressure of blood flowing which for example in adult rat arteries is 
100mmHg (13.3 kPa) (Mulvany and Halpern, 1977, Halpern, Mulvany et al., 1978).  
 
3.7.1. Artery preparation 
 
The CPA and SVA were dissected from the whole placenta as described in 
Chapter 3.2.1. The freshly cut tissue segments were immediately placed in warm PSS 
bubbled with O2 (see Table 3.7.7-1 for the different gas mixtures used). Starting at the 
chorionic plate, the tissue was then secured onto a 14cm petri dish filled with sylgard, 
using 25gauge needles, and then gently washed to remove any excess blood. The 
tissue was then stretched to reveal the translucent connective tissue and white dense 
arterial matter. The vessel was carefully dissected away from the surrounding tissue 
using a pair of Dumont microforceps (size 5, WPI) and mini vannas dissection 
scissors with superfine tips and viewed under a stereomicroscope (Olympus SZ60, 
Japan) with a fibre optic light source.  
The artery sample was then transferred to a 5cm sylgard petri dish and again 
secured using 25gauge (g) surgical needles. The connective tissue was dissected away 
from the arterial wall working along the vessel length in a clockwise direction. A 
small amount of connective was left in place to allow the vessel to be handled during 
the mounting procedure (described in Chapter 3.7.2). The clean vessel was cut in to 
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four 2mm segments using an eyepiece gratitude as a guide and transferred to the 
myograph chamber.  
The SVA were identified by continuing the dissection from the CPA. The 
SVA were then prepared in the same manner as CPA but a slightly different technique 
was employed to clean the vessel branches. The maternal portion of the placental 
tissue could be easily cleaned away from the vessels using the blunt end of a pair of 
dissection forceps to reveal a clean blood vessel. The sample was then transferred to 
the myograph chamber ready for mounting. The SVA required very little fine 
dissection and care was taken as to not to make contact with the arterial wall as this 
often caused an immediate clamping of the vessel lumen. The lumen could not then 
be manipulated in order to introduce the two fine wires and such vessels were not 
used for further analysis.  
 
3.7.2. Wire mounted arteries   
 
5ml of warm PSS was added to each chamber of the multi myograph system 
(Danish MyoTechnologies (DMT) myograph interface 610M version 2.2, Aarhus, 
Denmark). A 50µm tungsten wire was secured at one end of the jaw with the fixing 
screws (Figure 3.7.2-1B). The vessel was fed on the free end of the wire and 
positioned in the space between the two jaws before securing the wire with a second 
fixing screw. Care was taken to avoid any damage or stretching of the vessels to 
minimise the damage to the endothelium or artery by limiting the amount of vessel 
handling. A second wire was passed through the lumen and fixed to the opposite jaw 
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so that the two wires were in parallel and any remaining connective tissue is removed. 
Both wires were made taut to ensure the vessel segment was fixed in place within the 
myograph jaw. The remaining vessel segments were mounted in the same way and the 
myograph and one vessel was used as a time/vehicle control (described in Chapter 
3.7.10). The chamber was continually bubbled with O2 and the PSS was replenished 
every 15mins using vacuum suction (Figure 3.7.2-1A). The vessel was left to 
equilibrate for 1hr in oxygenated PSS and gradually heated to 37oC. The temperature 
of the myograph was continuously monitored with a temperature probe and PSS was 
replaced each time with equally warm bubbled PSS heated to 37oC using a water bath 
(SUB6, Grant instruments, Cambridge).  
 
A B
 
Figure 3.7.2-1 showing an individual myograph chamber. A shows the different 
components that comprise the complete myograph unit. The adjustable jaw is connected to a 
micrometer which can be used to distend the vessel. The second jaw is connected to a 
calibrated force transducer to measures the amount of force (mN) generated. B shows a vessel 
segment that has been mounted using two parallel wires. The vessel is positioned within the 
gap of the jaws and secured in place using the fixing screws (image adapted from 
www.dmt.dk). 
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An adjustable micrometer screw was used to separate the jaws and stretch the 
vessel between the two parallel wires. The calibrated force transducer (see Chapter 
3.7.3) measured forces between 0 and 30 mN. The force output was digitized with a 
PowerLab 8/30 (ADInstruments (ADI)) and LabChart software (ADI, Version 6.0) 
connected to a PC and data was collected at 10 Hz (Figure 3.7.2-2). 
 
4 tissue baths 
with vacuum 
suction
PowerLab data 
acquisition hardware
Dissection 
microscope
Myograph control 
panel
PC
 
Figure 3.7.2-2 shows wire myograph set-up which consisted of the dissection microscope 
and multi myograph system (DMT). Drugs and solutions were added directly to each bath 
and force generated was displayed on the control panel. The PC connected to the PowerLab 
recorder enabled viewing of the chart recordings in real time as well as storing of the data for 
further analysis.  
 
3.7.3. Calibration of force transducers 
 
The myography transducers were regularly checked and calibrated on a 
monthly basis using a myograph calibration kit (ADI). This involved tightly securing 
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a single wire to the jaw connected to the force transducer and the chamber was filled 
with warm PSS. The balance needle was secured in between the wire and the jaw and 
positioned into place over the myograph chamber using the bridge provided. A 2g 
weight was added to the balance which displayed the predicted force of 9.81mN. This 
was repeated for each chamber and the calibration was saved as a reference within the 
LabChart settings file.  
 
3.7.4. Normalisation procedure  
 
Following mounting of the arteries, the next step was to normalise the 
experimental conditions was undertaken. The aim of this procedure was to firstly 
standardise the vessels by applying the same target resting pressures and secondly to 
record the internal circumference of the artery at the set target pressure (see Chapter 
3.7.5.1). The pressure applied refers to the hydrostatic pressures found in vivo is 
referred to as L100. The optimum setting for L100 was calculated for placental vessels 
and have been described in Chapter 3.7.5. The individual internal circumference and 
segment length were measured in order to calculate the effective pressure (Pi). The 
segment length was measured using an eye piece graticule and the internal 
circumference was calculated by measuring the distance between the two parallel 
wires using a calibrated micrometer screw (Figure 3.7.4-1). These readings were then  
used to calculate the Pi using the Laplace equation (Mulvany and Halpern, 1977). 
 
Effective pressure (Pi)  ZDOOWHQVLRQLQWHUQDOFLUFXPIHUHQFHȆ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Wall tension (mN/mm) =  measured force (mN)/2x segment length 
 
Distance between the two jaws
Wires
Vessel
a b
 
Figure 3.7.4-1 illustrating the parallel sheet that forms when the mounted vessel is 
gradually distended. Measurements of the circumference of the two wires (a&b) and 
secondly the distance between the two jaws (determined by the micrometer screw) were 
needed to calculate the internal circumference.  
 
Gradually distending the vessels increased the internal circumference and 
resulted in the wall tension also increasing. Figure 3.7.4-2 shows an original trace 
recording in real time of the step wise distension of the vessel which gradually 
increases the wall tension (mN). This was recorded following a 60sec delay and along 
with the vessel length measurement was then used to determine the effective pressure 
(kPa) value using the Laplace equation described above.  
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Figure 3.7.4-2 showing an original trace recording as the vessel was subjected to 
increasing stretch. Each mounted vessel was gradually distended using the adjustable 
micrometer screw and the force generated was recorded after a 60sec delay. The x axis shows 
time (mins) and the y axis measures force (mN).  
 
The effective pressure was determined for each distension step using LabChart 
software. The calibration factors (segment length and wire diameters) were firstly 
entered along with the micrometer reading. The effective tension was then calculated 
based on the force generated by the vessel at each step. This was repeated until the 
target effective pressure was exceeded and an exponential curve was then plotted. The 
point on the curve that corresponded to our set target pressure was then used to adjust 
the micrometer screw. The vessel circumference at rest (IC1) and normalised (IC100) 
were also determined and our target vessel diameters were between 200-500µm. Any 
vessel outside this range were excluded from further analysis. Following 
normalisation, the vessels were then left to equilibrate for a further 15mins.  
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3.7.5. Initial experiment settings 
 
3.7.5.1. Determining the ideal resting tension    
 
The resting tension of any vessel is dependent upon the type of artery and the 
specific tissue from which the vessel has been isolated. At the same time, the 
physiological responses should closely reflect the conditions found in vivo (Mulvany 
and Aalkjaer, 1990, McPherson, 1992). As a result the first objective was to define a 
resting tension to ensure our experiments were all standardised to allow for 
comparisons to be made between groups. The traditional resting tension of 13.3 kPa 
(100mmHg) has been described with wire myography studies that have utilised 
resistance sized adult blood vessels (Mulvany and Halpern, 1977, Mulvany and 
Warshaw, 1979). However 5.1 kPa represents the transluminal pressure recorded 
across the IVS of the placenta and had been used in the literature for examination of 
placental vessels (Kleiner-Assaf, Jaffa et al., 1999, Wareing, Crocker et al., 2002). As 
a result we chose to validate the importance of the different resting tensions on CPA 
responsiveness at the two normalisation values (both at 0.9L100 see Chapter 3.7.5.2). 
The baseline tension at 13.3 kPa was 2.23 ± 0.4 kPa which was significantly higher 
than the 5.1 kPa baseline pressure of 0.06 ± 0.08 kPa (p<0.05). The passive wall 
tension contributed to 23% and 7% of the total wall tension generated at 13.3 kPa and 
5.1 kPa respectively. The normalised internal diameter of the vessels at 13.3 kPa was 
626 ± 13µm while at 5.1 kPa the internal diameter was 485 ± 9 µm (p<0.001).  
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A cumulative dose-response curve has been shown in Figure 3.7.5.1-1 as CPA 
were stimulated with increasing doses of the agonist U46619 (10nM-1µM). A classic 
sigmoidal dose-response curve was produced under both experimental settings with a 
dose dependent exponential increase in active effective pressure (kPa) followed by a 
plateau phase as the vessel reached its maximal response. Altering the normalisation 
pressure to 5.1 kPa resulted in a significant decrease in the maximal contraction to 
U46619 and (RM-ANOVA, p<0.05) when compared to each dose of U46619 applied 
at 13.3kPa. The half maximal (EC50) and sub-maximal concentrations (EC80) of the 
agonist across the two resting tension settings were compared and found not to be 
significantly different (Table 3.7.5.1-1). The signal to noise ratio was calculated at the 
two resting tension settings where the active tension (signal (S)) was divided by its 
standard deviation (SD) (noise (N)). This was found to be greater when vessels were 
stretched to the 13.3 kPa (S/N=5.2) compared with S/N=2.9 (p<0.05) at 5.1 kPa. As a 
result of these combined differences, for the present study CPA and SVA were set to 
the target transluminal pressure of 5.1kPa for all subsequent experiments. This 
enabled the maximal response to be observed from the isolated vessels whilst also 
closely matching the conditions found in vivo (Kaufmann, 1982, McPherson, 1992, 
Wareing, Crocker et al., 2002, Wareing, Greenwood et al., 2003).   
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Figure 3.7.5.1-1 shows the dose-response for CPA (N=16) which have been stimulated 
with increasing doses of U46619. Lowering the resting tension to 5.1 kPa (open squares) 
caused a downward shift in the dose-response curve. Data points are expressed as mean ± 
SEM along with vessels treated (n) from placentae (N). *p<0.05, **p<0.01, ***p<0.001.  
 
Table 3.7.5.1-1 showing the two resting tension setting and the respective LogEC50 and 
LogEC80 values calculated from the U46619 dose-response cure for CPA.  
Normalisation 
pressure 
kPa (n) 
LogEC50(M) 
± SEM 
p LogEC80(M) 
± SEM 
p 
13.3 (16) -8.3 ± 0.2 ns -7.9 ± 0.3 ns 
5.1 (16) -8.4 ± 0.1 -8.1 ± 0.2 
 
3.7.5.2. Optimal working diameter (L100) 
 
In addition to the resting pressures, the optimum internal diameter settings 
needed to be determined in order to observe the most active tension of the vessel 
segments. The optimal working diameter was determined experimentally for both 
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CPA and SVA in order to find the balance between applying stretch to the vessel and 
obtaining the maximum reactivity. The extent of stretch applied will determine the 
active tension that is generated when the vessel is stimulated with an agonist. A series 
of incremental steps were used to increase the vessel diameter from 0.5-1.0L100 
(Figure 3.7.5.2-1) (L100 representing the circumference of the vessel at rest and 
exposed to a transluminal pressure of 5.1 kPa). At each proportion of L100, the passive 
tension was recorded after which the vessel was stimulated with a single maximal 
dose of the agonist U46619 (1µM) to measure the total tension generated by the 
vessel.  
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Figure 3.7.5.2-1 showing the experimental protocol for determining the optimum 
working diameter. The original trace shows each incremental step that was used to adjust the 
vessel diameters. The black arrows indicate the different IC1 settings. The vessel was 
stimulated with a single dose of U46619 (1µM) (red arrows) and the maximum response was 
then recorded for each setting. The vessel was allowed to recover before the protocol was 
repeated at the next normalisation setting which ranged from 0.5-1.0L100.  
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The exponential plots of total and passive wall tensions for CPA and SVA 
under increasing vessel circumference have been shown in Figure 3.7.5.2-2. The 
difference between the total tension and the passive tension gives a measurement of 
the active wall tensions generated at each diameter setting. It was found that the active 
wall tension peaked at 0.9L100 with both CPA and SVA and further stretching of the 
vessel caused a decline in the active wall tension. At 1.1L100 the average active tension 
was -0.07 mN/mm and 0.03 mN/mm for CPA and SVA respectively. The internal 
normalised diameter (IC100) also increased exponentially with increasing L100 
settings and CPA were found to exceed the 500µm mark (dotted line) when the 
LQWHUQDO FLUFXPIHUHQFH ZDV DGMXVWHG WR /100. In contrast the SVA, which also 
showed a linear increase in vessel diameter peaked at 378 ± 13.7µm with the highest 
setting. Based on this evidence the vessel circumference was adjusted to 0.9L100 for 
both CPA and SVA. At this experimental setting the internal normalised diameter 
(IC100) was 524 ± 0.84µm for CPA and 329 ± 13.7µm for SVA which was 
significantly lower (p<0.05).  
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A. CPA (14)
B. SVA (8)
 
 
Figure 3.7.5.2-2 shows how the optimal working diameter for CPA (A) (N=14) and SVA 
(B) (N=8) were determined. The respective total (closed squares + solid black line), passive 
(closed circles + dotted black line) and active wall tensions (closed triangle + dotted grey line) 
generated with increasing vessel diameter settings are shown. The exponential curves showed 
that wall tension increases as the vessel is placed under more stretch and peaks at 0.9L100 with 
both CPA and SVA vessels. The effect of increasing stretch on the normalised internal 
diameter has also been shown (right panel) where the dotted line represents 500µm. Data are 
expressed as mean ± SEM along with vessels treated (n) from placentae (N). 
 
3.7.6. Assessment of vessel viability  
 
The first contraction to U46619 was used as an internal standard for that 
individual vessel. 7KH WDUJHWPD[LPDO DFWLYH HIIHFWLYH SUHVVXUHZDVN3DZLWK WKH
highest dose of U46619 and was set as the target Pi for all subsequent experiments 
(Halpern, Mulvany et al., 1978). Any vessel which did not achieve this Pi was 
excluded from our studies and any vessel which exhibited a 10% loss in contractile 
activity during the duration of the experiment was also removed from further analysis. 
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60mM of high K+ PSS (KPSS) (see Appendix I for composition) was used to assess 
the vessel viability at the end of each experiment and has been shown in Figure 
3.7.6-1. An immediate response was produced as the vessel contracts; however this 
response was short-lived and the vessel returned to its resting tension. The vessel did 
not also return to the original baseline and required several washes with fresh PSS to 
replenish the resting ion gradients. As the KPSS response could potentially alter the 
K+ ion concentration within the cells, the KPSS stimulation was used as the final step 
of each experiment to measure the level of vessel activity that remained intact and any 
vessel which failed to respond to KPSS stimulation was also omitted from the study.    
5mN
10mins
Baseline  
60 mM KPSS  
 
Figure 3.7.6-1 shows the immediate contraction that follows stimulation with 60mM KPSS. 
The response was short lived as the vessel returns close to its baseline tension. The KPSS 
stimulation was used at the end of the experiment to assess viability.   
 
3.7.7. Effect of pO2  
 
The effect of altered partial pressures of O2 (pO2) on the responses of placental 
vessels was also investigated using three different gas mixtures (British Oxygen 
Company, (BOC) UK) to perfuse the myograph chambers (Table 3.7.7-1). At the 
Chapter 3 
Materials and methods  
113 
 
lower O2 settings (5% and 2%) the PSS was replaced each time with warm PSS that 
had not been freshly bubbled.  
 
Table 3.7.7-1 summarising the different pO2 settings that were used and the corresponding 
calculated partial pressures of O2 (pO2).  
O2 (%) Gas mixture pO2 (mmHg) 
20 95% O2/5%CO2 156 
5 90% N2/5%O2/5%CO2 38 
2 93% N2/2%O2/5%CO2 16 
 
3.7.8. Drugs and solutions  
 
Cumulative dose-response curves were completed using the agonists listed in 
Table 3.7.8-1 in 2min increments with a 5min plateau. Drug compounds added to the 
chamber were made up in stock solutions daily. The total additions of each compound 
made up <1% of the total chamber volume. Time controls or vehicle controls (diluent 
only) were also included in each experiment.  
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Table 3.7.8-1 summarising the different agonists that were used to stimulate placental vessels 
along with the concentrations applied.  
Drug Diluent  Concentration range  
applied 
1M D-Lactic acid PSS pH 7.4, 7.2, 7.0, 6.8, 6.6, 
6.4. 
1M Sodium Bicarbonate 
(NaHCO3) 
PSS pH 7.4, 7.5, 7.6, 7.7, 7.8, 
7.9, 8.0. 
Acetylcholine (ACh) PSS 10-10, 10-9, 10-8, 10-7, 10-6, 
10-5M. 
Arginine vasopressin (AVP) PSS 10-10, 10-9.5, 10-9, 10-8.5, 10-8, 
10-7.5, 10-7, 10-6.5, 10-6M. 
Bradykinin (BK) PSS 10-10, 10-9, 10-8, 10-7, 10-6, 
10-5M. 
Hydrogen peroxide (H202) PSS 10-10, 10-9, 10-8, 10-7, 10-6, 
10-5M. 
IM Hydrochloric acid (HCl) PSS pH 7.4, 7.2, 7.0, 6.8, 6.6, 
6.4. 
Linoleic acid (LA) PSS 10-9, 10-8.5, 10-8, 10-7.5, 10-7, 
10-6.5, 10-6M. 
Riluzole (2-amino-6-
trifluoromethoxy benzothiazole) 
(RIL) 
Dimethyl 
sulfoxide 
(DMSO) 
10-9, 10-8.5, 10-8, 10-7.5, 10-7, 
10-6.5, 10-6M. 
NS1619 PSS 10-10,10-9, 10-8, 10-7, 10-6, 10-
5M 
Sodium Nitroprusside (SNP) PSS 10-10,10-9, 10-8, 10-7, 10-6, 10-
5M 
U46619 (9,11-dideoxy-
11alpha,9alpha-
epoxymethanoprostaglandin 
F(Į)) 
 
PSS 10-10, 10-9.5, 10-9,10-8.5, 10-8, 
10-7.5, 10-7, 10-6.5, 10-6M 
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3.7.9. Measurement of vasoconstriction and vasodilatation  
 
The first contractile response produced by each vessel to a specific stimulus 
was used to calculate the maximum constriction and normalised to 100%. Figure 
3.7.9-1 demonstrates how the maximum and minimum recordings were taken from 
the original trace. This was converted to the maximum constriction (100%) using the 
equation (max-min) and all subsequent responses were measured against the first 
contraction and expressed as a %.  
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% Relaxation (y) = Maximum  constriction (100%)-
Constriction remaining (x)
 
Figure 3.7.9-1 showing how the maximum constriction was measured using the original 
trace recordings. The maximum tension was subtracted from the minimum/baseline tension 
and represents 100% constriction. All subsequent contractions were then normalised to this 
value. For vasodilatation, the % of the contraction that remained was used to give a measure 
of the total % relaxation across each dose applied (equation).   
 
Relaxation was then measured as the % loss in maximum constriction when a 
specific vasodilator was applied to the pre-constricted vessels. This measurement was 
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deduced from the difference between the maximum constriction (100%) and the 
contraction which remains and has been shown in Figure 3.7.9-1.      
 
3.7.10. Drug assessment  
 
A range of ion channel modulators and control blockers were used in our 
study and have been summarised in Table 3.7.11-1. Each compound was added 
directly to the chamber 20mins prior to stimulation and diffused into the tissue bath. 
The baseline tension was assessed pre and 5mins post addition of each 
pharmacological agent. One vessel was used a time control where no further drugs 
were added to the tissue bath or as a vehicle control where the solvent alone was 
added. Concentrations applied were based on experiments performed in our lab along 
with published literature.  
 
3.7.11. Data analysis  
 
The concentration response curves were analysed by fitting the data to the four 
parameter logistic equation;  
y=(y min) +  (y max-y min/1 +  10(logEC50 -x) 
 
Where y max is the maximum contraction achieved, y min is the minimum 
contraction achieved and y is the response. Data were presented as mean ± SEM with 
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the number of vessels (n) treated from number of placentae (N). Each separate 
experimental observation was made using a single patient sample without any 
duplication, and the former was used for statistical analysis. Retrospective power 
calculations at 80% difference were performed using the Altman Nomogram (Whitley 
and Ball, 2002) and a minimum of six independent experimental observations from 
six different patients were required in order to have sufficient data to observe a 
significant trend. Normal distribution of the data sets were initially determined using 
the Shapiro±Wilk normality test. The concentration response curves were plotted and 
compared using global curve fitting using GraphPad Prism version 5 (GraphPad 
Software Inc, San Diego, CA, USA). The top and bottom plateaus were constrained 
and shared and the logEC50 values were compared between groups. Analysis of the 
pilot data revealed that the fitting of a sigmoidal dose response (variable slope) was 
the most appropriate choice for constructing a dose response curve and this method 
was applied for all the subsequent data. Statistical significance between the values 
was calculated using a one-way ANOVA and the appropriate post hoc test for 
multiple comparisons was chosen (Dunnett's for the comparison against the time 
control and Bonferroni comparison for multiple pairs) at each individual 
concentration of the agonists used. A p value of <0.05 was considered to be 
statistically significant.  
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Table 3.7.11-1 summarising the different ion channels blockers that have been used along 
with the main ion channel that will be inhibited. L-NAME was used to block release of EC 
dependent vasodilators while NaCl and Choline Cl was used to control for Cl- and Na+ ions 
respectively. The optimised concentrations were based on preliminary experiments.  
Drug (Blocker of) Abbreviation Concentration Diluent 
4-aminopyridine (Kv) 4-AP 1mM PSS 
Amiloride hydrochloride (NHE) AMIL 10µM PSS 
Apamin (SKCa) APA 10µM PSS 
Barium chloride (TWIK-2) BaCl2 1mM PSS 
Bupivacaine (TASK 1/3) BUP 200µM PSS 
Catalase (H2O2) CAT 200U/ml PSS 
Choline chloride (C5H14ClNO) Choline Cl 125mM PSS 
Copper chloride (TASK) CuCl2 1mM PSS 
Curcumin (TREK) CURC 10µM Ethanol (EtOH) 
Glibenclamide (KATP) GLB 50µM DMSO 
Iberiotoxin (BKCa) IBTX 200nM PSS 
Lidocaine (TASK) LIDO 100µM PSS 
L-Methionine (TREK) L-METH 1mM PSS 
L-NG-nitro-arginine methyl ester (NOS) L-NAME 100µM PSS 
Methanandamide (TASK) M.ANAN 100µM EtOH 
Nifedipine (CaV) NIFED 10µM PSS 
Omeprazole (H+//K+ATPase) OMP 10µM PSS 
Ouabain (Na+//K+ATPase) OUAB 50µM PSS 
Quinidine (TWIK) QUIN 200µM DMSO 
Ruthenium red (TREK) R.RED 10µM EtOH 
Sodium chloride  NaCl 1mM PSS 
Tetraethylammonium (K+) TEA 5mM PSS 
Zinc chloride (TASK) ZnCl2 1mM PSS 
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4. Comparing the structure of CPA and SVA  
4.1. Introduction 
  
The structure of a blood vessel can reveal important information about its 
function and the relative distribution of SMC around the lumen can help in 
understanding the vasoactive responses produced by such vessels. The vessels across 
the maternal and fetal interface of the placenta will be subject to very different 
conditions and this may influence the structural development of the vessels. This in 
turn may have important consequences for vessel function. We hypothesise that CPA 
and SVA from term placentae have a different cross sectional structure.  
 
4.2. Objectives  
 
x To compare the size and relative wall thickness of CPA and SVA transverse 
sections.  
x Use IHC to examine the distribution of SMC and EC in each vessel type. 
 
4.3. Materials and methods  
 
Freshly obtained samples of CPA and SVA were fixed and prepared for 
cryostat sectioning using the method described in Chapter 3.3. H&E staining was used 
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to measure the general structural anatomy of each vessel cross sectional area. IHC 
was used to examine the mixed cell populations found within each vessel wall. TEM 
(Appendix V) was also undertaken to image the vessel cross sections for 
ultrastructural details.    
 
4.4. Results 
 
4.4.1. H&E of CPA and SVA  
 
A single CPA surrounded by connective tissue has been shown in Figure 
4.4.1-1A while the SVA image shows two arteries that have been isolated from a 
single villous branch imaged at the same magnification (Figure 4.4.1-1B). H&E 
staining of CPA revealed the anterior portion bulges out of the chorionic plate. The 
most striking difference was that the SVA were smaller both in diameter and size in 
comparison to the CPA when imaged at the same magnifications. The stem villous 
(SV) veins could be visually distinguished by their larger sized lumens (not shown). 
Two adjacent SVA along with a single SV vein were consistently found in close 
proximity to each other which made it difficult to isolate one completely free SVA. 
Figure 4.4.1-1C&D shows the images under higher magnification and the differences 
in the CPA and SVA lumens can be visualised. SVA appear to have a smaller 
diameter which was further investigated (see Chapter 4.4). The EC can be identified 
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by a dense stain around the lumen which represents the one cell thick layer of EC and 
was seen with both CPA and SVA (Figure 4.4.1-1E&F).  
CPA SVA 
A
F
D
B
C
E CT
L
EE
L
CT
VW
VW
 
Figure 4.4.1-1 representative H&E staining of paired CPA and SVA 5µm thick vessel 
cross sections (N=12) are shown. A&B show the contrasting size of SVA compared to CPA 
vessels. C&D show the same cross section viewed at higher magnification. The lumen (L) 
can be identified in each artery. E&F show the endothelium layer, which can be distinguished 
as the dense coat at the margin of the vessel lumen, is intact in both vessels (arrow). 
Connective tissue (CT), Endothelial layer (E), Lumen (L), Vessel wall (VW). Scale bar 
500µm A&B, 200µm C&D, 100µm E&F. 
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The H&E images showed an uneven distribution of cells in the CPA wall. The wall 
thickness of CPA and SVA was calculated using the Cell^F software programme 
(Chapter 3.3.2). CPA were orientated so that the anterior section (the fetal facing 
portion) was compared to the posterior portion, representing the part of the vessel that 
is embedded inside the chorion (Figure 4.4.1-2). Figure 4.4.1-3A shows the 
contrasting size and structure of CPA and SVA which represent the different regions 
of the placenta the vessels were taken from. Comparing the wall thickness showed 
that the posterior section of CPA, but not SVA, was significantly thicker (p<0.001, 
N=10) when compared to the anterior portion (Figure 4.4.1-3B). The ratio of wall 
thickness in CPA anterior to posterior portions was 1:5 while in SVA tissue the ratio 
was 1:1 as an even distribution of cells around the vessel lumen was observed with 
SVA, regardless of vessel orientation.  
  
Figure 4.4.1-2 showing the orientation that was used of CPA as found within the 
placental bed (yellow box). The anterior portion can distinguished from the posterior portion 
which is embedded within the basal plate. (Image adapted from Benirschke, Kaufmann et al., 
2006).  
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Figure 4.4.1-3 A shows from where the wall thickness measurements were taken to 
compare the anterior (fetal facing) to posterior (maternal facing) sections of the artery 
for each matched sample. B shows the scatter graph of wall thickness recordings for CPA 
and SVA paired samples (N=10). The CPA showed a significant thickening of the posterior 
section of the blood vessel (p<0.001) and this was not seen with SVA.  
 
4.4.2. IHC to identify SMC  
 
Following H&E staining of isolated CPA and SVA the individual cell layers that 
comprise each vessel type using specific cell markers were identified. Immunostained 
frozen CPA and SVA tissue slices were positive IRUWKH60&PDUNHUĮDFWLQ (Figure 
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4.4.2-1). Immunoreactivity was localised to the vessel wall while the surrounding 
adventitia remained unstained. The blood vessels consisted mostly of SMC as 
cytokeratin, vimentin and fibroblast markers were all negative in both CPA and SVA 
(not shown). The endothelial markers CD31 and Von Willebrand also failed to 
produce a positive stain (not shown) which was unexpected as the H&E imaging 
shows the EC is present. As a result the vessels were imaged under higher 
magnification using TEM (Appendix VI) in order to determine if the EC layer was 
intact in both CPA and SVA.   
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Figure 4.4.2-1 showLQJSRVLWLYHVWDLQLQJEURZQRI&3$$DQG69$%ZLWKĮDFWLQ
(N=8). The stain is produced predominately in the vessel wall and the surrounding connective 
tissue remains unstained. Substituting primary antibody with control IgG (C&D) produced no 
stain confirming the specificity of the antibody used. Scale bar 200µm A-D.  
 
4.5. Discussion  
 
The data presented in this chapter has shown that important structural 
differences exist between the small arteries of the placenta which may depend upon 
the region of the placenta that is sampled. Importantly, very few studies have made 
direct comparisons with paired patient samples which are important for understanding 
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patient specific differences that may exist in placental function and to which the 
placenta adapts differently. H&E staining of CPA and SVA cross sections showed 
differences in the structural make up of each vessel which can be explained by the 
very different functions served by the different vascular beds. CPA found at the fetal 
interface of the placenta, emerging from the umbilical cord, are required to cope with 
the transfer of large volumes of blood. As a result they require a large lumen that is 
supported by a thick layer of SMC to help keep the vessel diameter constant. This was 
confirmed in every one of the 10 paired samples that were analysed and is consistent 
with features described in other studies (Fujikura and Carleton, 1968, Weser and 
Kaufmann, 1978, Kaufmann, Sen et al., 1979). In contrast, SVA are found at the 
maternal barrier and require thin vessel walls to increase the surface area for exchange 
when they come into close contact with maternal blood which is at a higher pO2.  It 
was found that each villous branch contained vessels that were in very close 
proximity to each other and thus made it difficult to isolate a single artery cleanly. 
This was in contrast to CPA and shows how the placenta can regulate the growth and 
differentiation of different vascular beds according to the function that is required in 
that specific tissue layer (Robertson, Brosens et al., 1973, Benirschke and Kaufmann, 
1995, Poston, McCarthy et al., 1995, Benirschke, 1998, Nikkels, 2007). IHC showed 
that vessels were negative for markers of cytokeratin and fibroblast while the two EC 
markers Von Willebrand and CD31 were also negative which was unexpected. This 
could reflect the rigorous cutting process used to prepare the vessels for staining 
(discussed in Chapter 4.5). The CPA wall thickness was dependent upon the 
orientation of the vessel within the chorionic plate bed as the fetal facing wall of the 
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CPA was significantly thinner compared to the maternal facing posterior section of 
the vessel and agrees with the findings of Fujikura (et al., 1968). In this study, IHC 
staining showed that the vessels were rich in SMC which was confirmed by the 
positive VWDLQLQJ IRU Į-actin. Evidence of atherosclerosis and hyperplasia were also 
observed, which would be expected as full term tissue that has reached its full growth 
potential was being examined. The structural make up of a blood vessel will have 
important consequences for vessel function. Our data has shown that vessels at the 
fetal maternal interface of the placenta can be histologically distinguished as the CPA 
and SVA have distinct phenotypes. These differences may reflect different blood 
pressures, blood flow, hormones or local factors experienced by the very different 
vascular beds across the fetoplacental cross sections (Sweeney, Jones et al., 2006). 
For example the thin walled part of CPA may be stressed more by blood flow and 
amniotic fluid pressure and presents another challenge for the vessels to adapt to. In 
contrast the posterior portion of the vessel will be more stable and may be the main 
regulator of the vessel diameter. This flexibility in vessels is also seen in arteries from 
joints and muscles, both of which are examples of tissue that require flexible 
movement (Fujikura and Carleton, 1968, Mulvany and Aalkjaer, 1990, Benirschke 
and Kaufmann, 1995, Benirschke, Kaufmann et al., 2006, Cindrova-Davies, Yung et 
al., 2007, Mulvany, 2007) .  
It has previously been reported that CPA from healthy pregnancies, have a 
distinct phenotype with thickening of the SMC layer only at the maternal facing 
portion of the vessel. This was first reported in CPA by Fujikura (et al., 1968) and 
later in CPV also by Fujikura (et al., 1990). Their data showed that the uneven 
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distribution of tissue around the lumen was a normal feature of placental surface 
vessels and not associated with a pathological condition. The important observation 
made was that this feature was present in all of the 110 samples analysed and appears 
after 17wks of gestation. The uneven spread of SMC around the lumen was only 
reported in arteries and veins <300µm in diameter, as chorionic plate vessels that 
branched further into the placenta did not carry this phenotype. Furthermore, the 
explanation put forward was that the asymmetrical pattern of cell layers around the 
lumen is the result of vessel thinning through cell shedding on one side of the blood 
vessel (Fujikura and Carleton, 1968, Fujikura and Hosoda, 1990, Nikkels, 2007). This 
histological feature is only seen with vessels immediately beneath the amnion and 
may actually help to anchor the vessels onto the basal plate as they are vulnerable to 
damage from fetal movements. It may also explain why this feature is only seen after 
17wks as this is the time when the fetus is growing rapidly in size and will inevitably 
press against the placenta (Fujikura and Hosoda, 1990, Benirschke and Kaufmann, 
1995, Babawale, Mobberley et al., 2002).  
SVA set the resistance for the rest of the fetal placental vessels and come into 
closest contact with maternal blood to exchange vital growth products for the placenta 
and fetus (Kaufmann, Mayhew et al., 2004). IHC examination of SVA has been 
carried out by Tanka (et al., 1999) who showed that SVA are very different from SV 
veins. Both SV vessels had circular SMC that were surrounded by longitudinal 
collagen fibrils, with the crucial difference that the SMC population was greater in the 
SV veins compared with the SVA. This difference in vessel structure would favour 
blood to flow towards the baby and the dense collagen layers may function to keep 
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the vessel length constant when the SMC contracts. There were also local differences 
in the phenotype of both arteries and veins and this could be attributed to the release 
of different local factors such as hormones, endothelial factors, pH, and lactate or CO2 
levels. Blood flow varies greatly within the placenta and presents different challenges 
to the blood vessels which need to autoregulate the vessel diameter in respond to these 
different insults (Robertson, Brosens et al., 1973, Kaufmann, Sen et al., 1979, Tanaka, 
Kuwabara et al., 1999).  
It is important for maternal and fetal blood products to be kept apart to avoid 
an immune response while at the same time the barrier between the two circulatory 
systems needs to be thin enough to allow exchange to occur. At term the 
synctytiotrophoblast can be as much as 2µm thin and any stress to the cell layers 
could damage this and rupture the barrier which is a risk linked to PE (Brosens, 
Robertson et al., 1972, Myatt, 2002, Baker and Kingdom, 2004, de Luca Brunori, 
Battini et al., 2005). It would be interesting to see if there are any structural 
differences in samples from stressed pregnancies as Cindrova-Davies (et al., 2007) 
has shown that labouring and non labouring placenta have different markers for 
oxidative stress. Furthermore, Stanek (2009) also described evidence of hypoxic 
lesions in placental samples from diabetic, PE and still birth pregnancies. There is 
also evidence of tissue distortion that is age dependant as the placenta grows and 
matures. By its very nature the placenta has a high metabolic rate and there is 
supporting evidence of oxidative stress occurring in healthy placental tissue samples 
(Zhou, Fisher et al., 1997, Jauniaux, Watson et al., 2000, Burton, Jauniaux et al., 
2009).  
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These studies demonstrate the importance of studying normal tissue to then 
have a basis with which to compare compromised pregnancy samples. However, there 
is a need to further develop the methods used in this study. The vessels used in this 
analysis were fixed immediately following tissue isolation. However the vessels 
should have been placed under pressurised conditions, before fixation, to allow the 
vessel wall thickness to be accurately measured. The observation that CPA had an 
uneven wall thickness could be due to loss of tissue structure as the vessel has been 
removed from its supporting connective tissue, which can be elucidated to by using 
pressurised vessels instead. In addition CD31 and Von Willebrand which are both EC 
markers, failed to produce a positive stain which suggests that there was a problem 
with antigen retrieval method. This issue would need to be resolved successfully 
before we could consider moving on ion channel antibodies. One alternative is to use 
a heat based antigen retrieval instead of the enzyme digestion method that we used. 
This involves heating the samples to promote cross linked epitopes to unfold and has 
been shown to improve IHC staining (Shi, Key et al., 1991). In this method the 
samples would require paraffin fixation instead of freezing which would help the 
samples to retain their structure. However, the drawback of high intensity heating of 
small structures like blood vessels is that the samples melt off the glass slides. This 
could be resolved by taking square blocks of tissue to examine a group of vessels 
rather than focussing on one isolated vessel. A further extension to the data presented 
in this thesis, is to show histologically, arteries from veins, which were easily 
distinguished by their differences in structure wall thickness. The makers Von 
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Willebrand, CD34 and CD31 should also be explored further to support this 
observation.   
 
4.5.1. Conclusion  
 
In summary our data has shown important morphological differences between 
CPA and SVA which help to understand the different responses produced by the 
vessels to different stimulants. Furthermore we observed that CPA have a distinct 
phenotype with vessel wall thickening restricted to the posterior portion of the vessel 
wall and supports our hypothesis. In contrast, SVA have a tubular appearance with an 
even distribution of SMC around the lumen. IHC staining showed that the vessels are 
ULFK LQ VPRRWKPXVFOHĮactin and H&E imaging showed the presence of intact EC 
which will be important for our functional studies (see Chapter 5).  
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5. Assessing the functional characteristics of CPA and SVA  
5.1. Introduction  
 
The placenta needs to maintain a low resistance system to deliver sufficient O2 
and nutrients to the fetus. Blood vessels within the placenta respond to challenges in 
maternal blood supply by altering the vessel diameter. There is also evidence to show 
that the response in particular of the CPA and CPV is dependent upon the level of 
oxygenation (Hampl, Bibova et al., 2002, Wareing, Greenwood et al., 2006a) but this 
has yet to be determined with SVA. The hypothesis to be tested is that CPA and SVA 
from across the fetomaternal interface of the placenta will respond differently upon 
stimulation with the same agonists and this response is influenced by pO2.  
 
5.2. Objectives   
 
x Define the optimal conditions required to study the functional response of 
placental resistance arteries.   
x Assess the vasoconstriction and vasodilatation properties of arteries sampled from 
the CPA and SVA.  
x Determine the influence of pO2 in mediating the responses to various stimuli. 
x Investigate the effect of ROS and pH stress in CPA and SVA.  
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5.3. Materials and methods  
 
Arteries from the CPA and SVA were prepared for wire myography (Chapter 
3.7) in order to gain functional information, at the normalisation setting of 0.9L5.1kPa. 
Dose-response experiments were performed using the agonists listed in Table 3.7.8-1 
under changing pO2 settings (Table 3.7.7-1).  
 
5.4. Results  
 
5.4.1. Sample number   
 
A total of 508 CPA (n) from 134 placentae (N) were included in our functional 
studies and displayed a 95% viability rate (described in Chapter 3.7.6). A further 27 
placentae (N) were used to isolate SVA and from the 105 SVA (n) that were 
successfully mounted only 46 (44%) proved to be viable for use in wire myography 
analysis.  
 
5.4.2. Vessel size  
 
The internal diameter when vessels were maximally relaxed (IC1) was 418 ± 
12.3µm for CPA (n=96) and 261 ± 9.6µm for SVA (n=46, p<0.001, Mann Whitney U 
test (MW-U)). Figure 5.4.2-1 shows the scatter plot of the spread of vessel sizes 
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included in our study. CPA were taken from the 4th branch following the umbilical 
cord artery branching and consistently had a diameter within the 200-500µm range for 
resistance sized vessels. The SVA had a significantly smaller diameter (p<0.001) and 
had a narrower IQR when compared to the CPA population.    
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Figure 5.4.2-1 Showing the scatter graph for the internal diameter (µm) values for CPA 
(N=96) and SVA (N=46) at rest (IC1). Data are shown as median ± IQR ***p<0.001.  
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5.5. Pharmacological investigations with CPA  
 
5.5.1. Response to contractile agonists  
 
5.5.1.1. AVP 
 
The first contractile agent investigated was AVP which triggered a dose 
dependent response with a maximal response (101 ± 5% of the KPSS contraction) at 
the highest dose tested. However there was a partial loss in the maximum constriction 
as the response did not stabilise (not shown). The contraction was not sustained nor 
reproducible with each subsequent stimulation so an alternative contractile agent was 
investigated.  
 
5.5.1.2. Thromboxane mimetic U46619 
 
Administration of the thromboxane mimetic U46619 produced a potent 
contraction (145 ± 2% of the KPSS contraction) that was stable for prolonged periods 
of time with no evidence of a loss in contraction. This desired stable contraction made 
U46619 our agonist of choice for use in our time controlled experiments when 
studying the vasodilatation responses. The dose-response curves for AVP and U46619 
have been summarised in Figure 5.5.1.2-1. The contractile response was immediate in 
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response to U46619 and achieved significance at 10-7.5M and 10-7M.  The EC50 values 
for the two agonists have been summarised in Table 5.5.1.2-1 and a lower 
concentration of U46619 was required to gain 50% of the maximum contractile 
activity of CPA although this was not significant. 
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Figure 5.5.1.2-1 showing the dose-response curve with the contractile agents U46619 
(N=6) (closed circles) and AVP (N=5) (open circles). U46619 produced a significant shift in 
the dose-response as the response was more potent. Data are presented as mean ± SEM along 
with vessels treated (n). *p<0.05, ***p<0.001. 
 
Table 5.5.1.2-1 summarising the EC50 values for U46619 and AVP.  
Vessels (n) LogEC50 (M) ± SEM p 
U46619 (6) -7.5 ± 0.1  
AVP (5) -6.8 ± 0.3 ns 
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5.5.2. Response to endothelium-dependent vasodilators  
 
5.5.2.1. ACh 
 
Following pre constriction with U46619 (1µM) CPA were exposed to 
incremental doses of ACh (10-10-10-5M). Figure 5.5.2.1-1 shows the original trace 
recording representing the dose dependant relaxation produced by CPA in response to 
ACh. A maximal relaxation response of 24 ± 5% was achieved at highest dose of ACh 
and was reduced to 21 ± 8% in the presence of L-NAME (p>0.05, n=5). The logEC50 
values extrapolated for each treatment has been summarised in Table 5.5.2.1-1.  
5mN
10minsU46619  
10-5M   WASH   
10-8M   
10-9M   10
-10M   
10-7M   10-6M  
Baseline  
 
Figure 5.5.2.1-1 showing an original trace with application of ACh in pre-constricted 
CPA. The vessel was then washed with fresh PSS to allow for recovery of the baseline. 
  
Table 5.5.2.1-1 summarising the EC50 values which have been obtained with ACh in the 
presence and absence of L-NAME.  
Vessels (n) LogEC50(ACh)M ± SEM Maximum Relaxation (%) ± SEM 
ACh (6) -7.4 ± 0.6 24  ± 5 
ACh + L-NAME (5) -7.1 ± 0.7 21 ± 8 
 
Chapter 5 
Assessing the functional characteristics of CPA and SVA 
138 
 
5.5.2.2. BK 
 
CPA pre-contracted with U46619 were exposed to stepwise increasing 
concentrations of BK (10-10-10-5M) and has been shown in Figure 5.5.2.2-1. A 
marginal relaxation response was produced by the placental vessels reaching a 
maximum relaxation of 13% (Table 5.5.3.1-1).    
 
5mN
10mins
U46619  
10-5M   
WASH   
10-8M   10
-9M   10-10M   
10-7M   10-6M  
Baseline  
 
Figure 5.5.2.2-1 showing an original trace with application of BK with pre-constricted 
CPA vessels. The vessel was then washed with fresh PSS to allow for recovery.  
 
5.5.3. Response to endothelium-independent vasodilators 
  
5.5.3.1. SNP 
 
SNP is an example of an endothelium-independent vasodilator and application 
of increasing concentrations of SNP (10-10 - 10-5M) again produced a steep relaxation 
with CPA between 10-9- 10-8M (Figure 5.5.3.1-1). Directly comparing the SNP 
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response with both ACh and BK shows that SNP causes a downward shift in the dose-
response curve and achieves signiILFDQFH DW -8M (Figure 5.5.3.1-2). Table 
5.5.3.1-1 summarises the EC50 values obtained with both endothelium-dependent and 
independent vasodilators using CPA.  
 
5mN
10mins
Baseline  
U46619  
10-10M   
WASH   
10-9M   
10-8M   10-7M   10-6M   10-5M  
 
Figure 5.5.3.1-1 showing an original trace with application of SNP with pre-constricted 
CPA. A steep relaxation response was observed with low dose application of the agonist.  
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Figure 5.5.3.1-2 summarising the dose-response curves for ACh (N=6), BK (N=4), and 
SNP (N=6). The SNP response (orange) was markedly greater when compared with BK 
(green line with grey *) and ACh (blue line with black *). Time control responses did not 
show any significant loss in the contraction. Data are presented as mean ± SEM along with 
vessels treated (n) from placentae (N). *p<0.05, **p<0.01, ***p<0.001. 
 
Table 5.5.3.1-1 summarising the EC50 values for both endothelium dependant and 
independent vasodilators with CPA.  
Vessels (n) LogEC50(M) ± SEM Maximum Relaxation (%) ± 
SEM 
ACh (6) -7.4 ± 0.8 24 ± 4 
BK (4) -7.3 ± 0.4 13 ± 2 
SNP (6) -8.1 ± 0.6 50 ± 8 
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5.6. Comparing CPA to SVA 
 
5.6.1. Effect of changing pO2 
 
A pO2 of 20% (156mmHg) is normally used for wire myography experiments to 
ensure the vessel is continually perfused with sufficient O2. This optimised the viability of the 
vessel for the duration of the experiments to be performed which can last KRXUV(Mulvany 
and Warshaw, 1979). However a pO2 of 5% (39mmHg) closely reflects the physiological O2 
concentrations found within the placenta in vivo (Wareing, Crocker et al., 2002, Wareing, 
Greenwood et al., 2006a). Furthermore pO2 of 2% (16mmHg) represents the 
pathophysiolgical levels of tissue oxygenation that have been observed with IUGR affected 
pregnancies (Economides and Nicolaides, 1989). As a result the importance of altering pO2 
was investigated to examine both the physiological and pathophysiolgical responses from the 
vessels. Table 5.6.1-1 summarises the baseline tension recording in each vessel type across 
the three different pO2 settings (each at 0.9L5.1kPa). No significant change was seen in the 
baseline tension across CPA and SVA perfused with changing pO2. The pH of the saline was 
also recorded and found not to be significantly altered across the different pO2 settings (IQR 
[7.42-7.45], p>0.05, n=14).  
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Table 5.6.1-1 Summarising the baseline tension in different pO2. There was no significant difference 
in the baseline passive tension when the O2 content was lowered across both CPA and SVA.  
pO2 (%) Vessels (n) Baseline tension (kPa) ± 
SEM 
p 
20 CPA (12) 0.16 ± 0.01  ns 
SVA (10) 0.14 ± 0.02 
5 CPA (16) 0.11 ± 0.03 ns 
SVA (13) 0.08 ± 0.03 
2 CPA (12) 0.12 ± 0.05 ns 
SVA (10) 0.09 ± 0.03 
 
5.6.2. Contractile responses  
 
The response to U46619 in both CPA and SVA was compared at different O2 
tensions. Figure 5.6.2-1 shows the vessels do remain viable across the differing pO2 
concentrations. The response to U46619 in CPA (Figure 5.6.2-1A) shows an initial increase 
in the contractile response with both 5% and 2% pO2 achieving significance at 10-8M 
(p<0.01). Further stimulation with U46619 fails to increase the active tension produced by 
the vessels. The maximum contraction to U46619 was significantly lower when compared 
with the contraction produced at 20% pO2 (p<0.001). The active pressure generated by CPA 
at 20% pO2 continued to increase exponentially and failed to reach a plateau with the highest 
concentrations of U46619 applied (10-6M). The dose-response at 5% and 2% overlap and 
showed no significant difference when directly compared across the dose-response curve. In 
contrast SVA displayed minimal contractions with U46619 at 20% and 5% (Figure 5.6.2-1 
B) However the response to U46619 significantly increased when the pO2 was lowered to 2% 
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(p<0.001 at 10-8-10-6M). Table 5.6.2-1 summarises the LogEC50 values for U46619 across 
the different pO2 settings. Comparing the response between CPA and SVA, it was interesting 
to note that the response at 2% pO2 was not significantly different as the SVA could display 
similar reactivity to U46619 displayed by CPA at this low pO2 setting. In contrast 
contractility with both the 20% and 5% pO2 treatments were significantly higher in CPA 
(p<0.001). Finally, it was shown that the response by CPA at 5% was matched by the 
response to U46619 at 2% pO2. 
 
Table 5.6.2-1  Summarising the EC50 values which have been obtained with U46619 across the 
different pO2 conditions.  
pO2 (%) Vessels (n) LogEC50 (U46619)M 
± SEM 
p 
20 CPA (12) -7.5  ± 0.1  *** -8 - -6M 
SVA (10) -7.0  ± 0.5 
5 CPA (16) -8.4 ± 0.1 *** -8.5 - -6M 
SVA (13) -8.3 ± 0.1 
2 CPA (12) -8.4 ± 0.1 ns 
SVA (10) -8.1 ± 0.3 
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Figure 5.6.2-1 summarising the dose-response curves with U46619 at different pO2 
concentrations. A shows the response of CPA. Lowering the pO2 to 5% (N=16) and 2% (N=12) 
caused a leftward shift in the dose-response which was significantly at the lower doses (10-8M). 
Vessels at 20% pO2 (N=12) continue to increase exponentially and fail to reach a plateau with the 
highest concentrations of U46619. B shows the dose-response curves for U46619 with SVA. The 
vessels show minimal contractility at 5% (N=13) and 20% O2 (N=10) while the response at 2% 
(N=10) is sLJQLILFDQWO\KLJKHU-8M. Data are presented as mean ± SEM along with vessels treated 
(n) from placentae (N). **p<0.01, ***p<0.001. 
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5.6.3. Vasodilatation responses  
 
The next objective was to compare the vasodilatation responses across CPA and SVA 
vessel with lowering pO2 conditions and has been illustrated in Figure 5.6.3-1. The maximal 
relaxation to SNP at 20% O2 was 30% and 4% in CPA and SVA respectively (p<0.001) 
(Table 5.6.3-1). Surprisingly, the SNP induced relaxation was enhanced as pO2 was lowered 
(Figure 5.6.3-2). CPA produced the highest relaxation at 5% while 2% pO2 caused the dose-
response to shift upwards but each treatment did not achieve significance across the SNP 
concentrations applied (Figure 5.6.3-2A). It was found that lowering the pO2 improved the 
response produced and 2% pO2 appeared to evoke the maximum relaxation response in SVA 
(Figure 5.6.3-2B). Table 3.2-1 summarises the LogEC50 values for SNP across the different 
pO2 settings. 
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Figure 5.6.3-1 shows the SNP response with CPA and SVA in 5% pO2. The representative trace 
shows the step wise relaxation to SNP with U46619 pre-contracted vessels. The response is 
immediate as the vessel reaches it maximum relaxation with the low doses of SNP and was seen with 
both vessels types. Further addition of SNP fails to enhance the relaxation seen. 
  
Table 5.6.3-1 summarising the EC50 values which have been obtained with SNP across the different 
pO2 conditions.  
pO2 (%) Vessels (n) LogEC50(M) ± 
SEM 
p Maximum Relaxation 
(%) ± SEM 
20 CPA (9) -8 ± 0.2  ***-8 - -5M 30 ± 8 
SVA (6) -6.0 ± 0.3 4 ± 2 
5 CPA (8) -8 ± 0.5 *** -7- -5M 55 ± 11 
SVA (6) -7 ± 0.2 27 ± 3 
2 CPA (5) -6.9 ± 0.2 ns 40 ± 4 
SVA (6) -6.4 ± 0.2 52 ± 8 
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Figure 5.6.3-2 summarising the concentration dependant dose-response curves to SNP across 
different pO2. A shows the response with CPA which showed the most relaxation at 2% (N=5) and 
5% pO2 (N=8) when compared to the response at 20% pO2 (N=9). B shows the responses to SNP with 
SVA. Lowering the pO2 improved the response produced with cumulative additions of SNP and was 
significantly different at 2% pO2 (N=6) when directly compared to the 5% (N=6) and 20% (N=6) 
responses. Data are presented as mean ± SEM along with vessels treated (n) from placentae (N). 
*p<0.05, **p<0.01, ***p<0.001. 
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5.6.4. Response to RIL  
 
The response to the TREK channel opener RIL was investigated with CPA and SVA 
to determine if the vessels could produce a response across the different pO2 treatments. 
Figure 5.6.4-1 shows the original trace recording of RIL application. A potent relaxation that 
was concentration dependant was seen with both CPA and SVA. Comparing the dose-
response curves (Figure 5.6.4-2) showed that lowering the pO2 induced a downward shift in 
the dose-response with both the 5% and 2% responses but this only achieved significance 
with CPA at 2% pO2 with application of 10-7.5M (p<0.001). The SVA response does not 
display such a change to the RIL relaxation under different pO2 settings and only the 5% 
treatment showed significantly more relaxation when compared to the 2% treatment (10-7M 
(p<0.05). Table 5.6.4-1 summarises the LogEC50 values for RIL across the different pO2 
settings. 
 
Table 5.6.4-1 summarising the EC50 values which have been obtained with RIL across the different 
pO2 conditions. No significant difference was observed across the different pO2 settings 
pO2 (%) Vessels (n) LogEC50(RIL) M  
± SEM 
p Maximum Relaxation 
(%) ± SEM 
20 CPA (6) -7.2 ± 0.06  ns 75 ± 5 
SVA (6) -7.1 ± 0.2 78 ±5 
5 CPA (6) -7.5 ± 0.1 ns 73 ± 6 
SVA (4) -7.4 ± 0.05 75 ± 4 
2 CPA (6) -7.5 ± 0.1 ns 76 ± 6 
SVA (4) -7.3 ± 0.03 74 ± 4 
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Figure 5.6.4-1 showing the original trace recording representing the RIL dose-response in CPA 
and SVA in 5% O2 perfusion. The representative trace shows the step wise relaxation to RIL in 
U46619 pre-contracted vessels. The potent response almost reaches the baseline tension with both 
SVA and CPA.  
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Figure 5.6.4-2 summarising the concentration response curves with RIL. A shows the dose 
response curve to RIL with CPA under the different pO2. At 5% (N=6) and 2% (N=6) pO2, the curve 
shifts to the left but only the 2% treatment was significantly different to 20% (N=6) at 10-7.5M. B 
shows the dose-response to RIL in SVA (N=6). Lowering the pO2 treatments showed that only 2% 
(N=4) was significantly different when compared with the 5% (N=4) response at 10-7M. Data are 
presented as mean ± SEM along with vessels treated (n) from placentae (N). *p<0.05, ***p<0.001.  
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5.6.5. Response to H2O2 
 
Blood vessels from a range of vascular tissues can respond to ROS by altering their 
vessel diameters to produce a cellular response. The aim of this series of experiments was to 
investigate the response of placental vessels to the ROS H2O2. Figure 5.6.5-1 shows the 
effect of increasing doses of H2O2 addition to pre-contracted CPA and SVA with 5% O2 
perfusion. The representative trace shows a concentration dependent relaxation produced by 
each vessel type which went beyond the baseline tension at the highest doses used. This was 
due to the fact that the treatment proved to be toxic for both the CPA and SVA as the vessels 
were unable to respond to further contractile stimuli (both with U46619 and KPSS) post 
washout. The importance of varying pO2 on the response to H2O2 was also compared. The 
dose-response curves were shown to be altered with both CPA and SVA as the pO2 was 
lowered from 20% to 5% and 2% (Figure 5.6.5-2). The response in CPA appeared to be 
biphasic and the greatest relaxation occurred at 5% pO2. While perfusion of SVA at 2% 
resulted in a small blunting of responses to H2O2. Table 5.6.5-1 summarises the EC50 values 
for H2O2 across the different pO2 settings and direct comparisons of the CPA and SVA 
responses showed that the 5% and 2% response was significantly different between the two 
placental vessels at 10-8M.  
The role of H2O2 as a vasoconstrictor has also been demonstrated in Figure 5.6.5-3 
which shows the original response of CPA stimulated with H2O2 at rest with 20% pO2. Both 
CPA and SVA produced a similar response with an immediate contraction that was short 
lived as the vessel begins to return to its resting tension. The response was not reproducible 
with each subsequent stimulation (Figure 5.6.5-4) with the agonist and this experiment again 
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proved to be toxic for both CPA and SVA which could no longer produce a response to a 
stimulant post washout. This was also the case when each concentration dose was applied in a 
random order.  
5mN
10mins
U46619  
10-9M   
WASH   
10-10M   
10-8M   
10-7M   
10-6M   
10-5M  
Baseline  
A. CPA 
2mN
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10-10M   
WASH   
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10-8M   
10-7M   
10-6M   
10-5M  
Baseline  
B. SVA  
 
 
Figure 5.6.5-1 illustrates the effects of H2O2 addition in pre-contracted CPA (A) and SVA (B) 
vessels with 5% O2 perfusion. The representative traces show a concentration dependent relaxation 
which exceeded the baseline tension.  
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Figure 5.6.5-2 summarising the response to H2O2 across different pO2 settings. A shows the 
response with CPA. The 5% pO2 (N=4) response at 10-6M was significantly different to both the 20% 
(N=6) and 2% (N=4) response curves. B shows the dose-response curves for SVA (N=6). The 5% 
(N=4) response was significantly different to the response at produced at 2% pO2 (N=4) at 10-8M. 
Data are presented as mean ± SEM along with vessels treated (n) from placentae (N). *p<0.05, 
**p<0.01, ***p<0.001. 
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Table 5.6.5-1 summarising the EC50 values obtained with H2O2 across the different pO2 conditions. 
The 5% & 2% pO2 treatment showed a significant difference between CPA and SVA both at 10-8M.  
pO2 (%) Vessel (n) LogEC50 (H2O2)M  
± SEM 
p 
 
Maximum Relaxation 
(%) ± SEM 
20 CPA (6) -5.5 ± 0.1 ns 60 ± 4 
SVA (6) -6.6 ± 0.1 73 ± 4 
5 CPA (4) -6.7 ± 0.4 * -8M 
 
74 ± 11 
SVA (4) -6.4 ± 0.2 76 ± 7 
2 CPA (4) -5.1 ± 0.2 * -8M 
 
59 ± 3 
SVA (4) -5.0 ± 0.3 54 ± 7 
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Figure 5.6.5-3 showing an original trace with application of H2O2 (10-10-10-5M) to CPA in 20% 
pO2. The recording shows the response with un-stimulated vessels. Both CPA and SVA produced a 
biphasic contraction that was short lived and could return to its resting tension.  
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Figure 5.6.5-4 showing the smooth curve graph summarising the contractile response to H2O2. 
CPA (N=6) and SVA (N=4) displayed a similar response to H2O2 application at rest. The response 
failed to achieve 50% of the maximum constriction produced with U46619. Data are presented as 
mean ± SEM along with vessels treated (n) from placentae (N).  
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5.6.6. Effect of alkaline pH at 20% pO2 
 
The pH of the PSS buffer was increased using 1M NaHCO3. Cumulative addition of 
the alkali resulted in a concentration dependent contraction which was seen with both SVA 
and CPA (Figure 5.6.6-1). The dose-response curves showed that CPA produce a contraction 
that peaked at 41% of the original U46619 constriction at pH 8.0 (Figure 5.6.6-2). This was 
significantly higher than the response produced by SVA which only achieved 3% of the 
maximal U46619 contraction (p<0.001 pH 7.7-8.0). The EC50 values extrapolated from the 
best fit curve have been summarised in Table 5.6.6-1.  
 
Table 5.6.6-1 summarising the EC50 values which have been obtained with NaCHO3 with CPA and 
SVA.  
Vessels (n) EC50 ± SEM p 
CPA (6) 7.6 ± 0.3  
SVA (4) 7.9 ± 0.2 ns 
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Figure 5.6.6-1 showing the representative trace recordings of NaHCO3 induced contractions in 
CPA (A) and to a lesser extent with SVA (B).  
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Figure 5.6.6-2 showing the concentration response curves for the effect of increasing the pH of 
the bathing saline at 20% pO2. The response with CPA (N=6) was significantly more potent when 
compared to SVA (N=4) but both responses did not match the maximal constriction achievable with 
the vessels. Data are presented as mean ± SEM along with vessels treated (n) from placentae (N). 
***p<0.001.   
Chapter 5  
Assessing the functional characteristics of CPA and SVA 
158 
 
5.6.7. Effect of acidic pH  
 
The pH of the bathing saline was lowered to investigate the effect of acidic pH stress 
on both CPA and SVA. Early work with hydrochloric acid (HCl) showed the response was 
immediate with a 0.2 change in pH (Figure 5.6.7-1). The acidic pH treatment produced no 
change in the vessel activity at rest but vessels pre-contracted with U46619 relaxed in 
response to incremental acidic pH changes to give a maximum relaxation of 59 ± 1.5% at pH 
6.4 in 20% pO2.  
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Figure 5.6.7-1 shows the response to HCl stimulation in CPA (N=4). A biphasic response was 
observed with an immediate loss in contraction that was followed by a slower recovery of the original 
contractile force. B shows the dose-response curve to low pH and values are shown as mean ± SEM 
along with vessels treated (n) from placentae (N). 
  
The response to lactic acid, which is endogenously found within circulations such as 
the placenta (Nicolaides, Economides et al., 1989) was then explored. Repeated application 
(20µl) of 1M lactic acid was added to the PSS buffer over 2min increments. The response to 
low pH was biphasic as the relaxation produced at each addition was reversible and the vessel 
could gradually return its maximum constriction. As a result the pH stimuli was instead 
added over increments of 10mins to ensure that we were able to observe the complete 
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response each time. Figure 5.6.7-2 shows the original trace recording for both CPA and SVA 
which produce a markedly similar biphasic response with both vessel types. A single 
response has been shown in Figure 5.6.7-2C to demonstrate the response when the pH is 
lowered from pH 7.4 to pH 7.2. The response is biphasic with an initial immediate loss in 
vessel tone (phase I) followed by the gradual reversal (phase II) as the vessel regains its 
original constriction level. This was repeated with each pH stimulus that is added. It was also 
found that washout of the vessel with fresh PSS alone produced a rapid increase in vessel 
tone as the pH was switched from pH 6.4 to the original at rest state of pH 7.4 (Figure 
5.6.7-2 red box).  
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Figure 5.6.7-2 showing representative trace recordings of the lactic acid induced relaxation in 
CPA (A) and SVA (B). Repeated doses of the acid lowered the pH by 0.2 units every 10mins and 
ranged from 7.2-6.4. The bathing saline was then replaced with fresh PSS which caused an immediate 
increase in the vessel tone (red box) as the pH level switched from pH 6.4 to 7.4. C shows the 
biphasic response to 1M lactic acid. Lowering the pH by 0.2units produced a rapid relaxation (Phase 
I) which was reversible. Phase II represents the period of recovery as the vessel can return to its 
maximum constriction. The relaxation produced with each pH stimulus was recorded at the peak 
relaxation produced (boxed).  
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Figure 5.6.7-3 summarises the dose-response curves with increasing concentrations 
of lactic acid across both CPA and SVA. The same pH stress was applied to vessels perfused 
with 20%, 5% and 2% O2 and reducing the pH from 7.4 to 6.4 caused a dose-dependent 
relaxation in both vessel types across each pO2 setting. However the steepest increase in 
relaxation was produced at 20% across CPA and SVA both of which also produced a linear 
dose-response curve at this pO2 setting. Reducing the pO2 to 5% causes an upward shift in the 
dose-response and the response was significantly lower when compared with the relaxation 
seen at 20% (p<0.01). Furthermore, reducing the O2 levels to 2% also attenuated the 
relaxation to acidic pH but this was significant (p<0.05) with SVA only at pH 6.8-6.4. Table 
5.6.7-1 summarises the EC50 values which have been obtained with 1M lactic acid across 
CPA and SVA. The upward shift in the relaxation was most evident for the 5% treatment in 
both CPA and SVA. Directly comparing the pH stress responses at each pO2 setting showed 
that the most significant difference was between the responses produced at 5% pO2.  
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Table 5.6.7-1 summarising the EC50 values which have been obtained with 1M lactic acid across CPA 
and SVA. *p<0.5, **p<0.01.   
pO2 (%) Vessels (n) LogEC50(M) ± 
SEM 
p 
 
Maximum Relaxation 
(%) ± SEM 
20 CPA (9) 6.9 ± 1.3  ns 61 ± 4 
SVA (6) 6.8 ± 0.5 69 ± 2 
5 CPA (8) 6.5 ± 1.3 ** pH 6.8 
*pH 7, 6.6 
45 ± 3 
SVA (6) 6.6 ± 0.7 34 ± 3 
2 CPA (5) 6.9 ± 1.2 ns 53 ± 3 
SVA (6) 6.8 ± 0.3 39 ± 7 
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Figure 5.6.7-3 showing the concentration response curves for the effect of increasing lactic acid 
concentrations. A summarises the pH dose-response in CPA across the three different pO2 conditions 
(N=9). Lowering pO2 to 5% (N=8) and 2% (N=5) caused an upward shift in the dose-response curve 
which was only significant at 5% O2. B summarises the response with SVA to pH (N=6). Lowering 
the pO2 produced a significant reduction in the maximum relaxation at both 5% (N=6) and 2% (N=6) 
pO2. Data are presented as mean ± SEM long with vessels treated (n) from placentae (N). *p<0.05, 
**p<0.01, ***p<0.001.  
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5.7. Response of PE-CPA at 20% pO2 
 
CPA from PE patients (N=4) (See Table 6.4.1-1 for patient details) obtained at 
ELLSCS (Chapter 3.2) were also included in our functional studies. Figure 5.7-1A 
summarises the scatter plot graph to show the variation in vessel diameters within each 
patient group. Isolating the same 4th branch of the CPA from PE placental samples was not 
found to be significantly different to NORM CPA. Figure 5.7-1B also shows the dose-
response curves which summarise the response to U46619 stimulation of CPA and the PE 
vessels demonstrated a greater contractile activity when examining the active effective 
pressure generated by the blood vessels. The increase in contractile activity was significantly 
greater with application of the higher doses of the vasoconstrictor (<10-7.5M). Table 5.7-1 
summarises the EC50 values obtained with U46619.  
 
Table 5.7-1 summarising the EC50 values obtained with U46619 stimulation of CPA across each 
patient group.  
Vessels (n) LogEC50(U46619)M  
± SEM 
p 
NORM (14) -7.9 ± 0.1  
PE (4) -8.2 ± 0.2 ns 
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Figure 5.7-1 summarising the contractile properties of vessels from NORM (N=14) and PE CPA 
(N=4). A shows the scatter plot of vessel diameters and no difference was observed in the two groups. 
Data are presented as median ± IQR. B summarises the dose-response curves with U46619 
stimulation which showed a significant difference in the response of PE-CPA with the higher doses of 
U46619. Data are presented as mean ± SEM along with vessels treated (n) from placentae (N). 
**p<0.01, ***p<0.001.  
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5.7.1. Response of PE CPA to SNP  
 
The relaxation response to SNP was examined using CPA from each patient and has 
been shown in Figure 5.7.1-1. Table 5.7.1-1 summarises the EC50 values which have been 
obtained with SNP using CPA and no significant difference in response to SNP was found 
when comparing PE to NORM samples.  
 
Table 5.7.1-1 summarises the extrapolated LogEC50 data for SNP along with the maximum relaxation 
produced by each different sample.  
Vessels (n) LogEC50(SNP)M ± SEM p Maximum relaxation 
 ± SEM 
NORM (14) -5.5 ± 0.1  63 ± 3 
PE (4) -5.7 ± 0.1 ns 49 ± 7 
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Figure 5.7.1-1 showing the response to SNP. PE-CPA (N=4) could produce a response to SNP and 
this was not significantly different to the NORM (N=14) response across each does applied. Data are 
presented as mean ± SEM along with vessel treated (n) from placentae (N).  
 
5.7.2. Response of PE CPA to RIL 
 
CPA from the PE group also demonstrated the ability to respond to the TREK opener 
RIL which again produced a potent relaxation that was dose dependant. The dose-response 
curve for each different sample have been summarised in Figure 5.7.2-1 and no significant 
change was seen with the response to RIL when comparing the response of NORM and PE 
CPA (Table 5.7.2-1).  
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Table 5.7.2-1 summarises the extrapolated LogEC50 data for RIL along with the maximum relaxation 
produced by each different sample.  
Vessels (n) LogEC50(RIL)M ± SEM p Maximum relaxation 
 ± SEM 
NORM (14) -6.6 ± 0.1  81 ± 5 
PE (4) -6.7 ± 0.1 ns 84 ± 5 
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Figure 5.7.2-1 response to RIL across different patient groups. No significant change was found in 
the response of PE-CPA (N=4) when compared with NORM (N=14). Data are presented as mean ± 
SEM along with vessels treated (n) from placentae (N).  
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5.7.3. Response of PE CPA to stress  
 
5.7.3.1. Response of PE CPA to H2O2 
 
H2O2 was applied to examine the response to ROS with PE CPA perfused with 20% 
pO2. PE CPA reach 100% relaxation as the vessel tone rapidly declined with application of 
H2O2 (Figure 5.7.3.1-1). There is also evidence of a biphasic response to H2O2 with the 
presence of small contractile oscillations in the vessels following the addition of the smaller 
doses of H2O2 only (red box). The relaxation response by PE CPA was shown to be 
significantly greater than the response of NORM CPA (Figure 5.7.3.1-2). Table 5.7.3.1-1 
summarises the extrapolated EC50 recordings in response to H2O2 application NORM and PE 
CPA.  
 
Table 5.7.3.1-1 summarising the LogEC50 values for H2O2 application which was found to be 
significantly different with PE-CPA.  
Vessels (n) LogEC50(H2O2)M ± SEM p Maximum relaxation 
 ± SEM 
NORM (14) -5.5 ± 0.1  60 ± 5 
PE (4) -6.8 ± 0.1 *<0.05 75 ± 5 
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Figure 5.7.3.1-1 showing the effect of H2O2 on pre-constricted PE CPA. A biphasic response was 
observed with  H2O2 application with an initial increase in vessel contraction that was followed by an 
immediate relaxation. This was overcome with higher doses of H2O2 -7M) to result in a potent 
relaxation response.  
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Figure 5.7.3.1-2 dose-response curves showing the response of CPA to H2O2 application. PE-
CPA (N=4) demonstrated a significant downward shift in the dose-response when compared with 
NORM (N=14) as the relaxation was elevated. Data are presented as mean ± SEM along with vessels 
treated (n) from placentae (N). **p<0.01, ***p<0.001.  
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5.7.3.2. Response of PE CPA to acidic pH  
 
 The response of CPA to application of lactic acid experiments was performed 
across each different CPA sample population. Figure 5.7.3.2-1 shows an original recording 
from the CPA as the pH was lowered. The vessels show evidence of a smaller loss in tone 
which was quickly recovered before the next insult was introduced. Figure 5.7.3.2-2 
summarises the dose-response curves with the application of lactic acid and PE showed 
significant inhibition from pH 7.0-6.4. Table 5.7.3.2-1 summarises the EC50 in response to 
increasing doses of lactic acid using CPA from a range of placental samples. The PE vessels 
produced the lowest relaxation in response to pH (37 ± 5 %) compared with NORM CPA (60 
± 5 %, p<0.01). The post wash out induced rapid contraction of the CPA was also seen with 
the PE samples (not shown).  
  
 
Chapter 5  
Assessing the functional characteristics of CPA and SVA 
173 
 
5mN
10mins
Baseline  
U46619   
7.2   7.0   
6.8   
6.4   
6.6   
pH + PE
 
Figure 5.7.3.2-1 showing the response to pH in CPA from a PE samples. An attenuated response 
to pH was observed as the initial loss of vessel tone (phase I) was reduced which also allowed for the 
recovery of vessel contraction (phase II) to be achieved sooner (red box).   
 
Table 5.7.3.2-1 summarising the dose-response data for acidic pH across different patient groups.  
Vessels (n) EC50 ± SEM p Maximum relaxation 
 ± SEM 
NORM (14) 6.9 ± 0.1  60 ± 5 
PE (4) 6.8 ± 0.1 <0.01 37 ± 5 
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Figure 5.7.3.2-2 summarising the effect of changing pH with NORM (N=14) and PE-CPA (N=4). 
A significant inhibition in the relaxation response to pH was seen with PE-CPA samples across the 
high pH range (pH 7.0-6.4). Data are presented as mean ± SEM along with vessels treated (n) from 
placentae (N). **p<0.01.  
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5.8. Discussion  
 
5.8.1. Comparing CPA to SVA 
 
The CPA and SVA represent very distinct regions of the placenta and will experience 
very different vascular challenges. Examining the cryosection preparations of CPA revealed a 
polarised phenotype with an uneven distribution of SMC around the lumen (Chapter 4.4.1). 
Further to this, SVA had a significantly small vessel diameter when compared to CPA. This 
difference in structure will have important consequences for the response of each vessel type 
to the flow of blood. Resistance arteries and arterioles have less SMC to surround the 
endothelial layer and the wall: lumen ratio will be an important determining factor in the final 
response of vessels (Mulvany and Warshaw, 1979, Mulvany and Aalkjaer, 1990, McPherson, 
1992). The wire myography has been developed as a research tool to provide an in situ model 
for studying isolated vessels. The widely applied transluminal pressure for adult vessels 
within the range of 200-ȝP is 13.3 kPa (Mulvany and Aalkjaer, 1990)which is higher 
than that found in the placental IVS, which is reported to be in the range of 2-5 kPa  
(Rodesch, Simon et al., 1992, Mawissa, Jauniaux et al., 1993, Kleiner-Assaf, Jaffa et al., 
1999, Kaufmann, Mayhew et al., 2004). In order for our data to be relevant it was imperative 
to match the conditions found in vivo and thus chose to apply a transluminal pressure of 5.1 
kPa with both CPA and SVA. The significance of this lower pressure setting has previously 
been shown by Wareing (et al., 2002, Wareing, Greenwood et al., 2003).  
Chapter 5  
Assessing the functional characteristics of CPA and SVA 
176 
 
Using the same experimental parameters allowed for direct comparisons to be made 
between each vessel. Upon stimulation with U46619 the CPA could generate significantly 
more active tension with 20% perfusion. The SVA produced a small contraction with the 
higher doses of U46619 and the dose-response curve failed to reach plateau suggesting that a 
much higher concentration of U46619 was required to obtain the maximum vessel response. 
However when considering both the wall thickness of SVA along with the smaller diameter, 
it could be possible that the transluminal pressure of 5.1kPa was beyond the stretch capability 
of the resistance vessel and may have restricted the response to U46619 stimulation. The 
contractile response of SVA increased when the pO2 was reduced from 20% (156mmHg) to 
5% (38mmHg) with the lowest pO2 setting of 2% (15mmHg) producing the most significant 
increase in active tension which could match the response produced by CPA at 2% pO2. 
When the pO2 was lowered to relative hypoxic levels (2%) the SVA responded with 
increased vasoconstriction. This suggests the SVA may need to maintain low pO2 to optimise 
the uptake of O2 maternal circulation and provides more evidence to suggest that the 
placental vessels can respond to changes in their microenvironment to effectively alter their 
vessel physiology.  
In contrast the SVA, CPA with a greater wall: lumen ratio produced the greatest 
response to U46619 stimulation. Lowering pO2 with CPA reduced contractile activity as the 
active tension produced at both 5% and 2% was significantly lower than that observed at 20% 
pO2. This suggests that CPA need to maintain their optimal vessel tone with high stretch and 
the apparent elasticity provided by the vessel wall is an adaptation to the large volumes of 
blood that flow through this transport system (Kaufmann, Sen et al., 1979, Mulvany and 
Aalkjaer, 1990, McPherson, 1992, Kaufmann, Mayhew et al., 2004, Wareing, Greenwood et 
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al., 2006a). The very nature of the placenta as an intermediary between the fetal and maternal 
circulations means the pO2 will significantly vary between each separate vascular region at 
crucial stages. Fetal pO2 levels are very different to adult pO2 levels, as shown by fetal 
haemoglobin which binds O2 with a higher affinity (Barker, Gluckman et al., 1993). It was 
interesting to see how altering the pO2 along with transluminal pressures could dramatically 
alter the contractile properties of the vessels which is an important factor to take into 
consideration when interpretating results.  The fetal and placental pO2 levels vary at different 
stages of placental development, and at the time of parturition, the pO2 can increase from in 
the umbilical arteries, at a time when the fetus will be taking its first breaths. This event could 
also impact upon our experimental analysis, as we are utilising end state tissue that has been 
collected post-delivery, during which time, the placenta has also been exposed to the ambient 
environment (Economides and Nicolaides, 1989).  
 
5.8.2.  Contractile responses 
 
Differences in the functional activity of a blood vessel allude to the tissue specific 
adaptations by each vessel to perform the different roles across the placenta. The early work 
with CPA made significant progress in understanding the response of vessels to contractile 
agents, changing pO2 and stress. The choice of the correct contractile agent was crucial for 
our functional studies. U46619 gave an immediate and potent response that was stable for 
long enough to allow for our time controlled experiments. Vasoconstriction is produced when 
TxA2 binds directly to its receptor in SMC which are expressed across the placental vascular 
system (Catella, Lawson et al., 1987, Howard, 1987, Hall, Han et al., 1989, Hedberg, Mento 
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et al., 1989, Myatt, 1992). U46619 is a thromboxane mimetic that has been widely used in 
placental studies as it gives both potent and reproducible contractions in isolated blood 
vessels. SVA could produce a response to U46619 but was significantly lower when 
compared to the response produced by CPA at the same pO2 settings. An important 
difference was found with SVA during the dissection and mounting procedure. The SVA 
were highly sensitive to touch as the lumen would immediately clamp shut upon contact and 
further manipulation with the dissection apparatus could not reverse this change. This 
highlights the very different nature of vessels from the placenta which are capable of 
regulating their own vessel tone without the need for external stimuli. It would also suggest 
that SVA may have responded differently with an alternative contractile agent such as Et-1 
(Allen, Skajaa et al., 1991, McCarthy, Woolfson et al., 1994, Sabry, Mondon et al., 1995a, 
Kingdom, Huppertz et al., 2000) or 20- Hydroxyeicosatetraenoic acid (20-HETE) which is 
powerful vasoconstrictor implicated in the control of blood flow sand like Tx is synthesised 
via the AA pathway (Schwartzman, Falck et al., 1989, Gebremedhin, Lange et al., 2000).  
 
5.8.3. Vasodilatation in the placenta  
 
A wide range of vasoactive substances are found within the placental circulation but 
there is a poor understanding as to which factor is key for mediating relaxation of specific 
placental vessels. There is also evidence of local differences existing within the placenta 
which have been attributed to the different functions performed by the distinct vessels 
(Chaudhuri and Furuya, 1991, Cipolla, Smith et al., 2009).  
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The role of the EC layer in mediating vessel activity was investigated using BK and 
ACh both of which promote the release of NO from EC which could not demonstrate a 
significant relaxation response both in the presence and absence of L-NAME. It is worth 
noting that L-NAME requires an additional hydrolysis step to improve its solubility in in 
vitro preparations which may explain why we only observed a small inhibition with the ACh 
response (Gardiner, Compton et al., 1991, Jovanovic, Grbovic et al., 1994c, Griffith and 
Kilbourn, 1996). An alternative competitive inhibitor of NO is L-NG-nitro-Arginine (L-
NNA) which is closely related to L-NAME and can easily permeate the cell membrane and 
along with methylene blue (MB) have shown to produce specific inhibitors of NO production 
and release (Griffith and Kilbourn, 1996, Sand, Andersson et al., 2006).  
A recent study (Sweeney, Wareing et al., 2008) reported a relaxation response to BK 
by placental vessels. The crucial between this and my study was the addition of a sub-
maximal dose (<1µM) of U46619 (EC80 dose) and vessels were allowed to stabilise for 
longer (10mins instead of 5mins in our study) prior to addition of BK. U46619 is potent 
vasoconstrictor which has the advantage that the contractile response stabilises which was in 
direct contrast to AVP which showed evidence of a loss in pre-tone. However the 
concentration used in our study (1µM) may have contributed to the poor relaxation response 
with both ACh and BK. It would be important to investigate this using sub maximal doses of 
U46619 and leaving the vessels for a longer period of time before adding the different 
vasodilators. 
In direct contrast to ACh and BK, the most potent and reproducible relaxation 
response was seen with the NO donor SNP, which exerts a response by directly targeting 
SMC. The response to SNP with CPA was matched by SVA across each pO2 setting and the 
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most significant relaxation response was seen at 5% pO2. The NO donor SNP has previously 
been reported to induce a relaxation response to be in the range of 50-70% relaxation with 
placental CPA and CPV (Mondon, Doualla-Bell Kotto Maka et al., 1995, Wareing, Crocker 
et al., 2002, Sweeney, Wareing et al., 2008) to support our findings. Sabry (et al., 1995a) 
demonstrated an endothelium-dependent relaxation with isolated SVA preparations and 
stripping the endothelium using human hair reduced the relaxation response to ACh and 
histamine which are both endothelium-dependent vasodilators. We chose to focus on SNP in 
our study but it would be interesting to observe the effects of these stimulants in our studies 
also. The response to SNP highlights the role of the EC layer in mediating vessel tone. Any 
damage to the EC layer has the potential to impair the production and release of PGI2, which 
is a potent vasodilator (Walsh, 1985).  
 
5.8.4. Response to RIL 
  
This study was the first to show the direct effects of the neuroprotectant RIL on both 
CPA and SVA placental vessels. RIL is an important antiglutamate agent with US Food and 
Drug Administration approval  with minimal side effects reported (Figure 5.8.4-1). RIL has 
been shown to oppose inward currents induced by VGCC and voltage dependent Na+ 
channels (NaV) to decrease the release of ACh and glutamate from pre synaptic neurons 
(McIntosh, Smith et al., 1996, Stutzmann, Pratt et al., 1996). It was revealed that 1µm 
produced a potent relaxation that reached upwards of 75% with CPA and 78% with SVA at 
20% pO2. CPA also showed that the relaxation was increased with lowering pO2 levels and 
the highest relaxation was produced in 2% pO2. In direct contrast, SVA showed an enhanced 
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response to RIL when the pO2 was lowered from 20% to 5%. However, when the pO2 was 
further reduced to 2%, we observed a significant reduction in the response produced by the 
placental vessels to suggest that pO2 is crucial for determining the effect of RIL. Low pO2 
can alter the gating of ion channels and at SVA showed a potent contractile response to 
U46619, a higher dose of RIL was required to produce an equivalent relaxation to that seen 
with 20% or 5% pO2.    
 
 
Figure 5.8.4-1 showing the structure of RIL (2-amino-6-trifluoromethoxy benzothiazole). Image 
obtained from www.sigma.com 
 
 
RIL slows disease progress of amyotrophic lateral sclerosis which is caused by a 
defect in axon transport of neurofilament proteins. RIL administration delays the progression 
of the disease and is currently used in a clinical setting (Stutzmann, Pratt et al., 1996). A 
recent finding by Stevenson (et al., 2009) helped to understand the protective role provided 
by RIL treatment as it was shown that RIL did not directly induce glutamate release but 
instead RIL decreased the phosphorylation of ERK and p38 to slow neurofilament transport.  
RIL has also shown an important role in protection against ischaemic brain injury 
linked with trauma and inflammation. This was demonstrated using a pressure induced model 
of retinal ischaemia in rats (Ettaiche, Fillacier et al., 1999). A 30min exposure to increased 
retinal pressure could induce ischaemia and this was significantly reduced with RIL 
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treatment. RIL can open K2P channels and inhibit Nav, and the authors speculated that this 
would reduce the depolarisation triggered by ischaemia to then prevent the over stimulation 
of glutamate receptors. This finding may also help to understand why we found that the 
response to RIL was partially pO2 dependent.  
More significantly, RIL has also been used to study VEGF signalling in human 
umbilical vein endothelial cells (HUVEC) (Yoo, Hyun et al., 2005). Hypoxia is an important 
stimulant for VEGF production to promote new blood vessel formation. This study (Yoo, 
Hyun et al., 2005) showed that the VEGF induced cell proliferation could be successfully 
inhibited by RIL and provides further support for the anti-ischaemic protection provided by 
RIL. This could also have significance for developing future anti-ischaemia therapies to treat 
placental pathologies and warrants further investigation. RIL is an emerging as an important 
therapeutic tool due to its multiple actions on intracellular signalling pathways. At high 
concentrations RIL displays anaesthetic like properties and can modulate the action of 
TREK-1 and TRAAK while also showing the potential to finely regulate its action on target 
tissues (Fink, Lesage et al., 1998, Duprat, Lesage et al., 2000, Reyes, Lauritzen et al., 2000, 
Cadaveira-Mosquera, Ribeiro et al., 2011). The potent response produced by both CPA and 
SVA demonstrates that RIL is also an important future candidate for regulating placental 
vascular function. The dose dependent and O2 dependent actions of the drug also provide 
avenues to target specific pathways without causing unwanted side effects. However to 
achieve this we firstly need to disseminate the precise ion channel targets of RIL and has 
been investigated in Chapter 7.  
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5.8.5. Response to stress stimuli  
 
Small vessels need to maintain their vessel diameters to keep a constant level of 
myogenic tone. This is achieved through the immediate response of vessels to stimuli such as 
repeated cycles of ischaemia/reperfusion (I/R) will be met with a redirection of blood flow as 
vessel tone alters (Archer and Michelakis, 2002, Bruce, Taggart et al., 2004). I/R and chronic 
hypoxia have been shown to be part of disease pathways including PE and are linked with the 
alterations in proton homeostasis which can also alter vascular tone  directly or indirectly 
(Holzer, 2009).  
 
5.8.5.1. Importance of pO2  
 
Our investigations revealed that lowering tissue perfusion from 20% to 2% could alter 
the maximum constriction and vasodilatation responses of placental vessels when the same 
stimulant was applied. The most contrasting change was seen with SVA which showed an 
elevation in the vessels contractile ability. The intrauterine environment has an important 
influence over development of the placental and fetal tissue. Early stage low pO2 has a 
protective role to prevent accumulation of ROS (Nicolaides, Economides et al., 1989, Boura, 
Leitch et al., 1998, Burton, Jauniaux et al., 2009). The level of pO2 was also an important 
factor in determining the response of placental vessels to SNP. SVA produced the most 
relaxation to SNP at 2% which is also when we observed the greatest response to U46619. In 
contrast 2% pO2 had the reverse effect on CPA which showed a loss in relaxation and a 
potent response to SNP at 5% pO2. The dose-response curve also showed a steep response to 
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SNP at 10-8M with this pO2 setting which suggests a key threshold limit was reached and the 
vessels demonstrated their full vasodilatation capacity in response to the agonist. This also 
suggests that tissue oxygenation is a determining factor for vessel functions and shows how 
changes in maternal oxygenation are instantly matched by changes in placental blood flow. 
The response to SNP to was also demonstrated with isolated vessels from healthy placental 
samples (Wareing, Crocker et al., 2002) under different O2 perfusion settings (21, 7 and 2% 
O2). It was shown that the response to SNP was unaltered with CPA with changing pO2 while 
our study used 5% perfusion and CPA showed a steep response to SNP and highlights how a 
narrow change in pO2 from 7% to 5% can have dramatic changes on the vessels response to 
the same stimuli. In contrast this study did demonstrate that the level of tissue O2 was 
important for controlling the response to SNP with CPV (Wareing, Crocker et al., 2002), 
which has parallels with our own observations with the SVA response to SNP in 2% pO2. 
The level of tissue perfusion also has an important influence on vessel function and 
this was demonstrated in a recent study (Maenhaut and Van de Voorde, 2011). Increases in 
cell mass will increase the level of tissue hypoxia as sufficient O2 is not delivered to all the 
tissue. This is a particular risk for adipose tissue and it was shown that hypoxia (95% N2) 
could cause a loss in vessel tone with mouse mesenteric vessels which had the surrounding 
fat tissue removed. In contrast vessels which still had a layer of adipose tissue intact produced 
a biphasic response with an initial contraction immediately followed by a relaxation. This 
finding demonstrates the role of surrounding tissue on controlling vessel function. This also 
highlights how small alternations in the resistance sized vessels which set the total peripheral 
resistance could have detrimental effects for the wider tissue (Bayliss, 1902, Bruce, Taggart 
et al., 2004, Maenhaut and Van de Voorde, 2011). Cipolla (et al., 2009) showed that repeated 
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treatments with I/R reduced basal NO production in rat parenchymal vessels. The vessels 
were still responsive to SNP to suggest SMC could still bring about a relaxation. A recent 
study examined placental tissue from terminated pregnancies at 7-16wks of development 
(Jauniaux, Watson et al., 2000). It was shown that the antioxidants CAT, GPx and SOD 
increase with increasing gestational age and the most significant correlation was with GPx 
which helps to breakdown the ROS H2O2. Our data showed that changing the perfusion of 
mounted vessels produced significant changes to the contractile and relaxation response of 
both CPA and SVA and provides an important parallel to the placental conditions found in 
vivo. The pO2 significantly alters at different stages of development and we have been able to 
show that this may then be translated with a change in the functional role of the placental 
vessels.   
 
5.8.5.2. H2O2 
 
Prolonged periods of low pO2 will also lead to an increase in ROS which used in vitro 
have demonstrated the ability to alter vascular function. In light of this evidence the action of 
H2O2 in CPA and SVA was investigated. It was shown that both vessels could relax in 
response to H2O2 but crucially this treatment was toxic. It was also shown that the vessels 
could also produce a transient contraction in response to H2O2 stimulation which was 
reversible as the vessel returned to baseline. It has been previously demonstrated that H2O2 
can induce a biphasic contraction and relaxation cycle that is only when pathophysiolgical 
concentrations were applied (Yang, Zheng et al., 1998). It was shown that the response was 
the result of moving Ca2+ ions as removing extracellular Ca2+ could block the contractions. A 
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recent study also supported our findings. Mills (et al., 2009) used a single dose of H2O2 (10-
4M) to stimulate CPA at rest and found the vessels could contract but the contraction was 
followed with an immediate relaxation as the vessels returned to their baseline tension. This 
response was completely inhibited in the presence of CAT. Importantly for our studies they 
failed to report evidence of H2O2 induced vasodilatation when applied at 10-8-10-4M while 
they did however demonstrate the peroxynitrite ONOO- could relax CPA. These finding 
demonstrate a role for ROS in regulating placental basal tone and may facilitate the long term 
adaptations to placental insufficiency. The lack of relaxation response H2O2 seen with this 
study may be attributed to the preparation
 
of H2O2. H2O2 is a very unstable molecule that is 
rapidly broken down and we used fresh preparations of H2O2 during our investigations and 
found that this had an important influence on our results.   
The treatment with H2O2 was found to be toxic for both the CPA and SVA. Perfusing 
the vessels with 20% pO2 may itself have been elevating the ROS concentrations as this level 
of perfusion represents the hyperoxia level for placental vessels. Adding further ROS insults 
may have overwhelmed the antioxidant pool of the isolated vessels and may have caused the 
loss in vessel function. This observation also highlights the danger of ROS accumulation 
which could be causing permanent changes to vessel physiology (McQuillan, Leung et al., 
1994).  
 
5.8.5.3. pH 
 
Prolonged periods of hypoxia can alter the pH of circulating blood and will have 
important consequences for the control of vascular tone. Acidic pH will also lead to chronic 
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metabolic inhibition as ATP levels can further fall to prolong the pH insult (Canzanelli, 
Greenblatt et al., 1939, Blechner, 1993, Burton, 2008). During our investigations, CPA and 
SVA were exposed to relative hypoxia (2% pO2) and we did not find a significant change in 
the pH of the bathing saline. Directly altering the external pH environment was then 
investigated and it was found that a potent response was produced across the pH range 
applied. It was shown that both CPA and SVA could constrict in response to alkaline 
conditions with increasing levels of NaHCO3. In contrast, acidic pH conditions (via 
application of lactic acid) did not alter the baseline tension but caused a biphasic relaxation 
response in pre-constricted vessels.  
Levels of metabolic acids such as lactic acid have been shown to increase at time of 
low tissue perfusion such as following the immediate delivery of the placenta (van Laar, 
Peters et al., 2010). Perfusing the tissue helps to remove lactate and reverse the tissue stress. 
One possible explanation for the transient response we observed is that as the tissue is 
continually perfused the lactate molecules are quickly removed from the tissue to restore 
normal vessel function (Weil and Tang, 1997). This could be investigated by reducing or 
removing perfusion from the vessel baths to see if tissue oxygenation is a determining factor 
of the response to lactic acid.  
Our results are supported by the findings of Shah (2008) who demonstrated that rat 
pulmonary arteries could firstly contract when the pH was increased from pH 7.3 to 8.3 using 
1M Sodium hydroxide (NaOH). In addition it was reported that the baseline tension when 
vessels were at rest was reduced when the vessels were exposed to acidic pH of 6.3 with 1M 
HCl. An exposure to low pH would be expected to inhibit K+ and increase baseline tension 
via depolarisation of the cell membrane (Bevan and Yeats, 1991). However this example 
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highlights the tissue specific differences that exist across different vascular systems. The 
pulmonary circulation is a good model for predicting the responses of placental vessels which 
have previously shown to produce similar responses (Hampl, Bibova et al., 2002).  
The response to an acidic pH stimulus has parallels with the response to seen with I/R 
treatments.  Lowering the pH by 0.2 units will introduce a massive H+ challenge to cause an 
immediate loss of vessel tone which is transient as the vessel can recover its contractile 
function. This second phase of the response (recovery phase II) is likened to the re-
oxygenation phase and may be the consequences of buffering agents within the saline which 
work to restore basal pH levels (Gaus, Demir-Weusten et al., 2002, Cowley, Sellers et al., 
2005). The most likely candidate could be HCO3- which can buffer the bathing solution to 
maintain a constant pH value. It was also interesting to see that an immediate contraction was 
produced in response to washout as the pH is switched from 6.4 to the normal pH of 7.4. This 
provides further support for our observations that increasing NaHCO3 concentrations to 
invoke alkaline conditions can produce a contraction in placental vessels. A recent study also 
investigated the response of vessels to lactic acid (Maenhaut and Van de Voorde, 2011). This 
study demonstrated a relaxation response of rat mesenteric vessels to hypoxia (95% N2). In 
contrast the same vessels did not produce a response to lactic acid application but crucially 
this study was with adult vessels and could highlight a response that is limited to the 
pulmonary (Shah, 2008) and placental circulations.  
The link between prolonged hypoxia and low pH environments was demonstrated 
with metabolic inhibitor 2,4-Dinitrophenol (DNP) in Chinese hamster ovary cells (COS) cells 
(Duprat, Lesage et al., 2000). This treatment lowered intracellular pH levels as ATP stores 
were rapidly depleted. A similar study (Byrne, Howard et al., 1997) used perfused whole 
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placenta with hypoxic conditioned media to mimic the effects of placental insufficiently and 
showed that a 20mins exposure to hypoxia was sufficient to lower the pH across the placental 
tissue. They also showed that the basal lactate levels were significantly higher and 
contributed to the lower pH recordings found within the placenta circulation. They also 
reported the venous blood samples showed the most rapid reductions in pH levels and 
provides a better understanding of how low placental perfusion can have wide ranging 
consequences for the whole placenta (Byrne, Howard et al., 1997, Otter and Austin, 1999).  
HFPV has been hypothesised to improve O2 uptake by redirecting blood flow to better 
perfused regions (Hampl, Bibova et al., 2002). In a similar light the relaxation/constriction 
coupled response produced by placental vessels challenged with acidic pH insults may 
restrict blood flow to limit the spread of H+ ions to the wider placental circulation. This could 
also allow for tissue perfusion to take place in order to remove the excess H+ ions in to the 
maternal circulation. Placental vessels have shown the capacity to respond to pH stress and 
this provides an insight into how the placenta can maintain its acid-base balance whilst 
maintaining its vascular tone. Placental vessels need to match the maternal perfusion pressure 
whilst maintaining a low resistance to blood flow. Applying chronic stress stimuli has 
demonstrated that the vessels are suitably adapted to perform this role while optimising the 
tissue perfusion (Howard, 1987, Byrne, Howard et al., 1997, Weil and Tang, 1997). This also 
provides further evidence that the placenta is an important organ that has yet much to reveal.  
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5.8.6. CPA from PE samples  
 
Examining the responses of vessels from healthy patients helps to better understand 
the differences between normal and adverse pregnancies. The functional responses from a 
small population of CPA from PE placenta were examined. The contractile response with 
U46619 was significantly altered with this group which agrees with published data 
(McCarthy, Woolfson et al., 1994, Myatt, 2002, Abad, Estan et al., 2003, Wareing, 
Greenwood et al., 2006b). The SNP response was similar between NORM and PE and the 
vessels were capable of responding to RIL which may be an important observation. The main 
difference was seen with the response to stress as the response to H2O2 was exaggerated as 
the PE CPA were highly sensitive to the effects of H2O2. An important factor to consider with 
this observation it that the vessels were perfused with 20% pO2 and this may be contributing 
to the production of ROS and a further insult with high doses of H2O2 may have resulted in 
overwhelming the antioxidant capacity of the already stressed tissue.  
The response to acidic pH stimuli was also seen with PE CPA samples but more 
significantly, the loss in tone was reduced when compared to the NORM group across the 
dose range. This also suggests that the placental vessels can adapt to changing conditions 
depending on the intrauterine environment and may alter the expression of key pH sensing 
ion channels to result in this altered response. This limited data set provides an insight into 
the altered vascular function of adverse pregnancy samples. The reduced ability to relax in 
response to an acidic pH stimulus could potentially be harmful as the excess H+ cannot be 
efficiently buffered out of the placental blood. This would carry the risk of spreading the low 
pH insult to other areas of the placenta and more importantly expose the fetus to the same 
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stress (Archer and Michelakis, 2002). It was significant that the pH response was blunted 
with PE samples and suggests the vessels may be less sensitive to low pH which is often the 
case when cells have been repeatedly exposed to the same stimuli (Bevan and Yeats, 1991, 
Gitterman, Wilson et al., 2005). However this study needs to be expanded to include more 
samples in order to better understand the importance of these differences.   
 
5.8.7. Future research  
 
The functional role of the CPA and SVA were compared across different pO2 settings 
to investigate different extremities of tissue perfusion. However it would have been more 
physiologically relevant to alter the pO2 within the same experimental set up. This would 
allow us to then observe the changes in vessel activity when a switch is made from normoxia 
to hypoxia for instance. The same pO2 settings were used for both CPA and SVA, however 
the pO2 varies across placental regions. For example, aW WHUP ZNV WKH S22 recorded 
within umbilical veins is 38mmHg and 16mmg within the arteries (Campbell, Dawes et al., 
1966, Kaufmann, 1982). The latter is also the level of pO2 that we used in our study to 
observe relative hypoxia for both SVA and CPA. The recorded pO2 within the IVS is 5% and 
was appropriate for SVA but 2% may potentially reflect normoxic conditions for CPA due to 
the close proximity to the umbilical vessels. It would be interesting to see the effects of <1% 
pO2 particularly with the CPA to see how this may alter vessel physiology.  
The main limitation with studying SVA was the reduced vessel viability which 
severely reduced our sample numbers. The vessels were sensitive to mechanical stretch, 
which significantly limited the opportunity to observe the effects of pre-incubating vessels 
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with various blockers. We should consider alternative methods of both collecting and storage 
of vessels to improve viability such as cold storage at 4ÛC of isolated placental explants 
(McIntyre, Williams et al., 1998). In this example it was shown that the EC was still viable 
after 6h. The lower temperature storage has the benefit that this will slow down apoptosis 
linked enzymes including caspases and proteases. It also has the benefit of reducing the 
metabolic rate of the tissue and slowing down hormones such as insulin from being released. 
The resulting reduction in glucose consumption also means that the O2 requirement will also 
fall so the tissue can be stored without the need for perfusion.  
Another alternative would be to increase the glucose concentration of PSS from the 
5.5mM used which reflects adult basal levels of glucose (Hay, 1995). Increasing the 
concentration may help to improve tissue viability, particularly for SVA, but may introduce 
oxidative stress and alter the pH. This would however help to improve the inclusion of 
invaluable samples such as PE or IUGR placentae which currently cannot be stored for long 
periods of time and as a result we had a limited number of samples in our study.  
A permanent change in the vessel activity was observed post H2O2 application as the 
vessels were no longer responsive to further stimulations. To investigate this we could collect 
examine the vessels and examine thin tissue preparations using IHC and/or confocal imaging 
of fresh tissue slices. This will let us examine any changes in the expression of ion channels 
which in the example of BKCa have been shown to occur following hypoxia. Evidence of 
oxidative stress could also be investigated to evaluate the vessel viability and this could help 
to better understand the response to H2O2. Another option to consider could be to use 
pressurised vessels to better investigate the role of H2O2. This method would allow for a 
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better distinction to be made as to the role of the EC and SMC in generating the biphasic 
response to H2O2 (Halpern, Osol et al., 1984, Dunn and Gardiner, 1995).  
Finally alternative vasoconstrictors such as Ang II, 5-HT, or the potent stimulant Et-1 
could be explored, as they may have a more potent influence on SVA in particular. The poor 
response by SVA may also be due to the method for tissue collection. Allen (1987) showed 
that the anaesthetics used during ELLSCS can alter the function of placental SVA and may 
explain why we encountered difficulties when working with these vessels. This could be 
investigated using samples following vaginal delivery where no anaesthetics have been 
administered.  
 
5.8.8. Conclusion 
 
In summary, the vascular responses of CPA and SVA were compared to gain a better 
insight into how blood flow is regulated across the fetomaternal interface of the placenta. The 
hypothesis was supported as the vessels could respond to the same stimuli to generate a 
response but crucially the force of the responses was significantly altered across CPA and 
SVA. It was also found that the level of tissue oxygenation had a powerful influence over the 
final response that was produced to each agonist investigated. The data presented from 
normal healthy pregnancies goes a long way in helping to build an understanding of the 
differences that exist in compromised pregnancies and secondly what effective treatments can 
be devised.  
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6. Expression of ion channels in CPA and SVA 
6.1. Introduction  
 
Ion channels have an important role in controlling the resting membrane 
potential and as a result have a central role in controlling vascular tone due to their 
influence on SMC. However there is very limited data available on K+ channels found 
within the placental vascular tissue. Electrophysiology data has demonstrated the role 
for hypoxia sensitive ion channels in resistance vessels (Hampl, Bibova et al., 2002) 
but limited information is available for these ion channels at the protein level. Our 
specific hypothesis here is that key O2 and pH sensitive K+ channels are differentially 
expressed across CPA and SVA.  
 
6.2. Objectives  
 
x Determine expression of 6 key K2P ion channels (TASK-1, TASK-3, TRAAK, 
TREK-1, TREK-2, and TWIK-2), along with the CaV1.2, BKCa and the KATP 
channel in CPA and SVA using the Western blotting technique. 
x To quantitate tissue specific differences in the expression of each ion channel 
across the different placental vessels using Western blotting.  
x Determine the cellular distribution of the key ion channels identified within CPA 
and SVA SMC using confocal microscopy. 
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6.3. Materials and methods 
 
Fresh CPA and SVA samples from NORM and PE placentae were 
immediately placed in liquid N2 (Chapter 3.4) and used for Western blotting analysis 
with the antibodies listed in Appendix II. The same antibodies were also used to 
investigate the subcellular location of each ion channel within cultured SMC using 
confocal microscopy (Chapter 3.6).  
 
6.4. Results 
  
6.4.1. Patient population  
 
In order to compare NORM and PE samples the first objective was to collect 
additional information contained within each SDWLHQW¶VPHGLFDO UHFRUGV 7KH SDWLHQW
and obstetric data has been summarised in Table 6.4.1-1 and all samples were 
obtained from ELLSCS (described in Chapter 3.2 ) from singleton pregnancies. The 
cord blood was sampled routinely for all complicated pregnancies such as PE, while 
NORM pregnancies were sampled at the discretion of health professionals. As a 
result, only 30 patients from the NORM pregnant group had complete cord blood pH 
recordings in their patient notes.  
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Table 6.4.1-1 summarising the patient demographics of samples prepared for Western blot 
analysis. Data are presented as mean (±SEM) or median [±IQR]. ** p<0.01 *** p< 0.001.  
Parameter NORM 
(N=40) 
PE 
(N=6) 
p 
Maternal age (yrs) 31.25 ± 0.9 29 ± 2.3 0.3 ns 
Primipara n (%) 11 (27.5%) 4 (66%) - 
Body mass index (kg/m2) 25 [22-32] 26.5 [23-30] 0.9 ns 
Max. systolic blood pressure 
outside labour (mmHg) 
125 ± 3.2 150 ± 6.1 0.01 * 
Max. diastolic blood pressure 
outside labour (mmHg) 
63 ± 1.5 96 ± 4 0.003 ** 
Proteinuria g/L - 3.97 ± 0.7 - 
Gestational age at delivery  (days) 271 ± 1.2 236 ± 8.0 0.0009 *** 
Birth weight (g) 3242 ± 73 2128 ± 320 0.0003 *** 
Birth weight centile  48 [15-73] 30 [18-50] 0.4 ns 
Placenta/Birth weight ratio 0.2 ± 0.02 0.3 ± 0.09 0.2 ns 
Gender n (% male) 14 (35%) 3 (50%) - 
Cord blood pH   
Venous (N) 
 
7.28 ± 0.02 
(30) 
 
7.27 ± 0.03 
(6) 
 
0.3 ns 
Arterial (N) 7.34 ± 0.01 
(30) 
7.32 ± 0.01 
(6) 
0.9 ns 
 
Only one patient out of the six PE samples was delivered post term (37wks) 
and the data showed that the gestational age at delivery and the birth weights were 
significantly lower in the PE group. However it was also shown that the normalised 
birth weight centile was not significantly different (p>0.05) between the two groups. 
Furthermore none of our samples were complicated with IUGR and that both arterial 
and venous cord blood samples did not show evidence of acidosis (pH <7.05 (van 
Laar, Peters et al., 2010)) across both NORM and PE patient populations. Examining 
the individual PE cases revealed some interesting information. One patient had a BP 
which could not be controlled and remained elevated 9 days post-delivery. The patient 
displayed no other symptoms and was finally discharged. A second PE case had a 
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SUHYLRXV KLVWRU\ RI 3( DV WKH SDWLHQW¶V own mother had been diagnosed with PE 
during the respective pregnancy while a final patient underwent an emergency LLSCS 
due to fetal distress. The final analysis was to determine the mean blood pressure for 
the PE patients. This was 150/96 and therefore meets the clinical parameter used to 
diagnose PE (>140/90) (detailed in Chapter 1.8.1). The second clinical marker for PE 
is proteinuria and this was determined using urinalysis with a simple dipstick test 
(Medi-Test® Protein 2) which gives a range from 1-5g/L. Recordings of >0.5g/L are 
considered to be indicators of PE and all 6 patients in this study had recordings above 
this critical value with a mean average of 4g/L of protein.  
 
6.4.2. Expression of BKCa  
 
The initial Western blot analysis was carried out using a monoclonal antibody 
(BD Transduction). However, this only revealed a 60 kDa band along with multiple 
non-specific bands as the blot was exposed for longer (not shown). We then opted for 
the polyclonal antibody as an alternative and found the 60 kDa band was seen along 
with the predicted 120 kDa band which corresponds to the large ĮVXEXQLWRIWKH%.Ca 
channel. The polyclonal antibody also had the advantage that the blot was cleaner as 
less non specific binding was observed. Figure 6.4.2-1A shows a detectable signal for 
the 120 kDa protein and the smaller 60 kDa band. The positive control RB produced 
strong expression for the 120 kDa band while the 60 kDa was not seen. In contrast the 
MYO and both CPA and SVA samples from normotensive pregnancies produced a 
strong band at 60 kDa and a fainter band at 120 kDa which was not always observed 
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with each sample studied. Each sample is shown with its paired sample where the 
BKCa antibody has been pre-absorbed using the control peptide. Only the RB 
produced a small amount of positive stain but the remaining samples failed to produce 
any bands when both blots were developed alongside each other. The next objective 
was to analyse our PE sample population and as a result we repeated the Western blot 
using the 6 PE matched CPA and SVA placental samples along with a NORM and PE 
MYO biopsy. The normalised signal intensities are shown for BKCa in Figure 6.4.2-1 
and semi quantitative analysis shows no significant difference in expression of BKCa 
when comparing each pair of sample (Table 6.4.2-1). Figure 6.4.2-1C shows the 
UHVXOWVIRUWKHĮ subunit detection in PE samples which was equally expressed across 
each pair of sample Comparing the mean values post normalisation failed to show any 
significant differences across the NORM and PE patient groups (Table 6.4.2-1).  
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Table 6.4.2-1 showing the densitometry data for each band detected in NORM and PE 
samples. Comparing the average values across each band size showed no significant 
difference in the expression of BKCa when comparing matched CPA and SVA samples or 
MYO samples 
 
 
BKCa N MW (kDa) 60 p 120 p 
 MEDIAN ± IQR MEAN ±SEM MEDIAN ± IQR MEAN ±SEM 
CPA  24 30 (23-58) 38±5 0.7 ns 24 (11-53) 92±28 0.2 ns 
PE-CPA 6 44 (39-53) 46±2 50 (37-71) 55±9 
SVA 24 31 (20-58) 38±5 0.4 ns 25 (13-111) 73±22 0.6 ns 
PE-SVA 6 43 (31-59) 44±4 65 (56-103) 76±10 
MYO 8 20 (0-28) 17±6 0.1 ns 96 (47-112) 92±15 0.9 ns 
PE-
MYO 
3 36 (26-41) 35±2 70 (60-90) 73±9 
RB 6 4 (0-20) 9±4  186 (107-329) 242±45  
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Figure 6.4.2-1 shows BKCa expression (red box) in CPA (lane 1), SVA (lane 3), and MYO 
(lane 5) from normal pregnancies and RB samples (lane 7) (A). Matched CPA and SVA 
samples were immunoblotted for the expression of the BKCa. Each blot was then stripped and re-EORWWHGZLWKȕ DFWLQ IRU ORDGLQJFRQWURODQG LV VKRZQEHORZHDFK ODQHB shows the box and 
ZKLVNHU SORW IRU HDFK SURWHLQ QRUPDOLVHG WR LWV LQGLYLGXDO ȕ DFWLQ H[SUHVVLRQC shows BKCa 
expression in CPA and SVA samples from PE samples (red box). Similar expression was 
observed in both CPA and SVA samples for the 60 kDa band but the 120 kDa was detected in 
abundance and appears to be higher in the SVA samples. D shows the box and whisker plot for 
each protein normalised to itV LQGLYLGXDO ȕ DFWLQ H[SUHVVLRQ. Each sample (A&C) is shown 
alongside anti BKCa antibody that has been pre-absorbed with control peptide (lanes 2, 4, 6 & 
8). Values shown are expressed as median ± IQR.    
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6.4.3. Expression of KATP   
 
A large 50 kDa protein size was observed which corresponds to the 
intracellular C domain of KATP (Appendix III). CPA, SVA and MYO samples were 
consistently positive for KATP expression and has been summarised in Figure 
6.4.3-1A. Comparing the placental vessels revealed no significant difference in 
expression across CPA and SVA samples (N=22, p=0.3 Figure 6.4.3-1B). The RB 
samples failed to produce a band in the predicted 50 kDa region so the data was not 
used for further analysis (discussed in Chapter 6.4.3.1). Control peptide was also used 
to validate the specificity of the antibody and developed alongside each sample of 
interest and revealed no non-specific signal. The following Western blot analysis 
involved PE samples of both CPA and SVA tissue (N=6) and Figure 6.4.3-1C&D 
shows the results for KATP expression across the PE placental samples alongside the 
normal and PE MYO biopsies. A 50 kDa protein was identified in each of the 6 
samples and no significant difference in the expression of KATP across the NORM and 
PE samples was found (Table 6.4.3-1).   
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Table 6.4.3-1 summarising the densitometry data for KATP expression in NORM and PE 
samples. CPA and SVA samples show no significant difference in the expression of KATP 
across the patient groups. 
KATP N MW (kDa) 50 p 
 MEDIAN ±IQR MEAN ±SEM 
CPA  22 48 (29-68) 51±4 0.8 ns 
PE-CPA 6 61 (58-68) 63±2 
SVA 22 45 (32-55) 49±5 0.5 ns 
PE-SVA 6 63 (53-77) 64±7 
MYO 6 73 (53-94) 77±11 0.3 ns 
PE-
MYO 
3 107 (104-123) 111±3 
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6.4.3.1. Antibody validation  
 
The positive control RB was chosen for its reported abundant expression 
levels for a range of ion channels including the K2P family of ion channels (Patel, 
Honore et al., 1998). However the Western blotting analysis failed to produce a 
 
Figure 6.4.3-1 showing a representative image for KATP expression (red box) in NORM 
CPA and SVA samples along with the positive controls MYO and RB (A). The 50 kDa 
target band was seen in CPA, SVA and MYO samples. B shows the box and whisker plot for 
each protein normaliseGWRLWVLQGLYLGXDOȕDFWLQH[SUHVVLRQ. C showing the detection of KATP in 
PE tissue samples (red box). D summarises the box and whisker plot for each protein 
QRUPDOLVHGWRLWVLQGLYLGXDOȕDFWLQH[SUHVVLRQDQGQRGLIIHUHQFHZDVIRXQGDFURVVWKHVDPSOHV
Each sample (A&C) is shown alongside anti KATP antibody that has been pre-absorbed with 
control peptide (lanes 2, 4, 6 & 8). Values shown are expressed as median ± IQR.  
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positive signal for expression of ion channels with RB, namely KATP, TASK-1, 
TASK-3 TRAAK and TWIK-2, although RB is a recommended positive control 
according to the information contained in the individual datasheets provided by the 
manufacturers (Alomone). Replacing the blocking agent marvel with BSA could not 
resolve this issue (not shown). Another possible explanation could be the poor 
separation of proteins during homogenisation of RB tissue, and was further 
investigated with the RB cell line SH SY57. SH SY57 cells produced a positive band 
within in the predicted region for each ion channel (Figure 6.4.3.1-1). However the ȕ
actin levels were significantly lower than that for the crude tissue samples, and as a 
result made statistical analysis difficult, so the cells were not used further. The MYO 
tissue was then used as a positive control for the antibodies in question.  
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Figure 6.4.3.1-1 showing the expression of TASK-1 in SH SY57 cells (red box) alongside 
anti TASK-1 antibody that has been pre-absorbed with control peptide (lane 2).  
 
We were also aware of the need for consistency with our Western blot blots, 
and used crude tissue preparations of tissue, instead of cultured cell lines. The MYO 
was a better reference control for validating the quality of the antibodies, as it was 
consistently positive for expression of our ion channels of interest. One MYO patient 
sample was used to validate each new batch of antibody ordered, to check for any 
variation in epitope specificity. From all the antibodies used in this study, an 
inconsistency was identified with the anti TREK-1 antibody, which had previously 
produced bands at 100-90, 60 and 50 kDa (Figure 6.4.3.1-2). However as new 
batches of the same antibody were ordered again, the 50 kDa band was detected only 
(see Chapter 6.4.4.4) with a loss of the larger proteins. During the course of this study, 
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LWZDVDOVRIRXQGWKDWWKHPDQXIDFWXUH¶VGDWDVKHHWKDGDOVREHHQXSGDWHGWRUHIOHFWWKLV
change in antibody sensitivity.    
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Figure 6.4.3.1-2 showing the preliminary detection of TREK -1 in (red box) alongside 
anti TREK-1 antibody that has been pre-absorbed with control peptide (lanes 2, 4, 6 
&8). The blot shows the early Western blot images that were obtained with TREK-1 which 
produced three distinct bands (100, 60 and 50 kDa). However these bands were not seen with 
every patient samples examined and may be attributed to differences in antibody batches.  
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6.4.4. Expression of K2P channels  
6.4.4.1. Expression of TASK-1 
 
Figure 6.4.4.1-1A shows the results with TASK-1 Western blotting. The 
antibody is raised against the intracellular C terminal which has a predicted molecular 
weight of 45 kDa (Appendix III). A clear band with a MW of 50 kDa was observed 
and was assumed to be the TASK-1 channel in both CPA and SVA tissue samples 
along with the MYO muscle biopsy while RB was negative for TASK-1 expression. 
A band at the 71/75 kDa region was observed in some samples which had a lower 
signal intensity compared with the 50 kDa protein. The percentage intensity of the 
different TASK-1 bands has been summarised in Figure 6.4.4.1-1B. Semi 
quantitative analysis showed that there was no significant difference in TASK-1 
expression across CPA and SVA both for the 50 kDa (N=31, p=0.37) and 71 kDa 
proteins (N=31, p=0.5). The MYO tissue was also positive for TASK-1 (50 kDa) and 
revealed an additional band at ~60kDa that was not seen with either CPA or SVA. 
PE samples were also analysed for expression of TASK-1 and a representative 
Western blot image has been shown in Figure 6.4.4.1-1C. The image revealed a 
dense band at 50 kDa across each sample as both the PE CPA and PE SVA tissue are 
positive along with NORM and PE-MYO tissue samples. However in contrast to the 
NORM CPA and SVA tissue the 71/75 kDa was not detected in abundance in any of 
the 6 samples obtained from PE placentae. The MYO was also analysed for 
expression of TASK-1 and revealed the same 50 kDa band, we also found that the 71 
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kDa was not revealed in either the normal or the PE-MYO. The normalised 
densitometry data has been summarised in Table 6.4.4.1-1 and we observed no 
significant differences in the expression of TASK-1 across the CPA and SVA tissue 
as well as the NORM MYO and PE-MYO tissue lysate.   
 
Table 6.4.4.1-1 summarising the average expression of TASK-1 in each sample studied. 
There was no significant difference in expression of TASK-1 (both protein sizes) in SVA and 
CPA samples.  
 
TASK-1 N MW 
(kDa) 
50 p 
 
71 p 
 
 MEDIAN ± 
IQR 
MEAN 
±SEM 
MEDIAN ± 
IQR 
MEAN ±SEM 
CPA  31 37 (27-49) 49 ± 7 0.6 ns 23 (19-48) 19 ± 4 0.9 ns 
PE-CPA 6 54 (45-58) 52 ± 3 19 (17-23) 20 ± 3 
SVA 31 42 (32-60) 48 ± 4 0.2 ns 31 (20-58) 29 ± 6 0.7 ns 
PE-SVA 6 55 (37-59) 55 ± 5 25 (19-31) 24 ± 3 
MYO 8 36 (26-56) 45 ± 7 0.8 ns 4 (0-56) 9 ± 1 0.5 ns 
PE-MYO 3 39 (38-55) 44 ± 5 0 (0-41) 13 ±10 
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Figure 6.4.4.1-1 showing a representative blot of TASK-1 expression (red box) in matched 
CPA and SVA samples along with MYO from normotensive controls (A). Two distinct 
bands were identified in CPA and SVA samples. These bands were also seen with MYO 
samples along with an additional band around the 65 kDa region. B shows the normalised 
densitometry data for the two main target proteins considered to be TASK-1. C shows a 
representative blot of TASK-1 expression in matched PE-CPA and SVA samples along with 
MYO from normal and PE pregnancies (red box). The 50 kDa protein was consistently 
observed while the 71 kDa protein was not detected in abundance. D shows the normalised 
densitometry data for the expression of TASK-1. Each sample (A&C) is shown alongside anti 
TASK-1 antibody that has been pre-absorbed with control peptide (lane 2, 4, 6 & 8). Values 
shown are expressed as median ± IQR. 
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6.4.4.2. Expression of TASK-3 
 
Figure 6.4.4.2-1A shows a representative Western blot image for the detection 
of TASK-3. Based on the data sheet provided with the antibody the predicted 
molecular weight is 47 kDa corresponding to the extracellular P1 loop of TASK-1 
(Appendix III). Western blot analysis revealed a protein band of approximately 51 
kDa which was consistently detected with each sample analysed (N=23) and was 
assumed to be TASK-3. The band was also observed in MYO tissue at the same MW 
while RB again did not produce any staining. No significant difference was shown in 
the expression levels of TASK-3 when comparing CPA and SVA (Figure 
6.4.4.2-1B). Figure 6.4.4.2-1C shows the Western blot analysis with PE derived 
placental samples. We again observed a band at 50 kDa and there was no significant 
difference in the expression levels of TASK-3 across each NORM and PE sample 
(Table 6.4.4.2-1). 
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Table 6.4.4.2-1 showing the average densitometry data for TASK-3 expression in each 
sample. No significant difference was found in the level of TASK-3 when comparing 
matched samples of CPA, SVA and MYO.  
 
TASK-3 N MW (kDa) 50 P 
 
 MEDIAN ± IQR MEAN ±SEM 
CPA  23 46 (34-65) 52±4 0.7 ns 
PE-CPA 6 54 (44-58) 52±6 
SVA 23 46 (29-60) 49±4 0.5 ns 
PE-SVA 6 55 (44-65) 54±4 
MYO 6 41 (26-74) 44±9 0.4 ns 
PE-MYO 3 39 (38-54) 44±7 
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Figure 6.4.4.2-1 showing TASK-3 expression (red box) in placental CPA and SVA from 
NORM samples (A). The MYO tissue lysate was also positive for TASK-3 expression. B 
VKRZVWKHER[DQGZKLVNHUSORWIRUHDFKSURWHLQQRUPDOLVHGWRLWVLQGLYLGXDOȕDFWLQH[SUHVVLRQ. 
C summarises the Western blot analysis of PE CPA and SVA and MYO from NORM and PE 
patient samples. Each sample produced a band at 50 kDa which corresponds to the monomer for 
TASK-3 (red box). D shows the box and whisker plot for TASK-3 expression for each sample 
analysed. Each sample (A&C) is also shown alongside anti TASK-3 antibody that has been pre-
absorbed with control peptide (lanes 2, 4, 6&8). Values are expressed as median ± IQR. 
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6.4.4.3. Expression of TRAAK 
 
TRAAK is another key K2P channel that we were interested in studying as 
this ion channel is closely related to TREK and shares a lot of its pharmacological 
properties. A small number of samples were analysed for the expression of TRAAK 
(N=8). Figure 6.4.4.3-1A shows the Western blot image for TRAAK revealing a 
single band at 51 kDa which closely matches the predicted molecular weight for the 
intracellular C terminus (52 kDa) (Appendix III). Figure 6.4.4.3-1B summarises the 
average band intensities for each sample analysed and we found no significant 
difference in the expression for TRAAK when comparing CPA with SVA (p=0.43). 
MYO (N=3) was also positive for the ion channel which appeared to be less abundant 
when compared to human placental tissue and may require further validation while 
RB failed to produce positive stain and was not used in further analysis. Figure 
6.4.4.3-1C shows a representative Western blot image for TRAAK in PE-CPA and 
SVA samples. A dense band at 50 kDa was observed which was similar to the band 
that was revealed using the NORM samples. Table 6.4.4.3-1 shows the normalised 
densitometry data for each sample and we did not see any significant differences in 
the expression TRAAK across the different tissue samples analysed.  
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Table 6.4.4.3-1 showing the normalised pixel intensity data for the TRAAK channel in 
NORM and PE samples. No significant difference was found in the expression of TRAAK 
across the two placental vascular beds.  
 
TRAAK N MW (kDa) 50 p 
 MEDIAN ± IQR MEAN ±SEM 
CPA  8 68 (35-77) 61±8 0.4 ns 
PE-CPA 6 37 (31-40) 35±4 
SVA 8 64 (38-78) 55±9 0.5 ns 
PE-SVA 6 48 (33-63) 47±7 
MYO 4 46 (35-73) 51±10 0.2 ns 
PE-MYO 3 75 (65-90) 76±7 
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Figure 6.4.4.3-1 showing TRAAK expression (red box) in CPA, SVA and MYO samples 
from NORM samples (A). B shows the % expression levels in each samplHUHODWLYHWRȕDFWLQ
C shows a representative Western blot for TRAAK expression in PE-CPA and SVA samples 
(red box). D shows the box and whisker plot which summarises the average pixel intensities 
once the data has been normalised to ȕDFWLQEach sample (A&C) is also shown alongside anti 
TRAAK antibody that has been pre-absorbed with control peptide (lane 2, 4, 6&8). Values are 
expressed as median ± IQR. 
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6.4.4.4. Expression of TREK-1 
 
Early work with the TREK-1 antibody revealed three distinct bands, one at 
100-90 kDa, one dense band at 75 kDa and a smaller band at 50 kDa. As the analysis 
was expanded to include more samples the 100 kDa was not always revealed each 
time. The datasheet provided with the antibody has also since been updated to show a 
single band at 50 kDa which represents the intracellular N terminal of TREK-1 
(Appendix III). Figure 6.4.4.4-1A shows a representative Western blot image and RB 
produced two bands at 100 and 50 kDa so we chose to discount the 75 kDa band from 
further analysis. The 50 and 100 kDa were closely related as when one band was seen 
in abundance the second was reduced. This suggests that the two bands may represent 
the monomer and dimer configuration of TREK-1. No difference was shown in 
expression between CPA and SVA (Figure 6.4.4.4-1B) while the CPA expression of 
the 50 kDa band was found to be significantly higher (p<0.05) when compared to 
MYO samples. The PE samples were also analysed and a clear band at 50 kDa was 
found across all the samples with a faint 100 kDa band which was difficult to identify 
(Figure 6.4.4.4-1C) (discussed in Chapter 6.4.3.1). Comparing matched CPA and 
SVA samples (Table 6.4.4.4-1) showed that there was no significant difference in the 
expression of TREK-1 (50 kDa) across the placental vascular beds while the 100 kDa 
was found to be significantly lower (p<0.05) in PE samples.  
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Table 6.4.4.4-1 showing the average densitometry data for TREK-1 in NORM and PE CPA, 
SVA, MYO along with RB tissue. We focused on the 50 and 100 kDa proteins which were 
also found with the RB positive control. Comparing the average expression levels for TREK-
1 at 50 kDa showed no significant difference across the different tissue samples while the 100 
kDa was detected in significantly lower levels in the PE vessel samples.  
 
TREK-1 N MW 
(kDa) 
50 p 
 
100 p 
 
 MEDIAN ± 
IQR 
MEAN ±SEM MEDIAN ± IQR MEAN ±SEM 
CPA  40 67 (31-121) 93±10 0.1 ns 23 (9-76) 43±5 <0.05* 
PE-CPA 6 44 (36-47) 42±3 2 (1-5) 3±0.6 
SVA 40 50 (33-94) 69±6 0.3 ns 18 (18-142) 41±6 <0.05* 
PE-SVA 6 41 (36-49) 41±2 3 (6-4) 3±0.4 
MYO 10 33 (0-40 30±6 0.8 ns 15 (7-36) 23±6 0.4 ns 
PE-MYO 3 32 (17-46) 31±8 15 (13-20) 17±0.8 
RB 6 29 (13-38) 34±6  13 (0-54) 24±6  
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Figure 6.4.4.4-1 showing TREK-1 expression (red box) in NORM CPA and SVA with 
MYO tissue (A) RB was also positive showing two bands at 50 and 100 kDa which may 
represent the monomer and dimer proteins of TREK-1. B shows the % expression following 
QRUPDOLVDWLRQWRȕDFWLQC shows a representative Western blot image for TREK-1 in PE-CPA 
and SVA. A clear 50 kDa band is visible but the 100 kDa can only be seen at a low level in the 
two MYO samples (red box). D shows the box and whisker plot which summarises the average 
pixel intensities once the data has been normalised to ȕ DFWLQ Each sample (A&C) is also 
shown alongside anti TREK-1 antibody that has been pre-absorbed with control peptide (lane 2, 
4, 6&8). Values are expressed as median ± IQR. 
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6.4.4.5. Expression of TREK-2 
 
The TREK-2 antibody recognises the intracellular C terminus and has a predicted 
molecular weight of 59 kDa (Appendix III). Figure 6.4.4.5-1A shows a representative 
Western blot image for the expression of TREK-2 in human placental CPA, SVA and 
MYO. RB was also included, and produced multiple bands on the Western blot 
confirming the presence of the ion channel including a dense band that was observed 
at 100 kDa. However the human tissue samples produced two distinct bands, also 
seen with RB, at 40 kDa and a doublet at 52-56 kDA which formed the focus of our 
analysis. The CPA expression for TREK-2 appeared to be lower but analysis of the 
data set showed that this was not significantly different to SVA (N=8, p>0.05) 
(Figure 6.4.4.5-1B). TREK-2 expression was examined in PE-CPA and SVA (Figure 
6.4.4.5-1C). In contrast to the normal tissue samples the PE tissue produced a dense 
band at 40 kDa both with CPA and SVA tissue which appears to be expressed in 
abundance when compared with the higher 52-56 kDa band but failed to show any 
significance (p>0.05). The average densitometry data has been summarised in Table 
6.4.4.5-1 and showed no significant difference in the TREK-2 across the different 
tissue samples analysed.  
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Table 6.4.4.5-1 summarising TREK-2 expression data form NORM and PE samples. No 
significant difference was found in the expression for TREK-2 across each subunit.  
 
 
TREK-2 N MW 
(kDa) 
40 P 52-56 p 
 
 MEDIAN  
± IQR 
MEAN 
±SEM 
MEDIAN 
 ± IQR 
MEAN ±SEM 
CPA  8 36 (24-46) 36±4  0.8 ns 34 (24-39) 34±3 0.3 ns 
PE-CPA 6 33 (24-47) 35±5 20 (17-22) 20±1 
SVA 8 43 (37-63) 56±13 0.3 ns 34 (22-37) 29±4 0.2 ns 
PE-SVA 6 27 (18-40) 29±6 15 (13-20) 16±2 
MYO 3 45 (38-73) 52±10 0.8 ns 19 (0-38) 19±11 0.8 ns 
PE-MYO 3 41 (33-66) 46±9  16 (16-19) 17±1 
RB 4 59 (32-84) 60±8 - 76 (18-142) 79±33 - 
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Figure 6.4.4.5-1 showing TREK-2 expression (red box) in placental samples (A). Multiple 
bands in the RB sample were found but the human tissue showed two bands one at 40 kDa and 
secondly a doublet at 52-56 kDa which was analysed. B shows the box and whisker plot which 
summarises the average pixel intensities once the data has been normalised to ȕDFWLQ C shows 
a representative Western blot image for TREK-2 in PE-CPA and SVA samples along with 
normal and PE-MYO tissue (red box). All samples showed positive expression for the K2P 
channel and control lanes confirm that this stain is specific. D shows the box and whisker plot 
which summarises the average pixel intensities once the data has been normalised to ȕDFWLQ
Each sample (A&C) is also shown alongside anti TREK-2 antibody that has been pre-absorbed 
with control peptide (lane 2, 4, 6&8). Values are expressed as median ± IQR. 
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6.4.4.6. Expression of TWIK-2  
 
The anti TWIK-2 antibody is raised against the intracellular C terminus with a 
predicted molecular weight of 35 kDa (Appendix III). Our results showed a 37 kDa 
band was seen along with the more abundant band at 50 kDa which was visible with 
CPA and SVA along with the MYO tissue (Figure 6.4.4.6-1A), while no staining was 
evident in RB. Analysis of these two bands revealed no significant difference in the 
expression of TWIK-2 across the two placental vessels (N=40, p<0.05). (Figure 
6.4.4.6-1B) Western blot analysis with our PE samples revealed that both CPA and 
SVA were positive for TWIK-2 expression along with the normal and PE MYO 
(Figure 6.4.4.6-1C). Comparing the samples shows that PE CPA expression for the 
37 kDa was higher when compared to PE SVA (N=6, p<0.05). The 50 kDa band was 
also significantly higher in PE CPA when compared to NORM CPA (p<0.001) 
(Table 6.4.4.6-1).  
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Figure 6.4.4.6-1 showing the difference in TWIK-2 expression (red box)across CPA and 
SVA (A) and revealed  a 37 kDa protein along with a more abundant 50 kDa band which is also 
seen in MYO samples. B shows the box and whisker plot for each sample and includes analysis 
of both bands that were observed. C shows a representative Western blot image for TWIK-2 in 
PE-CPA and SVA samples along with normal and PE-MYO tissue (red box). All samples 
demonstrated positive expression for the K2P channel. D shows the box and whisker plot which 
summarises the average pixel intensities once the data has been normalised to ȕ DFWLQEach 
sample (A&C) is also shown alongside anti TWIK-2 antibody that has been pre-absorbed with 
control peptide (lanes 2, 4, 6&8). Values are expressed as median ± IQR. 
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Table 6.4.4.6-1 summarising the calculated densitometry data for TWIK-2. The RB failed to 
give a positive signal and was not included in our analysis. Comparing matched CPA and 
SVA tissue samples revealed that only the 50 kDa band was significantly higher in PE CPA.  
 
6.4.5. Confocal analysis of CPA and SVA SMC  
 
6.4.5.1. Subcellular localisation of CaV1.2 
 
Initial attempts with Western blotting failed to identify the target protein in the 
range of 210-240 kDa predicted for CaV1.2 (Appendix III) and instead a series of 
smaller bands were isolated (not shown). Due to time constraints this was not 
investigated further. Instead, the expression of CaV1.2 was investigated using IF 
staining. Figure 6.4.5.1-1 shows the cellular distribution of CaV1.2 in CPA and SVA 
SMC. The positive IF is found throughout the cell body, and higher magnification 
shows the nucleus is completely clear of IF stain in both cell types. The ion channel is 
organised in a tight linear mesh that is spread across the cell body to allow the cell to 
TWIK-2 N MW 
(kDa) 
37 P 50 P 
 
 MEDIAN ± 
IQR 
MEAN 
±SEM 
MEDIAN 
 ± IQR 
MEAN ±SEM 
CPA  40 49 (24-110) 49±3 0.8 ns 33 (18-43) 30±4 0.01** 
PE-CPA  6 52 (42-58) 51±3 67 (58-135) 92±23 
SVA 40 48 (23-108) 46±4 0.5 ns 41 (19-50) 37±5 0.2 ns 
PE-SVA 6 32 (24-43) 34±4 45 (37-156) 81±28 
MYO 10 53 (25-74) 65±9 0.9 ns 38 (32-46) 39±4 0.6 ns 
PE-MYO 3 68 (42-89) 66±13 39 (36-55) 43±6 
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rapidly respond to external stimuli. No IF was produced when primary antibody (both 
mouse monoclonal & rabbit polyclonal) was replaced with control IgG (not shown).  
CaV1.2
CPA SVA 
A B
C D
N
N
N
N
 
Figure 6.4.5.1-1 showing immunodetection for CaV1.2 in SMC cultured from CPA (A) 
and SVA (B) (N=4). Images were captured using confocal microscopy and each row shows 
paired CPA and SVA samples at the same magnification. The yellow box (A&B) labels the 
region of the original images that was used to take images at higher magnification (C&D). 
The CaV1.2 channel shows similar expression pattern in both types of SMC with linear 
expression across the cell body while the nucleus (N) remains unstained. 
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6.4.5.2. Subcellular localisation of TASK 1 
 
Figure 6.4.5.2-1 shows the early images that were taken showing positive IF 
for TASK-LQSODFHQWDO60&FRQILUPHGE\WKH,)IRUĮDFWLQ7KH,)VWDLQLQJSDWWHUQ
was observed to be evenly distributed across the cell body with a granular distribution 
for TASK-1. The SVA SMC also showed evidence of intense staining around the 
nucleus which is most prominent in showing the peri-nuclear region in detail (white 
arrow). In contrast, CPA derived cells in Figure 6.4.5.2-1C show staining inside the 
nuclei which has also stained posiWLYHZLWKĮDFWLQVRPD\EHGXHWRDQDUWHIDFWFDXVHG
by antibody retention. No stain was observed with primary antibody that was pre-
absorbed with control peptide added in excess (not shown). 
SMC from the MYO also stained positive for TASK-1 expression (Figure 
6.4.5.2-2) along with the rat brain cell line SH SY57. The TASK-1 staining shows 
linear distribution in MYO cells across the cell body and the cell membrane with 
positive co-ORFDOLVDWLRQ ZLWK Į DFWLQ H[SUHVVLRQ 7KH 7$6.-1 expression is highly 
organised as all the staining is linear with very little granular distribution. SH SY57 
cells instead show only granular distribution which supports our observations made 
with CPA and SVA cells and suggests that K2P channels may have tissue specific 
distribution expression patterns.  
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Figure 6.4.5.2-1 showing TASK-1 positive IF in CPA and SVA SMC (N=10). The high 
magnification photomicrograph shows the distribution of TASK-1 within the cells. C&D 
show TASK-1 stain is diffuse across the cell body but there is an intense stain around the 
nucleus (white arrow) and is most prominent in SVA cells. In this instance the nucleus was 
also labelled with DAPI (blue) and the merged images do not show any co-ORFDOLVDWLRQZLWKĮ
actin (E&F).   
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Figure 6.4.5.2-2 showing TASK-1 staining in MYO SMC (A) and SH SY57 cells (B) 
(N=4). MYO show linear distribution of TASK-1 across the cell body and at the cell 
membrane (white arrow) which appears to overlap with Į actin. In contrast SH SH57 cells 
demonstrated a granular expression pattern across the cell body.  
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6.4.5.3. Subcellular localisation of TASK-3  
 
Figure 6.4.5.3.1-1 shows a representative IF image for TASK-3 expression 
using the polyclonal TASK-3 antibody (Alomone) in cells which are also positive for 
ĮDFWLQ7KH7$6.-3 positive stain is produced strongly across the cell body and the 
SVA image shows one large in the centre of the image where the nucleus has also 
stained highly positive for TASK-3 which is also seen to a lesser extent with CPA 
FHOOV6RPHRYHUOD\ZLWKĮDFWLQIF was also observed (Figure 6.4.5.3.1-1E&F white 
arrow)  
 
6.4.5.3.1. TASK-3 co-localisation with related K2P channel 
members 
 
The remaining images show representative IF photomicrographs using the 
monoclonal TASK-3 antibody (Appendix II (Abcam)) to investigate the co-
localisation with 3 related K2P channel members. TASK-3 and TASK-1 IF staining 
was positive in CPA and SVA cells however only the SVA cells showed evidence of 
co-localisation for the two different ion channels (Figure 6.4.5.3.1-2). TASK-1 
staining in CPA cells showed no overlap with TASK-3 but we observed an intense 
staining pattern outside the nuclear membrane (N) with both ion channels. The 
positive controls MYO and SH SY57 also stained positive for TASK-3 using the 
monoclonal antibody. It was interesting to see the MYO cells produced an intense 
stain at the peri-nuclear region (Figure 6.4.5.3.1-3A). In contrast the SH SY57 cells 
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show an expression pattern that is similar to the placental SMC expression for TASK-
3 with granular distribution across the cell body as well as staining inside the nucleus 
(Figure 6.4.5.3.1-3B). Merging the two separate images shows some evident co-
expression exits between TASK 1 and TASK-3 with SH SY57 cells. The TASK-3 and 
TREK-1 dual staining has been summarised in Figure 6.4.5.3.1-4. The CPA and SVA 
cells staining pattern was again granular for TASK-3 and found across the cell body 
with a dense stain around the nuclear membrane. Overlaying the two images revealed 
pockets of yellow IF stain to suggest some co-expressions, however further analysis 
failed to show any evidence of co-expression between the two closely related 
members of the K2P family (not shown). This is also similar to the pattern observed 
when TASK-3 and TWIK-2 was stained for in the same cells. Figure 6.4.5.3.1-5 
shows a diffuse IF stain was produced across the cell body with TASK-3 again 
showing staining at the nuclear membrane. However when we merge the images for 
TWIK-2 and TASK-3 we find that SVA cells show evidence of co-localisation with 
TASK-3 while CPA cells do not produce any yellow IF stain.  
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Figure 6.4.5.3.1-1 showing positive stain for TASK-3 using the rabbit polyclonal 
antibody (N=3). CPA and SVA SMC both demonstrate granular expression which is found 
across the cell body. Positive IF stain is also seen inside the nucleus (N) with both cells 
(C&D). E&F show the merged images and the SMC showed some evidence of TASK-3 
expression along Įactin filaments (white arrow) was observed.   
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Figure 6.4.5.3.1-2 showing dual staining with TASK-1 and TASK-3 in CPA (A&C) and 
SVA (B&D) SMC (N=6). The monoclonal TASK-3 antibody was used to investigate the 
relationship between the two ion channels. The IF staining was seen across the cell body but 
more intense outside the nucleus (N). Comparing the merged images shows that SVA cells 
(F) show most evidence of co-expression with TASK-1 as we can see areas of yellow IF.  
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Figure 6.4.5.3.1-3 showing TASK-3 and TASK-1 dual staining in the two positive controls 
MYO SMC (A) and SH SY57 cells (B) (N=4). The MYO produced a low signal for both 
TASK-1 and TASK-3 but we can see some intense stain around the nucleus (N). In contrast 
the stain intensity was high in SH SY57 cells and shows evidence of co-localisation when the 
images are merged. The stain pattern is very similar to that observed with TASK-1/3 staining 
in CPA and SVA SMC.  
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Figure 6.4.5.3.1-4 showing double staining with TASK-3 and TREK-1 (N=6). TASK-3 
shows a punctuate staining that is clustered around the nuclear membrane (A&B). Merging 
the images shows that TREK-1 and TASK-3 may potentially overlap in the cell body of both 
cells (E&F).  
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Figure 6.4.5.3.1-5 showing dual IF staining with TASK-3 and TWIK-2 (N=6). TASK-3 
stain appears lower in CPA SMC when compared with SVA. Merging TWIK-2 and TASK-3 
images shows some overlap as pockets of yellow IF stain are produced and this is most 
obvious in SVA cells (F). The increase in IF staining around the nuclear (N) membrane was 
also seen with TASK-3 and TWIK-2 (C&D).  
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6.4.5.4. Subcellular localisation of TREK-1 
 
Confocal imaging of CPA and SVA SMC showed positive TREK-1 
expression summarised in Figure 6.4.5.4-1. CPA and SVA SMC imaged at high 
magnification demonstrate a highly organised staining pattern for TREK-1 which is 
found in linear filaments that extend across the length of the cell. It was also found 
that the nucleus remained unclear in both cell types and control samples did not 
produce any non specific IF stain (not shown). One SVA SMC (Figure 6.4.5.4-1D) 
can be seen growing in isolation and increased TREK-1 expression was observed at 
the cell protrusions as the cell is extending its surface area (arrow). Merging the 
LPDJHVZLWKĮDFWLQVKRZVKLJKFR-expression between the two proteins as TREK-1 
RYHUODSV ZLWK Į DFWLQ DQG WKLV ZDV REVHUYHG LQ ERWK 69$ DQG &3$ SMC. The 
association between two or more proteins can be examined by studying the precise 
distribution of the pixels in each image. This was performed using the line scans that 
were taken for both TREK-1 and the matched Į actin image of each cell sample. 
Figure 6.4.5.4-2 VKRZVWKHSL[HOGLVWULEXWLRQSDWWHUQIRUĮDFWLQLn green and TREK-1 
in red. Any positive overlay will be seen as yellow pixels and the percentage of 
overlap can be expressed as a value between 0 and 1. Figure 6.4.5.4-3 also shows the 
line scans for a ROI that was selected (boxed) in each image. This scan was then 
converted to a graph to show the intensity of stain at specific µm across the cell. The 
IF VWDLQ SDWWHUQ VKRZV D OLQHDU GLVWULEXWLRQ IRU ERWK Į DFWLQ DQG 75(.-1 which 
overlap in both CPA and more prominently with SVA SMC and supports the findings 
from the pixel distribution analysis.  In further support of our observation with CPA 
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and SVA SMC, TREK-1 also shows linear distribution in MYO cells with co-
H[SUHVVLRQ ZLWK Į DFWLQ Figure 6.4.5.4-4A). In contrast SH SY57 cells have a 
granular expression pattern of TREK-1 (Figure 6.4.5.4-4B) which suggests the linear 
expression may be a specialised feature of SMC. SH SY57 cells also produces stain 
for TREK-1 within the nucleus as was seen with TASK 1/3 and suggests that this may 
be a real observation with this class of K2P channels. This also suggests our early 
work which also showed this in CPA and SVA SMC may not have been an artefact 
due to DAPI nuclear staining.   
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Figure 6.4.5.4-1 showing a close examination of TREK-1 staining in CPA (C) and SVA 
(D) vascular SMC (N=12). TREK-1 is organised in linear filaments across the cell body and 
merging with ĮDFWLQ VKRZVFOHDURYHUODS (yellow IF) (E&F). F shows the cell protrusions 
that help to increase the cell surface area and are important for cell to cell communication 
(white arrow).  
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Figure 6.4.5.4-2 showing the analysis that was been performed to determine the co-
ORFDOLVDWLRQZLWK Į DFWLQDQG TREK-1 expression (N=12). Each scan taken of the cell is 
used to create a 3D image (A) and can be explored along the X, Y and Z axis. B&C shows 
the pixel distribution when both images are merged and any yellow stain shows the areas of 
co-localisation (white box).   
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Figure 6.4.5.4-3  showing the line scan analysis that were performed for each image 
(N=12). The boxed areas show the ROI that was selected for analysis. The graphical 
UHSUHVHQWDWLRQVKRZVKRZWKHH[SUHVVLRQRIĮDFWLQFORVHO\RYHUODSVWKHVWDLQIRU75(.-1 in 
both SVA and CPA SMC. The X axis represents the distance in µm and the Y axis shows the 
intensity of IF stain.  
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Figure 6.4.5.4-4 showing TREK-1 staining in MYO SMC (A) and the cell line SH SY57 
(B) (N=4). MYO show a similar expression pattern which like CPA and SVA vascular SMC 
shows positive co-ORFDOLVDWLRQ ZLWK Į DFWLQ ,Q FRQWUDVt the TREK-1 shows granular 
distribution in the cell and nucleus of SH SY57 cells and there is no co-ORFDOLVDWLRQZLWKĮ
actin.   
 
6.4.5.5. Subcellular localisation of TWIK-2  
 
TWIK-2 IF staining was positive in both CPA and SVA SMC and has been shown 
in Figure 6.4.5.5-1. The images show SVA cells in particular produce a dense 
staining around the nuclear membrane (Figure 6.4.5.5-1C). Merging the images with 
Į DFWLQ VKRZV WKDW LVRODWHG UHJLRQV RI 7:,.-2 expression dR RYHUODSZLWK Į DFWLQ
(white arrows) and this is most clear at the cell membrane region. No stain was 
observed with primary antibody that was pre-absorbed with control peptide added in 
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excess (not shown). We then examined this staining pattern further by using line scan 
images to create a 3D image of the cells (Figure 6.4.5.5-2). The pixel distribution 
shows that there is no significant overlap with actin as very few yellow sections are 
seen. The graphical representation of the Z stacks shows that TWIK-2 stain does 
overlap with DAPI stain in the CPA example shown (Figure 6.4.5.5-3). But there is 
also a peak in TWIK-2 stain which coincides with the region immediately outside the 
nucleus and supports our observation that TWIK-2 is found in a high concentration 
around the nuclear membrane. TWIK-2 was also positive in SMC cultured from the 
MYO (Figure 6.4.5.5-4A) and also displays granular distribution across the cell body. 
However we also find that the nucleus has also been stained. This was also seen with 
SH SY57 cells (Figure 6.4.5.5-4B) which could be an important functional feature of 
K2P channels.  
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Figure 6.4.5.5-1 showing TWIK-2 positive immunoreactions in SMC cultured from CPA 
and SVA SMC (N=12). TWIK-2 shows granular distribution within the SMC and the SVA 
origin cells (D) shows an intense stain around the nuclear membrane (white arrow). E&F also 
show no significant overlap with TWIK- DQG Į DFWLQ ZKLOH WKH ZKLWH DUURZV VKRZ WKH
regions that occasionally show TWIK-2 co-ORFDOLVLQJZLWKĮDFWLQ 
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Figure 6.4.5.5-2 showing the distribution of actin and TWIK-2 stain (N=12). A 3D image 
was generated using the Z stack profile of each cell that is captured. The white box in shows 
the region where the stain overlaps and we failed to observe and significant overlap with the 
two proteins.  
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Figure 6.4.5.5-3 line scans for TWIK-2 (red) DQGĮDFWLQ (green) (N=12). A&B show the 
ROI (boxed) that were randomly selected for analysis. C shows TWIK-2 does overlap with 
DAPI stain (blue) suggesting some nuclear expression but more interestingly the TWIK-2 
stain also peaks immediately outside the nucleus which suggests expression at the nuclear 
PHPEUDQH7KHVWDLQGLVWULEXWLRQVKRZV WKDW WKHSHDNRIĮDFWLQH[SUHVVLRQGRHVQRWPDWFK
TWIK-2 so there is no significant overlap between the two proteins (C&D).   
Chapter 6 
  Expression of ion channels in CPA and SVA 
244 
 
A. MYO 
ɲ actin 
B. SH SY57 
TWIK-2 Overlay  
 
Figure 6.4.5.5-4 showing TWIK-2 expression in MYO SMC (A) and the SH SY57 cells 
(B) (N=4). A granular distribution is seen and there is positive staining with TWIK-2 in the 
nucleus which is seen with both cell types (white arrow). The MYO cells also show linear 
staining that is noticeable at the cell membrane with some evidence of overlap with ĮDFWLQ
expression (E&F). 
 
6.5. Discussion  
 
The aim of this chapter was to investigate the expression of a range of ion 
channels that have been linked with the response to stress due to its importance in the 
placenta. The first objective was to confirm the presence of each ion channel using 
Western blotting. This information was then used to investigate any potential inter 
tissue variations that may exist between CPA and SVA. The main ion channel 
candidates examined consisted of members that have been shown to be present in the 
placental vasculature along with the K2P members TWIK-2, TREK-2, TRAAK and 
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TASK-3 which were of particular interest to us due to their sensitivity to pH. To 
undertake this analysis matched samples of CPA and SVA from NORM and PE 
patients were collected for comparisons using Western blotting. In addition SMC 
from NORM samples were also used to examine the cellular localisation of each ion 
channel of interest.  
 
6.5.1. CaV1.2 channels 
 
Depolarisation of the cell membrane will open VGCC to allow [Ca2+]i to 
increase and this is crucial for driving an increase in the contraction of SMC. Most 
Ca2+ entry across the cell membrane is via the CaV1.2 channel which makes the ion 
channel an important target for controlling cell excitation. The protein structure for 
CaV1.2 reveals a large protein with a predicted molecular weight of 210-240 kDa 
(Appendix III) which was not identified by this study when using Western blotting 
analysis. Instead IF showed CaV1.2 expression in cultured SMC from both NORM 
CPA and SVA and shows an organised expression across the cell body. CaV1.2 are 
postulated to be important in the response mechanisms that detect changes in O2 
levels in the cell and in support of this, the placental response to hypoxia has shown to 
be inhibited with NIFED (Jakoubek, Bibova et al., 2006), implying a role for CaV1.2 
in the HFPV response (Robertson, Hague et al., 2000, Hampl, Bibova et al., 2002, 
Jakoubek, Bibova et al., 2006). This study identified expression of the ion channel 
across the SMC while the nucleus was devoid of positive IF as expected for a 
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membrane associated protein thus enabling the ion channel to respond to changes in 
depolarisation across the cell membrane to initiate a cell wide response.  
 
6.5.2. BKCa channels 
 
The BKCa channel is widely distributed in vascular tissue and is an important 
regulator of blood flow (Khan, Smith et al., 1997, Meera, Wallner et al., 1997). Our 
analysis showed that the BKCa was equally present across NORM and PE samples as 
no significant change in the level of expression between CPA and SVA samples was 
detected. Two bands were identified at 120 and 60 kDa which represents WKHĮVXEXQLW
of BKCa. The smaller 60 kDa band has been identified as a breakdown product of the 
larger BKCa protein and has also been described in bovine tracheal smooth muscle 
(Garcia-Calvo, Knaus et al., 1994). The MYO samples were also positive for BKCa 
ZKLOHWKHKLJKHVWH[SUHVVLRQZDVVHHQZLWKWKH5%VDPSOH7KHĮSURWHLQLVWKHSRUH
forming part of the ion channel and is needed for the channel to open while the 
UHJXODWRU\ȕVXEXQLWFRQIHUVWKHFKDQQHO¶VDFWLYDWLRQWKUHVKROGDQGLVUHVSRQVLEOHIRU
sensing Ca2+ levels (Meera, Wallner et al., 1997). The BKCa has previously been 
identified in the myometrium and proteins in the range of 110-120 kDa have been 
reported (Benkusky, Fergus et al., 2000, Matharoo-Ball, Ashford et al., 2003). In 
addition, the presence of BKCa in the CPA and CPV has previously been reported 
using the Alomone polyclonal antibody (Wareing, Bai et al., 2006) and agrees with 
our observations. This study (Wareing, Bai et al., 2006) reported a high density band 
in the region of 125 kDa in CPA with higher expression in CPV. They also showed 
Chapter 6 
  Expression of ion channels in CPA and SVA 
247 
 
the presence of smaller bands at 70 and 40 kDa. In addition mRNA for BKCa has been 
identified within the placental vasculature (Hampl, Bibova et al., 2002) however a 
low quantity signal for BKCa protein was identified to be in the region of 116 kDa in 
this study.  
A role for BKCa as an important O2 sensing ion channel has been demonstrated 
with fetal lung tissue (Resnik, Herron et al., 2006). The combined role of an increased 
pO2, post-delivery increase in ventilation, and increase in shear stress brings about 
widespread pulmonary vasodilatation to cope with the influx of pulmonary blood with 
the newly delivered baby. The lungs switch from being fluid filled to air filled and the 
pO2 increases 4-fold. This study examined the role of BKCa in modulating this 
adaptation to different pO2 environments using ovine pulmonary arterial SMC 
cultured under hypoxic (90% N2) or nomoxic conditions (95% air). It was reported 
WKDW VSHFLILFDOO\ H[SUHVVLRQ RI WKH Į DQG ȕ1 EXW QRW ȕ2 subunits of BKCa were up 
regulated under hypoxic culture conditions. This provides an insight into how low 
pO2 prepares the tissue for a rise in pO2 by maintaining high levels of K+ channel 
expression perhaps as a mechanism to redirect blood flow (Resnik, Herron et al., 
2006). This finding also illustrates how different tissues can adapt to changing pO2 
conditions by altering ion channel expression and may have parallels to when pO2 
changes upon entry of maternal blood in the IVS.   
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6.5.3. KATP channels  
 
KATP are important candidates as potential early markers of metabolic disease 
due to their dependence on low ATP within the cell to activate the ion channel. KATP 
is important for both long and severe exposure to pO2 stress and has been implicated 
in ischaemic preconditioning (Murry, Jennings et al., 1986). The K+ channel is widely 
expressed and has been shown to have a role in providing cardio-protection (Chen and 
Simard, 2001), inhibiting neural cell activity and is central in the mediating insulin 
release as part of glucose homeostasis (Hussain and Cosgrove, 2005). The pancreas is 
vulnerable to acidic environments making the KATP channel a suitable candidate as a 
pH sensing ion channel and KATP provides an important link between glucose 
metabolism and insulin secretion (Ashcroft, 2007). The activity of the ion channel is 
coupled to the cells metabolic status and ATP levels will therefore determine the 
gating of the ion channel (Tammaro and Ashcroft, 2009) 
The functional importance of KATP has been indirectly demonstrated with 
CGRP which induced a relaxation response across a range of placental vessels and 
this was inhibited in the presence of GLB (Dong, Vegiraju et al., 2004). In further 
support of this, a number of  KATP channel openers such as KRN2391 have shown to 
induce a potent relaxation in placental vessels implicating KATP channels in 
contributing to the control of vessel tone in the placenta (Wareing, Bai et al., 2006, 
Jewsbury, Baker et al., 2007). Western blot analysis revealed a band, thought to be 
KATP, at 55 kDa which has also been previously reported with CPA and CPV tissue 
(Wareing, Bai et al., 2006). The level of KATP was similar across both NORM and PE 
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paired CPA and SVA samples, which could be an important observation. The glucose 
demand of the placenta is particularly high during the second and third trimester when 
the fetus is growing at its fastest rate (DiGiacomo and Hay, 1989, Hay, 1995) and 
levels of CGRP are also high during this period (Dong, Vegiraju et al., 2004). The 
level of KATP expression identified in our study maybe a reflection of the altered 
placental function at term gestation and it would be interesting to see how the KATP 
protein levels vary with gestational age. This could also be important for 
understanding how glucose metabolism varies and how high maternal blood glucose 
seen with IDDM can alter the metabolic status of the placenta as glucose is readily 
transported across the placental membranes (Hay, 1995).  
 
6.5.4. K2P channels  
 
K2P channels are a newly identified family of K+ channels and very little is 
known as to their expression within the placental vasculature. The ion channels are 
important for maintaining the resting membrane potential and due to their properties 
of being leak channels, may have a role in maintaining the low resistance seen in the 
placenta.  
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6.5.4.1. TASK 1/3 channels  
 
TASK channels open at rest maintain the resting membrane potential and are a 
target for anaesthetics and acidic pH. TASK-3 shares 55% homology with TASK-1 
(Czirjak, Fischer et al., 2000) which makes both isoforms important candidates for 
responding to pH stress within the placenta. In addition to pH, TASK channels have 
also demonstrated O2 sensing properties and have been linked to cell death making 
them important oncogenic candidates (Duprat, Guillemare et al., 1995, Bayliss, Sirois 
et al., 2003, Voloshyna, Besana et al., 2008). TASK-1 mRNA has also been shown to 
be high within the placenta (Duprat, Lesage et al., 1997) and expression for the ion 
channel appears to increase with gestational age (Bai, Greenwood et al., 2005) 
implicating the ion channel in regulating cellular excitability within the placenta. The 
presence of both sub types of ion channels may be required to ensure the cell can 
respond to pH changes over a wide range and we found expression of both TASK 1/3 
at the whole tissue level and more importantly within SMC from CPA and SVA.  
Acidic environments will inhibit both TASK 1/3 but studies have shown that 
the exact pH value has contrasting effects on each ion channel. TASK-1 will be 
inhibited at pH 7.1-7.4 while TASK-3 is inactive at pH <6.7 (Duprat, Lesage et al., 
1997, Kim, Bang et al., 1999). The same stimuli can differently modulate channel 
activity such that the ion channels can respond to varying degrees of cell stress to 
bring about a rapid cell response. (Bayliss, Sirois et al., 2003). A role for TASK-3 but 
not TASK-1 was demonstrated to provide a link between the detection of low pH and 
the wake reflex which increases ventilation when pCO2 and therefore the pH of the 
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ECM in the brain falls (Holzer, 2009, Pang, Robledo et al., 2009). TASK channel 
gene expression has also been investigated in the human cytotrophoblast cells of the 
placenta. Bai (et al 2005) reported the presence of mRNA for TASK-1, 2, 4 and 5 but 
not TASK-3. Western blotting analysis revealed bands of 78 and 150 kDa and IHC 
analysis showed TASK-1 was positive in the cytotrophoblast region and more 
importantly showed co-expression with cytokeratin-7. We also observed a band at 71 
kDa which could be the same as the band reported with TASK-1 (Bai, Greenwood et 
al., 2005) or it could represent an additional breakdown product for TASK-1. TASK-1 
has been shown to produce a low intensity band at 122 kDa in CPA and CPV with no 
evidence of any inter-tissue differences. The same Western blot analysis showed an 
abundant band at 54-60 kDa with only RB and was absent with the placental tissue 
(Wareing, Bai et al., 2006). mRNA for TASK-3 was not detected in the 
cytotrophoblast cells (Bai, Greenwood et al., 2005) which indicates that TASK-3 may 
be restricted to the placental vasculature. We can investigate this by examining gene 
expression across the different placental membranes. Western blot analysis of MYO 
has also shown expression for TASK-1 with reported band sizes of 44 and 65 kDa 
(Bai, Bugg et al., 2005), the latter of which may also be the same band that we also 
identified. The Western blotting analysis for TASK-1 in particular highlights the 
variation in reporting of TASK-1 within the literature with studies that also used the 
same Alomone antibody.    
The localisation and tissue distribution of K+ channels such as K2P channels 
can give an insight into the how cellular functions are regulated. The two K2P 
channels TASK-1 and TASK-3 were shown to be expressed in SMC cultured from 
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placental vascular tissue. The IF staining pattern revealed a granular distribution for 
both TASK 1/3 and there was an intense stain around the peri-nuclear membrane and 
evidence of nuclear staining. The two ion channels do also appear to co-localise and 
this could enable the cells to amplify the response to external pH. Co-expression 
could suggest a common mechanism exists to ensure a rapid response is produced to 
the cell stimuli through the involvement of related ion channels to help bring about 
activation of a signalling cascade (Duprat, Lesage et al., 1997, Gonzalez, Jensen et al., 
2009). In vascular SMC this could modulate contractility to control vascular tone 
which is important for the placenta and has previously been shown to occur with 
TASK-1 and TREK-1 in cardiacmyocytes (Figure 6.5.4.1-1). 
 
 
Figure 6.5.4.1-1 shows TREK-1 (red) and TASK-1 (green) subcellular localisation in rat 
cardiac myocytes. TREK-1 is expressed along longitudinal strips and is concentrated at the 
cell membrane. TASK-1 is also visualised and shows co-expression at the cell membrane 
(Image obtained from Xian Tao, Dyachenko et al., 2006).  
 
Cross talk has previously been shown to occur with the use of selective knock 
downs of specific sequences for both ion channels (Kang, Han et al., 2004, Gonzalez, 
Jensen et al., 2009). We also observed evidence of co-localisation between TASK-3 
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and the closely related TWIK-2 and TREK-1, the latter of which supports the 
observations of Xian Tao (et al., 2006). The close association between K2P channels 
members may explain why the same stimuli can activate a response from more than 
one K2P member and why blockers such as halothane can block both TREK and 
TASK channel currents (Hartness, Lewis et al., 2001, Kang, Han et al., 2004). The 
presence of TASK-1/3 channels in CPA and SVA may help the placenta to respond to 
changes in the rate of flow from maternal blood and gives an insight into how the 
transport capacity of the placenta can be regulated by ion channels. The pH sensing 
property makes TASK channels important candidates for generating the vascular 
response to pH stimulus observed with CPA and SVA. 
 
6.5.4.2. TRAAK channels 
 
A small selection of CPA and SVA samples were used to demonstrate 
TRAAK expression within the placental vasculature with a single band at 50 kDa 
which was comparable across the two vessel samples. TRAAK channels have very 
similar properties to TASK and TREK channels and are potently activated by AA and 
stretch. mRNA for the ion channel has shown to be exclusively expressed in neuronal 
tissue (brain, spinal cord and retina) while the placenta is the only example of the 
peripheral localisation for TRAAK (Fink, Lesage et al., 1998, Reyes, Lauritzen et al., 
2000). The predicted molecular weight for TRAAK is in the region of 48 kDa 
(Appendix III) and we were able to isolate a protein band within this region.  
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TRAAK has been postulated to have a role in the placenta due to the 
abundance of AA which is a strong activator of TRAAK (Fink, Lesage et al., 1998). 
In neurons, AA is released at the pre-synaptic neuron to decrease neurotransmitter 
release and TRAAK activation would return the baseline potential (Fink, Lesage et 
al., 1998, Maingret, Patel et al., 2000). In the vascular tissue, placental TRAAK 
channels could function in a similar way and maintain the low vascular resistance. AA 
is also released under stress particularly ischaemia and inflammation and TRAAK 
activation can reduce cellular activity through hyperpolarisation of the membrane to 
prevent further action potentials and limit the damage possibly by preventing cell 
death (Maingret, Patel et al., 2000). TRAAK can also be distinguished from TREK as 
its currents are increased with intracellular alkalosis while acidification does not 
produce the same response (Fink, Lesage et al., 1998). This implicates TRAAK with 
the response that we observed to rising pH (alkalosis) that resulted in contraction of 
the placental vessels. In addition, TRAAK is also a target for RIL activation (Duprat, 
Lesage et al., 2000) and has similar activation affinities as TREK due to a similar 
motif that is shared (Maingret, Patel et al., 2000) but crucially DSSOLFDWLRQRIȝ0
of RIL activates TRAAK while it has a dual effect on TREK (discussed in Chapter 
6.5.4.3). TRAAK expression is high within the neuronal tissue and may explain the 
neuroprotective effects seen with RIL treatment (Duprat, Lesage et al., 2000). This 
may also explain the potent response we observed with RIL which may open TRAAK 
channels to bring about a potent relaxation of the placental vessels and provides an 
avenue for further work.  
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6.5.4.3. TREK 1/2 channels  
 
TREK-1 currents were first reported in rat brain slices where the ion channel 
has the highest expression levels (Fink, Duprat et al., 1996). Subsequent studies have 
shown that TREK is widely expressed in most tissue types with conserved regions 
between mammals. Many diverse stimuli trigger TREK channel activity which in turn 
has an incredible capacity to control cell function as most stimuli such as temperature, 
pHi and stretch are transmitted to the cell via TREK-1. It is an important 
mechanosensor as cell stretch and/or swelling will activate the ion channel and altered 
H[SUHVVLRQ ZLOO GLUHFWO\ UHIOHFW WKH LRQ FKDQQHO¶V LPSRUWDQFH LQ WKDW VSHFLILF
tissue/organ (Duprat, Guillemare et al., 1995, Maingret, Lauritzen et al., 2000, 
Maingret, Patel et al., 2000).  
The Western blotting analysis revealed a band for TREK-1 at 50 and 100 kDa 
and the two bands closely match the information provided by the datasheet (Alomone) 
as well as bioinformatics which predicts a 47 kDa protein size for the TREK-1 
channel subunit. However there is a discrepancy within the literature as to the size of 
the TREK-1 protein. TREK-1 expression in rat arteries revealed three bands at 100, 
45 and 25 kDa (Gardener, Johnson et al., 2004) while examination of airway 
epithelial cells has shown TREK-1 protein at 130 and 50 kDa (Davis and Cowley, 
2006) both of which used the same Alomone antibody. Within the uterus, MYO 
samples have been shown to express two bands at 56 and 90 kDa (Bai, Bugg et al., 
2005) while a 90 kDa and a larger 130 kDa band size has been reported within the 
cytotrophoblast cells of the human placenta (Bai, Greenwood et al., 2005). This small 
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selection of studies highlights the differences that can be reported when using the 
same antibody. During our investigations, we found that the 100 kDa was not readily 
detected with the same samples and may be due to changes in the antibody batches 
used. This can lead to false differences being identified when comparing tissue 
expression for TREK1 and as a result we cannot draw firm conclusions in the 
difference in expression for TREK-1 across the NORM and PE sample group. A 
recent study revealed that different splice variants of TREK-1 had dramatically 
altered the channel sensitivity to ions (Thomas, Plant et al., 2008). The two closely 
related isoforms of TREK-1 identified in the rat brain were shown to have opposing 
actions in allowing Na+ to enter the cell and this may be important for the pH 
sensitivity of TREK-1 which can activate NHE to restore the pH gradient across the 
cell membrane. The difference in TREK-1 expression can also alter the cellular 
response produced. RIL has the ability to both activate and inhibit TREK channel 
currents (Duprat, Lesage et al., 2000) which can help to distinguish the role of TREK 
from TRAAK in different tissues. This was shown with the response of mouse taste 
bud cells in response to acidic pH (Richter, Dvoryanchikov et al., 2004). Application 
of a low dose of RIL (500µM) could increase the response to citric acid as blocking 
TREK-1 enhanced the acid induced cell depolarisation. The identification of different 
TREK-1 isoforms requires further investigation to fully understand the importance of 
each different subtype. A recent study demonstrated a more accurate and reproducible 
method for detecting TREK-1 expression (Sandoz, Bell et al., 2011). This study 
utilised fluorescent tagging of the C-terminal to show expression of the ion channel 
was located at the cell membrane and the intensity of the fluorescent stain correlated 
Chapter 6 
  Expression of ion channels in CPA and SVA 
257 
 
with TREK-1 activation. The same approach could be used in our studies to examine 
the functional subunits of TREK-1 within the placenta.  
pH sensitivity can change depending on which ion channel is expressed. The 
closely related TREK-1 and TREK-2 share 78% homology and can be distinguished 
by their pH sensitivity (Ketchum, Joiner et al., 1995, Fink, Duprat et al., 1996). 
TREK-1 is closed at pH 7.32 within the cell while the same pH level outside the cell 
membrane will open TREK-2. TREK-2 is also activated by mechanical pressure in 
the cell although mRNA for TREK-2 has previously been shown to be absent in the 
MYO (Medhurst, Rennie et al., 2001, Bai, Bugg et al., 2005). However we did show 
positive expression for the ion channel using Western blot analysis in CPA, SVA, 
MYO and RB. Two main protein bands at 40 kDa and a 52-56 kDa were observed 
and the presence of a doublet has similarities to the doublet reported for TASK-1 
expression in cultured cytotrophoblast cells (Bai, Greenwood et al., 2005). The close 
association with TREK-1 and TREK-2 was investigated using site specific mutations 
(Sandoz, Douguet et al., 2009). It was shown that a conserved histidine sequence with 
TREK-1 and TREK-2 formed the pH sensor but a crucial difference in the short 
extracellular domain immediately after the proton sensor sequence P2Ct was 
responsible for producing the varied sensitivity to pH across TREK-1 and TREK-2 
(Sandoz, Douguet et al., 2009) and may underlie the capacity of the placental vessels 
are able to produce a response across the pH range.    
Examining the cellular distribution of TREK-1 revealed two staining patterns. 
Firstly TREK-1 expression was organised in linear filaments with some granular 
expression in both CPA and SVA cell types. The mechanosensitivity of TREK-1 may 
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EH FORVHO\ OLQNHGZLWK Į DFWLQ H[SUHVVLRQ DQG LQ VXSSRUW RI WKLV LW ZDV VKRZQ WKDW
TREK-DQGĮDFWLQGLGVLJQLILFDQWO\RYHUODSZKLFKDOVRVXSSRUWVWKHREVHUYDWLRQVRI
Laurtizen (et al. , 2005). They showed that TREK-1 activity could be altered when the 
Į DFWLQ QHWZRUN ZDV GLVUXSWHG DQG WKH HPEU\RQLF Vtriatal neurons had a reduced 
surface area and reduced growth cones which are vital for neuronal cell migration. 
Xian Tao (et al., 2006) also reported a linear expression pattern for TREK in 
ventricular cardiac muscle cells (Figure 6.5.4.1-1) and shows how the 
mechanosensitve nature of TREK-PD\EHFRQIHUUHGE\ LWVFORVHSUR[LPLW\ZLWKĮ
actin filaments. Linear organisation of an ion channel across the length of the cell can 
be important for the detecting and responding to changes in the cell volume which 
would occur under cell stretch or contraction. TREK-1 and other K2P channels work 
to oppose contraction and restore the cell membrane potential (Fink, Lesage et al., 
1998). Co-localisation is important for giving the cell a rapid response mechanism 
and protein crosstalk facilitates the activation of signalling cascades. Co-localisation 
also allows local regulation of channel activity to govern cell excitation. TREK-1 
expression at the membrane shows the ion channel can hyperpolarise the cell 
membrane upon stimulation and modulate Ca2+ entry into cell (Davis and Cowley, 
2006, Beckett, Han et al., 2008). This could be vital for controlling cell processes 
such as growth, migration, volume and cell shape and could also help it detect small 
changes in flow to increase stress on the blood vessel. The importance of the TREK-1 
response to stretch was shown in a recent study (Baker, Hennig et al., 2008) using 
bladder SMC. The bladder wall is stretched during the process of bladder filling 
however stretch sensitive ion channels have been implicated in maintaining SMC 
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quiescence to prevent unregulated contraction of the bladder wall. This study showed 
that the membrane potential remained stable under stretch which could be inhibited in 
the presence of the TREK-1 blocker L-METH. This finding implicates a role for 
TREK-1 in detecting and responding to stretch to modulate cellular activity (Baker, 
Hennig et al., 2008, Beckett, Han et al., 2008). TREK-1 may also respond in a similar 
manner to increases in stretch in the form of physical stress on the vessel to alter 
vascular SMC function and bring about a change in the vessel diameter and secondly 
provides an important target for pharmacological interventions to improve placental 
perfusion.    
TREK-1 expression was predominantly linear across the cell body but we did 
also observe some positive stain within the nucleus of SMC. Nuclear expression has 
previously been reported for TASK-1 within the cytotrophoblasts (Bai, Greenwood et 
al., 2005). TREK-1 expression was also found in SMC cultured from MYO and 
supports the findings of Bai (et al., 2005). This study reported TREK-1 expression to 
be localised to the membrane but interestingly also in the nucleus (Bai, Bugg et al., 
2005, Bai, Greenwood et al., 2005). In our study SH SY57 cells showed TREK-1 
positive staining inside the nucleus which has also been reported with neurons 
(Figure 6.5.4.3-1) (Maingret, Lauritzen et al., 2000, Nicolas, Lesage et al., 2004, 
Xian Tao, Dyachenko et al., 2006). This is an interesting observation which we 
initially did observe with placental SMC and attributed it to a processing artefact and 
chose to reduce the TREK-1 antibody concentration from 1:50 to 1:100 which 
resolved this issue along with removing the DAPI staining. However examining the 
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literature along with and our positive control (SH SY57 cells) and requires further 
validations to support this finding.  
  
 
Figure 6.5.4.3-1 immunofluorescence staining of TREK-1 in COS-7 cells transfected 
with human TREK-1. There is evidence of nuclear staining (red arrow) and the cells show 
an increase in cellular protrusions (yellow arrow). Scale bar 1µm. (Image adapted from Xian 
Tao, Dyachenko et al., 2006)).  
 
The localisation of TREK-1 in the nucleus suggests a role for TREK-1 in cell 
division as it may respond to an increase in the size of the nucleus to initiate cell 
division. TREK-1 has been shown to be selectively expressed in prostate cancer cells 
while healthy tissue remains clear. TREK-1 is an important oncogene for the 
detection of prostate cancer and inhibitors of TREK-1 have shown to reduce the 
population of cancerous cells (Voloshyna, Besana et al., 2008). Curcumin is an 
example of an antiproliferative agent that can block TREK-1 currents and maybe 
targeting TREK-1 channels on the nuclear membrane to alter cellular function. 
TREK-1 in the nucleus of placental vascular SMC may also form a similar function to 
trigger cell division and new vessel formation and maybe important in the placenta.  
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6.5.4.4. TWIK-2 channels 
 
TWIK channels are of particular interest to our study as the ion channel has 
been identified in tissues such as the stomach, pancreas, and small intestine, all of 
which maintain low [pH]o (Chavez, Gray et al., 1999, Patel, Maingret et al., 2000, 
Medhurst, Rennie et al., 2001). Expression for the ion channel was detected in CPA 
and SVA and two dominant bands at 37 and 50 kDa were identified. The 50 kDa band 
has also been shown (Davis and Cowley, 2006) along with a band at 83 kDa in airway 
epithelial cells. The study showed that cells which line the airway may have a role in 
gas exchange and the same pathway may function inside the placenta.  
The presence of TWIK-2 channels can provide an insight into how the pH 
gradient of the placenta maybe maintained. We observed an importance difference in 
the expression of TWIK-2 in PE samples and it was shown that TWIK-2 was 
specifically higher in PE CPA when compared to SVA and the 50 kDa band in PE 
CPA was higher when compared to the respective CPA expression levels in NORM 
samples. This apparent ion channel up regulation in PE suggests TWIK-2 expression 
may vary with diseased states and may provide a potential early indicator of altered 
vascular function. This could also help us to understand the reduced ability of PE 
CPA to relaxation in response to acidic pH environments (Chapter 5.7) and the ion 
channel up-regulation may be the result of an increased sensitivity of the PE vessels to 
pH. The increased presence of TWIK-2 may help to regulate vascular tone and 
furthermore suggests the TWIK-2 expression can be up regulated to increase the 
sensitivity of the tissue to changes in pH and prevent a loss in tone. Differences in 
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TWIK regulation give more information about cellular regulation. Liu (et al., 2003) 
showed that the expression profile of K+ channels in the human decidua altered with a 
change in the labour state and shows that the placenta can actively alter its ion 
channel profile to adapt to changing environments. Reduced TWIK-2 expression in 
SVA would favour cell membrane depolarisation and may contribute to the increase 
resistance seen with PE. This would hamper the ability of the placenta to regulate 
flow. Loss of TWIK-2 activity may reduce the vessels ability to detect and respond to 
low pH conditions. K2P channels may have a stabilising role to keep the membrane 
potential constant and loss of ion channel activity will promote cell depolarisation in 
response to [H+]i and allow Ca2+ to increase inside the cell.  
SMC from CPA and SVA showed granular distribution of TWIK-2 in CPA 
and SVA cells with a dense staining pattern around the nuclear membrane. SVA cells 
also show some linear filaments of TWIK-ZKLFKVKRZSRVLWLYHRYHUODSZLWKĮDFWLQ
filaments and has been reported previously in rat cerebral vascular SMC (Bryan, You 
et al., 2006). Davis (et al., 2006) also showed granular punctuate expression in airway 
epithelial cells but most TWIK-2 expression was membrane bound. More importantly 
it was shown that the TWIK-2 co-localisation with TASK-3 was most prominent in 
the SVA which may be an important difference to allow the two ion channels to 
regulate pH gradients across the placental interface. TWIK-2 has previously been 
shown to co-localise with TREK-1 in the rat hippocampal astrocyte cells (Zhou, Xu et 
al., 2009) and the functional association is responsible for the rapid response to 
ischaemia in this tissue. The presence of both TWIK-2 and TASK-3 at the SVA 
region of the placenta could help to amplify the response to changes in pH.  
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SVA at the fetal side of the placenta will be exposed to acidic pH as a result of 
reduced perfusion. Excess protons are harmful to the cell as they can cross the cell 
membrane with ease and alter the optimal working conditions for many important 
cellular pathways. pH sensitive sensors are important for reacting to this by triggering 
a Ca2+ influx to depolarise the membrane and in neurons this will trigger 
neurotransmitter release (Lesage, Mattei et al., 1996, Patel, Maingret et al., 2000). The 
taste bud cells found in the tongue have been used to demonstrate this reflex response. 
However to better understand the link between pH changes and Ca2+ movements 
Richter (et al., 2004) investigated the expression of key acid sensing channels and 
showed that the mRNA for the K2P members TWIK 1/2, TREK 1/2, and TASK-1/2 
were found on mouse taste bud cells with TWIK 1/ 2 levels being the highest. TWIK 
and TREK are sensitive to intracellular pH while TASK responds to extracellular 
changes in pH. This study also demonstrated that K2P channels may work to stabilise 
the cell membrane instead of directly initiating depolarisation (Cooper, Johnson et al., 
2004, Lin, Burks et al., 2004, Duprat, Lauritzen et al., 2007) and similarly TWIK-2 
may be important for restoring vessel function in the placental vasculature.     
 
6.5.5. Future research  
 
The results in this chapter presented Western blot analysis for whole placental 
vessel tissue and confocal IF was used to characterise the cellular location of our ion 
channels of interest within the SMC. This data analysis can be supported further by 
examining the mRNA expression levels across CPA and SVA in order to identify any 
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variations that may exist with channel regulation across CPA and SVA at the 
transcriptional level.  
In our investigations RB failed to give a positive signal with anti KATP, TASK-
1, TASK-3, TRAAK and TWIK-2 with Western blotting analysis although the 
epitopes used are highly conserved between mouse, rat and human species. This could 
reflect a problem with the method of homogenisation of the neuronal tissue which is 
less compact when compared to the tougher MYO tissue. We could consider using an 
alternative control tissue such as mouse brain or human brain, or alternatively 
pancreatic tissue could be used as it is also a rich source for K2P channels. In contrast, 
the neuroblastoma cell line SH-SY57 gave more reproducible results when the same 
antibodies were applied (Figure 6.4.3.1-1) and could be used as an alternative control 
sample with Western blotting analysis.  
The data presented here shows NORM and PE samples from separate Western 
analysis. This can introduce bias and it is more relevant to include a mixture of both 
NORM and PE blood vessels which have been randomised within the same blot. This 
would allow for a more representative comparison to be made across the two patient 
groups and reduce any bias in the analysis.   
The method used to quantify each Western blot image could also be improved. 
Semi quantification involves converting the captured image into a TIFF file to then 
measure the optical density of each band. The background intensity was then removed 
XVLQJ WKH UROOLQJGLVFRSWLRQDQG WKHDYHUDJHGHQVLW\ZDVQRUPDOLVHG WRȕDFWLQDQG
expressed as a percentage. However the converted images gave limited information 
about the size of the band for example TASK-1 was 2 fold larger in size on the blot 
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but following normalisation, WKHGDWDVKRZHGWKDWWKHH[SUHVVLRQZDVRIWKHȕ
actin. A better option may have been to measure total pixels for the entire band or the 
integral intensiW\RUSHDNKHLJKWDQGWKHQQRUPDOLVHWKLVYDOXHWRȕDFWLQ(Gassmann, 
Grenacher et al., 2009). Another limitation of applying the rolling disc is that vital 
pixel information can also be removed as overlapping lanes can distort this process. 
This may lead to the loss of smaller bands that could represent smaller sub units of 
our protein of interest. The molecular weights for our proteins of interest were 
deduced by comparing the separation of the pre-stained kaleidoscope molecular 
weight markers that were loaded with each western blot. However protein bands that 
were predicted to be 45 kDa in size were often detected at 50 kDa. This may be due to 
a poor separation of the pre-stained markers, particularly with proteins that are closely 
overlapping. A better alternative could be to use biotinylayted molecular weight 
markers which have a greater accuracy and have the additional advantage that they 
can be developed using chemiluminescence detection.  
$OO RI RXU GDWD ZDV QRUPDOLVHG WR WKH KRXVHNHHSLQJ SURWHLQ ȕ DFWLQ EXW LW
would have been better to perhaps normalise to MYO which proved to be a good 
control sample to use for each Western blot. This has the further advantage that the 
blot does not need to be stripped in order to be re-probed for ȕactin as some protein 
could be lost with this extra process. In addition more than one housekeeper-protein 
should be used to quantify protein levels as diseased states, as well as gestational age 
can alter the expression of such proteins to distort the analysis (Ferguson, Carroll et 
al., 2005) ȕ WXEXOLQ or glyceraldehyde-3-phosphate  are additional alternatives that 
have been used with RT-PCR analysis (Gassmann, Grenacher et al., 2009). Another 
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modification could be to include a wider range of SMC marker proteins such aVȕ-
tropomyosin, and h-FDOGHVPRQZKLFKDUH60&VSHFLILFSURWHLQVLQDGGLWLRQWRĮDFWLQ
This could resolve ambiguity regarding the nuclear stain which was seen sporadically 
ZLWKWKHĮDFWLQDQWLERG\ 
To extend the confocal staining it would be useful to firstly include TREK-2 
along with TRAAK to investigate the full spectra of K2P channel expression in 
placental vessels. Each ion channel shares homology with different members of the 
K2P family and it would be interesting to see if there is a degree co-localisation. The 
development of monoclonal antibodies will help with this. The main limitation with 
studying K2P channels was with the limited choice of antibodies available that 
recognise various epitopes. The only commercially available ones are supplied by 
Alomone or Santa Cruz while the recent anti-TREK-1 antibody supplied by Abcam is 
not yet not widely cited in the literature. Some peri-nuclear staining was observed 
particularly with TASK-3 may be organelles that are found at the nuclear membrane 
that express the ion channel. To investigate this we added monoclonal antibodies that 
stain the endoplasmic reticulum (ER) and Golgi but our pilot data did not show 
significant overlap with TASK 1, TWIK-2 and TREK-1 (not shown). One 
improvement to this method would be to use organelle markers in live cells which 
take up the fluorescent tags in normal cellular process and may be a more accurate 
way to label the cell organelles. Live cell imaging would also allow us to and add pH 
sensitive fluorophores such as carboxyl SNARF (Swietach, Camelliti et al., 2010) to 
see the precise SMC response to acidic pH stimuli. Co-localisation was important to 
our study but despite the accurate nature of dual confocal imaging some staining can 
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be due to the poor signal separation of the different fluorescent tags which can emit 
fluorescence in the wrong focal plane. An alternative technique to explore could be 
co-immunoprecipitation which is another method for investigating protein-protein 
cross links. This method involves separating functional structures of protein 
combinations according to the precise molecular weight of the protein dimer as well 
as probing these interactions through co-immunoprecipitation.   
 
6.5.6. Conclusion  
 
This study has reported for the first time the expression of key members of the 
K2P channel family, TWIK-2, TASK-3, TREK-2 and TRAAK both in whole tissue 
and within the SMC. Crucially there was no significant difference at the protein levels 
between the CPA and SVA while it was shown that expression of TWIK-2 
significantly varied between NORM and PE samples and may have important 
implications for the ability of the placenta to respond to pH stress The examination of 
SMC expression for each ion channel revealed important differences in the sub 
cellular localization of each ion channel and we observed an important interaction 
EHWZHHQ Į DFWLQ DQG.3 FKDQQHOV DQG WKLVZDV SDUWLFXODUO\ HYLGHQWZLWK75(.-1. 
The data also shows evidence for co-localisation of TASK-3 with other closely related 
K2P channels and requires further investigations.  
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7. Functional investigations of ion channels in CPA 
 
7.1. Introduction  
 
The Western blotting and confocal staining of CPA and SVA SMC findings described 
in Chapter 6 demonstrated the presence of the key O2 and pH sensing ion channels. The 
results also suggest the K2P member TREK-1 may have a role in controlling vasoconstriction 
and vasodilatation of the resistance vessels due to its close association with SM&ĮDFWLQ. The 
hypothesis that the response by CPA to external stress is mediated by O2 sensitive ion 
channels was tested. 
 
7.2. Objectives  
 
x Investigate the functional role of K+ channels in mediating CPA contractile and 
relaxation responses.  
x Determine the precise role of K+ channels in mediating the response to H2O2 and pH.  
 
7.3. Materials and methods  
 
CPA from the NORM patient group were studied using wire myography (Chapter 3.7) 
using the K+ activators and blockers listed in Table 3.7.8-1 and Table 3.7.11-1.   
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7.4. Results  
 
7.4.1. Effect of ion channel blockers on the U46619 contraction  
 
The effect of pre-incubation with a range of blockers on the U46619 vasoconstrictions 
was investigated. The first series of blockers were specific for the Ca2+ activated and voltage 
gated K+ channels. The effect on basal tone was assessed pre and post application of the 
different drugs and it was found that 4-AP caused an increase in the basal tone upon 
application (Figure 7.4.1-1).  
5mN
10mins
Baseline  
U46619   
4-AP   
 
 
Figure 7.4.1-1 shows the effect of 4-AP pre-incubation. CPA were treated with the blocker 20mins 
prior to the U46619 dose-response to stimulate the vessels. The red arrow shows the point at which 
the blocker is added and causes an immediate increase in the baseline tension.  
 
The blockers that produced a significant shift in the dose-response to U46619 have 
been summarised Figure 7.4.1-2. APA inhibited the contractile response at low doses which 
was reversed at the higher concentrations of U46619 (p<0.001 at 10-7.5M) and reached 
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plateau at 10-7M. The CaV1.2 blocker NIFED caused a significant reduction in the maximum 
response ranging from 10-8-10-6M as the vessels failed to achieve the maximum constriction. 
Figure 7.4.1-2B shows the response to U46619 is enhanced in the presence of 4-AP which 
causes a leftward shift in the dose-response curve and achieves significance at 10-8M 
(p<0.05). GLB produced a decreased response that was significant at 10-7M (p<0.05). Table 
7.4.1-1 summarises the resulting logEC50 values based on the best fit curve in the presence of 
each channel blocker and it was found that 4-AP along with APA had a significantly different 
EC50 value.   
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Table 7.4.1-1 summarising the EC50 values which have been obtained with U46619 in the presence of 
specific blockers.  
Treatment (n) LogEC50(M) ± SEM p 
U46619 (12) -7.5 ± 0.1  
U46619 + 4-AP (9) -7.8 ± 0.1 <0.01 
U46619 + AMIL (9) -7.3 ± 0.1 ns 
U46619 + APA (9) -7.8 ± 0.1 <0.01 
U46619 + BaCl2 (9) -7.6 ± 0.2 ns 
U46619 + Choline Cl (9) -7.6 ± 0.2 ns 
U46619 + CuCl2 (9) -7.6 ± 0.1 ns 
U46619 + GLB (9) -7.2 ± 0.2 ns 
U46619 + IBTX (9) -7.1 ± 0.1 ns 
U46619 + L-NAME (9) -7.2 ± 0.2 ns 
U46619 + NaCl (9) -7.4 ± 0.1 ns 
U46619 + NIFED (9) -7.3 ± 0.1 ns 
U46619 + TEA (9) -7.1 ± 0.1  ns 
U46619 + ZnCl2 (9) -7.6 ± 0.1  ns 
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Figure 7.4.1-2 summarising the U46619 (N=12) constriction when CPA have been pre-treated 
with ion channel blockers. A shows the effect of APA (N=9) incubation which causes an initial 
inhibition to the U46619 response but this is reversed with the higher dose concentrations to elevate 
the U46619 response. NIFED (N=9) significantly reduces the maximum constriction. B shows how 4-
AP (N=9) caused a significant left ward shift while GLB (N=9) pre-treatment produced a significant 
rightward shift as the maximum response was reduced. Data are presented as mean ± SEM along with 
vessels treated (n) from placentae (N). *p<0.05, **p<0.01, ***p<0.001. 
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Replacing NaCl with Choline Cl (C5H14ClNO) in the PSS buffer markedly enhanced 
the constriction produced by U46619 and achieved significance at the highest concentrations 
(10-8-10-7M) (Figure 7.4.1-3). BUP markedly reduced the maximal response to U46619 and 
achieved significance at the highest concentrations (10-6.5-10-6M, p<0.01). The logEC50 
values extrapolated from the best fit curve in the presence of each channel blocker have been 
summarised Table 7.4.1-2. The next group of blockers to be analysed included the TWIK-2 
blocker QUIN and the Na+/H+ pump blocker OUAB. Figure 7.4.1-3B shows that OUAB 
caused a leftward shift in the dose-response curve which achieved significance at 10-8-10-7.5M 
(p<0.01). In contrast QUIN restricted the maximum constriction to 45% of the original 
U46619 response and was significantly different (p<0.05) at 10-8-10-6M. The logEC50 values 
extrapolated from the best fit curve in the presence of each channel blocker have been 
summarised in Table 7.4.1-2 and the EC50 values were significantly different with QUIN and 
OUAB pre-incubation when compared to the vehicle controls.  
 
Chapter 7 
Functional investigation of ion channels in CPA 
274 
 
Table 7.4.1-2 summarising the EC50 values which have been obtained with U46619 in the 
presence of specific blockers. 
Treatment (n) LogEC50(M) ± SEM p 
U46619 (12) -7.5 ± 0.1 ns 
U46619 + BUP (9) -7.3 ± 0.1 ns 
U46619 + CURC (9) -7.3 ± 0.2 ns 
U46619 + LIDO (9) -7.1 ± 0.2 ns 
U46619 + L-METH (9) -7.2 ± 0.2 ns 
U46619 + M.ANAN (9) -7.0 ± 0.1 ns 
U46619 + OMP (6) -7.6 ± 0.1 ns 
U46619 + OUAB (6) -8.0 ± 0.2 <0.001 
U46619 + QUIN (4) -7.0 ± 0.1 <0.01 
U46619 + R.RED (6) -7.4 ± 0.1  ns 
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Figure 7.4.1-3 summarising the U46619 (N=12) constriction when CPA have been pre-
treated with different blockers. A shows the response with Choline Cl (N=9) which causes 
a significant increase in the response while BUP (N=9) showed a blunted contractile 
response. B. OUAB (N=6) caused a rightward shift to the response curve and this was only 
significant at 10-8-10-7.5M. QUIN (N=4) restricted the maximum constriction to 45% and 
achieved significance with the highest doses. Data are presented as mean ± SEM along with 
vessels treated (n) from placentae (N). *p<0.05, **p<0.01, ***p<0.001. 
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7.4.2. Response of ion channel activators  
7.4.2.1. NS1619  
 
The response to the BKCa agonist NS1619 was investigated with CPA. An 
original trace recording is shown in Figure 7.4.2.1-1 with CPA at 20% pO2. The 
vessels produced a dose dependent relaxation with a maximum relaxation of 92% 
(Table 7.4.2.1-1). The dose-response in the presence and absence of the K+ channel 
blockers TEA and IBTX been summarised in Figure 7.4.2.1-2. IBTX also produced 
the highest degree of inhibition to the NS1619 response and this was significant at 10-
6
-10-5M (p<0.05).  
 
5mN
10mins
Baseline  
U46619  
10-9M   
10-8M   
10-6M   
10-7M   
10-10M  
WASH   10
-5M  
 
Figure 7.4.2.1-1 showing an original trace with application of NS1619 (10-10-10-5M) in 
pre-constricted CPA. The vessels could produce a marked relaxation with increasing doses 
of the BKCa opener which almost reaches 100%. The vessel was then washed with fresh PSS 
to allow for recovery.  
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Figure 7.4.2.1-2 showing the dose-response curve with NS1619 (N=4) in CPA. Only IBTX 
(N=4) gave a significant inhibition with the highest doses (10-6-10-5M) used and time control 
responses were unchanged throughout. Data are presented as mean ± SEM along with vessels 
treated (n) from placentae (N). *p<0.05.  
 
Table 7.4.2.1-1 summarising the EC50 values for NS1619 in the presence and absence of 
BKCa inhibitors.  
Treatment (n) LogEC50(NS1619)M ± 
SEM 
p Maximum Relaxation 
(%) ± SEM 
NS1619 (4) -6.9 ± 0.2  
 
92 ± 9 
NS1619 + IBTX 
(4) 
-6.8 ± 0.7 ns 53 ±18 
NS1619 + TEA 
(4) 
-6.9 ± 0.3 ns 75 ± 8 
.  
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7.4.2.2.  Response to RIL in the presence of ion channel blockers 
at 20% pO2 
 
A potent and reproducible RIL induced vasodilatation in CPA and SVA has 
been demonstrated (see Chapter 5.6.4). The next objective was to investigate the 
potential ion channels that maybe targeted by the stimulant to bring about the 
relaxation response using CPA, and the response in the presence of TEA has been 
shown in Figure 7.4.2.2-1. 
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Figure 7.4.2.2-1 showing a representative trace of RIL induced concentration dependent 
relaxation of pre-contracted CPA. A shows the response to RIL which can induce a potent 
vasodilatation which appears to reach 100%. B shows the response in the presence of TEA 
which appears to inhibit the maximum relaxation and prevents the vessel from reaching its 
baseline tension.  
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The same experiment was repeated in the presence of a range of specific ion 
channel blockers. From the range of inhibitors applied only TEA caused a significant 
inhibition to the relaxation observed at 10-7-10-6.5M (p<0.001) (Figure 7.4.2.2-2). 4-
AP caused a significant inhibition to the RIL response but only with the highest dose 
used 10-6.5M (p<0.05). The extrapolated EC50 values for RIL have summarised in 
Table 7.4.2.2-1 along with the maximum % relaxation values in the presence of 
specific channel antagonists.  
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Figure 7.4.2.2-2 showing the dose-response with RIL (N=18) in the presence of specific 
ion channel blockers. The dose-response curve shows TEA (N=6) caused a reduction in 
relaxation which was significant at 10-7-10-6.5M. 4-AP (N=6) cause an upward shift to the 
curve as the response was partially inhibited but only achieved significance at 10-6.5M. Data 
are presented as mean ± SEM along with vessels treated (n) from placentae (N).. *p<0.05, 
***p<0.001.  
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Table 7.4.2.2-1 summarising the EC50 values which have been obtained with RIL in the 
presence of different blockers.  
Treatment (n) LogEC50(M) ± 
SEM 
p Maximum Relaxation 
(%)  ± SEM 
RIL (18) -7.2 ± 0.1  
 
76 ± 4 
RIL + 4-AP (6) -7.3 ± 0.2 ns 62 ± 4 
RIL + AMIL (6) -7.3 ± 0.1 ns 75 ± 6 
RIL + BaCl2 (6) -7.2 ± 0.1 ns 83 ± 7 
RIL + BUP (6) -7.2 ± 0.1 ns 79 ± 6 
RIL + CuCl2 (6) -7.5 ± 0.3 ns 89 ± 6 
RIL + CURC (13) -7.3 ± 0.1 ns 74 ± 7 
RIL + GLB (6) -7.2 ± 0.2 ns 67 ± 7 
RIL + IBTX (6) -7.1 ± 0.1 ns 67 ± 6 
RIL + LIDO (6) -7.1 ± 0.1 ns 80 ± 4 
RIL + L-METH (6) -7.3 ± 0.1 ns 75 ± 6 
RIL + L-NAME (12) -7.2 ± 0.2 ns 68  ± 5 
RIL + M.ANAN (6) -7.4 ± 0.1 ns 83 ± 7 
RIL + NIFED (6) -7.3 ± 0.1 ns 63 ± 4  
RIL + R.RED (6) -7.3 ± 0.1 ns 83 ± 6 
RIL + TEA (6) -7.1 ± 0.1  ns 58 ± 7 
RIL + ZnCl2 (6) -7.5 ± 0.2 ns 83 ± 9 
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7.4.3. Response to H2O2 in the presence of ion channel blockers at 
20% pO2 
 
The relaxation response of CPA to H2O2 was investigated in the presence of a 
range of specific blockers at 20% pO2 perfusion. The first H2O2 antagonist to be used 
was CAT which metabolises H2O2 into H2O. The response to H2O2 was significantly 
attenuated with CAT pre-incubation at 10-7M and 10-5M (Figure 7.4.3-1). CURC is 
known for its antioxidant properties, as well as being a TREK-1 blocker, could not 
demonstrate a significant shift in the response of CPA to H2O2. Figure 7.4.3-1B also 
shows the response to H2O2 in the presence of IBTX which appears not to be involved 
in the vasodilatation brought about through the application of H2O2. In contrast, a 
very interesting response was seen in the presence of L-NAME which caused an 
increased relaxation at the low concentrations and achieved significance at 10-8M 
(p<0.05, n=3). Only TEA demonstrated an inhibition of the H2O2 response at the 
lower doses of 10-8-10-7M and also at 10-5M (p<0.05, n=4). Table 7.4.3-1 summarises 
the EC50 values for each treatment and blocker used.  
The role of H2O2 as a vasoconstrictor has also been demonstrated in Figure 
7.4.3-2A which shows the original response of CPA stimulated with H2O2 at rest with 
20% pO2. The response was not reproducible with each subsequent stimulation with 
the agonist and we again found that this experiment proved to be toxic as vessels 
failed to produce a response to a stimulant following washout of H2O2. Figure 
7.4.3-2A also shows the response when a CPA from the same placenta was pre-
treated with CAT. The response was inhibited with the exception of only one 
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substantial contraction that was produced with the higher dose of H2O2 (10-6M). The 
varied nature of the response produced by the vessels made it difficult to produce a 
dose-response curve as all the points did not follow a classic sigmoid dose-response. 
Figure 7.4.3-2B shows the smooth curve with H2O2 stimulation of CPA in the 
presence of CAT and the BKCa inhibitor IBTX both of which did not exert a 
statistically significant effect on the vascular response.   
 
Table 7.4.3-1 summarising the EC50 values which have been obtained with H2O2 in the 
presence of specific blockers.  
Treatment  (n) LogEC50(H2O2)M ± 
SEM 
P Maximum Relaxation (%) 
± SEM 
H2O2 (6) -5.5 ± 0.1       54 ± 2 
H2O2 + CAT (5) -3.8 ± 0.1 <0.001 69 ± 2 
H2O2 + CURC (3) -6.1 ± 0.1 ns 54 ± 7 
H2O2 + IBTX (6) -5.7 ± 0.1 ns 50 ± 4 
H2O2 + L-NAME (3) -7.2 ± 0.2 <0.05 54 ± 2 
H2O2 + TEA (4) -6.0 ± 0.1 <0.05 57 ± 7 
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Figure 7.4.3-1 summarising the dose-response curves with H2O2 (N=6) with CPA in the 
presence of ion channel blockers. A shows the response in the presence of CAT (N=5) 
which causes a significant attenuation to the relaxation response. In contrast CURC (N=3) 
causes a slight downward shift to the response but this was not significant. B shows the 
response to H2O2 in the presence of IBTX (N=6) which does alter the dose-response curve. In 
contrast the relaxation steeped in the presence of L-NAME (N=3) while only TEA (N=4) 
showed a significant inhibition to the relaxation response. Data are presented as mean ± SEM 
along with vessels treated (n) from placentae (N). *p<0.05, **p<0.01.  
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Figure 7.4.3-2 showing the results of H2O2 application (10-10-10-5M) to CPA in 20% pO2. 
A shows an original trace recording which produces a contraction that was short lived as the 
vessel begins to return to its resting tension. The lower panel shows the response in the 
presence of CAT which could abolish the response to the agonist. Only a single contraction 
was produced at 10-6M. B shows the smooth curve for the response to H2O2 (N=6). CAT 
(N=4) blunts the response to the agonist while IBTX (N=3) causes an upward shift as the 
contraction appears to be enhanced. Data are presented as mean ± SEM along with vessels 
treated (n) from placentae (N).  
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7.4.4. Response to acidic pH in the presence of ion channel blockers 
at 20% pO2 
 
The effect of pre-incubation with a range of ion channel blockers on the acidic 
pH relaxation was also investigated using CPA. Figure 7.4.4-1 shows an original 
trace recording showing the effect when vessels have been pre-incubated with CuCl2 
which inhibited the recovery phase (red box) that was seen in response to the pH 
stress. Instead it was shown that the relaxation to pH stimuli stabilised in the presence 
of the ion channel blocker and interestingly the same effect was also observed with 
ZnCl2 (Figure 7.4.4-2). Figure 7.4.4-4B summarises the concentration response 
curves with lowering pH treatments. CuCl2 and ZnCl2 evoked a downward shift in the 
response curve as the relaxation was enhanced which achieved significance at pH 
<7.0. Table 7.4.4-1 summarises the resulting EC50 values based on the best fit curve 
in the presence of each channel blocker. The U46619 response in the presence of 
NIFED (Figure 7.4.4-3) was greatly reduced and the response to pH was altered as 
the vessel recovery following a pH insult was blunted. This had the effect of 
producing a steep relaxation curve to acidic pH in the presence of NIFED which was 
significant at pH 6.8-6.4 (Figure 7.4.4-4). From all the blockers that were 
investigated, only L-NAME was able to show an inhibition to the relaxation to pH 
stimulation which achieved significance at the highest doses used (pH 6.6-6.4) 
(Figure 7.4.4-4A).  
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Figure 7.4.4-1 shows a representative trace of the pH response in the presence (B) and 
absence (A&C) of CuCl2. The vessel was firstly treated with increasing doses of lactic acid 
(A) to record the maximal response to acidic pH stimulation. The vessel was then pre-treated 
with CuCl2 (B) and the pH response was again repeated. The biphasic response with lactic 
acid stimulation was altered (red box) as the phase II response is almost completely absent. 
The final panel shows recovery of the original pH response following successful washout of 
the blocker (C).  
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Figure 7.4.4-2 illustrating the experimental protocol used to assess the effect of ZnCl2 on 
the lactic acid response. The vessel was then pre-treated with ZnCl2, and the pH response 
was again repeated. The red box shows the absence of the phase II response which is blunted 
in the presence of the ion channel modulator.  
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Figure 7.4.4-3 shows a representative trace of the pH response in the presence of the 
CaV1.2 blocker NIFED. The contraction to U46619 was blunted but the pre-treated vessel 
could still demonstrate a biphasic response with lactic acid stimulation.  
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Figure 7.4.4-4  summarising the lactic acid induced relaxation when CPA (N=18) have 
been pre-treated with various blockers. A shows the responses to lactic acid in the presence 
of the TASK channel blockers. Both CuCl2 (N=6) and ZnCl2 (N=8) evoked a downward shift 
as the relaxation was enhanced and ZnCl2 achieved significance at pH <7.0. B shows the 
responses to lactic acid in the presence of the L-NAME (N=6) which produced an attenuation 
to the pH response at the highest doses. NIFED (N=6) causes a downward shift to the 
response curve as the relaxation was significantly elevated in the presence of the ion channel 
inhibitor (pH <6.8). Data are presented as mean ± SEM along with vessels treated (n) from 
placentae (N). *p<0.05, **p<0.01, ***p<0.001. 
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Table 7.4.4-1 summarising the EC50 values for the lactic acid concentration response curves 
in the presence of specific ion channel blockers.   
Treatment (n) EC50(M) ± SEM p Maximum Relaxation 
(%) ± SEM 
pH (18) 6.9 ± 0.1  54 ± 3 
pH + 4-AP (9) 6.9 ± 0.2   ns 55 ± 7 
pH + GLB (6) 7.0 ± 0.2 ns 45 ± 4 
pH + IBTX (6) 7.0 ± 0.1 ns 58 ± 6 
pH + L-NAME (6) 6.8 ± 0.1  ns 30 ± 7 
pH + NIFED (6) 7.0 ± 0.1 ns 74 ± 5 
pH + TEA (6) 7.0 ± 0.2 ns 44 ± 5 
 
The effect of using TREK-1 blockers on the response to lactic acid was also 
examined. Figure 7.4.4-5 shows an original trace recording to show the effect of 
CURC on the pH response. The vessel displays an increase in spontaneous tone 
oscillations (boxed) with CURC pre-incubation and when the pH was lowered , the 
relaxation was partially inhibited (Figure 7.4.4-5 red box) as the vessels can quickly 
recover the original contraction. In contrast, the second TREK-1 inhibitor L-METH 
(Figure 7.4.4-6) increased the amplitude of the original pH stimulus as the vessel tone 
is dramatically reduced with each repeated lactic acid dose. Figure 7.4.4-7 shows the 
response to lactic acid in the presence of the CURC which produced a significant 
inhibition to the response. L-METH evoked a downward shift as the relaxation was 
enhanced and achieved significance (p<0.001) at pH 7.2. Table 7.4.4-3 summarises 
the resulting EC50 values based on the best fit curve in the presence of each channel 
blocker.   
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Table 7.4.4-2 summarising the EC50 values for the lactic acid concentration response curves 
in the presence of specific ion channel blockers.   
Treatment (n) EC50(M) ± SEM p Maximum Relaxation 
(%) ± SEM 
pH (18) 6.9 ± 0.1  54 ± 3 
pH + AMIL (9) 6.9 ± 0.2   ns 45 ± 8 
pH + BaCl2 (6) 6.8 ± 0.1 ns 62 ± 5  
pH + CuCl2 (6) 7.0 ± 0.1 ns 75 ± 5  
pH + NaCl (6) 6.9 ± 0.2 ns 35 ± 4 
pH + OMP (6) 6.9 ± 0.1 ns 54 ± 3 
pH + OUAB (6) 6.8 ± 0.2 ns 39 ± 7 
pH + ZnCl2 (8) 7.0 ± 0.1 ns 72 ± 5  
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Figure 7.4.4-5 shows a representative trace of the pH response in the presence of CURC. 
The vessel displays an increase in spontaneous tone oscillations (boxed). The biphasic 
response to lactic acid stimulation was altered (red boxes) and a reduced relaxation was 
produced in response to lactic acid.  
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Figure 7.4.4-6 shows a representative trace of the pH response in the presence of L-
METH. The main difference in the presence of L-METH was that the loss in contraction in 
response to acidic pH was greatly increased (red box) with each pH stimulus.  
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Table 7.4.4-3 summarising the EC50 values for the lactic acid concentration response curves 
in the presence of different ion channel blockers.   
Treatment (n) EC50(M) ± SEM p Maximum Relaxation 
(%) ± SEM 
pH (18) 6.9 ± 0.1  54 ± 3 
pH + CURC (6) 6.7 ± 0.1 ns 34 ± 5 
pH + LIDO (8) 6.9 ± 0.2   ns 55 ± 7 
pH + L-METH (6) 7.2 ± 0.1  ns 67 ± 7 
pH + M.ANAN (6) 7.1 ± 0.2 ns 57 ± 6 
pH + R.RED (6) 6.9 ± 0.1 ns 62 ± 4  
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Figure 7.4.4-7 summarising the lactic acid induced relaxation when CPA (N=18) have 
been pre-treated with different blockers. CURC (N=6) produced a significant inhibition to 
the response. In contrast L-METH (n=6) evoked a downward shift as the relaxation was 
enhanced and achieved significance at pH 7.2. Data are presented as mean ± SEM along with 
vessels treated (n) from placentae (N). *p<0.05, **p<0.01, ***p<0.01. 
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7.4.4.1. Response to acidic pH response in the presence of ion 
channel blockers at 5% pO2 
 
Figure 7.4.4-1 summarises the dose-response curve for the acidic pH 
treatment with vessels perfused at 5% pO2. Directly replacing NaCl with Choline Cl 
could reduce the relaxation response and this was significant at the highest 
concentrations used (pH 6.6-6.4). The SKCA channel inhibitor APA caused a 
downward shift to the curve as a steep response was produced with the lowest doses 
of lactic acid which was most prominent at pH 7.0 (p<0.001). Table 7.4.4.1-1 
summarises the EC50 values which have been obtained with lactic acid in the presence 
of different blockers as well as the % maximum relaxation produced. 
 
Table 7.4.4.1-1 summarising the EC50 values for the lactic acid concentration response curves 
in the presence of specific ion channel blockers.   
 
Treatment (n) EC50(M) ± SEM p Maximum Relaxation 
(%) ± SEM 
pH (14) 6.9 ± 0.1 
 
37 ± 3 
pH + APA (6) 7.2 ± 0.2   *<0.05 48 ± 1 
pH + Choline Cl (8) 6.8 ± 0.2 ns 24 ± 4 
pH + QUIN (4) 6.7 ± 0.1 ns 46 ± 5 
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Figure 7.4.4.1-1 showing the dose-response to acidic pH with CPA (N=14) perfused in 
5% pO2. Choline Cl (N=4) could inhibit the relaxation response which was significant at the 
highest doses (pH 6.6-6.4). In contrast APA (N=6) caused a downward shift in the dose-
response curve and achieved significance at pH 7.0. Data are presented as mean ± SEM along 
with vessels treated (n) from placentae (N). *p<0.05, **p<0.01, ***p<0.001. 
 
The response to lactic acid in the presence of CuCl2 and ZnCl2 with 5% pO2 to 
examine the effects of TASK and TREK ion channel blockers which had 
demonstrated significant changes to the pH response at 20% pO2. A strikingly similar 
effect on the vessel response was seen with both CuCl2, ZnCl2, along with the 
anaesthetic BUP (Figure 7.4.4.1-2A). L-METH also increased the magnitude to the 
pH response as was the case at 20% pO2. The most interesting response was evoked 
by CURC which did not demonstrate a significant inhibition to the pH response. The 
maximal relaxation produced at 5% pO2 (37 ± 3%) was similar to the relaxation 
produced in the presence of CURC at 20% pO2 (34 ± 5% p>0.05). Table 7.4.4.1-2 
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summarises the resulting EC50 values based on the best fit curve in the presence of 
each channel blocker.   
 
Table 7.4.4.1-2 summarising the EC50 values for the lactic acid concentration response curves 
in the presence of specific ion channel blockers.   
Treatment (n) EC50(M) ± SEM p Maximum Relaxation 
(%) ± SEM 
pH (14) 6.9 ± 0.1  37 ± 3 
pH + BUP (4) 6.9 ± 0.2   ns 69 ± 4 
pH + CuCl2 (3) 6.9 ± 0.1 ns 79 ± 3 
pH + CURC (6) 6.7 ± 0.2 ns 34 ± 5 
pH + L-METH (6) 6.9 ± 0.1 ns 61 ± 5  
pH + ZnCl2 (4) 7.0 ± 0.2 ns 87 ± 4 
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Figure 7.4.4.1-2 summarising the lactic acid induced relaxation when CPA (N=14) have 
been pre-treated with blockers. A shows the response to TASK channel blockers. A 
significant increase in the relaxation response was seen with all inhibitors (BUP: N=4, CuCl2: 
N=6) and was most prominent with ZnCl2 (N=4) ZKLFKDFKLHYHGVLJQLILFDQFHDWS+B 
shows the responses to lactic acid in the presence of the TREK-1 blockers CURC (N=6) and 
L-METH (N=6). Only L-METH produced a significantly greater relaxation response to acidic 
S+ DW S+ 6.8. Data are presented as mean ± SEM along with vessels treated (n) from 
placentae (N). *p<0.05, **p<0.01, ***p<0.001. 
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7.5. Discussion  
 
Ion channels play a major role in the control of vascular function and have a 
powerful influence over the cell membrane potential. The expression of a number of 
key ion channels has been described in Chapter 6. The aim of the studies described in 
this chapter was to investigate the functional significance of candidate ion channels in 
the responses to modulators described in Chapter 5. Initially the responses of CPA in 
20% pO2 were examined for comparison to data already presented in the literature. A 
limited selection of experiments were again then performed in 5% pO2 to obtain data 
that would be more reflective of the responses in vivo.  
 
7.5.1. Alterations to the baseline resting tension 
 
The vessels of the placenta need to maintain a low resistance to flow and a 
change in the activity of CPA was seen in the presence of 4-AP. The peptide based 
inhibitor is similar to TEA in that it can inhibit a broad number of Kv (shaker) 
channels (Kaczorowski and Garcia, 1999). Application of the blocker altered the basal 
tone to suggest that K+ channels are open at rest are voltage gated ion channels and 
likely contribute to maintaining the basal tone of CPA. The contractile response to 
U46619 was elevated and may itself be the result of altered baseline activity. The 
most important role for Kv channels in the placental vasculature was shown by Hampl 
(et al., 2002). They demonstrated that the HFPV response seen could also be 
mimicked by application of 4-AP as Kv channel currents were also shown to inhibited 
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by hypoxia. They also demonstrated that the Kv1.5 and Kv 2.1 subunits were the most 
likely candidates for modulating the vasoconstriction in response to hypoxia and are 
targets for 4-AP. However for our studies it would be essential to determine the 
expression profile of the Kv channel expression in the placental vessels to fully 
understand the significance of this observation. The increase in baseline tension may 
have also contributed to the enhanced response to U46619 and is supported within the 
literature (Wareing, Bai et al., 2006).  
 
7.5.2. Modulation of the U46619 response   
 
Kv channels represent the largest family of K+ channels are also a target for 
TEA inhibition. From the present study it was noted that 4-AP and TEA along with 
the SKCa blocker APA increased the contractile activity of CPA in response to 
U46619 which suggests these K+ channels have a stabilising role and counteract 
vasoconstriction. A recent study demonstrated regional differences in the response to 
Kv channel openers across CPA and CPV to suggest a differential tissue distribution 
of the ion channels (Wareing, Bai et al., 2006, Kiernan, Barrie et al., 2010). This 
observation may hold the key to understanding the differences in response to 
changing pO2 between CPA and SVA and needs further explorations by examining 
the expression of Kv channels across both vessels.   
A twofold response was observed in the presence of APA with an initial 
inhibition to the contraction followed by an elevated contractile response as the 
concentration of U46619 was gradually increased. The dose-response curve suggests 
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a key threshold was reached to evoke a response from the CPA and provides evidence 
for the contribution of SKCa channel activity to vasoactivity within CPA. The role of 
SKCa channels has been investigated with uterine arteries and it was shown that the 
response to AVP was increased with APA pre-treatment (Kostrzewska, Modzelewska 
et al., 2008). Furthermore it was shown that the response to SNP was inhibited by 
APA implicating the ion channel as a target for NO mediated relaxation of blood 
vessels. SKCa together with IKCa channels are important for small resistance sized 
vessels and the blocker APA in combination with Triarylmethane-34 (TRAM-34) to 
block IKCa was shown to inhibit NO synthesis and promote hyperpolarisation in 
isolated HUVECs (Sheng and Braun, 2007). An increase in cytosolic [Ca2+]i 
stimulated the release of NO to oppose cell hyperpolarisation which could be 
successfully blocked in the presence of NOS inhibitors and crucially APA together 
with TRAM-34. This shows how ion channel activity is needed for NO synthesis to 
detect the changes in [Ca2+]i. SKCa in EC may help to maintain vessel quiescence and 
promote relaxation while in SMC blocking these channels may prolong that 
contraction and may explain the two stage response observed to U46619 in the 
presence of APA. The action of ion channels can vary across the EC and SMC and 
this would be better investigated with electrophysiological recordings of EC and SMC 
cultures in isolation to help dissect out the dual action of APA inhibition, as well as 
performing wire myography experiments with EC stripped vessels.   
In addition to the responses seen with K+ channel modulators, it was shown 
that replacing NaCl with Choline Cl increased the response to U46619 and OUAB 
pre-incubation also increased the vessel contraction in response to U46619 which has 
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parallels to the increased contractile response seen in the presence of Choline Cl. This 
implicates voltage gated Na+ (Nav) channels as being involved with controlling basal 
tone of CPA which may have a role in the removal of the excess H+ load to rapidly 
recover vessel function (discussed in Chapter 7.5.6).  
The inhibition in the response of CPA to U46619 was most obvious with 
NIFED which suggests the contraction to the agonist is dependent on Ca2+ 
movements, specifically extracellular Ca2+ (Striessnig, 1999). NIFED is an L-type 
Ca2+ channel antagonist and is widely used in an obstetric setting to treat pregnancy 
related hypertension as well as pre-term labour due to its potent anti-contractile 
properties. The drug is safe to use and has been shown not to alter blood flow to the 
placenta or uterine arteries (Allen, Andersson et al., 1991). However, paradoxically, 
our data suggests that the ion channel antagonist has a profound effect on CPA 
function and requires further investigations. The effect of the NIFED on placental 
vessels was also investigated using isolated vessels pre-contracted with 5-HT (Marin, 
Reviriego et al., 1990). This study showed that NIFED was effective in blocking the 
5-HT induced contractions while no effect was reported on the response to 40mM 
KPSS. It was also shown that removing extracellular Ca2+ from the bathing saline 
could mimic NIFED evoked responses and reduce the 5-HT induced contractions. 
This suggests that NIFED can exert a response by disrupting the movement of Ca2+ 
across the cell membrane while KPSS maybe dependent on VGCC (Marin, Reviriego 
et al., 1990, Cooper, Wareing et al., 2006). This also shows that gating mechanisms 
that control Ca2+ influxes operate differently in response to different vasoconstrictors 
and highlights the importance of using endogenous contractile agents to observe a 
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response that closely represents the physiological condition. Tanko (et al., 2000) 
demonstrated that the effect of NIFED action was dependent upon the contractile 
agent used. It was shown that NIFED could induce a dose dependant relaxation in 
porcine coronary arteries pre-FRQWUDFWHG ZLWK SURVWDJODQGLQ )Į 3*)Į (Tanko, 
Simonsen et al., 2000). It was also shown that that isobaric preparations of vessels 
were more sensitive to the addition of extracellular Ca2+ when compared with wire 
myography based vessel preparations. This illustrates how the experimental method 
used to study vessel in isolation can influence the response of isolated vessels, and the 
amount of pressure and stretch applied may potentially alter the activation of voltage 
sensitive Ca2+ channels.  
The functional role for KATP channels was investigated using the non-specific 
inhibitor GLB which reduced the contraction to U46619 while the basal tone was 
unaffected. KATP is an ion channel of interest for treating pregnancy related 
complications as its activity is dependent upon the cells¶ metabolic status and tissue 
oxygenation can modulate the function of KATP (Chen and Simard, 2001, Seino and 
Miki, 2003, Dong, Vegiraju et al., 2004). KATP ion channel openers such as pinacidil 
produce potent relaxations and may have a future role in IUGR/PE treatment 
(Wareing, Greenwood et al., 2006b, Jewsbury, Baker et al., 2007). In support of this it 
has been demonstrated that the CGRP produced relaxation is KATP dependent (Dong, 
Vegiraju et al., 2004). It was surprising that application of GLB opposed the response 
to U46619 and we can consider our observation in light of a related study. Wareing 
(et al., 2006) showed that the response pinacidil was not oxygen dependent as a pO2 
of 2% did not alter the relaxation response of CPA. The lower pO2. setting would be 
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expected to decrease ATP levels to open the ion channels and enhance the response to 
pinacidil but this was not seen. KATP is a key O2 sensing ion channel and ATP levels 
are closely linked to the oxidative state of the cell. High metabolism will increase the 
oxidative stress which has been shown to reduce KATP activity (Duprat, Guillemare et 
al., 1995, Seino and Miki, 2003, Tammaro and Ashcroft, 2009). We showed that in 
20% pO2, the contraction to U46619 was reduced which was surprising as blocking 
the ion channel should allow Ca2+ to increase inside the cell and reflects multiple 
effects of ion channels on controlling placental vascular function. KATP channels are 
important sensors of tissue ischaemia and the importance of this has been 
demonstrated in the brain. The cerebral tissue, like the placenta maintains a low pO2 
to limit ROS production. The main tissue damage linked with ischaemia is the 
resulting oedema due to cell swelling and understanding the molecular mechanisms 
that curtail to the development of tissue oedema have been crucial for reducing tissue 
damage in the brain (Chen and Simard, 2001, Sato, Costa et al., 2006). A recent study 
(Zhou, Fathali et al., 2009) compared neonatal rats treated with both severe and acute 
episodes of I/R with and without pre-treatment with GLB. It was shown that GLB 
could promote ischaemic protection treated but only with mild conditions of hypoxia. 
In severe I/R GLB was instead causing hypoglycaemia as blood glucose levels fell 
rapidly and this observation helps to understand why the CPA with GLB pre-
incubation gave a reduced response to U46619 stimulation (Chen and Simard, 2001, 
Zhou, Fathali et al., 2009).  
It was also shown that inhibition of TASK (BUP) and TWIK (QUIN) did not 
alter the resting tension of CPA but gave a significant attenuation to the U46619 
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response. A related study showed that application of BUP with rat pulmonary arteries 
could increase the baseline tension (Shah, 2008) and may reflect tissue specific 
differences with the action of the anaesthetic. The TWIK channel has highest 
expression in the placenta when compared to other related K2P members (Lesage, 
Guillemare et al., 1996). Modulation of the ion channel is complex and each blocker 
can exert different effects depending upon the tissue and cell type that is targeted 
(Goldstein, Bayliss et al., 2005). The blockers BaCl2 and QUIN were used and only 
QUIN reduced contraction to U46619 which can act on TWIK channel currents. The 
inhibition seen with both BUP and QUIN suggest a similar mechanism is involved in 
targeting the TASK and TWIK channels and implicates a role for K2P channels in 
determining the contractile function of placental CPA. A potential role for TWIK-2 
function was investigated in a recent publication examining the response of mouse 
taste buds. These cells, like the placenta have a high density of TWIK-2 channels 
implicating them in the activation of the cell in response to acidic pH. However this 
study failed to show a role for QUIN in mediating the action of TWIK-2 and 
suggested the ion channels have a stabilising role in controlling the cell membrane 
potential (Richter, Dvoryanchikov et al., 2004). Inhibiting the ion channel currents 
would result in an increase in the depolarisation of the cells to increase the response to 
U46619 but we found the opposite which suggests that Ca2+ entry into the cell is 
instead opposed when TWIK channel is blocked. We could investigate this with 
alternative TWIK blockers such as quinine or halothane (Goldstein, Bayliss et al., 
2005) to determine a more definitive role for TWIK in the placenta.  
 
Chapter 7 
Functional investigation of ion channels in CPA 
304 
 
7.5.3. Modulation of the response to NSI619 
 
The BKCa channel can be activated by a rise in [Ca2+]i, or membrane 
depolarisation and responds by promoting a K+ efflux to hyperpolarise the membrane. 
In blood vessels this results in a reduced contractility and BKCa channels have been 
shown to have a central role in controlling vessel myogenic control (Meera, Wallner 
et al., 1997). TEA can inhibit the ion channel but a more potent and selective 
antagonist is the scorpion toxin, IBTX (Kaczorowski and Garcia, 1999). Although we 
failed to demonstrate a role for BKCa in the U46619 response with IBTX, the channel 
opener NS1619 demonstrated a potent relaxation. Our previous data has shown 
expression of the BKCa channel using Western blot analysis (Chapter 6) and NS1619 
demonstrated a significant relaxation response in CPA (92%) compared to that seen 
with SNP (50%). In further support of this, the response to NS1619 was inhibited in 
the presence of TEA and more significantly with IBTX to suggest that the relaxation 
response is mediated by BKCa currents.  
The BKCa is largely activated by an influx of Ca2+ into the cell or changes in 
the membrane potential. However the ion channel activation can be optimised by 
second messenger signalling pathways and NO can also activate BKCa particularly in 
EC as part of a positive feedback mechanism to drive the synthesis and release of key 
vasodilators. (Khan, Smith et al., 1993, Meera, Wallner et al., 1997, Barlow, El-
Mowafy et al., 2000, Hampl, Bibova et al., 2002). CGRP can open the channel along 
with NO to initiate vessel dilatation (Saqueton, Miller et al., 1999). BKCa is widely 
expressed in a range of tissues and is an important therapeutic target for the treatment 
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of cardiovascular diseases such as stroke and hypertension. Moreover mitochondrial 
BKCa has also been implicated in providing cardioprotection (Liu, Hudetz et al., 1998, 
Sato, Saito et al., 2005, Liu, Sun et al., 2010). Ion channels, particularly K+ channel 
openers and inhibitors are important targets for diseases where the altered vessel 
function is the main contributing factor. Our finding that the BKCa channel opener 
NS1619 can induce a significant relaxation response in CPA suggests that BKCa could 
be a future drug target in the treatment of placental insufficiency and is an important 
avenue for future studies.  
 
7.5.4. Modulation of the response to RIL  
  
The response to RIL was investigated in the presence of a number of K2P 
channel inhibitors which have produced varied results. Similar to NS1619, we wanted 
to identify a suitable K2P channel opener to validate the potency of each ion channel 
blocker used. Our initial attempts with the TREK-1 agonist AA, which is found in 
abundance within the placental circulation, along with LA failed to produce a 
significant relaxation response. This could be attributed to the poor uptake of the lipid 
based agonists which may not have crossed the cell membrane to evoke a cellular 
response (Krischer, Eisenmann et al., 1998). We could explore alternative transport 
mechanisms that may improve the uptake of the lipids into cell.  
RIL has also been reported to open K2P channels with a high affinity for 
TRAAK and TREK-1 and we were able to show for the first time that the drug can 
induce a potent relaxation of both CPA and SVA (Chapter 6). The mechanism of RIL 
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action was investigated by Duprat (et al., 2000) who demonstrated with COS 
transfected with human TREK-1 and TRAAK, that RIL could stimulate whole cell 
currents. They crucially showed that the agonist had a transient effect on TREK-1 
activity as high doses (100µM) of RIL could open the channel which was followed by 
an inhibition of the TREK-1 currents (Fink, Lesage et al., 1998, Duprat, Lesage et al., 
2000). It is also worth noting that this study used 3-100µM of RIL to observe TREK-
1 and TRAAK currents. In our study 1nM-1µM application of RIL produced a 
UHOD[DWLRQ UHVSRQVH RI  ZKich suggests an additional mechanism may be 
responsible for the vasodilatation produced. We also examined the response to RIL in 
the presence of L-NAME which did not alter the relaxation response with CPA 
suggesting the response is endothelium-independent but requires further validation 
with alternatives NO inhibitors or eNOS knockout animal models. In contrast, the 
only inhibition to RIL induced relaxation was seen in the presence of the broad acting 
K+ channel blocker, TEA.  
The blocker 4-AP inhibited the relaxation response but only with the highest 
doses of RIL application. In a similar light, there is also evidence to show that along 
with altering glutamate release, RIL has a non-specific action on ion channels. The 
most recent evidence has shown RIL can alter the channel conductance of O2 
sensitive voltage gated Kv channels (Xu, Enyeart et al., 2001, Xing, Zhang et al., 
2003). Kv are important O2 sensors for the cells and their role in the placenta was 
investigated with placental CPV and CPA (Kiernan, Barrie et al., 2010). This study 
demonstrated a role for KV channels using KV channels openers and showed the most 
significant response was seen in response to openers of the KV1.2 subunit. Crucially 
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we did not observe the same effect with both TEA and 4-AP at 5% pO2 which 
suggests the level of tissue oxygenation may be more important for modulating the 
action of RIL which may target Kv channels (Howard, Hosokawa et al., 1984, Byrne, 
Howard et al., 1997, Cole, Plane et al., 2005, Plane, Johnson et al., 2005). The 
inhibition in the presence of 4-AP was only observed at the highest dose of RIL 
(1µM) and suggests that other candidate K+ channels may also be a target for RIL. 
Alternatively, RIL can bind to imidazoline receptors and such receptors have been 
shown to increase in the placenta with gestational age (Bagamery, Kovacs et al., 
1999). This receptor may be an alternative target for RIL and may help to explain the 
immediate response that is seen with both CPA and SVA and should be explored 
further.   
 
7.5.5. Modulation of the response to H2O2  
 
H2O2 has shown to produce both contractile and relaxation responses in 
various tissues and the biphasic action appears to involve separate mechanisms (Liu, 
Sun et al., 2010).  
7.5.5.1. Modulation of the H2O2 mediated contraction  
 
A small contraction was produced upon H2O2 application however the 
response by CPA was much smaller than the response seen with U46619 suggesting 
that all the SMC were not activated. The effects of H2O2 were abolished by CAT to 
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suggest the contractile activity produced is a direct response to H2O2. Our data 
showing that IBTX could enhance the response to H2O2 has also been reported within 
the literature (Liu, Sun et al., 2010). ROS can alter the movement of Ca2+ from 
internal stores to increase [Ca2+]i (Burton, 2008, Steinert, Wyatt et al., 2009). Ca2+ is 
important for controlling vessel tone and the finding that IBTX can increase the 
response suggests H2O2 can alter Ca2+ movements to evoke a response. However we 
could not investigate the significance of this as the response was too unstable to allow 
for a firm conclusion to be made.  
 
7.5.5.2. Modulation of the H2O2 mediated relaxation  
 
It was also shown that H2O2 could induce a relaxation response in pre-
constricted placental vessels. The mechanism of this action was investigated and the 
response to H2O2 was also inhibited by CAT pre-incubation but crucially this did not 
produce 100% inhibition to suggest that H2O2 may also be having an indirect effect on 
placental vessels to induce a relaxation response and requires further investigation. K+ 
channels represent a diverse ion channel family that have a high selectivity for the 
permeation of K+ ions. The non-specific K+ channel blocker TEA can inhibit a wide 
spectrum of K+ channels (Kaczorowski and Garcia, 1999) and we demonstrated that 
the H2O2 induced vasodilatation was significantly inhibited in the presence of the ion 
channel blocker. An earlier study used patch clamping to observe changes in BKCa 
activity (see Barlow and White, 1998) where porcine coronary artery SMC were 
treated with increasing doses of H2O2 and recordings showed an increase in BKCa 
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opening. This study was followed up by a more recent publication by the same group 
who investigated how this change in ion channel activity was produced (Barlow, El-
Mowafy et al., 2000). They showed that H2O2 could not directly act on the ion 
channel and instead the effect was dependent on phospholipase A(2) activity as 
specific inhibitors of this molecule could abolish the activity seen with BKCa. More 
interestingly the addition of AA could reproduce the changes in BKCa that were seen 
when H2O2 was added to suggest a similar mechanism is triggered. This study 
suggested H2O2 was producing an effect via opening of BKCa channels however we 
were only able to show a significant inhibition to the response in the presence of TEA 
and not IBTX (Barlow and White, 1998, Yang, Zheng et al., 1998).  
The relaxation response to H2O2 was significantly increased in the presence of 
L-NAME. Although this was shown in a small sample group, the result was surprising 
and appears to show that blocking NO will leave the placental vessels more 
vulnerable to the toxic effects of ROS to bring about a significant disruption to the 
control of vessel tone (Gardiner, Compton et al., 1991, Garland, Plane et al., 1995, 
Byrne, Howard et al., 1997). This also suggests that non-NO mediated relaxation 
pathways could be compensating for the loss of NO production. The observation that 
NO inhibition increases the relaxation response could have detrimental effects for the 
widespread control of vessel tone within the placenta and warrants further 
investigations. This also helps to understand why we found that PE-CPA also showed 
an increased sensitivity to H2O2 application (see Chapter 5). The response was 
investigated at 20% pO2 which would already lead to the production of ROS and 
further challenges with a ROS could be overwhelming the limited supply of 
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antioxidants available (Steinert, Wyatt et al., 2009) and it would be interesting to 
investigate the response at lower pO2 settings.  
 
7.5.6. Modulation of the response to acidic pH  
 
The main findings from studies reported in this thesis is that placental vessels 
can respond to acidic pH but only when the vessels had been pre-contracted with 
U46619. The most likely candidates implicated in this response are the acid sensing 
family of ion channels (ASIC). This was then investigated with modulators of Na+ 
transport. H+ ions are removed from the cell via ATP dependent Na+ transporters 
(Canzanelli, Greenblatt et al., 1939, Bishop and Weisfeldt, 1976, Aalkjaer, 1990). 
However OUAB (a Na+/K+ ATPase inhibitor) and the NHE inhibitor OMP along with 
the Na+ channel blocker AMIL failed to demonstrate a significant role for mediating 
the response to an acidic pH stimulus. AMIL is a diuretic that can block a number of 
Na+ channels with little subtype selectivity and the alternatives benzamil which is a 
lipophilic analogue of AMIL or the toxin psalmotoxin-1 (PcTx-1) should also be 
explored (Gitterman, Wilson et al., 2005). Instead, a reduction in the acidic pH 
response when NaCl was replaced with Choline Cl was seen. Removing extracellular 
Na+ by replacing it with Choline Cl should reduce the action of NHE. We found the 
response was indeed significantly attenuated which suggests Na+ ions are potentially 
involved in the recovery from acidic pH insults and could involve the exchange of 
HCO3- ion and requires further investigations.  
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The NO inhibitor L-NAME reduced the response to acidic pH application. 
One explanation for this observation may be due to the fact that NO may promote the 
loss in vessel tone in response to lactic acid application and inhibiting this pathway 
resulted in reduced relaxation response which may have implications for 
understanding the placental control of blood flow (Byrne, Howard et al., 1997, 
Aaronson, Sarwar et al., 2006, Holzer, 2009). The pH response at 20% pO2 was 
significantly inhibited and this was seen as a reduction in the recovery response 
(phase II) following a pH insult. This suggests that NO may have a role in recovery of 
vessel function (Myatt, Brewer et al., 1992, Jovanovic, Grbovic et al., 1994a, 
Kostrzewska, Modzelewska et al., 2008). L-NAME inhibits endothelial production of 
NO, yet the response to acidic pH was not completely abolished, which suggests that 
NO can still be produced from cell layers other than the EC such as SMC within the 
placental vessels. It also suggests that non NO mediated vasodilators such as EDHF 
and/or PGI2 could have a role to play (Jovanovic, Grbovic et al., 1994b, Byrne, 
Howard et al., 1997, Kublickiene, Kublickas et al., 1997).  
Pre-treatment with NIFED enhanced the response pH in 20% pO2. One 
explanation for this may be linked to the reduced contraction response to U46619 
produced in the presence of NIFED to limit the activation of the SMC. This makes it 
difficult to interpret the responses as the relaxation capacity is severely reduced. The 
XVHRIDQDOWHUQDWLYHFRQWUDFWLOHDJHQWVXFKDV3*)ĮVKRXOGEHinvestigated as it has 
been shown that vessels pre-treated with NIFED can still response to the agonist 
(Allen, Andersson et al., 1991). CPA could still produce a transient response upon 
stimulation with lactic acid in the presence of NIFED to suggest that NIFED 
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insensitive Ca2+ channels may still have an influence on placental arteries and Ca2+ 
channels maybe a target for metabolic stress.  
The lack of response to acidic pH in the presence of GLB was unexpected as 
KATP channels are important metabolic sensors. This can be explained by a recent 
communication that demonstrated that GLB was ineffective under acidic conditions 
(Lu, Gao et al., 2007). Sodium cyanide (NaCN) was used to induce metabolic stress in 
adult male guinea pig ventricular cells and the [pH]i was reported to rapidly declined. 
The authors showed that GLB could not alter the currents induced by NaCN. 
However activating NO production with L-arginine could enhance the currents seen 
in the presence of NaCN to implicate a role for NO in this response.  
A role for SKCa channels was demonstrated as the inhibitor APA enhanced the 
relaxation response with acidic pH at 5% pO2. At low pO2 K+ channels would be 
expected to be closed favouring an increase in vessel tone opposing relaxation. The 
SKCa and IKCa channels have been implicated to have a role in EDHF which is a 
compensatory mechanism that can replace NO function to help vessels recover tone. 
The ion channels are central to perceiving the stimulus such as shear stress to alter the 
EC membrane potential. The change in membrane potential will alter Ca2+ 
homeostasis and release Ca2+ from intracellular stores. The increase in Ca2+ is 
necessary for the release of diffusible vasodilator substances from the EC which 
evoke effects on the SMC to bring about relaxation. The spike in Ca2+ is essential for 
the release of NO and/or EDHF and therefore the inhibition of K+ channels is needed 
to maintain the [Ca2+]i. (Lopez-Barneo, Pardal et al., 1999, Cipolla, Smith et al., 2009)  
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The TREK-1 inhibitor CURC produced a significant inhibition to the response 
with an increase in tone oscillations. CURC is an anti-proliferative agent that can 
block actions of TREK-1 and also has important anti-oxidant properties. The 
inhibition by CURC was not seen at 5% pO2 and instead matched the response for 
CPA that were untreated. This suggests that CURC can provide antioxidant protection 
and may be a potential treatment for protecting placental vessels from oxidative 
stress. CURC increased tone oscillations to suggest vessel activity is being altered 
with loss of TREK-1 channel activity, so that hyperpolarisation and excitability are 
altered. L-METH is an amino acid based molecule that has been shown to inhibit 
TREK-1 currents (Baker, Hennig et al., 2008). Application of the inhibitor of TREK 
produced an increase in the relaxation response both in 20% and 5% pO2. TREK-1 is 
inhibited by [pH]i  and the enhanced response to acidic pH in the presence of L-
METH suggests the cell has lost the ability to detect the fall in pH to allow the loss in 
tone (phase I) to go unchecked (Buckler and Honore, 2005, Baker, Hennig et al., 
2008, Beckett, Han et al., 2008). In this instance L-METH was shown to block the 
response by bladder SMC to stretch. D-Methionine, which is the inactive form of the 
molecule, could not produce the effects seen and suggests the stretch sensitive TREK-
1 is modulated by L-METH. In a similar way, TREK-1 may also function to detect 
stretch in the vessel and trigger a relaxation response. However low pH conditions can 
also alter the ion channel conformation which makes investigating the role of 
inhibitors difficult to interpret. L-METH may be facilitating this action, or altering the 
ion channels sensitivity to pH and requires more evidence to support this prediction.  
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The response seen with acidic pH implicates a role for TASK channels which 
are inhibited by low [pH]o. Inhibition would prevent a K+ efflux and result in cell 
depolarisation and under acidic conditions to lead to constriction in vascular tissue. 
The depolarisation would also allow Ca2+ to enter (possibly via CaV1.2) the cell 
unopposed. However we observed that the relaxation response was produced by both 
CPA and SVA with low pH environments.  
 We further observed that pre-treatment with both CuCl2 and ZnCl2 could not 
inhibit the relaxation response triggered by low pH as the vessel could still relax but 
crucially we demonstrated that the increase in vessel tone (Phase II) seen immediately 
after the pH stimulus was blunted by both CuCl2 and to a greater extent with ZnCl2. 
This was seen at both 20% and the physiologically significant pO2 of 5%. The 
effectiveness of TASK channel inhibitors was demonstrated with adult rat pulmonary 
artery preparations. Shah (2008) examined the response of rat pulmonary arteries in 
response to the main TASK inhibitors BUP and ZnCl2. It was demonstrated that the 
baseline tension of the ring preparations increased upon inhibition of TASK channels 
by BUP and M.ANAN while application of 100µM of ZnCl2 did not alter vessel 
tension. Furthermore this increase in tension was most likely via Ca2+ entry as pre-
treatment with NIFED could abolish this small contraction. Electrophysiological 
recordings of such channels has shown that application of 100-200µM of ZnCl2 can 
reduce TASK currents by 50% (Gruss, Mathie et al., 2004). We used this 
concentration as a starting point and also found no change in the baseline response of 
CPA and opted to use the higher dose of 1mM in order to inhibit a significant number 
of TASK channels so to observe any effect on isolated arteries. Consistent with our 
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findings, Shah (2008) also showed the vessels constricted in response to alkaline pH 
conditions and relaxed in response to acidic pH. This finding suggests that acidic pH 
may in turn open TASK channels or alternatively activate another pH sensitive ion 
channel to cause the hyperpolarisation seen (Gurney, Osipenko et al., 2003, Gardener, 
Johnson et al., 2004). However in the study by Shah (2008), the vessels could no 
longer respond to both BUP and M.ANAN which does suggest that low pH does 
inhibit TASK channels to prevent a further K+ efflux. M.ANAN has multiple actions 
and can also inhibit the endocannabinoid receptors CB1 and CB2, thus the 
significance of this observation is also limited. The observation that low pH can 
induce a loss in vessel tone and secondly oppose the contraction in response to BUP 
appears to show that low pH could be altering the gating properties of TASK channel 
currents.  
The response to ZnCl2 can also be considered by the effects the trace element 
has on Ca2+ channel currents. ZnCl2 can inhibit the entry of Ca2+ into the cell 
(Busselberg, Michael et al., 1992) and may explain why we observed a blunting of the 
contraction that proceeds the initial relaxation. CuCl2 and ZnCl2 enhanced the 
response to pH at both 20% and 5% pO2 while NaCl2 did not alter the response so we 
can be confident that the response observed was due to actions of Zn2+ and Cu2+ ions. 
Zn2+ is present in low concentration within the ECM at 15µM and most is bound with 
proteins. In diseased states this can rise to 600µM. Ischaemia is an important 
modulator of Zn2+ levels and an increase in free unbound Zn2+ can alter neuronal 
excitability (Mathie, Sutton et al., 2006). Zn2+ can inhibit Ca2+ and Na+ channel 
currents along with TASK-1 to alter neurotransmitter release. The potency for TASK-
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1 makes Zn2+ a useful pharmacological tool for distinguishing TASK-1 from TASK-3 
currents (Goldstein, Bayliss et al., 2005). Cu2+ binds K2P channels with a high 
affinity and can bind to cysteine, histidine, or glutamate residues which can lead to 
dissociation between disulphide bridges which in the K2P example hold the pore 
forming domains in place. It can also cause indirect effects by altering the cells redox 
state and generate free radicals. Gruss (et al., 2004) examined the role of both trace 
elements in modulating HEK-293 cells stably transfected with human TREK-1 and 
TASK-3. It was shown that Cu2+ activated TREK-1 while an inhibition was seen with 
TASK-3. In addition Zn2+ can inhibit TASK-3 at a lower doses when compared to the 
inhibition seen with TREK-1. This provides a method for differentially blocking 
specific K2P channels and more importantly we used 1mM to observe an effect that 
may have been inhibiting both TREK and TASK channel currents.  
 
7.5.7. Future research   
 
This study can be extended by examining the response of SVA in the presence 
of each ion channel blocker to observe any potential variations that may exist. 
However to do this we need to address some issues with the methodology used in this 
study. The improvements to the wire myography method used have been highlighted 
in Chapter 5.8.7. However we can also identify key avenues for future research 
related to this chapter. The main limitation with our study is that the dose range for 
both pH and H2O2 go beyond physiological concentrations that would be found in 
vivo. Although this has the advantage of demonstrating the responses to chronic stress 
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the concentration used may be too severe and may have masked the true role of each 
ion channel in mediating this response. 
The work presented in this thesis was greatly hampered by the lack of 
specific ion channel antagonists particularly for the K2P channels. The trace elements 
used such as Zn+ and Cu+ have high affinities for TASK and TREK channel currents 
along with a range of voltage dependent ion channels (Gruss, Mathie et al., 2004, 
Mathie, Sutton et al., 2006). As a result we may have been observing the effects of 
blocking more than one ion channel. This can give unpredictable results and we may 
instead be observing some indirect effects of the blockers used. An alternative method 
could be the use of antibodies that can bind to the pore forming region of each ion 
channel. This approach has been demonstrated with the anti Kv1.5 antibody which 
binds to the C terminal domain (amino acid 542-602) close to the pore forming region 
of the ion channel. Another alternative is to use small interfering RNA (siRNA) 
knockdowns or antisense oligodeoxynucleotides in cultured EC and SMC  
preparations, which have successfully been used to inhibit significant levels of TASK 
currents (Hartness, Lewis et al., 2001). There is also a need to investigate the role of 
combining ion channel inhibitors to investigate any cross talk. This is particularly 
important for TASK and TREK channels which been have shown to co-localise in 
SMC (Xian Tao, Dyachenko et al., 2006) and inhibition of one ion channel may be 
compensated by the second accessory ion channel. This would also allow us to use 
lower concentrations of different inhibitors and observe responses that may be more 
physiologically relevant.  
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A wide range of ion channel inhibitors were applied often at high doses in 
order to block sufficient ion channel proteins, and observe an effect in CPA. An 
alternative could be to partially depolarise the cell membrane with a small dose of 
KPSS (10mM) to alter the electrochemical gradient of the cell and alter K+ 
movements. This would allow us to apply lower doses of the drug although this may 
introduce unwanted secondary effects on the vessel responses as the K+ balance of the 
cells at rest has been altered but is worth exploring. Some interesting responses were 
observed in the presence of L-NAME, which is an inhibitor of NO release. However 
we could not demonstrate a significant inhibition to the vasodilatation with ACh 
(Chapter 5.5.2.1) which suggests that L-NAME may be exerting other indirect effects 
on the vessels. As an alternative, methylene blue (MB), which inhibits guanylate 
cyclase to prevent the formation of NO, should be investigated, along with 
endothelium-denuded vessel preparations. MB has shown to be better at giving long 
term inhibition of endothelium-dependent relaxation responses and could be a better 
alternative to L-NAME (Griffith and Kilbourn, 1996). Another alternative is L-NNA 
or the cyclooxygenase (COX) inhibitor indomethacin which blocks PGI2 mediated 
responses which could be used in combination with NO blockers. Finally, we should 
also investigate the response of stripped placental vessels, where the EC is 
mechanically removed, to better dissect the roles of EC and SMC in isolation. An 
eNOS gene knockout animal models could be utilised to reveal invaluable 
information as to the role the EC plays in the physiological responses observed in this 
study. We also found evidence to suggest NO may act on the SMC directly to trigger 
a response and this could be further investigated with the NO activator-L-arginine 
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(Gardiner, Compton et al., 1991, King, Gude et al., 1995, Sabry, Mondon et al., 
1995b).  
 
7.5.8. Conclusion  
 
Ion channel modulators (both openers and inhibitors) are useful diagnostic 
tools for determining the role and function each ion channel plays in controlling 
vessel function. We have provided evidence for the involvement of K2P channels in 
the response to stress in placental vessels which supports our hypothesis. Response to 
acidic pH will activate a number of proton sensing ion channels and we have detected 
the presence of a number of K2P channel members in the placental blood vessels 
which may have a role in generating a response across the pH range. A difference in 
the ability of separate blockers to alter the different stages of the response helped to 
dissect out the two phase response and our findings implicate a role for other potential 
pH sensing ion channels. The study hypothesis is partly supported and evidence is 
provided to suggest that compensatory mechanisms may exist in the placental 
vasculature to facilitate the response to acidic pH stress and such candidate ion 
channels will be discussed in Chapter 8. The development of better pharmacological 
tools to allow the study of ion channel inhibition would help us to understand the true 
significance of our findings.  
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8. Discussion 
  
The placenta forms the main barrier between the maternal and fetal 
circulations where it serves to ensure the fetal nutrient and O2 supply. When the 
normal function of the placenta is perturbed, placental insufficiency may result and is 
an underlying factor for many pregnancy related disorders. The absence of an 
effective therapy to improve reduced placental blood flow is due to the poor 
understanding of the underlying mechanisms that regulate placental vascular function. 
The vasoactive responses of resistance arteries from the fetal and maternal interface of 
the placenta were investigated by this study. The work from this thesis has identified 
the presence of a number of important ion channels, and using wire myography, have 
determined the potential role of these ion channels in mediating the response to stress 
encountered in vivo, particularly pH.  
The arteries used in this study represent the main sites of resistance within the 
placental tissue. Previous studies have shown that these vessels do not readily respond 
to a number of agonists (McCarthy, Woolfson et al., 1994, Poston, McCarthy et al., 
1995) which presents a unique challenge in the study of the placental circulation 
which is devoid of neuronal connection. Knowledge of the physiological responses 
from normal healthy samples is an essential prerequisite for understanding PE and 
fetal growth restriction which are linked with impaired vascular perfusion. The key 
observations, that firstly the BKCa opener NS1619 and secondly the TREK-1 
modulator RIL could both produce a potent relaxation response that was greater that 
SNP induced relaxation may have far reaching implications. This implicates a role for 
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K+ channels in particular, in regulating the vascular function of the placenta. This 
study also provided the first evidence to show that RIL can relax both CPA and SVA 
which produced the highest level of relaxation when compared with other 
vasodilators. This important finding implicates a role for RIL in treating hypertensive 
related conditions in pregnancy that can alter the vasodilatation of the placenta. In 
further support of this we were also able to demonstrate that PE CPA could also 
respond to RIL stimulation with a similar efficacy. RIL could be an important future 
pharmacological target for treating increased contractile activity of placental vessels 
associated with conditions such as PE and IUGR. Further work is needed to better 
understand the precise mechanism of RIL action.  
The key findings presented in this thesis include:  
x The examination of key structural differences in the vessel cross sectional areas 
between the SVA and CPA, which represent the maternal and fetal portions of the 
placenta. 
x The demonstration that the pO2 of the perfusate was the most influential factor 
governing the contraction and relaxation responses of CPA and SVA. 
x The matched expression profiles of key O2 sensing and pH sensitive ion channels 
across CPA and SVA as demonstrated by confocal IF and Western blotting 
analysis. 
x Pharmacological investigations with CPA revealed a potential role for key proton 
sensing ion channels in mediating the response to stress which requires further 
exploration. 
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x Analysis of responses from PE samples highlighted some significant differences 
in ion channel expression, specifically TWIK-2, and response to H2O2 and acidic 
pH stress, and provides a basis for future work.  
 
8.1. Comparing placental vessels  
 
The main limitation in detecting adverse placental effects is that the 
fetomaternal circulation within the placenta cannot be assessed in situ. The study of 
isolated placental tissue has advanced our understanding of the placental autonomic 
control of blood flow. Blood vessels obtained at term were compared, namely the 
CPA and the SVA. The main technique used in this study was wire myography which 
allowed for a detailed characterisation of the vessel properties ranging from the ideal 
resting diameter to optimal contractile agent. The structural arrangement of the 
vessels revealed that the placental vasculature is highly differentiated and the 
differences that we observed with the contractile ability of CPA and SVA may be 
reflective of the temporal and spatial differences that exist in the flow of blood 
throughout the placenta. The most influential factor was shown to be the pO2 that was 
used to perfuse the isolated vessel segments. The results presented in this study reveal 
more about the normal working of the placenta in response to relative hyperoxia 
(20%), normoxia (5%) and hypoxia (2%). The main difference was seen with the 
contractile responses. SVA generated a lower constriction than the CPA in 20% pO2, 
but this contractile ability could be increased when the pO2 was lowered. One 
explanation for this reduced contractility may be that the lower population of SMC 
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within the thin walled SVA however the responses could almost match the CPA at 
low pO2 which suggests that alternative contractile agents should also be investigated. 
We also observed how a small change in the SNP concentration produced a very steep 
relaxation response. This latter observation is physiologically relevant, and suggests a 
key threshold was reached to activate all the relaxation capacity of the vessels. Each 
vessel also showed the ability to respond to changes in the extracellular environment 
and it was shown that the ROS, H2O2, could induce a permanent inhibition of the 
contractile activity of the blood vessels. We have provided further evidence to support 
the view that placental vessels should be studied at physiological pO2, stretch and 
flow conditions to better reflect the responses that would occur in vivo. 
The CPA are a continuum of the SVA and we found that the expression profile 
of key K+ channels showed comparable expression across the two vascular beds. This 
further helps to understand how both the CPA and SVA could generate similar 
responses to the same stimuli which was most evident when vessels were treated with 
H2O2 and changing pH conditions. It may also be possible to predict the effects 
certain blockers would have when used with SVA based on our CPA observations and 
is the important future step for advancing this study. The placenta is a rich source of a 
range of proteins and most ion channels will be expressed within the tissue. However 
there is a need to develop a more detailed expression profile at the SMC and EC level. 
The SMC IF staining has revealed some important information about how blood flow 
may be regulated across the placenta. Expression of the K2P channels within the 
placental vessels provides evidence for a potential role in the efficient exchange of 
nutrients across the placental transport system. This information can reveal new 
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insights into how the placenta can control and respond to changes within its 
microenvironment. Positive expression was shown for a number of key K2P channels 
along with the BKCa and KATP channel within healthy placental vessels. We were then 
also able to compare this data with that of mild PE cases and compile a detailed 
breakdown of each ion channel and its expression levels. The precise nature of the 
different K+ channel expressed within a tissue reveals details on how the tissue can 
bring about a response. More importantly this provides researchers information on 
how to modulate the tissue activity when targeting disease pathways such as PE. 
By comparing the responses of CPA and SVA we have been able to gain an 
important insight with regards to the control of blood flow within the placental 
vasculature. The placenta can divert blood flow to well perfused areas similar to that 
observed in the pulmonary circulations. Hampl (et al., 2002) has demonstrated the 
existence of HFPV that was significant in small resistance sized placental vessels. The 
redirection may help to improve tissue perfusion and is specific to resistance sized 
vessels (Hampl, Bibova et al., 2002, Hampl and Jakoubek, 2009). This also has 
similarities to the response seen with acidic pH and a change in vessel diameter would 
help to buffer the blood and remove excess H+ ions. Relaxation to pH response will 
reduce blood flow to allow to exchange and exchange the excess H+ ions. This will 
limit the damage of H+ exposure to spread to better ventilated areas. The resulting 
contraction that follows may help to regain normal blood flow, so that the disruption 
is not prolonged for longer than necessary. The excess in H+ concentration could alter 
the function of maternal SA which are in close contact with placental vessels at the 
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SVA junction. A crucial next step to take this study further would be to examine the 
response to such stress by the maternal SA.  
 
8.2. Importance of pH in other systems 
 
The placental vessels examined in our study demonstrated the presence of a 
fine control mechanism that can alter the vessel tone to induce a contraction in 
alkaline conditions and a relaxation with acidic pH. Important parallels can also be 
made with the regulation of pH within other tissues. A recent publication 
demonstrated the spatial removal of H+ from rat neonate cardiac myocytes involved 
cellular gap junctions which are highly permeable to H+ and was dependent on the 
CO2/HCO3- buffering capacity of the cell (Swietach, Camelliti et al., 2010). In 
addition cells also have Cl-/HCO3- and Cl-/OH- exchangers which determine the 
overall acid load of the cell and are responsible for responding to high concentrations 
of H+. The influx and efflux of H+ ions is rapid and under normal conditions the H+ 
content is maintained low. 
Acidosis within a tissue may be caused by inflammation, ischaemia or 
defective pH homeostasis, microbial acidity, or malignant tumours. Many pH sensors 
have been identified and are continuing to help understand disease processes (Holzer, 
2009, Vaughan-Jones, Spitzer et al., 2009). The most important role for pH sensors 
has been shown in the perception of pain and inflammation which can trigger a reflex 
response. Acidic pH will trigger mechanosensitive afferent neurons to cause 
sensitisation to the noxious stimulus (Holzer, 2004). Maintaining the pH within a 
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narrow range is of paramount importance for normal cellular functions including the 
control of vascular tone. Sensory neurons have a spectrum of acid sensing ion 
channels that respond to a range of noxious stimuli including pH to trigger an 
autonomic reflex, sensation, pain and inflammation. The autonomic response is 
mainly initiated by ion channels which have been implicated in the range of 
physiological and pathophysiolgical conditions (Bevan and Yeats, 1991, Gardener, 
Johnson et al., 2004, Holzer, 2009).  
The ion channels implicated in the pH response have shown to be tissue 
specific and reflect the different processes of the body (Chapter 8.4). The closest 
parallel with the placenta is the pulmonary system which also carries deoxygenated 
blood in the arteries. H+ accumulation has been identified as the main stimulus for 
coughing reflex. The pulmonary circulations shows evidence of both rapid and slow 
inactivation currents of afferent neurons that supply the lung tissues. Pulmonary SMC 
responses to acidic pH load have shown the ability to induce a relaxation response 
similar to what we observed in the placenta (Gurney, Osipenko et al., 2003, Gardener, 
Johnson et al., 2004, Shah, 2008). The stomach has a pH of 1 mainly due to the 
presence of HCl. The acid load is kept separate from other cells due to tightly 
regulated compartmentalisation and a strong mucosal barrier. The leak of fluids is a 
major risk factor in the onset of peptic ulcers. The H+/K+ATPase actively increase the 
H+ concentration within the stomach. The cells of the gastrointestinal tract are highly 
specialised to cope with HCl, a factor that is often overlooked by other research 
groups who expose a range of tissue to HCl to lower the pH content of cell (Bevan 
and Yeats, 1991). The urogenital tract can also cope with acidic pH environments in 
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the form of uric acid. The pathology of irritable bowel syndrome has been linked with 
a dysfunction in the uroepithelial barrier and bladder hyperactivity. The mechanism 
involved leads to a heightened sensitivity to acidic pH stimulus and treatment with 
capsaicin can reverse this (Bevan and Yeats, 1991, Holzer, 2009).  
 The high energy demanding cardiac muscle has provided an important insight 
into how pH regulation can alter under stress conditions. The most important 
determinant of pH homeostasis is the cells metabolic status and the cardiac myocytes 
can maintain an internal pH of 7.2 under normal conditions and small reductions in 
this can cause a reduction in contraction that is normalised within seconds and this has 
been attributed to the rapid movement of H+ across the membrane boundaries and the 
role of H+ transporters (Bevan and Yeats, 1991, Vaughan-Jones, Spitzer et al., 2009, 
Swietach, Camelliti et al., 2010). All of these separate examples highlight the range of 
strategies that are employed to deal with pH changes which the placenta is also a part 
of.  
 
8.3. The biphasic response to acidic pH 
 
The most important observation from our study was the transient, short lived 
response to acidic pH that was seen with CPA and SVA. Low pH has been reported to 
induce depolarisation while increasing pH will favour hyperpolarisation of the cell 
membrane (Bevan and Yeats, 1991). However we showed that low pH induced a two 
stage relaxation response as the contractile response could be recovered. One possible 
explanation for the biphasic response can be explained by the modulation of Na+/Ca2+ 
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homeostasis by extracellular and intracellular pH. The close association with pH 
balance and Ca2+ helps to explain how a change in the vascular tone can be produced 
in response to pH changes. The H+ load in pre-constricted vessels may trigger the 
entry of Na+ via the NHE to restore the normal cellular pH balance. Once this 
equilibrium has been restored, the excess Na+ are then pumped out of the cell via the 
Na+/Ca2+ exchanger to cause the phase II contraction (Figure 8.3-1). This also 
implicates a role for TREK-1 which is inhibited by acidic pH environments inside the 
cell while TASK is an extracellular pH specialist. Inhibiting each of these ion 
channels enhanced the relaxation response and suggests that a compensatory 
mechanism may exist that activates an alternative proton sensing ion channel in the 
absence of TASK currents. The initial loss in tone seen may be due Na+ moving down 
is electrochemical gradient to remove the H+ ions from the cell. As the [H+]i is 
restored to basal levels, the TREK-1 which may detect a change in cell stretch, may in 
turn initiate the recovery in vessel tone and to trigger an efflux of Na+ out of the cell, 
which may allow Ca2+ to enter and cause the slower contraction as part of the phase II 
response. This may also involve other candidate proton sensing ion channels. 
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Figure 8.3-1 shows the proposed mechanism that may bring about the biphasic response 
to acidic pH in placental vessels The H+ load causes an immediate relaxation and excess H+ 
is removed from the cells via the NHE. Once the H+ has been buffered we see a net efflux Na+ 
via the Na+/Ca2+ transporter. This would cause membrane depolarisation and as a result 
trigger the switch over to the contraction phase (phase II). TREK-1 may have a role in 
detecting the pH change to shift the balance from phase I to the contractile phase II. This may 
also explain why the relaxation was prolonged with TREK-1 currents were blocked with L-
METH.  
 
8.4. Proton sensing ion channels  
 
The pH balance of a tissue needs to be maintained within a narrow range. The 
fast acting nature of the response to acidic pH stimuli implicates the involvement of 
acid sensitive ion channels. Our studies showed that inhibition of the acid sensitive 
K2P channels TREK-1 and TASK-1/3 could modulate the response to acidic pH. 
However we failed to show a complete inhibition of the CPA response to low pH 
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which suggests other pH sensitive ion channels may also have a role in controlling the 
placental vessel response to extracellular pH changes. The four main types are the 
ASICs, K2P, TRP and the P2X family of ion channels which have been widely 
studies while the Kir, Kv and CaV1.2 have also been implicated in responding to mild 
changes with pH (see Table 8.4-1).  
Evidence from skeletal muscle has shown that the ion channels can evoke a 
biphasic response. It was reported that the human skeletal muscle cell line SJ-RH30 
were rapidly depolarised when the pH was reduced to pH 6.5 with immediate fast 
acting ASICs currents (Gitterman, Wilson et al., 2005). The authors reported a 
desensitisation and re-sensitisation cycle with further stimulation. This response was 
both dose and time-dependent as increasing the time interval between pH challenges 
reduced the amplitude of the rapid inward current observed with a change from pH 
7.4 to pH 6.5. Furthermore this was inhibited by AMIL (84%) and the more potent 
blocker PcTx-1 (91%) implicating a role for ASICs. The biphasic response seen could 
also have similar parallels with our observations with placental vessel which produced 
a repeated relaxation-contraction cycle when stimulated directly with lactic acid. It 
would be interesting to observe the responses in the presence of PcTx-1 which 
appears to produce a more potent inhibition to the ion channel activations.  
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Table 8.4-1 listing the main ion channels that have been implicated with pH evoked currents.   
Ion channel family Subunits Key references 
Acid sensitive ion 
channels (ASICs) 
ASIC1a, ASIC2a, 
ASIC1b, and ASIC3.  
(Stephan and Agnew, 1991, 
Gitterman, Wilson et al., 2005) 
Transient receptor 
potential (TRP) 
TRPV1, TRPV4, TRPC4, 
TRPC5, and TRPP2.  
(Waldmann, 2001, Dhaka, 
Uzzell et al., 2009) 
K2P TALK, TASK-1, TASK-2, 
TASK-3, TWIK-1, 
TALK-2, and TRESK.  
(Lesage, 2003, Richter, 
Dvoryanchikov et al., 2004, 
Bai, Greenwood et al., 2005, 
Wareing, Bai et al., 2006) 
Proton sensing G 
protein coupled 
receptors 
OGR1, GPR4, G2A, and 
TDAG8.  
(Holzer, 2009, Swietach, 
Camelliti et al., 2010) 
Voltage dependent ion 
channels 
Kv1.3, Kv1.4, Kv11.1, 
CaV1.2, and TTX sensitive 
Na+ channels 
(Perney and Kaczmarek, 1991, 
Stephan and Agnew, 1991, 
Williams, Fyfe et al., 2008, 
Vaughan-Jones, Spitzer et al., 
2009, Kiernan, Barrie et al., 
2010) 
Ligand gated ion 
channels  
P2x1-5, P2x7, and 
GABAA.  
(Valera, Hussy et al., 1994, 
Burnstock, 2000, Lee, Bardini 
et al., 2000, Dixon, Yu et al., 
2004, Roberts, Greenwood et 
al., 2006, Warren, Harvey et 
al., 2008) 
Other ion channels Cl- channels, gap junction 
ion channels (connexins), 
hyperpolarisation 
activated cyclic nucleotide 
gated channels and 
epithelial Na+ channels 
(ENaC) 
(Kulanthaivel, Furesz et al., 
1992, Drummond, Welsh et al., 
2001, Bhalla and Hallows, 
2008, Holzer, 2009)  
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8.5. The placenta as a diagnostic tool   
 
The finding that tissue oxygenation and pH can alter vascular function of the 
placenta may have far reaching consequences for the fetus. The fetus is at risk of 
exposure to reduced perfusion occurring in the placenta. Early stress and a failure of 
maternal SA to adapt to pregnancy will place more demand on the placental perfusion 
system to prolong the stress exerted on the vulnerable vessels (van Laar, Peters et al., 
2010). This can alter the fetal programming in the long term as gene expression may 
change and emphasises the need for an adequately performing placenta in pregnancy 
(Jansson and Powell, 2007, Goldenberg, Culhane et al., 2008, van Laar, Peters et al., 
2010). In support of this, changes to maternal nutrition during pregnancy can alter the 
glucose metabolism of the placenta to alter the expression of key glucose transporters 
within the placental membranes (Settle, Sibley et al., 2006, Jansson and Powell, 
2007). Importantly, the fetus is receptive to changes in the intrauterine environment to 
adapt to the post natal environments. The development plasticity of the hypothalamic 
pituitary adrenal axis requires vital signals at key points of development to determine 
the structure and function of cells within each organ system.  
This also makes the placenta an important diagnostic tool for detecting fetal 
stress early on (Pardi, Cetin et al., 1993). The careful monitoring of blood pH during 
labour is crucial for limiting the spread of fetal stress and is used as a basis for 
determining the intervention strategies that commonly result in an emergency LLSCS 
(Jansson and Powell, 2007, van Laar, Peters et al., 2010). In a similar way, the 
maternal blood pH could be monitored in future to help evaluate the severity and 
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duration of any potential risk to the fetus across the duration of pregnancy. This study 
has demonstrated that blood vessels from healthy pregnancies could respond to 
altered pH environments and crucially this response appears to be altered in PE 
vessels. This response may be a reflection of the intrauterine environment whereby 
the placenta can alter its ion channel expression profile to increase its sensitivity to pH 
stress and may be an important observation.   
 
8.6. Future research  
 
The individual methods used in this study have been validated in Chapters 4-7. 
However we can also identify some important new directions to further advance this 
body of work.  
1. This study focused on resistance arteries within the placenta and the next priority 
should be the placental veins which carry the oxygenated blood. In addition the 
placenta cannot be studied in isolation and information gained from vessels 
within the maternal MYO will provide an insight into the adaptations of the 
maternal circulation in response to hypoxia and pH insults. The placental needs to 
modify its own perfusion rate in order to match the blood flow of the maternal 
circulation and it would be interesting to observe the response of MYO vessels to 
changing conditions.   
2. The level of pO2 was varied by altering the gas mixture that was used to 
continually perfuse the myograph chambers. However we should also monitor the 
dissolved content of O2 within the saline with an O2 probe (such as mini Clarke 
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style electrode). This could allow us to quantify the O2 consumption by recorded 
the O2 input and output. We should also consider altering the level of tissue 
oxygenation within the same experiment to observe the response when pO2 is 
lowered from 20% to 5% and 2%.   
3. The pO2 was an important factor in determining the vessel responses to various 
stimuli while pCO2 was constant at 5% in each experiment. Under reduced 
perfusion conditions when pO2 is low pCO2 will rise and this can contribute to 
low pH environments. We should also explore this by altering the pCO2 levels 
when perfusing CPA and SVA in wire myography preparations and for use in 
SMC cell culture.  
4. The level of tissue damage following stress insults (H2O2 and low pH) should 
also be assessed by utilising IHC to identify markers for lipid peroxidation. This 
method has the further benefit that transverse sectioned vessels can be used to 
identify precisely which cells are targeted by ROS. This will also gives idea of 
the tissue redox state as the response to oxidative stress is dependent on the 
availability of antioxidants within the tissue. We could also measure 
mitochondrial activity which is more reflective of tissue viability (MTT assay for 
fixed tissue or Rhodamine 123 for viable tissue) to investigate the mechanism for 
the apparent H2O2 induced toxicity in CPA and SVA. In relation to this, Western 
blot analysis should be performed on vessels used for wire myography based 
studies. We could examine the expression of O2 sensitive ion channels when 
vessels have been exposed to low pO2 and H2O2 stress.  
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5. The role of other metabolic inhibitors should be explored, such as NaCN or DNP 
which can inhibit metabolic activity and rapidly deplete ATP stores to cause the 
intracellular pH to fall. Similarly the effects of other ROS agents should be 
examined, including Xanthine oxidase and its inhibitor Xanthine dehydrogenase 
which are released following hypoxic injury and found in high levels in the 
placental circulation (Mills, Wareing et al., 2009).   
6. Ca2+ is important for mediating the cell excitability and we can investigate the 
role of Ca2+ movements in response to different stimuli. We also need to separate 
the role of extracellular and intracellular stores of Ca2+ which can be addressed 
by removing Ca2+ from the PSS while internal Ca2+ stores can be depleted with 
thapsigargin. Another method that allows for the monitoring of Ca2+ movements 
is confocal myography. Wire myography provides information about the force 
generated by the vessel while confocal myography allows for the incorporation of 
fluorescent markers to monitor the movement of ions such as Ca2+ (with inositol 
trisphosphate (IP3) or Fura PE-3) (see Drummond and Tuft, 1999) as well as H+ 
ions using pH dyes (carboxyl SNARF) along with ROS molecules. The 
monitoring of Ca2+ can also help us to determine if the tone oscillations that we 
observed were caused by movements of Ca2+. We can also assess the 
effectiveness of various blockers applied by comparing the Ca2+ spikes to gain 
temporal and spatial data pre and post incubation with the applied drugs.  
7. The functional studies were severely hampered by the 20mins window for tissue 
collection and as a result a large number of samples were excluded from our 
studies. This is due to the fact that placental ATP levels have been reported to 
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reduce by 75% beyond this time point. One way to address this issue may be with 
the overnight storage of the whole placenta at 37ºC to help recover ATP stores 
and improve tissue survival. Wareing (et al., 2011) have shown evidence to 
suggest that isolated placental CPA and CPV can remain viable for 48h (personal 
communication) This may help to improve the isolation and longevity of SVA 
which had the most variable tissue survival rate, however a previous study 
provided evidence to show the vessel contractility to KCl was diminished in 
vessels stored at 4ÛC overnight while fresh vessels gave the most reproducible 
contractions (Abad, Estan et al., 2003). During this study, we limited our 
LQYHVWLJDWLRQVWRKUVDVPLWRFKRQGULDODFWLYLW\FDQRQO\EHPDLQWDLQHGIRU-
12hrs. To improve this we could also consider increasing the glucose 
concentration of PSS. However raising glucose levels can alter the pH of PSS and 
more importantly could alter the metabolic rate of the tissue to introduce 
oxidative stress. A further modification we could make is to alter the method used 
to dissect the vessels. In our study we dissected the vessels in an ambient 
environment and this may have introduced oxidative stress as the tissue was not 
continually perfused. Furthermore once the vessel is mounted it was then 
perfused with constant O2 and this reperfusion will also add to the oxidative 
stress insult. One solution would be to conduct the dissection in biological safety 
cabinet perfused with 5% O2 to match normoxic conditions found within the 
placenta.  
8. The most significant change we can make is to move on to studying single cells 
from the placental vasculature to dissect the roles of the EC from SMC using 
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cultured cells and single cell microfluorimetry. We should consider altering the 
cell culture conditions with respect to the pO2/pCO2 levels that are used to grow 
the freshly isolated SMC, as growing cultures under relative hyperoxia (95% 
air/5%CO2 mixture) could indirectly alter O2 sensitive ion channels. The wire 
myography data has shown that 5% pO2 is a good reflection of the physiological 
growth conditions for the placental vessels, and the same settings should be 
applied to minimise the risk of altering ion channel expression under different 
pO2 environments.  
9. We can also use electrophysiology to study single cell responses with the patch 
clamp technique of the whole cell to gain information about the conductance of a 
single ion channel (Khan, Smith et al., 1993). This allows for the monitoring of 
action potentials in more detail and crucially to observe the intracellular and 
extracellular movements of ions across the cell membrane. Patch clamping also 
enables the internal cellular environment to be controlled and would allow us to 
alter the [pH]i and may also improve delivery of lipid based agonists such as AA 
across the cell membrane. To do this we ideally require freshly dispersed cells 
and our preliminary attempts have been shown in Figure 8.6-1. The enzyme 
papain (1.5mg/ml) was used according to the method described by Drummond (et 
al., 1999, Albarwani, Heinert et al., 1995) who successfully isolated SMC from 
rat pulmonary arteries. This method achieved some success however I was unable 
to demonstrate a whole patched SMC in order to record ion channel activities 
across the cell. As a result the cell dispersal method used requires further 
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optimisation to obtain a substantial yield of fresh cells and explore this avenue of 
research.  
 
Day 0 Day 5
 
Figure 8.6-1 illustrating the results of fresh cell dispersal using CPA. At day 0 individual 
SMC (black arrows) were successfully isolated from the vessel explants along with a large 
population of RBC (red arrow). At day 5 we observed most cells were no longer viable and 
showed evidence of cell necrosis. Cells which were viable proved to be difficult to patch to 
record whole cell currents. Scale bar 200µm.  
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9. Conclusion 
The placenta is an important biological barrier and is the first site of exposure 
for toxins including H+ from the maternal and fetal circulations as well as the 
amniotic fluid. Despite this important role very little research is being undertaken to 
characterise the response of vessels to chronic stress stimuli and secondly very little 
information is available to show the contributions of specific ion channels in 
mediating these responses. The possible reasons for a fall in pH could be due to 
prolonged hypoxia, impaired removal of fetal metabolites or maternal influences. We 
have demonstrated how small changes in the extracellular environment can have 
dramatic consequences for the placental resistance arteries. The CPA and SVA from 
healthy samples have demonstrated the existence of efficient mechanisms to generate 
a response to cope with external stress. This information may help to better devise 
early interventions aimed at improving placental and therefore fetal perfusion. Our 
observations also implicate a range of key ion channels expressed across the placenta 
which may have future therapeutic implications in the control of vascular tone in the 
placenta and forms the basis for further research. However the true importance of 
these observations will be revealed with the development of highly selective 
pharmacological tools and single channel electrophysiological recordings. This future 
research will help to identify the underlying mechanisms of the proton mediated 
responses and understand its physiological importance in the placental circulation.  
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Appendix  
I. Solution compositions  
 
0.1M PBS working dilution   
 
200ml PBS stock, 300ml 5M NaCl, 770ml H2O. 
 
0.5M PBS stock   
 
5mM Na2HPO4, 5mM NaH2PO4, pH 7.2-7.4 with 1M NaOH 
 
10% Ammonium persulphate (AP) 
 
0.1g Ammonium persulphate in 1ml H2O. 
 
3% H2O2  
 
280ml PBS stock, 20ml 30% H2O2 . 
 
4% w/v Paraformaldehyde   
 
4g PFA dissolved in dH2O at 60ºC. pH 7.4 using 1M NaOH. Stored at -80ºC for 3 
months.  
 
%RXLQ¶VVROXWLRQ 
  
75ml Picric acid, 25ml 40% Formaldehyde, 5ml Glacial acetic acid. 
 
DMEM 
 
500ml tissue culture medium supplemented with 10% (v/v) heat inactivated fetal 
bovine serum (FBS), 100 units/ml penicillin and 100µg/ml streptomycin.  
 
HBSS 
  
5ml of 1mol/l HEPES & 5ml penicillin/streptomycin in 500ml HBSS. 
 
Homogenisation buffer  
 
320mM Sucrose, 10mM Tris base pH 7.8, 50mM KCl, 1mM 
ethylenediaminetetraacetic acid (EDTA), 0.5% Igepal, protease inhibitor cocktail 
(Sigma) (1:500) supplemented with fresh  phosphatase inhibitor cocktail (Sigma) 
1:100.  
 
  
KPSS (mmol/l) 
  
60 KCl, 25 NaHCO3, 2.5 MgSO4, 3.2 CaCl2, 1.2 KH2PO4, 5.5 glucose, 0.034 EDTA 
pH7.4, stored at 4ºC. 
 
Lamelli buffer/sample loading buffer 
  
Oȕ-mercaptoethanol, 950 µl sample loading buffer (Biorad). 
 
PBS:Glycerol       
  
Equal v/v of PBS:Glycerol.       
 
PSS (mmol/l)  
 
119 NaCl, 4.7 KCl, 25 NaHCO3, 2.5 MgSO4, 1.6 CaCl2, 1.2 KH2PO4, 5.5 glucose, 
0.034 EDTA pH7.4, Stored at 4ºC. 
 
Resolving gel (12%) 
  
4.1ml dH2O, PO$FU\ODPLGHPOUHVROYLQJJHOEXIIHU7ULVEDVHS+ȝO
6'6ȝODPPRQLXPSHUVXOIDWH$36ȝO111¶1¶-
Tetramethlyethlyenediamine (TEMED). 
 
Running buffer 
  
15.1g Tris, 94g Glycine, 50ml 10% SDS in 1L H2O.  
 
Solubilisation buffer  
  
20mM Tris base pH 7.5, 10mM EDTA, 120mM NaCl, 50mM KCl, 2.5% Igepal 
supplemented with fresh protease inhibitor cocktail (Sigma) (1:500) and phosphatatse 
inhibitor cocktail (Sigma) 1:100). 
 
 Stacking gel (4%) 
  
3.4ml dH2O, 0.85ml Acrylamide, 0.625ml resolving gel buffer (Tris base pH6ȝO
6'6ȝO$36ȝO7(0(' 
 
  
TBS-Tween (TBST) 0.1% 
  
1L TBS, 1ml Tween-20. 
 
Transfer buffer  
  
24mM Tris Base, 80mM glycine, 20% methanol. 
 
Tris buffered saline (TBS) 
  
12.11g Tris, 146.1g NaCl, in 5L H2O pH to 7.4 with 5M HCl. 
 
  
II. Working dilutions of antibodies  
Table II-1 detailing the dilution factor for each antibody included in our studies according to 
which technique was used.   
Antibody Host Type Working 
Dilution & 
Technique 
Secondary antibody 
& Conjugate 
Alpha actin 
(DakoCytomation) 
Mouse Monoclonal 1:50 IF 
 
 
1:50 IHC 
1:50 FITC (Sigma) 
1:1000 FITC (Molecular 
Probes) 
Vectorstain Elite Kit 
(Universal) (Vector 
laboratories)   
Beta actin 
(Abcam) 
Rabbit Polyclonal 1:8000 WB 1:30000 AP (Sigma) 
1:2000 AP 
(DakoCytomation) 
BKCa 
(Alomone) 
Rabbit Polyclonal 1:500 WB 
 
 
1:40 IF 
 
 
1:30000 AP (Sigma) 
1:2000 AP 
(DakoCytomation) 
1:50 FITC (Sigma) 
1:1000 TRITC (Molecular 
Probes) 
BKCa  
(BD Transduction 
laboratories) 
Mouse Monoclonal 1:750 WB 
 
1:40 IF 
1:1000 AP 
(DakoCytomation) 
1:50 FITC (Sigma) 
1:1000 FITC (Molecular 
Probes) 
CD31 
(Abcam)  
Mouse Monoclonal Ready to use 1:50 FITC (Sigma) 
Cytokeratin 
(DakoCytomation) 
Mouse Monoclonal 1:50 IF 
1:50 IHC 
1:50 FITC (Sigma) 
Vectorstain Elite Kit 
(Universal) (Vector 
laboratories)   
Cytokeratin 
AE1 (Abcam) 
Mouse Monoclonal 1:50 IF 
1:50 IHC 
1:50 FITC (Sigma) 
Vectorstain Elite Kit 
(Universal) (Vector 
laboratories)   
Fibroblast 
(DakoCytomation) 
Mouse Monoclonal 1:50 IF 
1:50 IHC 
1:50 FITC (Sigma) 
Vectorstain Elite Kit 
(Universal) (Vector 
laboratories)   
CaV1.2 (Alomone) Rabbit Polyclonal 1:200 WB 
 
1:50 IF 
1:2000 AP 
(DakoCytomation) 
1:50 FITC (Sigma) 
1:1000 TRITC (Molecular 
Probes) 
KATP 
(Alomone) 
Rabbit Polyclonal 1:200 WB 1:30000 AP (Sigma) 
  
TASK-1 
(Alomone) 
Rabbit Polyclonal 1:200 WB 
 
 
1:50 IF 
 
 
1:30000 AP (Sigma) 
1:2000 AP 
(DakoCytomation) 
1:50 FITC (Sigma) 
1:1000 TRITC (Molecular 
Probes) 
TASK-3 
(Abcam) 
Mouse Monoclonal 1:50 IF 1:1000 TRITC (Molecular 
probes) 
 
TASK-3 
(Alomone) 
Rabbit Polyclonal 1:200 WB 
 
 
1:50 IF  
1:30000 AP (Sigma) 
1:2000 AP 
(DakoCytomation) 
1:50 FITC (Sigma) 
1:1000 TRITC (Molecular 
Probes) 
TRAAK  
(Alomone) 
Rabbit Polyclonal 1:200 WB 
 
1:30000 AP (Sigma)   
 
TREK-1 
(Alomone) 
Rabbit Polyclonal 1:500 WB 
 
 
1:100 IF 
 
 
1:30000 AP (Sigma) 
1:2000 AP 
(DakoCytomation) 
1:50 FITC (Sigma) 1:1000 
TRITC (Molecular 
probes) 
TREK-2 
(Abcam,)  
Rabbit Polyclonal 1:300 WB  1:30000 (Sigma) 
TWIK-2 
(Alomone) 
Rabbit Polyclonal 1:200 WB 
 
 
1:50 IF 
 
1:30000 AP (Sigma) 
1:2000 AP 
(DakoCytomation) 
1:50 FITC (Sigma) 
1:1000 TRITC (Molecular 
Probes) 
Vimentin 
(DakoCytomation) 
Mouse Monoclonal 1:20 IF 
 
1:50 FITC 
 
Von 
Wilebrand 
(DakoCytomation) 
Rabbit Polyclonal 1:200 IF 
1:200 IHC 
1:50 FITC 
Vectorstain Elite Kit 
(Universal) (Vector 
laboratories)   
 
  
III. Antibody amino acid target sites and predicted molecular weight 
(mw).  
Table III-1 summarising the epitope target sites for each antibody used along with the 
predicted mw. (Information obtained from www.alomone.com/p_postcards/database)  
 
Antibody Epitope 
location 
Amino acid residue  Predicted 
mw 
(kDa) 
BKCa Intracellular 
C-terminal 
 
132 
CaV1.2 Intracellular 
loop 
between 
domains II 
and III. 
 
 
240 
KATP Intracellular  
C-terminal  
 
43 
TASK-1 Intracellular  
C-terminal 
 
45 
TASK-3 Extracellular 
P1 loop 
 
47 
  
TRAAK Intracellular  
C-terminal 
 
52 
TREK-1 Intracellular  
N-terminal 
 
50 
TREK-2  Intracellular  
C-terminal 
 
59 
TWIK-2 Intracellular 
C-terminal 
 
35 
 
 
  
IV. Suppliers  
Abcam 
 
330 Cambridge Science Park 
Cambridge 
CB4 0FL 
UK 
Web http://www.abcam.com 
Abnova Abnova GmbH c/o EMBLEM 
Boxbergring 107 
69126 Heidelberg 
Germany 
Web: http://www.abnova.com 
E-mail: sales@abnova.com 
ADI  ADInstruments Ltd 
Unit B, Bishops Mews 
Transport Way 
Oxford 
OX4 6HD 
Tel: +44 (0)1865 332050 
Fax: +44 (0)1865 332051 
Web: http://www.adinstruments.com 
Alomone 
 
Caltag-Medsystems Ltd.  
Whiteleaf Business Centre 
11, Little Balmer 
Buckingham, Bucks 
MK18 1TF 
UK 
Tel:+44 (0)1280 827466  
Web http://www.alomone.com/ 
E-mail: sales@caltagmedsystems.co.uk 
BD Transduction Laboratories BD Biosciences  
21588 Network Place  
Chicago, IL 60673-1215  
Tel: 44.1865.78.16.66  
Fax: 44.1865.78.16.27 
Web http://www.bdbiosciences.com/home.jsp 
E-mail admetox@bd.com 
Biorad 
 
Bio-Rad Laboratories Ltd.  
Bio-Rad House  
Maxted Road 
Hemel Hempstead 
Hertfordshire  
HP2 7DX 
Tel: +44 (0)208 328 2000 
Fax: +44 (0) 208 328 2550 
Web: http://www3.bio-rad.com/ 
E-mail: uk.lsg.marketing@bio-rad.com 
  
British oxygen company (BOC) 
 
 
BOC Ltd 
The Priestley centre 
Guilford  
Surrey 
GU2 7XY 
Tel: 01483579857 
Fax: 01483505211 
Web: www.boconline.co.uk 
DakoCytomation 
 
Dako UK Ltd 
Cambridge House 
St Thomas Place, Ely 
Cambridgeshire  
CB7 4EX 
Tel: +44 (0)1 353 66 99 11 
Fax: +44 (0)1 353 66 73 09 
Web: www.dako.co.uk 
E-mail: info.uk@dako.com 
Danish Myotechnologies (DMT) Skejby Science Ctr. 
Skejbyparken 152 
DK-8200 Aarhus N 
Denmark    
Tel: +45 87 41 11 00 
Fax: +45 87 41 11 01 
Web: http://www.dmt.dk 
E-mail: administration@dmt.dk 
Enzo Life Sciences Enzo Life Sciences (UK) Ltd (Formerly BIOMOL Int, L.P.) 
Palatine House  
Matford Court 
Exeter  
EX2 8NL 
UK 
Tel:0845 601 1488 (UK customers) 
Fax: +44 1392 825910 
Web: http://www.enzolifesciences.com/contact-us/ 
E-mail: info-uk@enzolifesciences.com 
Fisher Scientific 
 
Fisher Scientific UK Ltd, 
Bishop Meadow Road, 
Leicestershire 
LE11 5RG 
Tel: 01509 231166 
Fax: 01509 231893 
Web: http://www.fisher.co.uk 
Lonza 
 
Lonza Biologics 
Granta Park Great Abington  
Cambridge  
CB216GS 
Tel: +44 1223 895100 
Fax: +44 1223 895191 
Web: http://www.lonza.com 
E-mail: contact.slough@lonza.com 
Molecular probes 
 
 
Invitrogen Ltd 
Inchinnan Business Park 
Paisley 
UK 
PA4 9RF 
  
Tel: 0141 814 6100 
Fax: 0141 814 6260 
Web: http://www.invitrogen.com 
E-mail: euroinfo@invitrogen.com 
Santa Cruz 
 
 
 
Santa Cruz Biotechnology, Inc. 
Bergheimer Str. 89-2 
69115 Heidelberg 
Germany 
Tel: +49 6221 4503 0 
Fax: +49 6221 4503 45 
Web: http://www.scbt.com 
E-mail: europe@scbt.com 
Sigma Aldrich 
 
Sigma-Aldrich Company Ltd. 
The Old Brickyard 
New Road 
Dorset 
SP8 4XT 
UK 
Tel: +44 1202 712300 
Fax:+44 1202 715460 
Web: http://www.sigmaaldrich.com/united-kingdom.html 
E-mail: ukcustsv@europe.sial.com 
Tocris 
 
Tocris Bioscience 
Tocris House, IO Centre 
Moorend Farm Avenue 
Bristol,  
BS11 0QL 
United Kingdom 
Tel: + 44 (0)117 916-3333 
Fax: + 44 (0)117 916-3344 
Web: http://www.tocris.com/contact.php  
E-mail: customerservice@tocris.co.uk  
Vector Laboratories 
 
3, Accent Park, Bakewell Road 
Orton Southgate 
Peterborough 
PE2 6XS 
Tel: (01733) 237999 
Fax: (01733) 237119 
Web http://www.vectorlabs.com/uk 
E-mail: vector@vectorlabs.co.uk 
VWR 
(formerly BDH) 
Hunter Boulevard  
Magna Park  
Leicestershire  
LE17 4XN 
Tel: 0800 22 33 44 
Web: http://uk.vwr.com 
E-mail: uksales@uk.vwr.com 
WPI World Precison Instruments UK 
Astonbury farm business centre 
Stevenage 
Herts 
SG2 7EG 
Tel: (01438) 880 025 
Fax: (01438) 880 026 
Web: http://www.wpiinc.com 
  
  
V. Patient information sheet & Consent forms  
  
VI. Transmission Electron Microscopy (TEM) imaging of CPA and SVA 
 
CPA and SVA matched samples (N=3) were prepared for TEM work by an 
AMU technician on our behalf. From the 3 paired samples that were prepared 1 CPA 
and 1 SVA ultrathin (70nm) slice was selected for TEM imaging. The slides were 
viewed using a FEI Tecnai 12 BioTWIN microscope and the images were captured 
with a Megaview III camera using Soft Imaging System software.  
 
Protocol  
 
Briefly the tissue samples were cut into small 1mm3 rings and fixed overnight 
with 3% Glutaraldehyde. Following this incubation the tissue specimens are washed 
in 0.1M cacodylate buffer. The tissue was then post fixed in 1% osmium tetroxide in 
0.1M cacodylate buffer. Following five 1min washes in distilled water the samples 
were dehydrated with graded alcohol treatments (50%, 70%, 90% and 100% for 
15mins each) before finally being treated with 100% propylene oxide for a final 
15mins. The samples were then infiltrated with resin (mixed with propylene oxide at 
ratio of 3:1) for 4h at RT. Finally the tissue was embedded in a plastic mould which 
was left to polymerise overnight at which point the sections were ready for cutting. 
Semi-thin (0.5µm) sections were prepared to correctly orientate the tissue before 
cutting ultrathin (70nm) sections. This was performed using a diamond knife 
(Diatome) and collected on a copper mesh grid ready for viewing.  
 
  
Results   
 
Tissue slices were imaged with TEM which gave a more detailed examination 
of the cell layers within the CPA and SVA. The advantage of TEM imaging is that 
cell types can be identified with greater clarity according to their ultrastructural detail. 
The SMC can be identified by the presence of myofilaments while the single cell 
layer of EC can be distinguished by the elastic lamina (EL) which separates the EC 
layer from SMC. The semi-thin sections that were used to orientate the CPA and SVA 
sections and localise the area of interest for ultra thin sections (white box) for TEM 
are shown in Figure VIA. A single red blood cell (RBC) can be seen inside the vessel 
lumen (L) of the CPA (Figure VIA). SVA were imaged at the same magnification as 
CPA but many more cell layers can be seen including the EC and SMC along with CT 
which marks the area outside the vessel (Figure VIB). The SMC appeared to be 
evenly distributed around the thin vessel wall while it was not possible to image all 
three layers within a single photomicrograph with CPA. The three important portions 
of a blood vessel; namely the lumen, EC and SMC where are present in both CPA and 
SVA tissue slices. These images also show that the EC layer does appear to remain 
intact following vessel isolation. More importantly no cytokeratin or fibroblast cells 
were observed as the vessels consisted predominantly of SMC. Some fat droplets (not 
shown) were found sporadically around the SMC layer of CPA. This is an important 
sign of metabolically active cells as fat droplets are vital long term energy stores 
(Weser and Kaufmann, 1978).  
  
A
B
 
Figure VI showing TEM micrographs of human placental CPA (A) and SVA (B) (n=1 
from N=1). The inserts show the original tissue slice and the region that was magnified 
(white box). The SMC layer can be seen with CPA with a single RBC inside the lumen. In 
contrast three distinct cell regions including the EC, SMC and CT can be seen with SVA 
imaged at the same magnification. Collagen (CL), Connective tissue (CT), Endothelial cell 
(EC), Elastic lamina (EL), Lumen (L), Nucleus (N), Red blood cell (RBC), Smooth muscle 
cell (SMC). Scale bar 10µm.  
 
